Development of electrospun nanofibrous-based scaffolds for bone regeneration by Martins, Albino
Albino Manuel Pereira Martins
Dezembro 2009
UM
in
ho
|2
00
9
Development of electrospun 
nanofibrous-based scaffolds 
for bone regeneration.
D
ev
el
op
m
en
t o
f e
le
ct
ro
sp
un
 n
an
of
ib
ro
us
-b
as
ed
 
sc
af
fo
ld
s 
fo
r 
bo
ne
 r
eg
en
er
at
io
n.
Al
bi
no
 M
an
ue
l P
er
ei
ra
 M
ar
tin
s
Universidade do Minho
Escola de Engenharia
Tese no Programa de Doutoramento em
Engenharia de Tecidos, Medicina Regenerativa e 
Células  Estaminais
Albino Manuel Pereira Martins
Dezembro 2009
Development of electrospun 
nanofibrous-based scaffolds 
for bone regeneration.
Universidade do Minho
Escola de Engenharia
Trabalho efectuado sob a orientação do
Professor Nuno João Meleiro Alves das Neves
e do
Professor Rui Luís Gonçalves dos Reis

 iii 
 
Acknowledgements 
 
During the course of my PhD, several people contributed to accomplish this 
thesis, both professionally and personally. To them, I would like to deeply express my 
gratitude and dedicate this dissertation. 
First of all, I would like to acknowledge my thesis supervisor, Professor Nuno 
M. Neves, for his constructive criticism, for supporting new ideas and intellectual 
property protection, clarifying my ideas about the importance of scientific policy, and 
the scientific brainstormings. He is meticulous in planning the experiments, in the 
evaluation and discussion of the experimental data, and in the drawing of conclusions 
(good or not so good) from the data generated. I herein gratefully acknowledge him 
for believing in me, trust in my scientific contribution of the ‘Naturally Nano’ project. 
Indeed, this project was of utmost importance for my PhD work. I also thank the 
possibility given to be involved in other parallel projects, which made me feel more 
responsible and were of utmost importance for my researcher career. 
I also thank Professor Rui L. Reis for giving me the opportunity to joint the 3B’s 
Research Group and to be the co-supervisor of my PhD work. He is an example to 
follow in leadership and intelligence, capacity to motivate people and scientific policy; 
he is an inspiration and mentor. I should also remember his benevolence to me and 
to my family. 
I should also present my gratitude to Alexandra P. Marques for her guidance 
and reviewing criticism of biological data. I am also grateful to Susana Faria for her 
help on all the statistical analysis performed, making the results more statistically 
sound and correctly analysed. 
I would like to dedicate a special thank to my colleagues José V. Araújo, Marta 
Alves da Silva, Ana C. Guimarães, Sangwon Chung, Iva Pashkuleva, Ana Rita C. 
Duarte, Vitor M. Correlo, Adriano J. Pedro and Rui A. Sousa, and to my friends 
Elisabete D. Pinho and Pedro Costa, who significantly contributed to the success of 
my experimental work and scientific inventiveness. 
 iv 
 
I also appreciated the technical support of Eng. José Cunha and Mr. Américo 
Rodrigues in the development of the electrospinning apparatus, the patience of Elsa 
Ribeiro during the SEM/EDS analysis, and of Carmen Serra from C.A.C.T.I. at the 
University of Vigo for the interferometric optical profilometry and XPS measurements 
and data interpretation. 
To finalize my professional acknowledgements, I would like to dedicate a 
special thanks to the worldwide spread 3B’s colleagues. 
 
I should also acknowledge the Portuguese Foundation for Science and 
Technology (FCT) for my PhD grant SFRH/BD/24382/2005, the ‘Naturally Nano’ 
project (POCI/EME/58982/2004) and the European Integrated Project GENOSTEM 
(LSH-STREP-CT-2003-503161) for the initial scholarship. 
 
No domínio pessoal, gostaria de reconhecer e demonstrar a importância da 
minha esposa e do meu filhote (apesar de alheio a tudo o que se passa) no decorrer 
proveitoso do Doutoramento. Eles constituíram, constituem e constituirão a minha 
motivação para a vida pessoal e profissional. 
Aos meus queridos pais e irmão agradeço toda a dedicação como família 
berço, a confiança no ‘filho mais velho’, o apoio financeiro aos meus estudos de 
licenciatura, o amor e carinho para toda a vida. 
Aos meus sogros agradeço todo o auxílio que têm proporcionado à minha 
família.
 v 
 
Development of electrospun nanofibrous-based scaffolds for bone regeneration 
 
Abstract 
 
Biomaterials and scaffolds play a significant role in many strategies followed in regenerative 
medicine and tissue engineering. Those systems are intended and designed to help and guide the cells  
to contribute for the tissue regeneration process. To achieve that goal, the system needs to actively  
participate in the signaling process for the cells. It is widely  believed that a successful scaffold should 
mimic the main properties and structure of the extracellular matrix  of the tissue of interest.  
The fibrous nature of the natural extracellular matrix  (ECM) has led many researchers to focus 
on the development of fiber-based scaffolds. Electrospinning has emerged as a very promising 
technology enabling to produce synthetic polymeric ultrafine fibers. These fibers in mesh-like structure 
have diameters in the submicron range which results in a high surface area-to-volume ratio and high 
porosity . The meshes have a typically  random dis tribution or, in some special cases, some preferential 
directions of alignment. Despite the claim similarity  to the morphology of natural ECM, the surface 
chemical properties of electrospun nanofibers must be optimized. It is herein shown that defined plasma 
treatments are able to improve the proliferation of different cell types (fibroblastic, chondrogenic  and 
osteogenic) when seeded at the surface of those meshes. 
Bone ECM is a complex ordered hierarchical s tructure, as a result of the assembling of collagen 
fibrils at several length scales, ranging from macro to the nanoscale. To test the interest of those 
morphologies, patterned nanofiber meshes were developed, hav ing areas of uniax ial/parallel alignment 
and areas of orthogonal/random dis tribution of fibers. Those patterned nanofiber meshes, not only  
induced human bone marrow mesenchymal stem cell (hBMSCs) guidance at the early  culture periods,  
but also influence the cell ECM deposition along the predefined fiber direction.  
Electrospun nanofibrous structures, due to the inherent planar s tructure, could compromise a 
successful reconstruction or regeneration of thick tissues. Two alternative strategies are proposed to 
overcome this limitation and allowing developing complex ordered fibrous structures that may mimic the 
hierarchical organization of bone. One structure involves aligned microfibers processed by a 3D rapid 
prototyping technique, intercalated by electrospun nanofiber meshes. Human osteobastic-like cells  
showed significantly  higher proliferation and maturation when dynamically  seeded on these hierarchical 
fibrous scaffolds, adhering preferentially  to the nanofiber meshes. The other s tructure developed is  
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composed by randomly dis tributed microfibers reinforced by electrospun chitosan nanofibers, processed 
by melt extrus ion and assembled by fiber bonding. The PBS/Cht-based composite scaffolds sustained 
ECM deposition and mineralization, as suggested by the increased amount of calcium phosphates 
produced by the hBMSCs under osteogenic induction conditions. 
Among the very interesting properties of electrospun nanofiber meshes, their morphological 
similarity  to the natural ECM is very attractive for tissue engineering applications. However, the small 
size of the pores constitutes a limitation for the infil tration of cells into the inner regions of the fibrous 
scaffold, hindering its application for thicker 3D tissues. Herein, we propose the electrospinning of a dual 
composition nanofiber mesh to solve the low cell infil tration capacity  on random electrospun nanofiber 
meshes. The production is followed by the selective dissolution of one fraction of the dual mesh to 
generate open porosity . The obtained meshes showed statis tically  significant larger pores, without 
inducing significant alterations on their morphology. Those highly  porous meshes allow human 
osteoblastic cells infiltration into the full thickness of the mesh structure, showing enhanced v iabili ty  and 
proliferation.  
The properties of electrospun nanofiber meshes were also explored as bioactive agent release 
systems. Based in large surface area of the meshes, the release rate of a drug/bioactive agent may be 
modulated by the concentration of loading in the system. We intended to promote the release of the 
bioactive agent close to the cells to maximize its efficacy. An osteogenic differentiation factor,  
dexamethasone, was incorporated into electrospun nanofiber meshes at different concentrations (5, 10,  
15 and 20 wt.%  polymer), in a single-s tep process. The 15 wt.%  nanofibrous system was selected for 
the cell studies because of its typical morphology and the sustained release of a biologically  relevant 
dexamethasone concentration. An increased alkaline phosphatase concentration and deposition of 
mineralized matrix  was observed on dexamethasone releasing nanofibrous system, cultured with 
hBMSCs in dexamethasone-absent osteogenic differentiation medium, showing the potential of this  
strategy for bone related applications.  
We proposed herein different ways to overcome some of the limitations of the electrospun 
meshes for bone tissue engineering related applications. The strategies enabled showing that,  by 
systematically  facing its limitations, we could generate s tructures that have many more possibili ties,  
enabling also its application in many different problems in the context of tissue engineering and 
regenerative medicine.  
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Desenvolvimento de estruturas de suporte ao crescimento celular à base de 
nanofibras produzidas por ‘electrospinning’ para regeneração de osso 
 
Resumo 
 
Os biomateriais e as estruturas de suporte ao crescimento celular, ou ‘scaffolds’, desempenham 
um papel importante em inúmeras estratégias de medicina regenerativa e engenharia de tecidos. Esses 
sistemas são projectados e desenhados a fim de auxiliar e guiar as células durante a regeneração 
tecidular. De forma a alcançar este objectivo, o ‘scaffold’ deve imitar as propriedades e estrutura da 
matriz extra-celular (ECM) do tecido alvo. 
A natureza fibrosa da ECM tem direccionado os investigadores no desenvolv imento de 
‘scaffolds’ fibrosos. O ‘electrospinning’ é uma das tecnologias mais promissoras na produção de fibras 
poliméricas sintéticas ultra-finas. Essas fibras organizadas numa estrutura semelhante a uma malha 
têm diâmetros sub-micrométricos, resultando numa elevada área de superfície e porosidade. As malhas 
têm,  tipicamente, uma dis tribuição aleatória ou,  em alguns casos especiais,  direcções preferenciais de 
alinhamento. Apesar da similaridade morfológica destas malhas com a ECM nativa, as propriedades 
químicas da superfície das nanofibras devem ser optimizadas. Demonstra-se nesta tese que 
tratamentos de plasma específicos podem melhorar a proliferação de diferentes tipos celulares 
(fibroblasticos, condrogénicos e osteogénicos) quando semeados à superfície dessas malhas.  
A ECM do osso é uma estrutura hierárquica organizada e complexa, resultante do arranjo 
espacial de fibri los de colagénio a diversas escalas, partindo da dimensão nanométrica. Para testar a 
relevância dessa morfologia, foram desenvolv idas malhas de nanofibras com padrão definidos,  
contendo áreas de alinhamento uniax ial/paralelo e áreas de distribuição ortogonal/aleatória das fibras.  
Essas malhas de nanofibras padronizadas induzem não só a orientação de células estaminais  
mesenquimais de medula óssea humana (hBMSCs) para tempos de cultura curtos, mas também 
influenciam favoravelmente a deposição de ECM ao longo das fibras com alinhamento predefinido.  
Estruturas produzidas por ‘electrospinning’, dev ido à sua estrutura planar, poderão 
comprometer o sucesso da reconstrução ou regeneração de tecidos espessos. Duas estratégias 
alternativas foram aqui propostas para ultrapassar esta limitação e permitir o desenvolv imento de 
estruturas fibrosas ordenadas complexas que podem recapitular a organização hierárquica do osso.  
Uma estrutura envolve microfibras alinhadas processadas por uma técnica de prototipagem 
tridimensional, intercaladas por malhas de nanofibras produzidas por ‘electrospinning’. Células 
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osteoblásticas humanas demonstraram niveis de proli feração e maturação significativamente mais  
elevadas, quando semeadas dinamicamente nesses ‘scaffolds’ fibrosos hierárquicos, aderindo 
preferencialmente às malhas nanofibrosas. Uma outra estrutura desenvolv ida é composta por 
microfibras aleatoriamente dis tribuídas reforçadas por nanofibras de quitosano produzidas por 
‘electrospinning’, processadas por extrusão e aglomeradas por compressão a quente. Estes ‘scaffolds’ 
compósitos à base de PBS/Cht reforçados sustentam uma acrescida deposição de ECM e 
mineralização, como sugerido pelo aumento de fosfatos de cálc io produzidos pelas hBMSCs cultivadas 
em condições de indução osteogénica.  
A semelhança morfológica das malhas de nanofibras com a ECM é muito atraente para várias 
aplicações em engenharia de tecidos. No entanto, a pequena dimensão dos poros constitui uma 
limitação à infi ltração de células, prejudicando a sua aplicação na geração de tec idos mais espessos.  
Nesta tese, propõe-se a produção de uma malha nanofibrosa com dupla composição para solucionar a 
baixa capacidade de infil tração celular em malhas aleatórias. A subsequente dissolução selectiva de 
uma das fracções da malha permite obter maiores porosidades. As malhas obtidas demonstraram um 
aumento estatis ticamente significativo do tamanho dos poros, sem alteração da sua morfologia.  
Demonstrou-se que estas malhas altamente porosas permitem a infil tração das células osteoblásticas 
humanas em todo o volume da sua estrutura, apresentando maior v iabil idade e proliferação celular. 
As malhas produzidas por ‘electrospinning’ foram também exploradas como sis temas de 
libertação de agentes bioactivos. Pretendia-se uma libertação do agente bioactivo directamente na 
v izinhança das células, de modo a maximizar a sua eficácia. Um componente indutor da diferenciação 
osteogénica, dexametasona, foi incorporado nas malhas nanofibrosas em diferentes concentrações (5,  
10, 15 and 20 wt.%  polymer), num passo único. A concentração de fosfatase alcalina e a deposição de 
matriz mineralizada aumentadas foram observadas em sis temas nanofibrosos com libertação de 
dexametasona cultivados com hBMSCs em meio de diferenciação osteogénica sem dexametasona,  
demonstrando o potenc ial desta estratégia em aplicações ósseas. 
Neste trabalho propusemos diferentes possibilidades para obv iar a importantes limitações das 
malhas produzidas por ‘electrospinning’ quando aplicadas em estratégias de regeneração de tecido 
ósseo. Estas estratégias permitiram demonstrar que, encarando sis tematicamente essas limitações, foi 
possível desenvolver estruturas com maiores potenc ialidades e funcionalidades acrescidas. Estes 
desenvolv imentos podem ainda estender o seu potencial a outras aplicações em engenharia de tecidos 
e medicina regenerativa. 
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Structure of the thesis 
 
The present thesis is divided in 6 sections, organized according with the 
defined aims, the nature of the experiments performed and the results obtained. The 
level of complexity of the problem being studied and the biological assays used to 
characterize the developed systems were the main parameters taken into account in 
the organization and sequence of those sections. The sub-division in chapters is 
based in a series of related papers published in international journals or submitted for 
publication, which are identified in the front page of each chapter. Therefore, each 
thesis chapter is presented in an adapted version of the published or submitted 
manuscript style, keeping its contents, but intended to have a consistent structure 
between the various thesis chapters. 
 
The first section consists of a comprehensive and detailed literature review 
about the development of electrospun nanofiber meshes for tissue engineering 
applications. This literature review begins with an in depth description of the 
electrospinning apparatus, governing parameters, and recent developments and 
potentialities of this technology. 
The second section of the thesis includes a detailed analysis of the materials 
used, the processing techniques, the techniques used for the scaffolds 
physicochemical characterization. The biological tests with both model cell lines and 
primary cultures of human bone marrow mesenchymal stem cells are also described. 
The biological assays include the analysis of the cell viability and proliferation, the 
quantification of an osteoblastic marker, specifically alkaline phosphatase (ALP), 
immunolocalization of some osteoblastic proteins and quantification of osteoblastic 
genes expression. 
The third section reports the surface modification of electrospun PCL 
nanofibers by different plasma treatments. Although the electrospun nanofibers 
herein used are made of a synthetic biodegradable polymer, the plasma surface 
modifications induced an increment of the viability and proliferation of the different 
model cell types. 
 xxxi  
 
The fourth section includes 3 chapters, based on a series of related papers 
that present the development of complex ordered nanofibrous-based scaffolds. The 
first chapter of this section reports on studies using patterned nanofibrous structures 
produced by electrospinning. The second chapter includes 3D nanofibrous-based 
scaffolds consisting of electrospun nanofiber meshes intercalled between layers of 
rapid prototyping microfibers. In the third chapter of this section, electrospun 
nanofiber meshes were incorporated into melt-extruded microfibers, acting as a 
mechanical reinforcement. The biological relevance of those structures was tested, 
envisioning a more advanced bone tissue engineering strategy. 
The fifth section presents significant contributions to overcome the limitations 
of the typical electrospun nanofiber meshes aiming at increasing their biological 
functionality. In the first chapter of this section it is presented a strategy to overcome 
the cell infiltration limitations of electrospun nanofiber meshes. The second chapter of 
this section, being the last research chapter of the thesis, reports on electrospun 
nanofibers capable of release an osteogenic differentiation factor. Its bioactivity is 
shown by the successful osteogenic differentiation of hBMSCs cultured in those 
highly functional structures. 
In the final section of this thesis, the sixth, it is presented the overall 
conclusions obtained from the collection of research works previously presented and 
it is also discussed the future perspectives and lines of research to be followed. 
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Chapter 1 
 
 
 
Electrospinning: processing technique for tissue engineering 
scaffolding 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on the following publications: Martins A, Reis RL, Neves NM. Electrospinning: 
processing technique for tissue engineering scaffolding. International Materials Reviews 2008; 
53(5):257-274 and Martins A, Araujo JV, Reis RL, Neves NM. Electrospun nanostructured scaffolds for 
tissue engineering applications. Nanomedicine 2007; 2(6):929-942. 
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1.1. Abstract 
 
Electrospinning has attracted tremendous interest in the research community 
as a simple and versatile technique to produce synthetic polymeric ultrafine fibers 
with diameters ranging from a few micrometers to tens of nanometers. Recently, 
some natural origin polymers have also been successfully electrospun. Owing to their 
very small diameter, polymeric nanofibers exhibit unusual properties such as high 
specific surface area, flexibility in surface functionalities and superior mechanical 
properties. In addition, electrospun non-woven meshes could physically mimic the 
extracellular matrix structure of native tissues. These remarkable properties render 
electrospun nanofibers useful for many applications, particularly those related to the 
field of biomedical engineering. The first part of this review is intended to provide a 
fundamental survey of the electrospinning process (e.g. apparatus, governing 
parameters) and of recent improvements of the technique, including associated 
structural modifications of polymeric nanofiber meshes. The prospective tissue 
engineering/biomedical applications of electrospun polymeric nanofibers are then 
reviewed, namely, wound dressings, medical prostheses, drug delivery systems, DNA 
release and tissue engineering scaffolds. The essential properties of scaffolds in 
terms of the structural features of electrospun nanofiber meshes are discussed. 
Finally, the future perspectives for applications of electrospun nanofibers, particularly 
in the field of tissue engineering, are considered. 
 
 
1.2. Introduction 
 
Nanostructures and the nanotechnologies to produce them have been a 
subject of intensive research due to the unique properties that can be obtained and 
their potential applications in many areas. A large number of technologies have 
already been demonstrated as being able to generate nanostructures in the form of 
fibers [1, 2], among them electrospinning. The electrospinning technique may be 
considered as a variation of the electrostatic spraying (or electrospraying) process [3], 
used in technologies such as time of flight secondary ion mass spectrometry [4] and 
Electrospi nning for Tissue Engineering Scaffolding  
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other spectrometric methods [5]. In electrospraying, small droplets or particles are 
formed as a result of the varicose break-up of the electrified jet that is often present 
with a solution of low viscosity [6]. In electrospinning, a solid fiber (composed of a 
viscous polymer solution) is produced by the generated electrical field. Subsequently, 
nanofibers are formed by continuous stretching, due to the electrostatic repulsion 
between the charged nanofibers and the evaporation of the solvent [3]. 
 Although the term ‘electrospinning’, derived from ‘electrostatic spinning’, was 
proposed relatively recently (around 1994), its origin as a viable fiber spinning 
technique can be traced back to the mid 1930s. Formhals [7] patented, in 1934, his 
first invention, describing the process and the apparatus for producing artificial 
filaments using electric charges. In 1964, Taylor [8] developed fundamental studies 
on the jet formation process. The observed conical shape of the jet was later referred 
by other researchers as the ‘Taylor Cone’. In subsequent years, the focus shifted to 
studying the structural morphology of nanofibers owing to the development of atomic 
force microscopy (AFM), transmission electron microscopy (TEM) and even scanning 
electron microscopy (SEM) tools. Researchers were occupied with the structural 
characterization of fibers and the understanding of the relationship between the 
structural features and process parameters [3, 9-16]. A major upsurge in 
electrospinning research took place due to the application potential of nanofibers in 
areas such as filtration systems, protective clothing, catalyst substrates, photonics, 
sensors and tissue engineering scaffolding [1, 17-20]. Strangely enough, although the 
electrospinning process has been known for more than 70 years, the mechanism by 
which nanofibers is formed is not fully understood. Although a number of studies have 
been carried out to investigate the mechanism of fiber formation in order reproducibly 
to control scaffold design, little theoretical understanding has been achieved. 
 According to the review by Huang et al. [1] more than 100 different polymers 
have been successfully spun into ultrafine fibers using this technique (most dissolved 
in solvents yet some electrospun from melt) for various applications. The potential 
applications in cell biology and tissue engineering has resulted in a large number of 
biodegradable polymers being electrospun into nanofibers, including 
poly(caprolactone) (PCL) [21-27], poly(lactic acid) [28-30] (PLA), poly(glycolic acid) 
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(PGA) [31, 32] and poly(lactide-co-glycolide) (PLGA) [33-36]). In addition to these 
synthetic biodegradable polymers, natural biopolymers, such as DNA [14, 37], silk 
fibroin [38-41], fibrinogen [42, 43], dextran [44], collagen [45-48] and chitosan [49, 50] 
have been successfully processed by electrospinning. Relative to synthetic polymers, 
natural origin polymers have good biocompatibility; conversely, their processability is, 
in general, poor. 
 A number of functional polymers envisaged for specific applications have been 
directly electrospun into nanofibers. However, many functional polymers are not 
suitable for use with electrospinning, because of their limited molecular weights 
and/or solubilities. One of the most effective strategies for solving this problem is to 
blend them with polymers that are well suited for electrospinning [18]. This is a 
feasible approach that may not only reduce the potential problem of cytotoxicity, as a 
result of using a chemical cross-linking reagent, but also provides a well designed 
solution for overcoming the shortcomings of synthetic and natural polymers. Indeed, 
the production of new biomaterials with good biocompatibility and improved 
mechanical and physical/chemical properties has been achieved [51-55]. 
 Electrospinning is an attractive approach for polymer biomaterials processing, 
providing an opportunity to control morphology, porosity, and composition using 
relatively unsophisticated equipment. Unlike conventional fiber spinning processes 
that produce fibers with diameters in the micrometre range [56], electrospinning is 
capable of producing fibers in the nanometre diameter range, which are typically 
deposited in the form on non-woven fabrics. Nanofibers provide a connection 
between the nanoscale and the macroscale world, since although their diameters are 
in the nanometre range, they are very long entities, sometimes of the order of 
kilometers [14]. Even the largest diameters produced by electrospinning are more 
than 10 times smaller than those that can be extruded to manufacture textile 
structures and woven mats. 
 When the diameters of polymer fiber materials are shrunk from the micrometre 
(e.g. 10-100 µm) to the submicrometre or nanometre scale (e.g. 10-100 nm), several 
interesting properties arise, such as very large surface area to volume ratio (which for 
a nanofiber can be 1000 times of that of a microfiber), flexibility in surface 
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functionalities and superior mechanical performance (e.g. stiffness and tensile 
strength) compared with any other known form of the material [1]. It is known that the 
natural extracellular matrix (ECM) of various tissues is composed of randomly 
oriented collagen fibers with nanometre scale diameters. Indeed, the architecture of 
the electrospun nanofibrous structure is dimensionally, but not morphologically, 
similar to those of some natural ECMs [2, 19]. The non-woven mats produced have 
the additional advantages of controllable pore size, high porosity with interconnected 
pores and permeability [27, 57]. These outstanding properties make the polymer 
nanofibers effective candidates for many important applications, particularly for tissue 
engineering/biomedical applications. 
 The present review is organised into three main sections. First, the 
fundamentals of the electrospinning process are considered; this survey includes an 
overview of the electrospinning apparatus and the parameters governing the process 
(the effects of these processing parameters have been reviewed in detail previously) 
[58, 59]. Recent developments of the electrospinning process enabling production of 
different nanofibrous structures (e.g. core/sheath combinations, hollow, porous or 
aligned nanofibers) are also reviewed (some of these nanofiber structures have been 
reviewed previously) [60, 61]. 
The following section provides an extensive discussion of the potential tissue 
engineering/biomedical applications of electrospun nanofibers, such as wound 
dressing, medical prostheses, drug delivery systems, DNA release and tissue 
scaffolding, with a focus on the electrospun polymer structures and biological 
evidence. This approach is intended to capture the state of the art of understanding 
for each type of biomedical application and is the distinctive feature of the present 
review: a critical assessment of electrospinning as a technique to produce tissue 
engineered scaffolds. While similar information has been presented in other reviews 
[62-69], these articles have not covered these tissue engineering/biomedical 
applications in comparable depth.  
The next section reviews scaffold target properties and the extent that  these 
have been achieved by electrospinning nanofibers. The achievements to date and the 
deviations from the target properties are of utmost importance in identifying the 
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process improvements required to obtain the tailored nanofibrous scaffolds needed 
for tissue engineering applications. The review concludes with a section covering 
future perspectives on applications and opportunities raised by the development of 
electrospinning, particularly in the field of tissue engineering. 
 
1.3. Electrospinning process 
 
Electrospinning involves applying a very high voltage to a capillary filled with 
the polymer solution to be spun. Mutual charge repulsion induced by the electrical 
field causes a force directly opposite to the surface tension of the polymer fluid. As 
the intensity of the electrical field is increased, the hemispherical surface of the fluid 
at the tip of the capillary tube elongates to form a conical shape, known as ‘Taylor 
cone’, observable in various spinning techniques. With increasing electrostatic field, a 
critical value is attained when the repulsive electrostatic force overcomes the surface 
tension of the polymer solution and a charged jet of fluid is ejected from the tip of the 
Taylor cone [3, 14]. 
 As the jet progresses from the capillary towards the collector, the forces from 
the external electrical field accelerate and stretch the jet. Stretching and evaporation 
of the solvent molecules cause the jet diameter to become smaller. As the radius of 
the jet becomes smaller, the radial forces from the charge can become large enough 
to overcome the cohesive forces of the fiber and cause it to split into two or more 
fibers, that is, to splay. This jet division process occurs several more times in rapid 
succession and produces a large number of small electrically charged fibers moving 
toward the collector. The divided jets repels each other, thereby acquiring lateral 
velocities and chaotic trajectories, which gives a brush like appearance in the region 
beyond the point at which the jet first splays. Splaying and elongation appear to occur 
simultaneously in many cases [14]. However, recent observations of Yarin et al. [16] 
suggested that the jet, while moving towards the collector, undergoes a chaotic 
motion or bending instability, due to the repulsive forces originating from the charged 
ions within the electrospinning jet. Because electrospinning is a continuous process, 
the fibers could be as long as several kilometres. In the electrospinning process, 
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these long fibers can be assembled into a three-dimensional, non-woven mat as a 
result of bending instability of the spinning jet (Figure 1.1). 
 
1.3.1. Electrospinning apparatus 
 
There are basically three components to complete a functional electrospinning 
setup: a high voltage power supply (HVPS), a spinneret constituted by a glass 
capillary tube or a needle of small diameter, and a grounded metal collecting screen 
(Figure 1.2). The electrospinning apparatus is usually set up in a chemical hood to the 
exhaustion of organic vapours. In addition, a closed, non-conductive environment with 
temperature and humidity control is required to avoid interference from environmental 
factors, such as air turbulence [67]. Several groups [70-72] working on 
electrospinning have adopted different solutions for the polymer flow through the 
needle. Some have simply opted for placing the capillary perpendicularly, letting the 
polymer fluid dropping with help of gravity and placing the collector underneath [71]. 
Sometimes the capillary can be tilted at a defined angle to control the flow rate 
through the capillary [72]. Other authors use the capillary horizontal and a pump is 
used to initiate the droplet. The pump is also used in the case of vertical feeding [70]. 
The electrode can be inserted either in the polymer fluid or placed onto the tip of the 
capillary if a syringe with a metal needle is used [12]. The collector is usually a plane 
metal sheet or a grid that can be covered with a fabric, although rotating cylinders 
covered with a grounded aluminium sheet could also be used [73].  
  
 
Figure 1.1 - SEM micrograph of polycaprolactone (PCL) nanofibers in a mesh, 
produced by electrospinning. 
 10 
 
Figure 1.2 - Schematic representation of electrospinning apparatus (adapted from 
reference [25]). 
 
 Most polymers commonly used in electrospinning are dissolved in appropriated 
solvents before being electrospun [1, 3, 14, 20]. Molten polymers can also be 
processed into nanofibers through electrospinning, usually at relatively high 
temperatures [74]; the polymer melt is introduced direct into the capillary tube rather 
than the solution. However, electrospinning of a polymer melt must be performed in a 
vacuum condition. 
 
1.3.2. Processing parameters 
 
The foregoing discussion suggests that the following parameters significantly affect 
the electrospinning process: (a) intrinsic solution properties: viscosity, elasticity, 
conductivity, and surface tension [3, 9, 10], (b) operational conditions: hydrostatic 
pressure in the capillary tube, electrical potential at the capillary tip, capillary diameter 
and distance between tip and collecting screen [12, 25], (c) ambient parameters such 
as solution temperature, humidity and air velocity in the electrospinning chamber [13, 
20].B y appropriated tuning of one or more of these parameters, fibers may be 
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successfully electrospun from water soluble polymers, biopolymers or liquid 
crystalline polymers. 
Generally, the polymer solution must have a concentration high enough to 
have sufficient number of polymer entanglements yet not so high that the viscosity 
prevents the polymer flow induced by the pump and the stretching caused by the 
electrical field. The solution must also have a surface tension low enough, a charge 
density high enough and a viscosity high enough to prevent the jet from coalescing 
into droplets before the solvent has evaporated [3]. In the electrospinning process, 
the properties of the solvent, such as volatility and polarity (dielectric constant), have 
a significant influence on the morphology and diameter of the electrospun fibers. The 
electrospinning of a polymer in a polar solvent generally produces ultrathin fibers with 
smaller average diameters, although the effect of solvent polarity on the fiber 
diameters has not been systematically studied [9]. Morphological changes can occur 
upon decreasing the distance between the spinneret and the collector. Increasing the 
distance or decreasing the electrical field decreases the probability of beads in the 
mesh, regardless of the concentration of the polymer in solution [12]. 
 As long as a polymer can be electrospun into nanofibers, ideal targets would 
be: (1) the fibers diameters be uniform, consistent and controllable, (2) that the fiber 
surface be defectfree, (3) that continuous single nanofibers be collectable. However, 
to date, these three targets have proved by no means easily achievable. As long as 
no splitting is involved, one of the most significant parameters influencing the fiber 
diameter is the solution viscosity: high viscosity results in a larger fiber diameter. In 
general, fiber diameter tends to decrease with increasing electrospinning voltage, 
although the influence is not as strong as that of the polymer concentration. An 
additional challenge is to control the uniformity of fiber diameters with current 
electrospinning equipment [3, 10, 11, 13]. The base of the Taylor cone when formed 
is equal to the orifice diameter of the needle. Therefore, it was hypothesized that a 
change in the length of the base of the Taylor cone will potentially influence the forces 
necessary for its formation, the formation of the jet and thus the diameter of the 
nanofibers. As predicted, a decrease in the base of the Taylor cone (orifice diameter) 
caused a decrease in the average diameter of the nanofibers formed [1]. 
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 The structure and morphology of electrospun fibers is also affected by the 
spinneret tip to collector distance because of their dependence on the deposition 
time, evaporation rate and whipping or instability regions. Shorter spinneret tip 
collector distances tend to produce wetter fibers and beaded structures. Thus, 
aqueous polymer solutions require longer distances to dry fiber formation than 
systems that use highly volatile organic solvents. The flowrate of the polymer at the 
syringe is another important process parameter, since it influences jet velocity and 
material transfer rate. Therefore, the fiber diameters and the pore size are larger 
when the polymer flowrate is higher. Increased flowrate also increases the tendency 
to form beaded morphologies [13]. Indeed, a common problem encountered in 
electrospinning is the formation of structure defects, such as beads and pores caused 
by local excess of solvent, which may occur in polymer nanofibers (Figure 1.3) [75]. 
The beads may form as a result of an instability in jet initiation, which is correlated 
with properties of the polymer solution (viscosity and surface tension) as well as there 
being insufficient force to stretch the polymer jet. This effect may be due to the 
electrical field or to the boundary conditions such as a spinneret tip diameter. In other 
words, it is more likely to be possible to electrospin bead free fibers from thicker 
spinneret tips with higher polymer concentration solution. Fiber diameter could be 
significantly decreased by decreasing polymer concentration, although there is a limit 
to obtain uniform nanofibers without beads. Furthermore, adding filler material into a 
polymer solution can also result in fibers free from beads [1]. 
 
 
Figure 1.3 - SEM micrograph of polyvinylpyrrolidone (PVP) nanofibers with beads in 
its structure. 
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1.3.3. Recent developments on electrospinning process 
 
Electrospinning apparatus is simple in construction and there have been no 
significant developments in the equipment design in the past decade. Some research 
groups [21, 25, 47, 54, 76-78] have improvised the basic electrospinning set-up to suit 
their experimental needs in terms of materials and applications. In improve control of 
the electrospinning process and thus, tailor the structures of resultant fibers, the set-
up (in particular, the collector and the spinneret) has also been modified. In general, 
electrospinning is a process with limited productivity because the polymer solution 
has to be fed at relatively slow rates (usually less than 1 ml/h), to obtain ultrathin 
fibers. Productivity enhancement for commercializing products obtained by 
electrospinning is under active research, with emphasis on multiple spinneret 
designs, and alternative experimental set-ups have recently been demonstrated [76]. 
However, there is still debate on the potential of scaling up this technology for 
commercialization. From the available published literature and the current state of 
understanding of the electrospinning process, it is likely that commercial scaling-up of 
the electrospinning process will be achieved only when a more fundamental 
understanding of the process and better control of the instability behaviour of the jets 
is achieved [20]. 
 The conventional set-up for electrospinning involves the use of a single 
capillary as the spinneret and thus is suitable only for generating fibers with one 
particular composition in each run of fabrication, exhibiting a solid interior and a 
smooth surface. Recent demonstrations established that nanofibers with some 
specific secondary structures (e.g. core/sheath or hollow, and porous) could also be 
prepared if appropriated processing parameters (e.g. electrical field strength, 
concentration of solution and feedrate of solution) or new designs of spinnerets were 
employed. With the use of the conventional electrospinning set-up, it is possible to 
fabricate core/sheath nanofibers from a polymer solution containing two polymers that 
will phase separate as the solvent is evaporated. Core/sheath or hollow nanofibers 
could also be fabricated by coelectrospinning of two different polymeric solutions 
through a spinneret comprising two coaxial capillaries [54, 77, 79-82] (Figure 1.4). It 
has thus amply been demonstrated that electrospinning is capable of fabricating
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Figure 1.4 - (A) Schematic illustration of the setup for electrospinning nanofibers 
having a core/sheath structure. The system is based in a spinneret with two coaxial 
capillaries. (B) SEM micrograph of a uniaxially aligned array of TiO2 hollow fibers after 
both mineral oil extraction from the core and calcination (adapted from reference 
[77]). 
 
nanostructures with complex functionalities. It is also speculated that it will be 
possible to fabricate hollow nanofibers with multiple walls using a spinneret 
composed of more than two coaxial capillaries [18]. 
The specific surface area of a nanofiber can be greatly increased when its 
structure is switched from solid to porous [82]. Increase in surface areas is beneficial 
to many applications that include catalysis, filtration, absorption, fuel cells, solar cells, 
batteries or tissue engineering. Two slightly different approaches have been reported 
to introduce a porous structure into the bulk of an electrospun nanofiber. One is 
based on the selective removal of one component used to produce nanofibers made 
from a two phase material, such as a composite or a blend. The other involves the 
use of phase separation technology during electrospinning with appropriate spinning 
parameters [9] (Figure 1.5). 
 Most nanofibers obtained to date are in the non-woven form, which can be 
useful for a small number of applications such as filtration, tissue engineering 
scaffolds, implant coating film, and wound dressing. However, by analogy with the
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Figure 1.5 - SEM micrographs of PLLA fibers with pores at the surface obtained via 
electrospinning of a solution of PLLA in dichloromethane (adapted from reference [9]). 
 
traditional fiber and textile industry, only when continuous single nanofibers or
uniaxial fiber bundles are obtained will their range of applications be expanded. This 
is a very tough target to achieve with electrospun nanofibers, because the polymer jet 
trajectory is a complex three-dimensional “whipping” path, caused by bending 
instability, rather than a straight line. To date, no continuous long fiber yarn has been 
reported and the publications related to aligned nanofibers are very limited [1]. It has 
been suggested that by rotating a cylinder collector at a very high speed (up to 
thousands of revolutions per minute), electrospun nanofibers could be oriented 
circumferentially (e.g. PGA and type I collagen) [73]. 
However, the fiber alignments were achieved only to some extent. The reason 
why a perfect alignment is difficult to achieve can be attributed to the fact that the 
chaotic motions of polymer jets are not likely to be coherent and are not controllable. 
Even so, a large amount of work has been carried out in the field of nanofiber 
alignment, regarding the use of rotating systems as collectors in the electrospinning 
process [21, 23, 83-88]. A significant advance in collecting aligned electrospun 
nanofibers has been made by Theron et al. [89], who described a novel approach to 
position and align individual nanofibers on a tapered and grounded wheel like bobbin. 
The tip like edge substantially concentrates the electrical field so that the as spun 
nanofibers are almost all attracted to and continuously wound onto the bobbin edge of 
the rotating wheel. Investigation is continuing to understand the alignment 
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characteristics in terms of varying the shape and size of frame rods, the distance 
between the frame rods, and the inclination angle of a single frame [1]. Fong et al. 
[90] obtained aligned nylon 6 fibers by rapidly oscillating a grounded frame within the 
electrospun polymer jets. In another approach, it was demonstrated that using a 
multiple field technique, the polymer jet, usually in chaotic oscillating motion as it 
approaches the collection target, can be straightened to some extent [11]. Li et al. 
[91] recently demonstrated that the geometrical configuration of a conductive collector 
had a profound effect on the orientation of electrospun nanofibers (Figure 1.6). Using 
a collector consisting of two conductive strips separated by a gap of variable width 
(up to several centimetres), electrospun fibers could be uniaxially aligned over long 
lengths during the spinning process [92-94]. This collecting process has been termed 
the ‘gap method of alignment’, and it results in single electrospun fibers, oriented and 
suspended between two collection plates. In a different strategy, copper wires spaced 
evenly in the form of a circular drum as a collector resulted in sheets with 1 cm wide 
strips of aligned nanofibers [95]. In a recent paper, Teo and Ramakrishna [65] 
described a simple method of obtaining a fiber bundle of micrometre scale diameter 
from nanofibers aligned between two parallel steel blades with a gap between them. 
A similar structure composed of aligned nanofibers, developed by Dalton and 
colleagues [96], was obtained using two grounded collection rings or circular disks 
equidistant from the spinneret, by rotating one of the collection rings. 
It may also be possible to integrate electtrospinning with conventional 
lithographic techniques to obtain new fabrication platforms for generating patterned 
microstructures from a variety of materials and a broad range of length scales. 
Czaplewski et al. [97] deposited nanofibers of poly(methyl methacrylate) as templates 
for the formation of functional nanomechanical devices (e.g. nanomechanical 
oscillators), combined with lithographically defined support structures. Afterwards, Liu 
and collaborators [98] developed sensor devices that utilized individual oriented 
polymeric nanowires of polyaniline/poly(ethylene oxide) deposited on lithographically 
defined microelectrodes. 
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Figure 1.6 - A, B and C) Schematic illustration of collectors based in gold electrodes 
deposited over insulating substrates. D, E and F micrographs obtained by dark-field 
optical microscopy of PVP nanofibers collected between the electrodes A, B and C, 
respectively (adapted from reference [91]). 
 
1.4. Tissue engineering/Biomedical applications of electrospun nanofibers 
 
From a biological perspective, almost all human tissues and organs are 
deposited in some kind of nanofibrous form or structure [2]. Examples include, among 
many others, bone, collagen, cartilage and skin [99-101]. All of these are 
characterized by well organized hierarchical fibrous structures realigning on a 
nanometre scale [102]. As such, current research in electrospun polymer nanofibers 
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has focused extensively on biomedical products. Tissue engineering has been 
recognized, for some time, as a promising alternative to the use of autografts or 
allografts for tissue reconstruction and regeneration [103-105]. This approach utilises 
cells, biomaterial scaffolds and signalling molecules for the repair of disease or 
damage tissues. However, other applications are also envisaged, such as wound 
dressings and prostheses. 
 
1.4.1. Wound dressing 
 
An ideal dressing will cover and protect a wound, providing an environment at 
the surface of the wound in which healing can take place at the maximum rate, with 
good dermosthetical appearance [66]. Modern dressings are developed to serve the 
purpose of facilitating wound healing apart from the basic function of covering wounds 
and protecting them from infections. It has been noted by several authors [43, 66, 
106] that an ideal dressings is required to (1) be haemostatic, (2) be efficiency as a 
bacterial barrier, (3) absorb excess exudates, (4) provide and maintain a moist 
environment or appropriate water vapour transmission rate, and provide adequate 
gaseous exchange, (5) conform to the limits of the wound area, (6) adhere to healthy 
tissue but not to wound tissue, i. e., to show functional adhesion, (7) be painless to 
the patient and easy to remove, and (8) provide these qualities at an affordable cost. 
 Current efforts using polymer nanofibrous membranes as medical dressings 
are still at an early stage (Figure 1.7). Fibrinogen is a soluble protein that is present in 
the blood plasma and has been shown to play a key role in wound healing. Human 
and bovine fibrinogen nanofiber mats have been electrospun and developed for their 
potential use as a tissue engineered scaffold, wound dressing or haemostatic 
bandage [43, 106, 107]. Electrospun poly(ethylene-co-vinyl alcohol) membranes also 
appear to be favourable substrates for tissue engineering, wound coverage and 
healing; one has been shown to support the culturing of aortic smooth muscle cells 
and dermal fibroblasts [108]. Recently, cytocompatibility and cell behaviour of primary 
normal human keratinocytes (NHK) and fibroblasts cultured on silk fibroin (SF) 
nanofibrous membranes were also reported [40, 41]. The adhesion of cultured cell 
types was evaluated using type I collagen, fibronectin or laminin as substrates, which 
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Figure 1.7 - Mouse lung fibroblasts (L929 cell line) adhered on plasma-modified PCL 
nanofiber meshes. 
 
were adsorbed onto the SF nanofibers. The results indicated that type I collagen, one
of the integrin ligands, is functionally active in terms of cell adhesion onto the 
electrospun SF nanofibers for both keratinocytes and fibroblasts tested. In another 
study, the same research group produced a nanofibrous matrix of type I collagen from 
calfskin via electrospinning [109]. In cell activity assessment, electrospun collagen 
nanofibers coated with type I collagen or laminin were found to promote cell adhesion 
and spreading of NHK. Additionally, the effect of collagen nanofibers on open wound 
healing in rats and athymic mice [110] was very effective as wound healing 
accelerators in early stage wound healing. In those studies, SF and type I collagen 
nanofiber non-wovens produced by electrospinning were introduced for wound 
dressing and scaffolds for tissue engineering. The performance of electrospun 
nanofibrous polyurethane (PU) membranes as dressings was examined in vivo using 
a pig model [107]. To validate the application in the medical field, morphological 
properties of the membranes were characterized and wound healing was 
investigated. This wound dressing showed controlled evaporative water loss, 
excellent oxygen permeability and promoted fluid drainage owing to the presence of 
porous nanofibers and inherent properties of PU. Histological examination confirmed 
that epithelialization rate was increased and the exudate in the dermis was well 
controlled by covering the wound with the electrospun membrane. 
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1.4.2. Medical prostheses 
 
Polymer nanofibers fabricated via electrospinning have been proposed for a 
number of soft tissue prostheses applications, such as arterial blood vessel [111, 112] 
and breast [113]. Electrospun biocompatible polymer nanofibers can also be 
deposited as a thin porous film onto a hard tissue prosthetic device designed to be 
implanted into the human body [114]. 
 The search for vascular grafts substitutes has been a half century endeavour. 
Although polytetrafluoroethylene [115] and polyethylene terephthalate (PET) (Dacron) 
[116] have been successful in treating the pathology of large diameter arteries (> 6 
mm, inner diameter), no materials have been successful in replacing small diameter 
blood vessels (< 6 mm). The first approach using the electrospinning technique to 
obtain biomimetic vascular graft scaffolds was developed by Stitzel and colleagues 
[117]. The graft was fabricated with collagen fibers wound on a stainless mandrel and 
covered with electrospun PLA. The vascular construct was seeded with human aortic 
smooth muscle cells (SMCs) and general cellular orientation along the principal stress 
lines was observed. In a recent article, Venugopal et al. [118] reported the 
development of biocomposite nanofiber scaffolds of PCL and collagen types I and III. 
In vitro studies with coronary artery SMCs revealed that these biocomposites 
constitute promising scaffolds for the regeneration of smooth muscle tissue for blood 
vessel engineering. 
 In recent years, creating a biodegradable polymer scaffold with an 
endothelialized surface has become an attractive concept for replacement of small 
diameter blood vessels. Taking this into account, Xu et al. [119] cultured human 
vascular endothelial cells (ECs) on electrospun and solvent cast poly(L-lactic acid) 
(PLLA) substrates with different surface roughness and showed that EC function was 
enhanced on the smooth solvent cast surface relative to the rough electrospun 
surface of PLLA nanofibers. Interestingly, in previous works [120, 121], the same 
research group demonstrated that a nanofiber matrix of the block copolymer of 
poly(L-lactic acid)-co-poly(ε-caprolactone), P(LLA-CL), could support the adhesion 
and proliferation of ECs and SMCs. This synthetic nanofiber matrix combined the 
advantages of synthetic biodegradable polymers with the biocompatible mimicking 
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architecture of extracellular matrix, to have great potential for blood vessel 
engineering. To facilitate viability, attachment and phenotypic maintenance of human 
coronary artery ECs, an electrospun collagen coated P(LLA-CL) nanofiber mesh was 
fabricated through plasma treatment followed by collagen coating [122]. The collagen 
coated nanofibrous structure also showed mechanical properties suitable for tissue 
engineered vascular grafts (Figure 1.8). A similar study was recently presented by 
Jeong et al. [123], demonstrating the effectiveness of a dynamic culture on the 
engineering of vascular grafts. Additionally, for prosthetic vascular grafts, directional 
bias of fibers with respect to the tubular axis is required to mimetically obtain 
anisotropic vascular grafts so as to improve burst strength. Aligned P(LLA-CL) 
nanofibrous scaffold have been successfully produced [87]. Cell culture results of 
SMCs on the nanofibrous scaffold indicated that cells adhered and migrated along the 
direction of aligned nanofibers, showing observed a significant improvement over 
polymer films. 
Vascular graft scaffolds have also recently been fabricated using electrospun 
polymer blends of type I collagen from calf skin (45 %), elastin from ligamentum 
nuchae (15 %) and PLGA (40 %) [124]. The biocompatibility of the scaffolds was 
tested with bovine ECs and SMCs and assessed by MTT metabolic assay and neutral 
red assays. The biocompatibility of the electrospun vascular scaffolds was also tested 
 
 
Figure 1.8 - Fabricated bilayered tubular construct composed of a polyurethane tube 
with the interior surface coated with collagen. (A) SEM micrograph of the tube. (B) 
Magnified image of region 3 in the micrograph (adapted from reference [153]). 
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in vivo. Favorable interactions between SMCs and ECs on the scaffold were 
demonstrated by cellular morphology, histology and immunostaining. Ma et al. [125] 
processed a conventional polymer used in vascular grafts, PET, into non-woven 
nanofiber mat via electrospinning. To overcome the chemical and biological inertness 
of the PET surface, gelatin was covalently grafted onto the PET nanofibrous surface. 
Endothelial cells were cultured on the original and gelatin modified PET nanofiber 
meshes and results demonstrated an improvement of spreading and proliferation of 
the ECs, maintaining their phenotype. Altogether, these studies demonstrate the 
potential of electrospinning as a method to fabricate functional vascular grafts for 
clinical applications, using different biomaterials. 
 
1.4.3.  Drug delivery systems 
 
The ability to influence the fiber diameter, by changing the polymer solution 
concentration and/or its surface tension, and the ability to incorporate therapeutic 
compounds into the mats during spinning process afforded the prospect of preparing 
useful polymer systems for controlled drug delivery. Moreover, two potential 
advantages of the electrospinning approach are the avoidance of melt processing, 
which is especially important for heat sensitive drugs, and minimization of the initial 
burst. The nature of the polymer can direct the use of the electrospun fibers with 
water soluble polymers giving rise to immediate release dosage forms and water 
insoluble (i.e. biodegradable or non-biodegradable) polymers, being useful for 
sustained release systems. Thus, the fabrics generated with water soluble carriers 
could be used in oral dosage formulations by direct incorporation of the materials into 
a capsule or by further processing (i.e. milling of the fabrics) [126]. Covalent 
conjugation of drugs to polymers represents an alternative strategy for moderating the 
rates of drug release. This strategy, however, requires the presence of side 
chains/functional groups, which are generally only abundant in some hydrophilic 
biodegradable polymers. Unfortunately, the electrospun membranes prepared from 
hydrophilic polymers generally have poor mechanical strength, especially in their 
swollen state, and also tend to disintegrate faster in vivo. Moreover, chemical cross-
linking is generally needed to solidify and stabilise the electrospun membranes 
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prepared from hydrophilic polymers, and most of those chemical reactions have 
potential toxicity. In addition, hydrophilic and water soluble polymers tend to leach out 
rapidly from the blends when incubated in an aqueous environment. Thus, it is 
necessary to find hydrophilic polymers that are soluble in organic solvents and 
insoluble in water under physiological conditions, for preparing composite electrospun 
membranes [52]. 
 Drug delivery devices including polymer nanofibers are based on the principle 
that dissolution rate of a drug may be mediated by the surface area of both the drug 
and the corresponding carrier. Since drugs and carrier materials can be mixed 
together to produce nanofibers by electrospinning, various interaction modes in the 
resulting nanostructured products can be envisaged: (1) the drug as tiny particles 
attached to the surface of the nanofiber carriers, (2) both drugs and carriers are in 
nanofiber form, resulting in an interlaced structure, (3) a blend of drugs and carrier 
materials integrated into a single type of composite nanofibers, and (4) the carrier 
material is electrospun into a tubular form in which the drug particles are 
encapsulated. Modes (1) and (2) tend to give rise to a problem of burst release in the 
initial stages of incubation and therefore, modes (3) and (4) may be preferred [1]. 
Kenawy et al. [127] were the first to describe the incorporation of a drug into 
polymeric nanofibers. They found that electrospun poly(ethylene-co-vinylacetate) 
(PEVA) released 65 % of its drug (tetracycline hydrochloride) content within 120 h, 
whereas the 50:50 material (PEVA/PLA) released ~ 50 % over the same time period. 
Mats of PLA fibers exhibited some instantaneous release, most probably caused by 
tetracycline hydrochloride on the fiber surfaces. In addition, the percentage of 
tetracycline released after 5 days from electrospun PEVA was only about twice that 
released from Actisite (tetracycline periodontal fibers). In general, the total percentage 
release from the cast films was lower than that from the electrospun mats, as would 
be expected due to the much lower surface area of the former. In other work, 
bioabsorbable nanofiber membranes of PLA were used for loading an antibiotic drug, 
Mefoxin (cefoxitin) [128]. 
 For potential use in topical drug administration and wound healing, poorly 
water soluble drugs loaded in water soluble and water insoluble nanofibrous polymer 
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carriers were investigated [126, 129]. Verreck et al. [129] reported that solvent casting 
and melt extrusion of hydroxypropylmethylcellulose results in samples that rapidly 
release itraconazole, with the solvent cast film giving more complete release. 
Samples produced using electrostatic spinning resulted in a complete in vitro release 
over time, but the dissolution rate was slower than for either the cast thin films or the 
melt extruded, milled powder. Additionally, it was shown that drug loaded polymer 
electrospun nanofibers were able to disperse drugs in an amorphous state, which 
facilitates drug dissolution. 
 Zeng and co-workers [130] described a perfect inclusion of Rifampin and 
Paclitaxel inside PLLA fibers, in that no burst release of drug was observed. These 
drugs are lipophilic and highly soluble in PLLA/chloroform/acetone solution. When the 
solution jet was rapidly elongated and the solvent evaporated quickly, the drug 
remained compatible with PLLA. Doxorubicin hydrochloride (a hydrophilic drug) was 
also used in this study and limited solubility in the electrospinning solution was 
reported. During the rapid evaporation of the solvent, phase separation took place 
quickly between the drug and PLLA. Therefore, the solubility and compatibility of the 
drug in the drug-polymer-solvent system was a decisive factor. 
 Electrospun nanofibrous meshes can also be used as carriers for hydrophilic 
drugs, where the drug release profile can be finely controlled by the modulation of 
scaffold morphology, porosity and composition. By taking advantage of the unique 
solubility characteristics of poly(ethylene glycol)-g-chitosan (PEG-g-CHN), Jiang and 
colleagues [52] prepared by electrospinning a highly porous composite membrane 
composed of PLGA and PEG-g-CHN, without the need for cross-linking. These 
membranes are mechanically robust and flexible, and have high porosity, 
hydrophilicity and capacity to sustained release of ibuprofen, rendering them suitable 
for direct application to atrial tissue. Kim and co-workers [131] successfully 
incorporated a hydrophilic antibiotic drug, Mefoxin (cefoxitin sodium), into electrospun 
PLGA and PLGA/PLA/PEG-b -PLA (80:5:15) nanofibers, without the loss of structure 
and bioactivity. It was demonstrated that the introduction of an amphiphilic PEG-b -
PLA block copolymer in the polymer matrix reduced the cumulative amount of the 
release at earlier time points and prolonged drug release rate to 1 week. In addition, 
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the released cefoxitin sodium from electrospun scaffolds was found to be structurally 
intact as well as effective in Staphylococcus aureus growth inhibition, in both static 
and dynamic environments. 
 The use of electrospun fibers as drug carriers will be also promising in future 
biomedical applications, especially post-operative local chemotherapy. Along those 
lines, Katti et al. [132] reported the development of a novel bioresorbable, polymeric 
nanofiber based antibiotic delivery system for the treatment of wounds; Cefazolin was 
incorporated into PLGA nanofibers using the free acid form of the antibiotic. Zong et 
al. [133] examined the effect of using electrospun non-woven bioabsorbable PLGA 
impregnated with antibiotics (Mefoxin) as an anti-adhesion membrane based on an in 
vivo rat model. These delivery systems would potentially have two functions: as a 
topical/local antibiotic delivery system and as a resorbable/biodegradable gauze 
whose degradation products are easily metabolized by the body. A particular 
advantage of this delivery system would be the possibility of delivering uniform and 
highly controlled doses of bioactive agents at the wound site via the high surface area 
to volume ratio of the nanofiber system. Another advance in post-operative localised 
drug administration focused on vascular grafts. Sustained delivery of heparin to the 
localised adventitial surface of the grafted blood vessels has been shown to prevent 
vascular smooth muscle cells (VSMC) proliferation leading to graft occlusion and 
failure. Luong-Van et al. [134] successfully incorporated heparin into electrospun PCL 
fiber mats. The effect of heparin incorporation on the fiber morphology was studied, 
as well as heparin dispersion and release rates. A homogeneous distribution of 
heparin was found throughout the fiber mats and continuous diffusional release over 
14 days. In addition, the fibers did not elicit a proinflammatory response, as assessed 
through in vitro macrophage assay, and the released heparin was effective in 
preventing the proliferation of VSMCs in culture. 
 A number of authors [44, 127-134] have successfully encapsulated drugs into 
electrospun fibers by mixing the drugs in the polymer solution to be electrospun. 
Fewer, however, have encapsulated proteins in electrospun polymer fibers [135-137]. 
Proteins such as growth factors are often the most important biochemical signalling 
agents for tissue engineering applications. A recent study developed by Chew et al. 
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[135] demonstrated the feasibility of encapsulating human nerve growth factor (NGF) 
by electrospinning it into a biodegradable fiber composed of the copolymers poly(ε-
caprolactone) and ethyl ethylene phosphate (PCLEEP). Partially aligned protein 
encapsulated fibers were obtained and the protein was found to be randomly 
dispersed throughout the electrospun fibrous mesh in aggregate form. A sustained 
release of NGF from electrospun fibrous mesh for up to 3 months was observed. 
Additionally, it was confirmed that the NGF released at the end of this time period 
was, at least partially, bioactive in stimulating PC12 cells differentiation into neurons. 
In another study, Zeng et al. [137] reported the release of comparable large proteins 
from electrospun poly(vinyl alcohol) (PVA) nanofibers obtained by electrospinning. 
The release of fluorescin isothiocyanate labelled bovine serum albumin or luciferase 
from electrospun PVA nanofibers was demonstrated; the burst release was retarded 
significantly by a post-electrospinning coating of highly hydrophilic poly(p-xylylene). 
The preservation of enzyme activity and the continuous release of the intact enzyme 
from the immersed fibers meets a fundamental prerequisite for the application of 
enzymes or other sensitive agents released from electrospun nanofibers under 
physiological conditions. 
 
1.4.4. DNA release 
 
Fibers produced by electrospinning form a large, interconnected porous 
network that is ideal for drug, gene, as well as cell delivery. Fang and Reneker [37] 
have previously reported on electrospinning of DNA fibers, utilising purified genomic 
DNA (calf thymus Na-DNA) as the polymer. Luu et al. [34] utilised the unique 
capabilities of electrospinning to develop a biologically active scaffold for gene 
delivery. This study appears to be the first report describing the successful dispersion 
of plasmid DNA into polymeric solutions of PLA-PEG and PLGA, generating 
biologically active composite scaffold via electrospinning. Preliminary data indicate 
that, by manipulating the scaffold’s properties (fiber diameter, porosity or pore size), it 
should be possible to accurately control the release of DNA from the scaffold, and 
thus decrease the rate of release at earlier times and sustain a more linear release for 
longer time periods. Additionally, these results indicated that the DNA released from 
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the scaffold was not only intact, but also capable of cellular transfection. In a 
subsequent study, the same group [138] developed a novel core-sheath DNA 
nanoparticle composed of condensed plasmid DNA in a triblock copolymer of 
poly(lactide)-b-poly(ethylene glycol)-b -poly(lactide). The mixture of encapsulated DNA 
and PLGA was then electrospun to form a non-woven nanofibrous and 
nanocomposite scaffold. This structure was capable of controlled release bioactive 
plasmid DNA in an intact form and transfect preosteoblastic MC3T3 cells in culture. 
Together, these results demonstrated that by understanding and using the molecular 
interactions of block copolymers and plasmid DNA in solution, novel structures and 
additional functionality can emerge. A deep understanding on the molecular self-
assemblies and the electrospinning process has enabled the development of an 
effective gene delivery vehicle. 
 
1.4.5. Tissue templates/scaffolds 
 
A biodegradable scaffold is commonly recognized as an indispensable element 
in engineering living tissues. Scaffolds are used as temporary templates for cell 
seeding, proliferation and differentiation, to lead to the regeneration of the tissue [59, 
103-105]. The design of biomaterial scaffolds for tissue engineering is an attempt to 
obtain functional replacement of the ECM, to support the desired cellular 
differentiation and maintain phenotype specific activities. Nanofibrous materials, by 
virtue of their morphological similarities to natural ECM, have been considered as 
promising scaffolds for tissue engineering applications. The difficulties with these 
structures include poor control of porosity and limited mechanical properties. 
 Diverse tissues that undergo injury could benefit from the potentialities of the 
nanofibrous structures produced by electrospinning. For instance, in cartilage 
regeneration, induction and maintenance of chondrocyte differentiation are obtained 
by embedding cells in agarose, or alginate, or in the form of a high density pellet. 
However, such cultures lack the mechanical stability provided by PCL nanofibrous 
scaffold, as described by Li et al. [22]. In subsequent work [24], it was demonstrated 
that electrospun nanofibers of PCL effectively support transforming growth factor β1 
induced chondrogenesis of adult human mesenchymal stem cells (hMSCs). The level 
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of differentiation appeared to be equivalent to that observed in high density pellet 
cultures of hMSCs. In addition, nanofibrous scaffolds allowed cells to be grown on the 
same surface throughout their entire course of differentiation and maturation. The 
same group, in another study [139], showed that PCL nanofibrous scaffolds not only 
support the maintenance of a chondrogenic phenotype, but also provide a suitable 
scaffold for the osteogenic, chondrogenic, and adipogenic differentiation of hMSCs. In 
a recent study, Subramanian et al. [140] have evaluated a novel electrospun 
chitosan/polyethylene oxide (PEO) mat composed of oriented submicron fibers for its 
tensile properties and biocompatibility with canine chondrocytes (cell attachment, 
viability and proliferation). The results demonstrated that the electrospun aligned 
fibers had a higher modulus than anisotropic cast films, and provided good 
chondrocyte biocompatibility. A similar biological study [141], with chitosan/PEO 
nanofibers deposited as a non-woven membrane or as a highly aligned bundle, was 
developed with human chondrocytes (HTB-94 cell line) and osteoblasts (MG-63 cell 
line). Experimental results showed that the nanofibrous structure promoted adhesion 
and maintained characteristic cell morphology and viability throughout the period of 
study, properties of particular interest in tissue engineering for controlled drug release 
and tissue remodelling. In other recent work [142], starch based nanofiber meshes 
were presented as support structures for bovine articular chondrocytes proliferation 
and maturation, as demonstrated by the formation of extracellular matrix 
(glycosaminoglycans quantification) and immunoexpression of collagen types I and II. 
Interesting work by Yoshimoto et al. [27] demonstrated that electrospun PCL 
nanofibers are capable of supporting attachment and proliferation of rat bone marrow 
derived MSCs, which maintain their phenotypic shape and differentiation into 
osteoblastic cells under dynamic culture conditions. Shin et al. [143] implanted MSC-
PCL constructs subcutaneously in rats and showed new bone formation at the 
implantation site. These results were later confirmed by Boudriot and colleagues 
[144], who demonstrated osteogenic differentiation of hMSCs on a three-dimensional 
matrix of electrospun PLLA nanofibers. Therefore, nanofibrous structures processed 
by electrospinning could also be promising scaffolds for bone tissue engineering. 
Recently, Zhang et al. [55] coelectrospun gelatin with PCL to produce composite 
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fibrous scaffolds, which exhibited improved mechanical properties (namely, 
elongation and deformation), as well as more favorable wettability, than nanofibers 
obtained from either gelatin or PCL alone. Additionally, cell culture experiments with 
bone marrow stromal cells (BMSCs) showed favorable interactions (i.e. attachment 
and spreading) and cellular migration into the fibrous structure of this artificial 
polymeric material. In a recent study, guided bone regeneration (GBR) composite 
nanofiber membranes were successfully fabricated by electrospinning of PCL/calcium 
carbonate (CaCO3) [145]. Human osteoblasts (hFOB1.19 cell line) were cultured on 
composite nanofibrous GBR membranes, and MTS assay and SEM observation 
revealed good cell attachment and proliferation. Another study [146] had also 
evaluated the osteoblast attachment and proliferation on composites of PCL 
nanofibers containing nanoparticles hydroxyapatite (nHA). Results demonstrated that 
cells seeded on PCL/nHA fibrous scaffolds presented higher viability than the cells 
seeded on scaffolds containing PCL/CaCO3 or PCL alone. That behavior was 
attributed to the ability of nHA to promote bone cell activities. Recently, the formation 
of an apatite layer has been induced over electrospun PCL nanofiber meshes, without 
the occurrence of pore occlusion [147]. The biological influence of this biomimetic 
coating on osteoblatic like cells was assessed. It was shown that PCL nanofiber 
meshes coated with an apatite layer support and enhance the proliferation of 
osteoblasts for long culture periods (Figure 1.9). 
Nair and colleagues [148] recently produced non-woven nanofiber meshes 
from poly[bis(p-methylphenoxy)phosphazene] (PNmPh) by electrospinning. This 
biodegradable polymer is a polyphosphazene, a class of inorganic-organic polymers 
known for their high biocompatibility, high temperature stability and low temperature 
flexibility. Furthermore, the electrospun nanofiber mats were studied to evaluate the 
biological performance. It was found that these mats supported the adhesion of 
bovine coronary artery endothelial cells, as well as promoting adhesion and 
proliferation of osteoblastic like MC3T3-E1 cells (mouse immortalized calvarial cells). 
This study indicated that the PNmPh nanofiber matrices could promote cell matrix 
and cell-cell interactions, making them potential candidates for various biomedical 
applications.
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Figure 1.9 - SEM micrografts of electrospun poly(ε-caprolactone) nanofiber meshes 
after biomimetic calcium phosphate coating, keeping the porous morphology (A) 
(adapted from the reference [68]). Morphology of Saos-2 cells cultured for 14 days on 
PCL nanofiber meshes coated with a biomimetic coating (B) (adapted from the 
reference [147]). 
 
 Many researchers [38-41, 149] have investigated silk proteins, mainly SF, as 
candidate materials for biomedical applications, because it has several distinctive 
properties including good biocompatibility, good oxygen and water vapour 
permeability, biodegradability and minimal inflammatory reaction. Jin et al. [38] 
reported the ability of electrospun silk matrices to support human BMSCs attachment, 
spreading and growth in vitro, suggesting the potential use of these biomaterial 
matrices as scaffolds for tissue engineering. Electrospun silk fibroin mats were 
comparable with other biodegradable electrospun mats using PGA [31, 41], PLGA 
[33-36], collagen [45-47], collagen/PEO blends [51] that were tested for use as 
scaffolds for tissue regeneration. In fact, smooth muscle cells were observed to 
infiltrate an electrospun collagen (calfskin) nanofiber matrix and were well integrated 
into the network within 7 days of culture [46]. Matthews [45] also performed an in vitro 
study with chondrocytes, where it was also demonstrated that electrospun collagen 
type II scaffolds support cell proliferation and are readily infiltrated. More recently, a 
comparative study of collagen, gelatin (denaturated collagen), solubilised alpha-
elastin and recombinant human tropoeslatin as biopolymeric materials for fabricating 
tissue engineering scaffolds by electrospinning was developed by Li and colleagues 
[150]. In contrast to collagen and gelatin, which could be spun into fibers in the 
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nanometre scale, the diameter of alpha-elastin and tropoelastin fibers was always in 
the range of microns. The characterization of the mechanical tensile moduli of 
electrospun fibers was also reported. Cell culture studies confirmed that these 
electrospun engineered protein scaffolds support attachment and growth of human 
embryonic palatal mesenchymal cells. 
 Numerous topographical and chemical strategies have been undertaken to 
create micro- and nanoscale enhanced features to regulate cell morphology and 
function [102, 151, 152]. In fact, very little was previously known about the textural 
effects of the fibrous matrix on tissue engineering. Park et al. [40] studied the 
cytocompatibility and human oral keratinocytes behaviour on the different textures of 
SF (woven matrix of microfibers, films and non-woven matrix of nanofibers). Their 
results indicated that the SF nanofiber matrix promotes cell adhesion and spreading, 
using type I collagen as substrate, better than SF film and SF microfiber matrices. In 
subsequent work [53], they demonstrated that a PLGA/chitin composite non-woven 
matrix can be a better candidate than the PLGA non-woven matrix in terms of cell 
adhesion and spreading for normal human keratinocytes, and that the PLGA and 
PLGA/chitin matrices are good matrices for normal human fibroblasts. These 
nanofibrous matrices showed promise for biomedical applications, such as wound 
dressing and scaffolds for tissue engineering. In a different topographical approach, 
nano- to micro-structure biodegradable poly(L-lactide-co-ε-caprolactone) (PLCL) 
fabrics were prepared by electrospinning [153]. Physical characterization revealed 
that a decrease in the fiber diameter of the fabric resulted in a decrease in the 
porosity and on the pore size. This was followed by an increase in fiber density and 
mechanical strength. Biological assays demonstrated that human umbilical vein 
endothelial cells (HUVECs) were well adhered and proliferated on the small diameter 
fiber fabrics (0.3-1.2 µm in diameter), whereas markedly reduced cell adhesion, 
restricted cell spreading and no signs of proliferation were observed on the large 
diameterfiber fabric (∼ 7.0 µm in diameter). The discussion suggests that electrospun 
elastomeric nanofiber fabric may be useful as temporary functional scaffolds in 
cardiovascular and muscular tissue engineering. 
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 Nanofibrous structures were recently proposed as a potential cell carrier for 
neural tissue engineering by Yang et al. [29]. Production of PLLA nanofibrous 
scaffolds and the biological performance of neural stem cells (NSC) when seeded into 
those scaffolds was described. It was concluded that this nanostructure supports 
neural stem cell adhesion and enable NSCs differentiation and outgrowth of neurites. 
Later, the production of perfectly aligned PLLA fibrous scaffolds was achieved and in 
vitro studies demonstrated the elongation and neuritis outgrowth of NCS parallel to 
the direction of fiber alignment [88]. Moreover, a comparative study with electrospun 
microfibers revealed a significant effect on the cell orientation. However, the NSC 
differentiation rate was higher for nanofibers than for microfibers. 
 Several studies on creating cardiac muscle cell constructs have also been 
reported [154, 155]. Studies that used a synthetic polymer scaffold typically 
concluded that the stiffness of the scaffold hindered tissue contractions [59, 153]. A 
study developed by Shin et al. [154] introduced an in vitro system for engineered 
myocardium using a degradable, nanofibrous scaffold made of PCL by electrostatic 
fiber spinning. The cardiomyocytes penetrated the entire scaffold and stained 
positively for cardiotypical proteins, i.e. actin, tropomyosin and cardiac troponin-I. The 
work presented provides an alternative approach to engineered myocardium by 
relying on a synthetic polymer that provides sufficient stability and low opposition to 
contractions. In a similar approach [155], biodegradable polymer nanofibers of PLLA 
and PLGA (PLA10-GA90+PLLA and PLGA+PEG-PLA) were assessed for use in 
heart and cardiac tissue constructs. Primary rat cardiomyocytes (CMs) were cultured 
onto nanofibrous scaffolds and a dense multilayer of cells was obtained. It was also 
observed that CMs over electrospun PLLA scaffolds developed mature contractile 
structures (sarcomeres). 
 Skeletal muscle tissue engineering represents an attractive approach to 
overcome problems associated with autologous transfer of muscle tissue and provide 
a valid alternative for tissue replacement in the enhancement of muscle regeneration. 
In this context, Riboldi et al. [156, 157] investigated the potential use of electrospun 
DegraPol (degradable polyesterurethane) membranes as fibrous scaffolds for 
skeletal muscle tissue engineering. To evaluate their suitability for this specific 
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application, scaffolds were characterized with reference to their morphological, 
degradative and mechanical properties. Subsequently, cell viability, adhesion and 
differentiation on coated (with collagen, fibronectin and Matrigel - a gelatinous 
protein mixture) and uncoated DegraPol electrospun membranes were investigated 
using murine and rat myoblast cell lines (C2C12 and L6, respectively) and primary 
human satellite cells. The electrospun DegraPol membranes showed satisfactory 
mechanical properties (linear elastic behaviour up to 10 % deformation, E modulus in 
the order of megapascals) and good cellular response in preliminary adhesion and 
differentiation experiments (cellular adherence and proliferation on differently coated 
electrospun membranes, accompanied with positive staining for myosin heavy chain). 
 Originally, in the field of liver tissue engineering, galactosylated nanofiber 
meshes were suggested as potential scaffolds by Chua et al. [158]. In this study, 
highly porous nanofiber scaffolds of PCLEEP were grafted with poly(acrylic acid) and 
subsequently, covalently conjugated with galactose ligands. Hepatocytes, isolated 
from male Wister rats, cultured on galactosylated scaffolds, exhibited similar 
functional profile in terms of cell attachment, ammonia metabolism, albumin secretion 
and cytochrome P450 enzymatic activity as those on the functional two-dimensional 
substrate. Galactosylated PCLEEP nanofiber mesh demonstrated the unique 
properties of promoting hepatocyte aggregates within the mesh and around the fibers, 
forming an integrated spheroid nanofiber construct. Indeed, this construct would be 
advantageous in the design of bioartificial liver assisted devices. 
 Mechanical forces play a central role in the physiology of a wide variety of 
tissues. Several researchers [159, 160] have reported that cyclic mechanical stretch 
increases ECM production in cultured fibroblasts on flexible membranes. Additionally, 
when connective tissue cells are grown on deformable substrates and subject to an 
applied cyclic strain field, the cells align perpendicular to the greatest strain direction. 
Lee et al. [83] studied the effect of fiber alignment in polyurethane nanofibers and 
direction of mechanical stimuli on the ECM generation of human ligament fibroblast 
(HLF). The results indicated that HLF cultured in aligned nanofibers had a similar 
morphology to ligament fibroblasts in vivo. The aligned structure led to increased 
ECM production, and the aligned HLFs were more sensitive to strain in the 
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longitudinal direction. Consequently, aligned nanofibers can constitute a promising 
base material for tissue engineered ligament in that they are a biomimetic structure 
and provide the mechanical environment ligament fibroblasts encounter in vivo. 
 
1.5. Desired properties of electrospun nanofibers as scaffolds 
 
Tissue Engineering is emerging as an alternative approach for the 
(re)generation of functional tissues damaged by disease or trauma, and in replacing 
failing or malfunctioning organs. Biomaterials play a significant role in these modern 
strategies of regenerative medicine and tissue engineering. They can be used to tailor 
the biophysical and biochemical milieus that direct cellular behaviour and function into 
the desired regeneration of tissues. Moreover, the scaffold should act as a template 
for the neovascularization of the regenerated tissue and could actively participate in 
the regeneration process through the release of growth/differentiation factors. Various 
degradable biomaterials, either natural or synthetic, have been processed into 
scaffolds for tissue engineering [59, 103, 104, 161-164]. Essentially, the success of 
tissue engineering methods is highly dependent on the properties of the scaffold. 
Basic scaffold design requirements include biodegradability, biocompatibility, high 
surface area/volume ratio (porosity and interconnectivity) and mechanical integrity 
[59, 165-168]. 
 It is agreed [162, 167] that a candidate scaffold should closely mimic the 
structural and functional properties of the materials found in the native ECM of the 
host tissue. Therefore, the ultimate goal of the scaffold is the production of an ideal 
structure that can replace the natural ECM until host cells can repopulate and 
resynthesize a new natural matrix. It is well known that most natural ECMs are 
composed of randomly oriented fibrils of nanometer scale diameters. The morphology 
and architecture of the electrospun structure aims at being similar to those of some 
natural ECMs [2, 66]. Biological performance is regulated by the biological signals 
from growth factors, extracellular matrix, and also by the surrounding cells. More 
sophisticated efforts to mimic this natural scaffold are being pursued by many groups 
[169, 170] that are exploring the development of biomaterial/biochemical composites 
incorporating biological agents such as growth factors and other key cell regulatory 
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molecules. This objective has also been pursued using electrospun nanofiber 
meshes, although little attention has to date been given to the loading growth factors, 
so far [135, 136]. 
 The pores of a tissue engineering scaffold constitute the space in which the 
cells reside. It is generally agreed that a highly porous microstructure with 
interconnected pores and a large surface area is desirable to allow cell seeding and 
migration throughout the material. Furthermore, the scaffolds should exhibit adequate 
microporosity, to encourage capillary ingrowth. High porosity provides more 
opportunities for cell colonization and makes the diffusion of gases, nutrients and 
metabolic waste between scaffold and environment more efficient. Given the 
importance of the pore structure of tissue engineering scaffolds, a variety of 
techniques have been proposed to obtain an appropriate substrate for cell culture 
[103, 166, 171-189]. Many of these techniques employ organic solvents or high 
temperature, and the preservation of biocompatibility and the crystalline structure of 
the polymer are problematic. To overcome the above limitations, electrospun fibrous 
matrices can be used as alternative scaffolds in tissue engineering applications. 
When nanofibers are created in the electrostatic field, they are deposited randomly on 
the collector, layer by layer, and a wide variety of pore diameters (distances between 
fibers) are formed [27, 34, 52, 57, 153]. However, the strongest limitations of 
nanofibrous structures are their inherent two-dimensional character and the difficulty 
in controlling pore size. In most TE applications it is desirable to have scaffolds with a 
pore size that enables migration of the cells into the inner regions of the structure. 
The cells must remain viable, thus requiring an efficient exchange of nutrients and 
metabolites with the culture medium. The porosity of the electrospun meshes hinders 
the migration of cells, but is suitable for diffusion of nutrients and metabolites. Thus, 
new developments of the technology are needed to overcome the difficulty of cell 
migration when seeded at the mesh surface. Furthermore, the degree of porosity 
always influences other properties of the scaffolds such as its mechanical stability, 
and its value should always be balanced with the mechanical needs of the particular 
tissue that is targetted.  
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 The purpose of a scaffold is not only to provide a surface for cell residence but 
also to maintain mechanical stability at the host defect site. Mechanical stability is 
dependent primarily on the selection of the biomaterial, the architectural design of the 
scaffold, and the cell-material interactions [59, 166]. A well designed tissue 
engineered scaffold has to meet, at least, two mechanical requirements to be 
effective. The scaffold must retain structural integrity and stability when a physician 
handles and implants it into the defect site of the host. After surgery, the structure at 
the implant site must provide sufficient biomechanical support during the process of 
tissue regeneration and structure degradation. Electrospun fibers have 
nanostructured surface morphologies with small pores that influence mechanical 
properties like tensile strength and modulus [55, 122, 153, 157]. Also, aligned 
nanofiber composites provide better mechanical properties than a randomly aligned 
nanofiber composite structure [73, 190]. 
 It is also highly desirable to use processing methods that are efficient and that 
can be used to regulate the chemical, biological and material properties of the 
fabricated matrix [59, 166]. Methods such as solvent casting [181, 184, 185], fiber 
bonding [56, 176, 180, 191], injection moulding [172, 173, 175, 186-188], and rapid 
prototyping [174, 177, 178, 183, 189], among others, have been used for the 
fabrication of porous scaffolds. These scaffolds were proposed for tissue engineering 
of various tissues including bone, cartilage, tendon, blood vessel and heart valve 
[100, 103, 104, 165, 192]. However, most of the scaffolds could only replace the lost 
tissue physically but not functionally [193]. In electroprocessing, the shape of the 
scaffolding and orientation of fibers within an engineered matrix can be regulated by 
controlling the motion of target mandrel and source polymeric solution. Presumably, 
the incorporation of various degrees of cross-linking into this type of nonwoven matrix 
can be used to further tailor the material properties of the matrix to specific 
applications. As a processing strategy, electrospinning is rapid, efficient and 
inexpensive, and can be used to fabricate complex, reliable scaffolds. For example, 
blends [55] or laminates [54] of different materials can be produced with this 
technique. Electrospinning can even be used to incorporate slight structural 
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adjustments into an engineered material by regulating the orientation of nanofibers 
within the fabricated network [46, 83, 86-88]. 
 A significant advantage of the electrospinning process is the ability to fabricate 
non-woven, nanometre-scale fibrous structures [14]. The architecture of the scaffold 
is dynamically changed as the polymer fibers are hydrolyzed and degraded over time, 
which allows the colonising cells to build up their own ECM [33]. Indeed, the main 
goal of tissue engineering approach is to develop a biocompatible scaffold material 
which is degradable over a controllable time scale into non-toxic products that may 
disappear together with new tissue formation, leaving natural tissue replacement 
[167]. Thus, an electrospun structure composed of ultrafine nanofibers would be more 
susceptible to hydrolysis than thicker fibers when used to culture cells for tissue 
engineering applications, because of enhanced water contact due to the large surface 
area [22]. However, the molecular weight decrease during in vitro degradation of 
electrospun PCL materials were much lower than those for solvent casted PCL films, 
which may be due to enhanced diffusion of oligomers out of the fibers (as a result of 
high surface/volume ratio), which would reduce the effects of autocatalytic 
degradation [194]. Bolgen and colleagues [194] demonstrated a faster degradation 
rate in vivo than in vitro, attributed to the enzymatic degradation of PCL in addition to 
the hydrolytic degradation. Recently, Liang and collaborators [138] established that 
the biodegradation rate, as well as the hydrophilicity of the electrospun scaffolds, 
could be finely turned with different material compositions (PLGA or PLA-b -PEG-b -
PLA triblock copolymer and DNA). It was demonstrated that the electrospun scaffold 
containing those four compositions, which exhibited an ideal biodegradation profile, 
good hydrophilicity, and stable mechanical properties in aqueous conditions, was 
suitable for biomedical applications including biodegradable scaffolds for tissue 
engineering and prevention of post-operative adhesions [28]. 
 
1.6. Future perspectives 
 
Electrospinning is a relatively old technology [7], which was appeared in the 
literature for more than 70 years. Despite the progress made in process modification 
and control, considerable challenges remain. 
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Improved process models needed to achieve better understanding of the 
mechanisms and to explain observed phenomena such as nanofibers pore formation 
during electrospinning [9] and hollow fibers formation [77, 79-82]. Another need is to 
model nanofiber deposition on substrates, both stationary and moving, to improve the 
nanofiber alignment when using newly developed processes [11, 65, 73, 83-96], 
which may itself lead to the development of novel techniques. Models for multiple jet 
electrospinning should also be improved, as well as the modelling of jet interactions 
[195]. It is unclear, at this stage, as to what extent the aggregation and conformation 
of polymer chains are affected by the electrospinning process. Those changes are 
mainly related to the solvent used. The solvents have a crucial role since they are 
expected to solvate the polymer molecules, thus forming the electrified solution jet. A 
systematic study regarding the influence of the type of solvent and polymer 
concentration on the polymer chain conformation and, consequently, in the properties 
of the polymer structure and morphology in the nanofiber meshes, is needed. In 
summary, a fundamental experimental and theoretical analysis of the process is 
needed to develop flexible and reliable methods to fabricate nanofibers and their 
assemblies and composites [196]. 
To date, most of the electrospun fibers obtained have been synthetic. More 
attention should be given to natural biopolymers (e.g. chitin, chitosan, alginate, 
starch, hyaluronic acid and dextran), with the aim of achieving fibers with better 
biocompatibility and performance. The present authors believe that the successful 
conversion of natural biopolymers into ultrafine and nanofibrous structures will 
provide new opportunities and enhance the possibilities of their use in bioengineering 
and other demanding applications. 
 A number of authors successfully encapsulated drugs into electrospun fibers 
by mixing or dissolving the drugs in the electrospun polymeric solution. However, the 
encapsulation of proteins is yet to be studied in detail, despite their biochemical 
importance as signalling agents for tissue engineering applications. Core/sheath or 
hollow nanofibers are a more recent revolutionary product of electrospinning. 
Application of those structures in tissue engineering and regenerative medicine will, it 
is hoped, allow drugs, growth factors, enzymes, peptides or even DNA to be 
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embedded into the core of biodegradable polymer nanofibers, and released as 
required [19]. In addition, using a synthetic polymer as the core material and natural 
polymer as the shell material, nanofibers with strong mechanical strength and good 
biocompatibility should be obtained [54]. In addition, using this method, strong 
inflammatory reactions could be avoided. It is also possible to speculate that the 
fabrication of hollow nanofibers with multiple walls by using more complex spinnerets 
composed of more than two coaxial capillaries may be technically feasible [18]. 
Recently [197, 198], the possibility of producing encapsulated cells in 
microfibers (so-called microthreads by the authors) and meshes by the 
electrospinning technology has been explored (Figure 1.10). In this approach, 
immortalized (human brain astrocytoma cell line) and primary cells (porcine vascular 
and rabbit aorta smooth muscle cells) were loaded into poly(dimethylsiloxane) 
(PDMS) nanofibers, using a coaxial needle configuration. It was demonstrated that 
electrospun cells remain viable over long culture periods, showing no evidence of 
cellular damage. Works pioneering the incorporation of living cells into electrospun 
nanofibers were carried out by Lee et al. [199] and Salalha et al. [200], demonstrating 
efficient encapsulation of viruses (M13) and bacteria (Escherichia coli and
 
 
Figure 1.10 - Image from the electrospinning process embedding living cells in the 
fiber structure. (adapted from the reference [198]). 
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Staphylococcus albus). Another approach [201, 202] used rat aorta vascular SMCs 
electrosprayed simultaneously with elecrospun poly(ester urethane) urea to produce 
a hybrid tissue engineered construct. This approach, denominated by ‘cellular 
microintegration’, was proposed in the context of blood vessel replacement, aiming at 
seed the cells during the fabrication of nanofibrous tubular scaffolds. Indeed, these 
biomicrofabrication methods allow the production of biohybrid scaffolds with 
promising applications in regenerative medicine, an approach that will surely be 
further explored in future. 
Biomaterial scaffolds are designed to support cell and tissue growth, aiming on 
a macroscopic level to match the properties of the organs to be replaced, without 
being able to recreate the complexity and nanoscale detail observed in real organs at  
the level of the matrix interaction [102]. The ability to engineer materials to a similar 
level of complexity may become a reality, through the fabrication of novel 
biodegradable polymeric matrices by combining electrospinning methodologies with 
well-established techniques for materials processing (e.g. injection moulding, solvent 
casting, 3D plotting). For example, a three-dimensional micro-/nanostructure 
comprising electrospun nanofibers deposited on a wet-spun microfibers scaffold has 
recently been developed [56] (Figure 1.11). Its biological functionality was 
demonstrated by the culturing of human osteoblast-like cells, bone marrow stromal
 
 
Figure 1.11 – Optical micrograph (A) of micro-nano fiber combined scaffolds. SEM 
micrograph (B) of human osteoblast like cells (Saos-2) seeded on nano and micro-
fiber combined scaffolds after 14 days of culture (adapted from the reference [56]). 
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cells and endothelial cells (HUVECs and microvascular endothelial cells) [56, 203, 
204]. This hierarchical structure was developed to mimic the highly organized fibrous 
structure of bone tissue, not forgetting the vascular system. Combining 
nanostructured scaffolds with the incorporation of biological signals into the scaffold 
fabric is also likely to prove a most rewarding approach [162]. 
 
1.7. Conclusions 
 
Numerous studies reported the use of electrospun fiber meshes in tissue 
engineering. However, some technical barriers remain uncrossed and many possible 
configurations of the process were not fully exploited. Despite the high level of 
porosity and high specific surface area of the non-woven fiber meshes, the pore size 
usually is too narrow to allow cell migration through the inner regions of the fiber 
mesh scaffolds. This is the most serious limitation of these structures, and may 
compromise its use in the regeneration of tissues. Variations in the electrospinning 
setup or in the deposition pattern may be valuable strategies to control pore size. 
Strategies already suggested in the literature include the use of porogen agents such 
as salt particles [205] or chemical blowing agent [206]. Most biological studies with 
electrospun nanofiber meshes show that cells tend to stay at their surfaces. This 
behaviour is observed even when the pore size is sufficiently large to allow cells to 
migrate into the inner regions of the mesh scaffolds. Coating with cell-affine materials 
such as collagen was proposed to facilitate cell ingrowth into the core of meshes 
[122, 207]. 
Other limitation of the electrospun nanofiber meshes in tissue engineering is 
the typical two-dimensional thin structure. Fibrous meshes are generally obtained as 
planar sheets, which may limit the applicability of those structures to the regeneration 
of layered tissues. During processing, the time of deposition may be increased in 
order to produce 3D structures. However, in practice this is not feasible, since this 
way it is progressively more difficult to control the fiber deposition process. By 
complementing or associating electrospinning with other techniques, it may be 
possible to obtain macroporous structures with tissue-scale motifs, this being a 
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promising strategy to produce scaffolds that combine good mechanical properties and 
adequate topography for cell fixation. In our understanding, much more effort is 
required to produce 3D stable macroporous structures, exploring the advantages of 
electrospun fiber meshes and avoiding their limitations. The production of mesh 
structures together with well-controlled properties and architecture of individual fibers, 
such as alignment, would enable the production of structures that would have a huge 
impact in the tissue engineering field. 
Appropriate biomaterials tuned for specific cell types have also unsolved 
challenges. As previously mentioned, different cell types behave and react according 
to the fiber composition [119]. Efforts to improve cell attachment may include bulk 
modification [39, 146] or surface activation [31, 122, 125, 147, 208] of the fiber 
meshes. Both strategies have been followed to improve interactions of specific cell 
types with the surface of fiber meshes. Eventual residual solvent in the meshes is 
another subject that is not sufficiently discussed and that might considerably affect 
the cell viability and the efficacy of these meshes as supports for tissue engineering. 
 
1.8. References 
 
1. Huang ZM, Zhang YZ, Kotaki M, Ramakrishna S. A review on polymer 
nanofibers by electrospinning and their applications in nanocomposites. Composites 
Science and Technology 2003; 63(15):2223-2253. 
2. Smith LA, Ma PX. Nano-fibrous scaffolds for tissue engineering. Colloid 
Surface B 2004; 39(3):125-131. 
3. Doshi J, Reneker DH. Electrospinning process and applications of 
electrospun fibers. Journal of Electrostatics 1995; 35(2-3):151-160. 
4. Van Vaeck L, Adriaens A, Gijbels R. Static secondary ion mass 
spectrometry: (S-SIMS) part 1. Methodology and structural interpretation. Mass 
Spectrometry Reviews 1999; 18(1):1-47. 
5. Briggs D. Surface analysis of polymers by XPS and static SIMS. Cambridge, 
UK: Cambridge University Press, 1998. 
Electrospi nning for Tissue Engineering Scaffolding  
43 
6. Gañán-Calvo AM, Dávila J, Barrero A. Current and droplet size in the 
electrospraying of liquids. Scaling laws. Journal of Aerosol Science 1997; 28(2):249-
275. 
7. Formhals A, inventor. Process and apparatus for preparing artificial threads. 
USPatent 1975504, 1934. 
8. Taylor G. Disintegration of water drops in an electric filed. Proceedings of 
Royal Society A 1964; 280:383-397. 
9. Bognitzki M, Czado W, Frese T, Schaper A, Hellwig M, Steinhart M, et al. 
Nanostructured fibers via electrospinning. Advanced Materials 2001; 13(1):70-72. 
10. Deitzel JM, Kleinmeyer J, Harris D, Beck Tan NC. The effect of processing 
variables on the morphology of electrospun nanofibers and textiles. Polymer 2001; 
42(1):261-272. 
11. Deitzel JM, Kleinmeyer JD, Hirvonen JK, Beck Tan NC. Controlled 
deposition of electrospun poly(ethylene oxide) fibers. Polymer 2001; 42(19):8163-
8170. 
12. Frenot A, Chronakis IS. Polymer nanofibers assembled by electrospinning. 
Current Opinion on Colloid and Interface Science 2003; 8(1-2):64-67. 
13. Megelski S, Stephens JS, Bruce Chase D, Rabolt JF. Micro- and 
nanostructured surface morphology on electrospun polymer fibers. Macromolecules 
2002; 35(22):8456-8466. 
14. Reneker DH, Chun I. Nanometre diameter fibres of polymer, produced by 
electrospinning. Nanotechnology 1996; 7(3):216-223. 
15. Tan SH, Inai R, Kotaki M, Ramakrishna S. Systematic parameter study for 
ultra-fine fiber fabrication via electrospinning process. Polymer 2005; 46(16):6128-
6134. 
16. Yarin AL, Koombhongse S, Reneker DH. Bending instability in 
electrospinning of nanofibers. Journal of Applied Physics 2001; 89(5):3018-3026. 
17. Dersch R, Steinhart M, Boudriot U, Greiner A, Wendorff JH. 
Nanoprocessing of polymers: applications in medicine, sensors, catalysis, photonics. 
Polymers for Advanced Technologies 2005; 16(2-3):276-282. 
 44 
18. Li D, Xia YN. Electrospinning of nanofibers: Reinventing the wheel? 
Advanced Materials 2004; 16(14):1151-1170. 
19. Ma ZW, Kotaki M, Inai R, Ramakrishna S. Potential of nanofiber matrix as 
tissue-engineering scaffolds. Tissue Engineering 2005; 11(1-2):101-109. 
20. Subbiah T, Bhat GS, Tock RW, Pararneswaran S, Ramkumar SS. 
Electrospinning of nanofibers. Journal of Applied Polymer Science 2005; 96(2):557-
569. 
21. Baker BM, Mauck RL. The effect of nanofiber alignment on the maturation 
of engineered meniscus constructs. Biomaterials 2007; 28(11):1967-1977. 
22. Li WJ, Danielson KG, Alexander PG, Tuan RS. Biological response of 
chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) 
scaffolds. Journal of Biomedical Materials Research, Part A 2003; 67A(4):1105-1114. 
23. Li WJ, Mauck RL, Cooper JA, Yuan X, Tuan RS. Engineering controllable 
anisotropy in electrospun biodegradable nanofibrous scaffolds for musculoskeletal 
tissue engineering. Journal of Biomechanic 2007; 40(8):1686-1693. 
24. Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, et al. A three-
dimensional nanofibrous scaffold for cartilage tissue engineering using human 
mesenchymal stem cells. Biomaterials 2005; 26(6):599-609. 
25. Neves NM, Campos R, Pedro A, Cunha J, Macedo F, Reis RL. Patterning 
of polymer nanofiber meshes by electrospinning for biomedical applications. 
International Journal of Nanomedicine 2007; 2(3):1-16. 
26. Pham QP, Sharma U, Mikos AG. Electrospun poly(epsilon-caprolactone) 
microfiber and multilayer nanofiber/microfiber scaffolds: Characterization of scaffolds 
and measurement of cellular infiltration. Biomacromolecules 2006; 7(10):2796-2805. 
27. Yoshimoto H, Shin YM, Terai H, Vacanti JP. A biodegradable nanofiber 
scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 
2003; 24(12):2077-2082. 
28. Kim K, Yu M, Zong X, Chiu J, Fang D, Seo YS, et al. Control of 
degradation rate and hydrophilicity in electrospun non-woven poly(D,L-lactide) 
nanofiber scaffolds for biomedical applications. Biomaterials 2003; 24(27):4977-4985. 
Electrospi nning for Tissue Engineering Scaffolding  
45 
29. Yang F, Xu CY, Kotaki M, Wang S, Ramakrishna S. Characterization of 
neural stem cells on electrospun poly(L-lactic acid) nanofibrous scaffold. Journal of 
Biomaterials Science - Polymer Edition 2004; 15(12):1483-1497. 
30. Zeng J, Chen X, Xu X, Liang Q, Bian X, Yang L, et al. Ultrafine fibers 
electrospun from biodegradable polymers. Journal of Applied Polymer Science 2003; 
89(4):1085-1092. 
31. Boland ED, Telemeco TA, Simpson DG, Wnek GE, Bowlin GL. Utilizing 
acid pretreatment and electrospinning to improve biocompatibility of poly(glycolic 
acid) for tissue engineering. Journal of Biomedical Materials Research, Part B - 
Applied Biomaterials 2004; 71B(1):144-152. 
32. Boland ED, Wnek GE, Simpson DG, Pawlowski KJ, Bowlin GL. Tailoring 
tissue engineering scaffolds using electrostatic processing techniques: A study of 
poly(glycolic acid) electrospinning. Journal of Macromolecular Sciences - Pure 
Applied Chemistry 2001; 38(12):1231-1243. 
33. Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK. Electrospun 
nanofibrous structure: A novel scaffold for tissue engineering. Journal of Biomedical 
Materials Research 2002; 60(4):613-621. 
34. Luu YK, Kim K, Hsiao BS, Chu B, Hadjiargyrou M. Development of a 
nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG 
block copolymers. Journal of Controlled Release 2003; 89(2):341-353. 
35. Sahoo S, Ouyang H, Goh JCH, Tay TE, Toh SL. Characterization of a 
novel polymeric scaffold for potential application in tendon/ligament tissue 
engineering. Tissue Engineering 2006; 12(1):91-99. 
36. Xin XJ, Hussain M, Mao JJ. Continuing differentiation of human 
mesenchymal stem cells and induced chondrogenic and osteogenic lineages in 
electrospun PLGA nanofiber scaffold. Biomaterials 2007; 28(2):316-325. 
37. Fang X, Reneker DH. DNA fibers by electrospinning. Journal of 
Macromolecular Science - Physics 1997; 36(2):169-173. 
38. Jin HJ, Chen JS, Karageorgiou V, Altman GH, Kaplan DL. Human bone 
marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials 2004; 
25(6):1039-1047. 
 46 
39. Li CM, Vepari C, Jin HJ, Kim HJ, Kaplan DL. Electrospun silk-BMP-2 
scaffolds for bone tissue engineering. Biomaterials 2006; 27(16):3115-3124. 
40. Min BM, Jeong L, Nam YS, Kim JM, Kim JY, Park WH. Formation of silk 
fibroin matrices with different texture and its cellular response to normal human 
keratinocytes. International Journal of Biololical Macromolecules 2004; 34(5):281-
288. 
41. Min BM, Lee G, Kim SH, Nam YS, Lee TS, Park WH. Electrospinning of 
silk fibroin nanofibers and its effect on the adhesion and spreading of normal human 
keratinocytes and fibroblasts in vitro. Biomaterials 2004; 25(7-8):1289-1297. 
42. McManus MC, Boland ED, Simpson DG, Barnes CP, Bowlin GL. 
Electrospun fibrinogen: Feasibility as a tissue engineering scaffold in a rat cell culture 
model. Journal of Biomedical Materials Research, Part A 2007; 81A(2):299-309. 
43. Wnek GE, Carr ME, Simpson DG, Bowlin GL. Electrospinning of nanofiber 
fibrinogen structures. Nano Letters 2003; 3(2):213-216. 
44. Jiang H, Fang D, Hsiao BS, Chu B, Chen W. Optimization and 
characterization of dextran membranes prepared by electrospinning. 
Biomacromolecules 2004; 5(2):326-333. 
45. Matthews JA, Boland ED, Wnek GE, Simpson DG, Bowlin GL. 
Electrospinning of collagen type II: A feasibility study. Journal of Bioactive and 
Compatible Polymers 2003; 18(2):125-134. 
46. Matthews JA, Wnek GE, Simpson DG, Bowlin GL. Electrospinning of 
collagen nanofibers. Biomacromolecules 2002; 3(2):232-238. 
47. Zhong SP, Teo WE, Zhu X, Beuerman RW, Ramakrishna S, Yung LYL. An 
aligned nanofibrous collagen scaffold by electrospinning and its effects on in vitro 
fibroblast culture. Journal of Biomedical Materials Research, Part A 2006; 
79A(3):456-463. 
48. Sefcik LS, Neal RA, Kaszuba SN, Parker AM, Katz AJ, Ogle RC, et al. 
Collagen nanofibres are a biomimetic substrate for the serum-free osteogenic 
differentiation of human adipose stem cells. Journal of Tissue Engineering and 
Regenerative Medicine 2008; 2(4):210-220. 
Electrospi nning for Tissue Engineering Scaffolding  
47 
49. Geng XY, Kwon OH, Jang JH. Electrospinning of chitosan dissolved in 
concentrated acetic acid solution. Biomaterials 2005; 26(27):5427-5432. 
50. Ohkawa K, Cha DI, Kim H, Nishida A, Yamamoto H. Electrospinning of 
chitosan. Macromolecular Rapid Communications 2004; 25(18):1600-1605. 
51. Huang L, Nagapudi K, Apkarian RP, Chaikof EL. Engineered collagen - 
PEO nanofibers and fabrics. Journal of Biomaterials Science - Polymer Edition 2001; 
12(9):979-993. 
52. Jiang HL, Fang DF, Hsiao BJ, Chu BJ, Chen WL. Preparation and 
characterization of ibuprofen-loaded poly(lactide-co-glycolide)/poly(ethylene glycol)-g-
chitosan electrospun membranes. Journal of Biomaterials Science - Polymer Edition 
2004; 15(3):279-296. 
53. Min BM, You Y, Kim JM, Lee SJ, Park WH. Formation of nanostructured 
poly(lactic-co-glycolic acid)/chitin matrix and its cellular response to normal human 
keratinocytes and fibroblasts. Carbohydrate Polymers 2004; 57(3):285-292. 
54. Zhang YZ, Huang ZM, Xu XJ, Lim CT, Ramakrishna S. Preparation of 
core-shell structured PCL-r-gelatin Bi-component nanofibers by coaxial 
electrospinning. Chemistry of Materials 2004; 16(18):3406-3409. 
55. Zhang YZ, Ouyang HW, Lim CT, Ramakrishna S, Huang ZM. 
Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds. Journal 
of Biomedical Materials Research, Part B - Applied Biomaterials 2005; 72B(1):156-
165. 
56. Tuzlakoglu K, Bolgen N, Salgado AJ, Gomes ME, Piskin E, Reis RL. Nano- 
and micro-fiber combined scaffolds: A new architecture for bone tissue engineering. 
Journal Materials Science: Materials in Medicine 2005; 16(12):1099-1104. 
57. Khil MS, Bhattarai SR, Kim HY, Kim SZ, Lee KH. Novel fabricated matrix 
via electrospinning for tissue engineering. Journal of Biomedical Materials Research, 
Part B - Applied Biomaterials 2005; 72B(1):117-124. 
58. Rutledge GC, Fridrikh SV. Formation of fibers by electrospinning. 
Advanced Drug Delivery Reviews 2007; 59(14):1384-1391. 
 48 
59. Agrawal CM, Ray RB. Biodegradable polymeric scaffolds for 
musculoskeletal tissue engineering. Journal of Biomedical Materials Research 2001; 
55(2):141-150. 
60. Greiner A, Wendorff JH, Yarin AL, Zussman E. Biohybrid nanosystems 
with polymer nanofibers and nanotubes. Applied Microbiology and Biotechnology 
2006; 71(4):387-393. 
61. Murugan R, Ramakrishna S. Design Strategies of Tissue Engineering 
Scaffolds with Controlled Fiber Orientation. Tissue Engineering 2007; 13:1845-1866. 
62. Ashammakhi N, Ndreu A, Piras AM, Nikkola L, Sindelar T, Ylikauppila H, et 
al. Biodegradable nanomats produced by electrospinning: Expanding 
multifunctionality and potential for tissue engineering. Journal of Nanoscience and 
Nanotechnology 2007; 7(3):862-882. 
63. Barnes CP, Sell SA, Boland ED, Simpson DG, Bowlin GL. Nanofiber 
technology: Designing the next generation of tissue engineering scaffolds. Advanced 
Drug Delivery Reviews 2007; 59(14):1413-33. 
64. Pham QP, Sharma U, Mikos AG. Electrospinning of polymeric nanofibers 
for tissue engineering applications: a review. Tissue Engineering 2006; 12(5):1197-
1211. 
65. Teo WE, Ramakrishna S. Electrospun fibre bundle made of aligned 
nanofibres over two fixed points. Nanotechnology 2005; 16(9):1878-1884. 
66. Zhang YZ, Lim CT, Ramakrishna S, Huang ZM. Recent development of 
polymer nanofibers for biomedical and biotechnological applications. Journal of 
Materials Science: Materials in Medicine 2005; 16(10):933-946. 
67. Li WJ, Mauck RL, Tuan RS. Electrospun nanofibrous scaffolds: production, 
characterization, and applications for tissue engineering and drug delivery. Journal of 
Biomedical Nanotechnology 2005; 1:259-275. 
68. Martins A, Araujo JV, Reis RL, Neves NM. Electrospun nanostructured 
scaffolds for tissue engineering applications. Nanomedicine 2007; 2(6):929-942. 
69. Ndreu A, Nikkola L, Ylikauppila H, Ashammakhi N, Hasirci V. Electrospun 
biodegradable nanofibrous mats for tissue engineering. Nanomedicine 2008; 3(1):45-
60. 
Electrospi nning for Tissue Engineering Scaffolding  
49 
70. Bognitzki M, Frese T, Steinhart M, Greiner A, Wendorff JH, Schaper A, et 
al. Preparation of fibers with nanoscaled morphologies: electrospinning of polymer 
blends. Polymer Engineering and Science 2001; 41(6):982-989. 
71. Koombhongse S, Liu W, Reneker DH. Flat polymer ribbons and other 
shapes by electrospinning. Journal of Polymer Science, Part B: Polymer Physics 
2001; 39(21):2598-2606. 
72. MacDiarmid AG, Jones Jr WE, Norris ID, Gao J, Johnson Jr AT, Pinto NJ, 
et al. Electrostatically-generated nanofibers of electronic polymers. Synthetic Metals 
2001; 119(1-3):27-30. 
73. Kim JS, Reneker DH. Polybenzimidazole nanofiber produced by 
electrospinning. Polymer Engineering and Science 1999; 39(5):849-854. 
74. Lyons J, Li C, Ko F. Melt-electrospinning part I: Processing parameters and 
geometric properties. Polymer 2004; 45(22):7597-7603. 
75. Hsu CM, Shivkumar S. Nano-sized beads and porous fiber constructs of 
Poly(ε-caprolactone) produced by electrospinning. Journal of Materials Science 2004; 
39(9):3003-3013. 
76. Fang D, Hsiao BS, Chu B. Development of multiple-jet electrospinning 
technology for mass production of nanofibers.  14th Annual International TANDEC 
Nonwovens Conference 2004; 1-11. 
77. Li D, Xia YN. Direct fabrication of composite and ceramic hollow nanofibers 
by electrospinning. Nano Letters 2004; 4(5):933-938. 
78. Yu JH, Fridrikh SV, Rutledge GC. Production of submicrometer diameter 
fibers by two-fluid electrospinning. Advanced Materials 2004; 16(17):1562-1566. 
79. Huang ZM, Zhang Y, Ramakrishna S. Double-layered composite 
nanofibers and their mechanical performance. Journal of Polymer Science, Part B: 
Polymer Physics 2005; 43(20):2852-2861. 
80. Jiang HL, Hu YQ, Zhao PC, Li Y, Zhu KJ. Modulation of protein release 
from biodegradable core-shell structured fibers prepared by coaxial electrospinning. 
Journal of Biomedical Materials Research, Part B - Applied Biomaterials 2006; 
79B(1):50-57. 
 50 
81. Li D, Babel A, Jenekhe SA, Xia YN. Nanofibers of conjugated polymers 
prepared by electrospinning with a two-capillary spinneret. Advanced Materials 2004; 
16(22):2062-2066. 
82. Loscertales IG, Barrero A, Marquez M, Spretz R, Velarde-Ortiz R, Larsen 
G. Electrically forced coaxial nanojets for one-step hollow nanofiber design. Journal of 
the American Chemistry Society 2004; 126(17):5376-5377. 
83. Lee CH, Shin HJ, Cho IH, Kang YM, Kim IA, Park KD, et al. Nanofiber 
alignment and direction of mechanical strain affect the ECM production of human 
ACL fibroblast. Biomaterials 2005; 26(11):1261-1270. 
84. Nerurkar NL, Elliott DM, Mauck RL. Mechanics of oriented electrospun 
nanofibrous scaffolds for annulus fibrosus tissue engineering. Journal of Orthopaedic 
Research 2007. 
85. Sundaray B, Subramanian V, Natarajan TS, Xiang RZ, Chang CC, Fann 
WS. Electrospinning of continuous aligned polymer fibers. Applied Physics Letters 
2004; 84(7):1222-1224. 
86. Teo WE, Kotaki M, Mo XM, Ramakrishna S. Porous tubular structures with 
controlled fibre orientation using a modified electrospinning method. Nanotechnology 
2005; 16(6):918-924. 
87. Xu CY, Inai R, Kotaki M, Ramakrishna S. Aligned biodegradable 
nanofibrous structure: a potential scaffold for blood vessel engineering. Biomaterials 
2004; 25(5):877-886. 
88. Yang F, Murugan R, Wang S, Ramakrishna S. Electrospinning of 
nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue 
engineering. Biomaterials 2005; 26(15):2603-2610. 
89. Theron A, Zussman E, Yarin AL. Electrostatic field-assisted alignment of 
electrospun nanofibres. Nanotechnology 2001; 12(3):384-390. 
90. Fong H, Liu W, Wang CS, Vaia RA. Generation of electrospun fibers of 
nylon 6 and nylon 6-montmorillonite nanocomposite. Polymer 2002; 43(3):775-780. 
91. Li D, Wang YL, Xia YN. Electrospinning of polymeric and ceramic 
nanofibers as uniaxially aligned arrays. Nano Letters 2003; 3(8):1167-1171. 
Electrospi nning for Tissue Engineering Scaffolding  
51 
92. Dersch R, Liu TQ, Schaper AK, Greiner A, Wendorff JH. Electrospun 
nanofibers: Internal structure and intrinsic orientation. Journal of Polymer Science, 
Part A - Polymer Chemistry 2003; 41(4):545-553. 
93. Li D, Wang YL, Xia YN. Electrospinning nanofibers as uniaxially aligned 
arrays and layer-by-layer stacked films. Advanced Materials 2004; 16(4):361-366. 
94. Schnell E, Klinkhammer K, Balzer S, Brook G, Klee D, Dalton P, et al. 
Guidance of glial cell migration and axonal growth on electrospun nanofibers of poly-
epsilon-caprolactone and a collagen/poly-epsilon-caprolactone blend. Biomaterials 
2007; 28(19):3012-3025. 
95. Katta P, Alessandro M, Ramsier RD, Chase GG. Continuous 
electrospinning of aligned polymer nanofibers onto a wire drum collector. Nano 
Letters 2004; 4(11):2215-2218. 
96. Dalton PD, Klee D, Moller M. Electrospinning with dual collection rings. 
Polymer 2005; 46(3):611-614. 
97. Czaplewski DA, Verbridge SS, Kameoka J, Craighead HG. 
Nanomechanical oscillators fabricated using polymeric nanofiber templates. Nano 
Letters 2004; 4(3):437-439. 
98. Liu H, Kameoka J, Czaplewski DA, Craighead HG. Polymeric nanowire 
chemical sensor. Nano Letters 2004; 4(4):671-675. 
99. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular 
Biology of the Cell. Fourth Edition ed. London, UK: Garland Science, 2002. 
100. Seal BL, Otero TC, Panitch A. Polymeric biomaterials for tissue and organ 
regeneration. Materials Science and Engineering: Reports 2001; 34(4-5):147-230. 
101. Zagris N. Extracellular matrix in development of the early embryo. Micron 
2001; 32(4):427-438. 
102. Stevens MM, George JH. Exploring and engineering the cell surface 
interface. Science 2005; 310(5751):1135-1138. 
103. Gomes ME, Reis RL. Biodegradable polymers and composites in 
biomedical applications: From catgut to tissue engineering Part 1 Available systems 
and their properties. International Materials Reviews 2004; 49(5):261-273. 
 52 
104. Gomes ME, Reis RL. Tissue engineering: Key elements and some trends. 
Macromolecular Bioscience 2004; 4(8):737-742. 
105. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260(5110):920-
926. 
106. Layman JM, Kenawy E-R, Watkins JR, Carrjr ME, Bowlin GL, Wnek GE. 
Development of the Biohemostat - a treatment modality for high pressure bleeding 
based on super absorbent polymer and electrospun membranes. Polymer Preprints 
2003; 44:94-95. 
107. Khil MS, Cha DI, Kim HY, Kim IS, Bhattarai N. Electrospun nanofibrous 
polyurethane membrane as wound dressing. Journal of Biomedical Materials 
Research, Part B - Applied Biomaterials 2003; 67B(2):675-679. 
108. Kenawy ER, Layman JM, Watkins JR, Bowlin GL, Matthews JA, Simpson 
DG, et al. Electrospinning of poly(ethylene-co-vinyl alcohol) fibers. Biomaterials 2003; 
24(6):907-913. 
109. Rho KS, Jeong L, Lee G, Seo BM, Park YJ, Hong SD, et al. 
Electrospinning of collagen nanofibers: Effects on the behavior of normal human 
keratinocytes and early-stage wound healing. Biomaterials 2006; 27(8):1452-1461. 
110. Powell HM, Supp DM, Boyce ST. Influence of electrospun collagen on 
wound contraction of engineered skin substitutes. Biomaterials 2008; 29(7):834-843. 
111. How TV, inventor. Synthetic vascular grafts, and methods of 
manufacturing such grafts. U.S.Patent 4552707, 1985. 
112. Stenoien MD, Drasler WJ, Scott RJ, Jenson ML, inventors. Silicone 
composite vascular graft. U.S.Patent 5866217, 1999. 
113. Pinchuk L, Martin Jr JB, Maurin AA, inventors. Breast prostheses. 
U.S.Patent 5376117, 1994. 
114. Buchko CJ, Kozloff KM, Sioshansi A, O'Shea KS, Martin DC. Electric field 
mediated deposition of bioactive polypeptides on neural prosthetic devices.  Materials 
Research Society Symposium - Proceedings; 1996; Boston, MA, USA: Materials 
Research Society; 1996. p. 23-28. 
Electrospi nning for Tissue Engineering Scaffolding  
53 
115. Vinard E, Lesèche G, Andreassian B, Costagliola D. In vitro 
endothelialization of PTFE vascular grafts: A comparison of various substrates, cell 
densities, and incubation times. Annals of Vascular Surgery 1999; 13(2):141-150. 
116. Williams SK, Jarrell BE. Tissue-engineered vascular grafts. Nature 
Medicine 1996; 2(1):32-34. 
117. Stitzel JD, Pawlowski KJ, Wnek GE, Simpson DG, Bowlin GL. Arterial 
smooth muscle cell proliferation on a novel biomimicking, biodegradable vascular 
graft scaffold. Journal of Biomaterials Applications 2001; 16(1):22-33. 
118. Venugopal J, Zhang YZ, Ramakrishna S. Fabrication of modified and 
functionalized polycaprolactone nanofibre scaffolds for vascular tissue engineering. 
Nanotechnology 2005; 16(10):2138-2142. 
119. Xu CY, Yang F, Wang S, Ramakrishna S. In vitro study of human 
vascular endothelial cell function on materials with various surface roughness. 
Journal of Biomedical Materials Research, Part A 2004; 71A(1):154-161. 
120. Mo XM, Xu CY, Kotaki M, Ramakrishna S. Electrospun P(LLA-CL) 
nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial 
cell proliferation. Biomaterials 2004; 25(10):1883-1890. 
121. Xu CY, Inai R, Kotaki M, Ramakrishna S. Electrospun nanofiber 
fabrication as synthetic extracellular matrix and its potential for vascular tissue 
engineering. Tissue Engineering 2004; 10(7-8):1160-1168. 
122. He W, Ma ZW, Yong T, Teo WE, Ramakrishna S. Fabrication of collagen-
coated biodegradable polymer nanofiber mesh and its potential for endothelial cells 
growth. Biomaterials 2005; 26(36):7606-7615. 
123. Jeong SI, Kim SY, Cho SK, Chong MS, Kim KS, Kim H, et al. Tissue-
engineered vascular grafts composed of marine collagen and PLGA fibers using 
pulsatile perfusion bioreactors. Biomaterials 2007; 28(6):1115-1122. 
124. Stitzel J, Liu L, Lee SJ, Komura M, Berry J, Soker S, et al. Controlled 
fabrication of a biological vascular substitute. Biomaterials 2006; 27(7):1088-1094. 
125. Ma ZW, Kotaki M, Yong T, He W, Ramakrishna S. Surface engineering of 
electrospun polyethylene terephthalate (PET) nanofibers towards development of a 
new material for blood vessel engineering. Biomaterials 2005; 26(15):2527-2536. 
 54 
126. Verreck G, Chun I, Peeters J, Rosenblatt J, Brewster ME. Preparation 
and characterization of nanofibers containing amorphous drug dispersions generated 
by electrostatic spinning. Pharmaceutical Research 2003; 20(5):810-817. 
127. Kenawy ER, Bowlin GL, Mansfield K, Layman J, Simpson DG, Sanders 
EH, et al. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-
vinylacetate), poly(lactic acid), and a blend. Journal of Controlled Release 2002; 81(1-
2):57-64. 
128. Zong XH, Li S, Chen E, Garlick B, Kim KS, Fang DF, et al. Prevention of 
postsurgery-induced abdominal adhesions by electrospun bioabsorbable nanofibrous 
poly(lactide-co-glycolide)-based membranes. Annals of Surgery 2004; 240(5):910-
915. 
129. Verreck G, Chun I, Rosenblatt J, Peeters J, Van Dijck A, Mensch J, et al. 
Incorporation of drugs in an amorphous state into electrospun nanofibers composed 
of a water-insoluble, nonbiodegradable polymer. Journal Of Controlled Release 2003; 
92(3):349-360. 
130. Zeng J, Xu X, Chen X, Liang Q, Bian X, Yang L, et al. Biodegradable 
electrospun fibers for drug delivery. Journal of Controlled Release 2003; 92(3):227-
231. 
131. Kim K, Luu YK, Chang C, Fang DF, Hsiao BS, Chu B, et al. Incorporation 
and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-
based electrospun nanofibrous scaffolds. Journal of Controlled Release 2004; 
98(1):47-56. 
132. Katti DS, Robinson KW, Ko FK, Laurencin CT. Bioresorbable nanofiber-
based systems for wound healing and drug delivery: Optimization of fabrication 
parameters. Journal of Biomedical Materials Research, Part B - Applied Biomaterials 
2004; 70B(2):286-296. 
133. Zong XH, Kim K, Fang DF, Ran SF, Hsiao BS, Chu B. Structure and 
process relationship of electrospun bioabsorbable nanofiber membranes. Polymer 
2002; 43(16):4403-4412. 
Electrospi nning for Tissue Engineering Scaffolding  
55 
134. Luong-Van E, Grondahl L, Chua KN, Leong KW, Nurcombe V, Cool SM. 
Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. 
Biomaterials 2006; 27(9):2042-2050. 
135. Chew SY, Wen J, Yim EKF, Leong KW. Sustained release of proteins 
from electrospun biodegradable fibers. Biomacromolecules 2005; 6(4):2017-2024. 
136. Sanders EH, Kloefkorn R, Bowlin GL, Simpson DG, Wnek GE. Two-
phase electrospinning from a single electrified jet: Microencapsulation of aqueous 
reservoirs in poly(ethylene-co-vinyl acetate) fibers. Macromolecules 2003; 
36(11):3803-3805. 
137. Zeng J, Aigner A, Czubayko F, Kissel T, Wendorff JH, Greiner A. 
Poly(vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the 
retardation of enzyme release by additional polymer coatings. Biomacromolecules 
2005; 6(3):1484-1488. 
138. Liang DH, Luu YK, Kim KS, Hsiao BS, Hadjiargyrou M, Chu B. In vitro  
non-viral gene delivery with nanofibrous scaffolds. Nucleic Acids Research 2005; 
33(19):1-8. 
139. Li WJ, Tuli R, Huang XX, Laquerriere P, Tuan RS. Multilineage 
differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous 
scaffold. Biomaterials 2005; 26(25):5158-5166. 
140. Subramanian A, Vu D, Larsen GF, Lin HY. Preparation and evaluation of 
the electrospun chitosan/PEO fibers for potential applications in cartilage tissue 
engineering. Journal of Biomaterials Science - Polymer Edition 2005; 16(7):861-873. 
141. Bhattarai N, Edmondson D, Veiseh O, Matsen FA, Zhang MQ. 
Electrospun chitosan-based nanofibers and their cellular compatibility. Biomaterials 
2005; 26(31):6176-6184. 
142. Alves da Silva M, Crawford A, Mundy J, Martins A, Araujo JV, Hatton PV, 
et al. Evaluation of extracellular matrix formation in PCL and SPCL nanofiber meshes 
when seeded with bovine articular chondrocytes. Tissue Engineering, Part A 2009, 
15:377-385. 
 56 
143. Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using 
mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue 
Engineering 2004; 10(1-2):33-41. 
144. Boudriot U, Goetz B, Dersch R, Greiner A, Wendorff JH. Role of 
electrospun nanofibers in stem cell technologies and tissue engineering. 
Macromolecular Symposia 2005; 225:9-16. 
145. Fujihara K, Kotaki M, Ramakrishna S. Guided bone regeneration 
membrane made of polycaprolactone/calcium carbonate composite nano-fibers. 
Biomaterials 2005; 26(19):4139-4147. 
146. Wutticharoenmongkol P, Sanchavanakit N, Pavasant P, Supaphol P. 
Preparation and characterization of novel bone scaffolds based on electrospun 
polycaprolactone fibers filled with nanoparticles. Macromolecular Bioscience 2006; 
6(1):70-77. 
147. Araujo JV, Martins A, Leonor IB, Pinho ED, Reis RL, Neves NM. Surface 
Controlled Biomimetic Coating of Polycaprolactone Nanofiber Meshes to Be Used as 
Bone Extracellular Matrix Analogues. Journal of Biomaterials Science - Polymer 
Edition 2008, 19(10):1261-1278. 
148. Nair LS, Bhattacharyya S, Bender JD, Greish YE, Brown PW, Allcock HR, 
et al. Fabrication and optimization of methylphenoxy substituted polyphosphazene 
nanofibers for biomedical applications. Biomacromolecules 2004; 5(6):2212-2220. 
149. Meechaisue C, Wutticharoenmongkol P, Waraput R, Huangjing T, 
Ketbumrung N, Pavasant P, et al. Preparation of electrospun silk fibroin fiber mats as 
bone scaffolds: a preliminary study. Biomedical Materials 2007; 2(3):181-188. 
150. Li MY, Mondrinos MJ, Gandhi MR, Ko FK, Weiss AS, Lelkes PI. 
Electrospun protein fibers as matrices for tissue engineering. Biomaterials 2005; 
26(30):5999-6008. 
151. Flemming RG, Murphy CJ, Abrams GA, Goodman SL, Nealey PF. Effects 
of synthetic micro- and nano-structured surfaces on cell behavior. Biomaterials 1999; 
20(6):573-588. 
152. Wang S, Cui W, Bei J. Bulk and surface modifications of polylactide. 
Analytical and Bioanalytical Chemistry 2005; 381(3):547-556. 
Electrospi nning for Tissue Engineering Scaffolding  
57 
153. Kwon IK, Kidoaki S, Matsuda T. Electrospun nano- to microfiber fabrics 
made of biodegradable copolyesters: structural characteristics, mechanical properties 
and cell adhesion potential. Biomaterials 2005; 26(18):3929-3939. 
154. Shin M, Ishii O, Sueda T, Vacanti JP. Contractile cardiac grafts using a 
novel nanofibrous mesh. Biomaterials 2004; 25(17):3717-3723. 
155. Zong XH, Bien H, Chung CY, Yin LH, Fang DF, Hsiao BS, et al. 
Electrospun fine-textured scaffolds for heart tissue constructs. Biomaterials 2005; 
26(26):5330-5338. 
156. Riboldi SA, Sadr N, Pigini L, Neuenschwander P, Simonet M, Mognol P, 
et al. Skeletal myogenesis on highly orientated microfibrous polyesterurethane 
scaffolds. Journal of Biomedical Materials Research 2008; 84(4):1094-1101. 
157. Riboldi SA, Sampaolesi M, Neuenschwander P, Cossu G, Mantero S. 
Electrospun degradable polyesterurethane membranes: potential scaffolds for 
skeletal muscle tissue engineering. Biomaterials 2005; 26(22):4606-4615. 
158. Chua KN, Lim WS, Zhang PC, Lu HF, Wen J, Ramakrishna S, et al. 
Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber 
scaffold. Biomaterials 2005; 26(15):2537-2547. 
159. Berry CC, Cacou C, Lee DA, Bader DL, Shelton JC. Dermal fibroblasts 
respond to mechanical conditioning in a strain profile dependent manner. Biorheology 
2002; 40(1-3):337-345. 
160. Sambajon VV, Cillo Jr JE, Gassner RJ, Buckley MJ. The effects of 
mechanical strain on synovial fibroblasts. Journal of Oral and Maxillofacial Surgery 
2003 ;61(6):707-712. 
161. Azevedo HS, Gomes ME, Malafaya PB, Marques AP, Salgado AJ, Reis 
RL. Natural origin degradable polymers in biomedical applications. In: Mallapragada 
S, Narasimhan B, editors. Handbook of biodegradable polymeric materials and their 
applications. California: American Scientific Publishers, 2006. p. 13-31. 
162. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular 
microenvironments for morphogenesis in tissue engineering. Nature Biotechnology 
2005; 23(1):47-55. 
 58 
163. Malafaya PB, Gomes ME, Salgado AJ, Reis RL. Polymer based scaffolds 
and carriers for bioactive agents from different natural origin materials. Advances in 
Experimental Medicine and Biology 2003; 534:201-233. 
164. Mano JF, Silva GA, Azevedo HS, Malafaya PB, Sousa RA, Silva SS, et 
al. Natural origin biodegradable systems in tissue engineering and regenerative 
medicine: present status and some moving trends. Journal of Royal Society Interface 
200; 4(17):999-1030. 
165. Hutmacher DW. Scaffolds in tissue engineering bone and cartilage. 
Biomaterials 2000; 21(24):2529-2543. 
166. Karande TS, Ong JL, Agrawal CM. Diffusion in musculoskeletal tissue 
engineering scaffolds: Design issues related to porosity, permeability, architecture, 
and nutrient mixing. Annals of Biomedical Engineering 2004; 32(12):1728-1743. 
167. Mooney DJ, Mikos AG. Growing new organs. Scientific American 1999; 
280(4):60-65. 
168. Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: State of the 
art and future trends. Macromolecular Bioscience 2004; 4(8):743-765. 
169. Gallardo A, Abraham GA, Elvira C, Vázquez B, San Román J. Polymeric 
matrices for release of growth factors, hormones and other bioactive agents. In: Reis 
RL, Cohn D, editors. Polymer based systems on tissue engineering, replacement and 
regeneration. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2002. p. 37-
52. 
170. Pillai O, Panchagnula R. Polymers in drug delivery. Current Opinion in 
Chemical Biology 2001; 5(4):447-451. 
171. Baran ET, Tuzlakoglu K, Salgado AJ, Reis RL. Multichannel mould 
processing of 3D structures from microporous coralline hydroxyapatite granules and 
chitosan support materials for guided tissue regeneration/engineering. Journal of 
Materials Science: Materials in Medicine 2004; 15(2):161-165. 
172. Correlo VM, Boesel LF, Bhattacharya M, Mano JF, Neves NM, Reis RL. 
Properties of melt processed chitosan and aliphatic polyester blends. Materials 
Science and Engineering A 2005; 403(1-2):57-68. 
Electrospi nning for Tissue Engineering Scaffolding  
59 
173. Correlo VM, Pinho ED, Pashkuleva I, Bhattacharya M, Neves NM, Reis 
RL. Water absorption and degradation characteristics of chitosan-based polyesters 
and hydroxyapatite composites. Macromolecular Bioscience 2007; 7(3):354-363. 
174. Dhariwala B, Hunt E, Boland T. Rapid prototyping of tissue-engineering 
constructs, using photopolymerizable hydrogels and stereolithography. Tissue 
Engineering 2004; 10(9-10):1316-1322. 
175. Gomes ME, Ribeiro AS, Malafaya PB, Reis RL, Cunha AM. A new 
approach based on injection moulding to produce biodegradable starch-based 
polymeric scaffolds: Morphology, mechanical and degradation behaviour. 
Biomaterials 2001; 22(9):883-889. 
176. Gomes ME, Sikavitsas VI, Behravesh E, Reis RL, Mikos AG. Effect of 
flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured 
on starch-based three-dimensional scaffolds. Journal of Biomedical Materials 
Research - Part A 2003; 67(1):87-95. 
177. Hutmacher DW, Schantz T, Zein I, Kee Woei N, Swee Hin T, Kim Cheng 
T. Mechanical properties and cell cultural response of polycaprolactone scaffolds 
designed and fabricated via fused deposition modeling. Journal of Biomedical 
Materials Research 2001; 55(2):203-216. 
178. Landers R, Pfister A, Hübner U, John H, Schmelzeisen R, Mülhaupt R. 
Fabrication of soft tissue engineering scaffolds by means of rapid prototyping 
techniques. Journal of Materials Science 2002; 37(15):3107-3116. 
179. Malafaya PB, Elvira C, Gallardo A, San Román J, Reis RL. Porous 
starch-based drug delivery systems processed by a microwave route. Journal of 
Biomaterials Science - Polymer Edition 2001; 12(11):1227-1241. 
180. Mikos AG, Bao Y, Cima LG, Ingber DE, Vacanti JP, Langer R. 
Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and 
transplantation. Journal of Biomedical Materials Research 1992; 27(2):183-189. 
181. Murphy WL, Dennis RG, Kileny JL, Mooney DJ. Salt fusion: An approach 
to improve pore interconnectivity within tissue engineering scaffolds. Tissue 
Engineering 2002; 8(1):43-52. 
 60 
182. Oliveira AL, Malafaya PB, Reis RL. Sodium silicate gel as a precursor for 
the in vitro nucleation and growth of a bone-like apatite coating in compact and 
porous polymeric structures. Biomaterials 2003; 24(15):2575-2584. 
183. Pfister A, Landers R, Laib A, Hübner U, Schmelzeisen R, Mülhaupt R. 
Biofunctional Rapid Prototyping for Tissue-Engineering Applications: 3D Bioplotting 
versus 3D Printing. Journal of Polymer Science, Part A: Polymer Chemistry 
2004;42(3):624-638. 
184. Silva RM, Elvira C, Mano JF, San Román J, Reis RL. Influence of β-
radiation sterilisation in properties of new chitosan/soybean protein isolate 
membranes for guided bone regeneration. Journal of Materials Science: Materials in 
Medicine 2004; 15(4):523-528. 
185. Silva RM, Silva GA, Coutinho OP, Mano JF, Reis RL. Preparation and 
characterisation in simulated body conditions of glutaraldehyde crosslinked chitosan 
membranes. Journal of Materials Science: Materials in Medicine 2004; 15(10):1105-
1112. 
186. Sousa RA, Kalay G, Reis RL, Cunha AM, Bevis MJ. Injection molding of a 
starch/EVOH blend aimed as an alternative biomaterial for temporary applications. 
Journal of Applied Polymer Science 2000; 77(6):1303-1315. 
187. Temenoff JS, Mikos AG. Injectable biodegradable materials for orthopedic 
tissue engineering. Biomaterials 2000; 21(23):2405-2412. 
188. Vaz CM, van Doeveren PFNM, Reis RL, Cunha AM. Soy matrix drug 
delivery systems obtained by melt-processing techniques. Biomacromolecules 2003; 
4(6):1520-1529. 
189. Woodfield TBF, Malda J, De Wijn J, Pe?ters F, Riesle J, Van Blitterswijk 
CA. Design of porous scaffolds for cartilage tissue engineering using a three-
dimensional fiber-deposition technique. Biomaterials 2004; 25(18):4149-4161. 
190. Schreuder-Gibson H, Gibson P, Senecal K, Sennett M, Walker J, 
Yeomans W, et al. Protective textile materials based on electrospun nanofibers. 
Journal of Advanced Materials 2002; 34(3):44-55. 
191. Gomes ME, Godinho JS, Tchalamov D, Cunha AM, Reis RL. Alternative 
tissue engineering scaffolds based on starch: Processing methodologies, 
Electrospi nning for Tissue Engineering Scaffolding  
61 
morphology, degradation and mechanical properties. Materials Science and 
Engineering C 2002; 20(1-2):19-26. 
192. Laurencin CT, Ambrosio AMA, Borden MD, Cooper Jr JA. Tissue 
engineering: Orthopedic applications. Annual Review of Biomedical Engineering 
1999; 1(1):19-46. 
193. Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. 
Biomaterials 2003; 24(24):4353-4364. 
194. Bolgen N, Menceloglu YZ, Acatay K, Vargel I, Piskin E. In vitro and in vivo 
degradation of non-woven materials made of poly(ε-caprolactone) nanofibers 
prepared by electrospinning under different conditions. Journal of Biomaterials 
Science - Polymer Edition 2005; 16(12):1537-1555. 
195. Theron SA, Yarin AL, Zussman E, Kroll E. Multiple jets in electrospinning: 
Experiment and modeling. Polymer 2005; 46(9):2889-2899. 
196. Dzenis Y. Spinning continuous fibers for nanotechnology. Science 2004; 
304(5679):1917-1919. 
197. Jayasinghe SN, Irvine S, McEwan JR. Cell electrospinning highly 
concentrated cellular suspensions containing primary living organisms into cell-
bearing threads and scaffolds. Nanomedicine 2007; 2(4):555-567. 
198. Townsend-Nicholson A, Jayasinghe SN. Cell electrospinning: a unique 
biotechnique for encapsulating living organisms for generating active biological 
microthreads/scaffolds. Biomacromolecules 2006; 7(12):3364-3369. 
199. Lee S-W, Belcher AM. Virus-based fabrication of micro- and nanofibers 
using electrospinning. Nano Letters 2004; 4(3):387-390. 
200. Salalha W, Kuhn J, Dror Y, Zussman E. Encapsulation of bacteria and 
viruses in electrospun nanofibres. Nanotechnology 2006; 17(18):4675-4681. 
201. Stankus JJ, Guan J, Fujimoto K, Wagner WR. Microintegrating smooth 
muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials 2006; 
27(5):735-744. 
202. Stankus JJ, Soletti L, Fujimoto K, Hong Y, Vorp DA, Wagner WR. 
Fabrication of cell microintegrated blood vessel constructs through 
electrohydrodynamic atomization. Biomaterials 2007; 28(17):2738-2746. 
 62 
203. Santos MI, Fuchs S, Gomes ME, Unger RE, Reis RL, Kirkpatrick CJ. 
Response of micro- and macrovascular endothelial cells to starch-based fiber meshes 
for bone tissue engineering. Biomaterials 2007; 28(2):240-248. 
204. Santos MI, Tuzlakoglu K, Gomes ME, Fuchs S, Unger RE, Piskin E, et al. 
Nano- and micro-fiber combined scaffolds: An innovative design for improving 
endothelial cell migration in bone tissue engineering approaches. Tissue Engineering 
2006; 12(4):986-987. 
205. Nam J, Huang Y, Agarwal S, Lannutti J. Improved Cellular Infiltration in 
Electrospun Fiber via Engineered Porosity. Tissue Engineering 2007; 13(9):2249-57. 
 206. Kim G, Kim W. Highly porous 3D nanofiber scaffold using an 
electrospinning technique. Journal of Biomedical Materials Research, Part B - Applied 
Biomaterials 2007; 81(1):104-110. 
207. Zhang YZ, Venugopal J, Huang ZM, Lim CT, Ramakrishna S. 
Characterization of the surface biocompatibility of the electrospun PCL-collagen 
nanofibers using fibroblasts. Biomacromolecules 2005; 6(5):2583-2589. 
208. Chen F, Lee CN, Teoh SH. Nanofibrous modification on ultra-thin 
poly(epsilon-caprolactone) membrane via electrospinning. Materials Science & 
Engineering C - Biomimetic and Supramolecular Systems 2007; 27(2):325-332. 
  
 
 
 
 
 
 
 
 
Section II 
 
 
DETAILED DESCRIPTION OF EXPERIMENTAL TESTING 
AND MATERIALS 
 
  
 
 65 
Chapter 2 
 
 
 
Materials & Methods 
 66 
 
The main aim of this chapter is to describe, in greater detail, the experimental 
work and protocols related to experiments performed and the obtained results. It will 
introduce the rationale of this PhD work, namely the aspects concerning the selection 
of the materials, the scaffolds processing methodologies and the physicochemical 
and biological characterization techniques. 
 
2.2. Materials 
 
2.2.1. Polycaprolactone 
 
Polycaprolactone (PCL) is a biodegradable polyester whose chemical structure 
is shown in Figure 2.1. It is hydrophobic in its wettability and semicrystalline, with a 
melting point of around 60 °C and a glass transition temperature of about -60 °C. PCL 
is derived by chemical synthesis from crude oil and can be synthesized by a ring 
opening polymerization of a cylic lactone monomer (i.e. ε-caprolactone). 
PCL is degraded by hydrolysis of its ester bonds in physiological conditions 
(such as in the human body) [4, 5]. Recently, PCL has stimulated significant research 
into its potential use as a biomaterial, mainly due to its good biocompatibility and 
exceptional ability to form compatible blends and copolymers with a wide range of 
other polymers, producing materials with unique elastomeric properties [6]. PCL is a 
Food and Drug Administration (FDA) approved material that is used in the human 
body as a drug delivery device, suture or adhesion preventing barrier [7-9]. 
The PCL used in this PhD work, commercially available as TONE™ polymer 
(Mw = 80000 Da), was purchase from Union Carbide Chemicals and Plastics Division 
(Bound Brook, New Jersey). 
 
 
Figure 2.1 - Chemical structure of polycaprolactone 
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2.2.2. Poly(ethylene Oxide) 
 
Poly(ethylene oxide) (PEO) is a linear or branched polyether often terminated 
with hydroxyl groups that are derived from neutralization of the terminal ether 
repeated unit in the chain (Figure 2.2). PEO oligomers are most commonly 
synthesized via anionic ring-opening polymerization of ethylene oxide (EO) [10]. 
Typically, materials with Mw < 100000 are usually called poly(ethylene glycol) (PEG), 
while higher molecular weight polymers are classified as PEO. PEO is clear, 
colorless, odorless, inert to many chemical agents, stable against hydrolysis, and 
nontoxic [10]. Biocompatibility and lack of immunogenicity make PEO an important 
polymer for biomedical applications. Another important property of PEO is its solubility 
in water, as well as in many organic solvents (e.g. methylene chloride, ethanol, 
toluene, acetone, and chloroform) depending on its molecular weight [11]. The used 
PEO (Aldrich, Germany) has a Mw ~ 100000, a glass transition temperature (Tg) of -
67 ºC, a melting point at 65 °C, a density of 1.13 g/ml and a viscosity of 12-50 cP (5 
% in H2O at 25 ºC). 
PEG is one of the most frequently used water-soluble polymers for biomedical 
applications because of its high water solubility and chain flexibility [11]. The high 
degree of hydration and flexibility confers it as protein resistant, biocompatible, and 
non-immunogenic. The PEG has been used to prolong the half-life of enzymes 
conjugated to the molecule thereby decreasing liver uptake. The PEGs have also 
been used in drug delivery to increase water-solubility of poorly soluble drugs such as 
paclitaxel. The long circulating property of PEG is used to improve tumor targeting 
and accumulation of monoclonal antibody fragments by the passive enhanced 
permeability and retention (EPR) mechanism. The PEG stabilized liposomal 
formulations of many drugs have similarly found application in drug delivery. 
 
 
Figure 2.2 – Chemical structure of poly(ethylene oxide) 
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2.2.3. Starch-Polycaprolactone blend 
 
Starch is a polysaccharide carbohydrate consisting of a large number of 
glucose units joined together by glycosidic bonds. It consists of two types of 
molecules: the linear and helical amylose and the branched amylopectin (Figure 2.3). 
Amylose is a linear polymer of several thousand glucose residues linked mainly by 
α(1→4) bonds (Figure 2.3 A). Amylopectin is a polysaccharide and highly branched 
polymer of glucose units linked in a linear way with α(1→4) glycosidic bonds (Figure 
2.3 B). Branching takes place at the α(1→6) bonds occurring every 24 to 30 glucose 
units. 
Starch has been successfully incorporated in many synthetic polymeric 
systems to lower its cost and increase its biodegradability [12-15]. Additionally, the 
use of starch-based materials have attracted great attention in tissue engineering 
applications due to the advantages of being non-cytotoxic, having good mechanical 
properties and being processed by various methodologies, including by melt-based 
routes. 
A  
 
B  
Figure 2.3 - Chemical structures of the amylose (A) and amylopectin (B) molecules. 
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Starch-based scaffolds obtained from a blend of corn starch and 
polycaprolactone (SPCL) have been proposed as candidates for bone tissue 
engineering applications, as well as drug delivery systems, in multiple studies from 
our group [16-22]. Indeed, successful results were demonstrated in terms of cell 
viability, proliferation and maturation of osteoblastic cells or differentiation of bone 
marrow stromal cells. Additionally, in vivo studies also demonstrate that 
biodegradable starch-based materials did not induce a severe immune response [23]. 
Accordingly, the 30:70 (wt.%) SPCL blend was purchased to Novamont (Novara, 
Italy). The thermal and mechanical properties of the SPCL were previously reported 
[24-26]. Briefly, starch effectively increased the non-isothermal crystallisation rate of 
PCL, effectively reinforced PCL and enhanced its damping properties, as it might help 
in the dissipation of the mechanical energy generated by the patient movements. 
 
2.2.4. Poly(butylene succinate) 
 
Poly(butylene succinate) (PBS) is an aliphatic polyester, sold under the 
trademark Bionolle [27]. It was obtained from Showa Highpolymer Co. Ltd. (Tokyo, 
Japan), with the reference 1050, a polybutylene succinate copolymer. Bionolle® has 
been shown to be biodegradable in a variety of natural environments, decomposing 
into water and carbon dioxide. It has been processed into films, sheets, filaments, 
nonwoven fabrics, laminates, molded foams and injection-molded products for 
diverse applications, namely in agriculture, fishery, forestry, civil engineering and for 
common household goods. 
Pure PBS presents a hydrophobic behavior with low water uptake (~ 1.5 %) 
and displayed a decrease in the mechanical properties without any appreciable 
weight loss (~ 0.5 %), after 60 days of immersion in the isotonic saline solution [28]. 
This polymer presents a melting temperature (Tm) of 104.3 % and an enthalpy (∆H) 
value of 60.8 J/g, comparing to the ∆Hm of a 100 % crystalline PBS (110.3 J/g), 
determined by differential scanning calorimeter (DSC) [29]. Additionally, the material 
data sheet reported a density of 1260 g/L, a heat of combustion of 23.6 KJ/g and a 
glass transition temperature (Tg) of -32 ºC. 
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2.2.5. Chitosan 
 
Chitosan (α(1→4)-2-amino-2-deoxy-β-d-glucan) is the alkaline deactylated 
product of chitin, which is the principal organic component of the exoskeleton of 
invertebrates such as crustaceans (crabs, shrimp, etc.), insects and spiders, being 
also found in the cell walls of fungi and many algae. It is a linear polysaccharide 
composed of randomly distributed β-(1→4)-linked D-glucosamine (deacetylated unit) 
and N-acetyl-D-glucosamine (acetylated unit) (Figure 2.4). 
Important parameters affecting the characteristics of chitosan are its molecular 
weight (Mw) and its degree of deacetylation (DD) [30]. The degree of deacetylation of 
chitosan refers to the ratio between the deacetylated and acetylated units. Chitosan is 
a semi-crystalline polymer and the degree of crystallinity depends on the degree of 
deacetylation. 
Chitosan is one of the most appealing biomaterials for prospective applications 
in tissue engineering and drug delivery [31-34], due to its biological properties such 
as potential biocompatibility and immunological, antibacterial and wound-healing 
activity [32, 35, 36], Additionally, chitosan shares structural characteristics with 
various glucosaminoglycans (GAGs) and hyaluronic acid (HA) present in various 
tissues, namely in articular cartilage [37, 38]. 
The chitosan herein used was purchased to France Chitine (Orange, France). 
Firstly, chitin was isolated from shrimp shells and squid bones by deproteinization 
and/or demineralization, respectively. The chitosan was further obtained by the 
removal of enough acetyl groups (CH3-CO) from the chitin molecule - deacetylation 
process -, releasing the amine groups (NH) and giving the chitosan a cationic 
characteristic. 
 
 
Figure 2.4 - Chemical structure of chitosan 
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Considering the described procedure, chitosan raw-materials sometimes 
possess an insoluble fraction which could be remaining chitin or other type of 
impurities. For that reason, a purification procedure was carried out. 
 
2.2.5.1. Purification of chitosan 
 
 A determined amount of chitosan (~ 50 g) was dissolved in an aqueous acetic 
acid solution (1 %) at ~ 1 wt.%. The insoluble material was removed by filtration with 
Whatman® ashless filter paper (20-25 µm). The obtained clear solution was 
neutralized using a NaOH solution (final pH ~ 8). The obtained white gel was 
centrifuged to remove the exuded liquid and systematically rinsed with distilled water, 
until no changes in the pH were observed. The chitosan gel was further washed with 
ethanol, freeze-dried, ground to powder and dried at 60 ºC overnight. 
 Since the purification process can affect the final physicochemical properties of 
this natural polymer, determination of the average viscosity molecular weight (Mv) and 
the degree of deacetylation (DD) was performed.  
 
2.2.5.2. Determination of the viscosity average molecular weight 
 
 To evaluate the molecular weight of polymeric chains various methods can be 
used: widespread are viscometric and gel permeation chromatographic techniques. 
Viscosity is empirically related to molecular weight, because the measurement 
depends upon the hydrodynamic volume of the macromolecule, which is a function of 
the molecular weight, conformational properties and polymer-solvent interactions [39-
41]. Measurements of solution viscosity are made by comparing the flow time t 
required for a specific volume of polymer solution to flow through a capillary tube with 
the correspondent flow time t0 for the solvent. Relative viscosity (ηr) (equation 2.1) 
and specific viscosity (ηsp) (equation 2.2) are calculated from t and t0, according to the 
following equations: 
00r t/tη/ηη ≅=
  (2.1) 
1ηη rp −=s
   (2.2) 
 72 
 
Several equations are available for determining the intrinsic viscosity [η] of a 
polymer. These equations are found to be valid at sufficiently low concentrations, 
assuring that the polymer chains are free to move individually in the solvent, i.e., the 
kinetic units are not aggregates but single polymer molecules. The equations derived 
by Huggins [40] (equation 2.3) and Kraemer [41] (equation 2.4) relate ηsp and ηr, 
respectively, with the polymer concentration in the solvent (c in g/dL or any other units 
proportional to this), according to the following expressions: 
[ ] [ ] cηk'η/η 2sp +=c
  (2.3) 
[ ] [ ] cη'k'η/cηln 2r −=
    (2.4) 
The Huggins (KH) and the Kraemer (KK) coefficients give information on the polymer-
solvent interactions, being the KH lower values (ranging from 0.25 to 0.5) and the KK 
negative values related to a better solvation of the polymer chains [42]. Theoretically, 
KH + KK should be equal to 0.5. The intrinsic viscosity [η] is a theoretical value 
calculated at the limit of infinite dilution using those equations: 
[ ] 0csp /c)(ηη ==
 (Huggins) (2.5) 
[ ] 0cr /c)η(ln η ==
 (Kraemer)     (2.6) 
The graphical extrapolation (c=0) using both equations is expected to result 
approximatly in the same values of [η] for a particular polymer-solvent system. 
To allow performing that quantification, five chitosan fresh solutions with 
different concentrations were prepared, in the range that gives ηr between 1.1 and 
1.9. The purified chitosan samples were dried in the oven overnight and accurately 
weighted in an analytical balance (± 0.1 mg). The residual water was determined 
thermogravimetrically (TGA) and the concentration of the chitosan solutions corrected 
accordingly. First, the weighted chitosan powder was completely dissolved in acetic 
acid (AcOH) 0.5 M. A suitable amount of sodium acetate (AcONa) was added to give 
a final concentration of 0.2 M. A blank solution was prepared in the same way, but 
without chitosan. The flow time for each solution was obtained from five reproducible 
measurements, using an Ubbelohde viscometer at 25.0 ± 0.1 ºC. The intrinsic
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Figure 2.5 - Linear regressions obtained by plotting /cη sp  or /cηln r  against c, 
according to the Huggins or Kraemer equations, respectively. 
 
viscosity [η] was calculated by linear regression plotting /cη sp and /cηln r  against c 
(Figure 2.5). 
The viscosity average molecular weight (Mv) is calculated based on the Mark-
Houwink equation: 
[ ] av )k(Mη =
   (2.7) 
being [η] = 5.91 dL/g (previously determined), Mv in Da, k = 3.5x10-4 and a = 0.76 for 
0.5 M AcOH/0.2 M NaOAc aqueous solution as solvent at 25 ºC (independent of the 
DD at these conditions) [43]. Accordingly to the intrinsic viscosity calculated, 
theviscosity average molecular weight of the purified chitosan from France Chitine 
was 416 kDa. 
 
2.2.5.3. Determination of the degree deacetylation 
 
Although being apparently a simple analytical problem, the determination of 
the DD revealed to be not simple. A large number of methods were proposed in the 
literature, including Fourier transformed infrared spectroscopy (FTIR) [44-46], 
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potentiometric [47] and conductometric titration [48], ultraviolet (UV) 
spectrophotometry [49-51], ninhydrin assay [52], and nuclear magnetic resonance 
(NMR) spectroscopy [53, 54]. The great number of methods described in the literature 
may be regarded as an advantage, but these methods differ in reliability, robustness, 
precision and accuracy over the entire DD range. To overcome those considerations, 
three different methods were applied to ascertain about the DD of our chitosan batch, 
namely 1H-NMR, FTIR and UV spectrophotometry. 
Nuclear magnetic resonance (NMR) spectroscopy is one of the most useful 
techniques for characterizing polymeric biomaterials [11]. The basic principle behind 
NMR involves the detection of absorption or emission of radiation resulting from the 
interaction of an applied EM radiation with nuclear spins of the polymeric molecules 
when the energy levels in the latter are split by an external magnetic field. The 
primary prerequisite of NMR is that the material contains atoms whose nuclei contain 
an unpaired proton or neutron that possess nuclear spin properties. Since most 
polymeric biomaterials possess high concentration of 1H they can be characterized by 
NMR. The early applications of 1H resonance high resolution NMR to polymers were 
at 60 or 100MHz (field strengths of 1.4 and 2.3 T respectively) and detailed 
information on the chain structure. Therefore, the 1H-NMR is commonly considered 
the reference method to determine the DD of chitosan [53]. To improve the solubility 
and to obtain high quality NMR spectra in solution state, chitosan samples were 
partially depolymerised and the spectra recorded at 60 ºC. Making use of the signal 
from the chitosan 1H-NMR spectra peaks of acetyl group, namely Ic and Ie peaks (see 
Figure 2.6), the DD was calculated using the equation 2.8 [53]. 
100
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   (2.8) 
Applying the equation 2.8, it was calculated a DD of 87.7 ± 0.4 % for the 
purified chitosan from France Chitine. 
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Figure 2.6 - Identification of the chitosan 1H-NMR spectra peaks (adapted from 
reference [1]) 
 
FTIR methods are widely used to determine the DD of chitosan and, since the 
determination is performed in the solid state, they are also suitable to determine the 
DD of insoluble chitin (DD < 40). FTIR has been often preferred because it is a quick 
and low-cost method. The method requires the construction of a specific calibration 
line for each particular sample and for each deacetylation procedure it is necessary to 
obtain reference values of DA [45]. Consequently, the FTIR methods involve the 
comparison between the absorbance of a band assigned exclusively to one of the 
monosaccharides and a suitable internal reference band to correct for film thickness 
or sample concentration (KBr disks). A considerable effort has been devoted to 
identity the right combination of bands and respective baselines, which led to a large 
number of proposed methods found in the literature [44-46, 55]. In our first attempt to 
determine the DD by FTIR we used the method proposed by Baxter et al. [55] and the 
bands proposed by Brugnerotto et al. [46] that are depicted in Table 2.1. 
The values determined by means of FTIR using the 3450 cm-1 band (assigned 
to the -NH and -OH stretching bands) are lower than the DD achieved by using the
band at 1420 cm-1 (method II). These differences could be due to the uptake of
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Table 2.1 - Calibration curves to determine the DD using the FTIR spectrum of 
chitosan that make use of different combinations of bands and baselines. The 
absorbance (A) is the height at the band maximum corrected by the intercepting with 
the respective baseline 
Method Band (cm-1) 
Baseline 
(cm-1) Calibration curve 
DD 
(%) 
I [52] 1655 1800 - 1600 DD = 100 - (A1655/A3450) x 115  72,0 ± 1,0 3450 4000 - 2500 
II [42] 1320 1355 - 1270 A1320/A1420 = 0.3822 + 0.03133 (100 - DD)  88,4 ± 0,9 1420 1495 - 1405 
III [42] 1320 1355 - 1270 A1320/A3450 = 0.03146 + 0.00226 (100 - DD) 73,7 ± 2,9 3450 4000 - 2500 
 
 
 
atmospheric moisture from the oven-dried chitosan samples. The water band at this 
region (-OH stretching) is superimposed with the chitosan concentration reference 
band (3450 cm -1), and its intensity is possible to be overestimated. However, the 
better accuracy of the method II is confirmed in comparison with the results of DD 
determined by 1H-NMR, the reference method. 
Muzzarelli and Rocchetti [49] firstly propose the use of the 1st derivative UV 
spectrophotometry as a simple and time saving, but accurate and precise method to 
determine the DD of chitosan samples. This method allows its determination for high 
deacetylated chitosans which can be hardly analyzed by techniques that record the 
signs of the N-acetyl group: when this group is removed by extensive deacetylation 
processes and the degree of acetylation (DA) becomes lower than 20 %, the errors 
associated with the reading become exceedingly large. Therefore, our group [56] 
derived a mathematical expression avoiding the use of empiric correction curves for 
highly deacetylated samples. In this case, the DA is determined directly from the 
mass concentration of chitosan solutions and the first derivative value of its UV 
spectra at 202 nm (the acetic acid solutions zero crossing point), over the entire 
range of the DD of chitosan. Applying this method, a DD of 87.7 ± 0.4 % was 
determined, which is very similar to the DD of purified chitosan determined by means 
of both 1H-NMR and FTIR-method II. 
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2.3. Scaffolds Fabrication 
 
2.3.1. Electrospinning 
 
The elements of a basic electrospinning unit include a high voltage power 
supply (HVPS) with an electrode connected to  the needle of a syringe reservoir, that 
contains the polymeric solution, and a ground metallic collector placed at a defined 
distance from the tip of the metalic needle (Scheme 2.1). 
 
 
Scheme 2.1 - Schematic representation of the electrospinning apparatus (adapted 
from reference [3]) 
 
The electrospinning apparatus developed during the course of this PhD 
comprises: two semi-commercial HVPS, a syringe pump, a ground collector, a cuboid 
chamber with a 3D position system and an isolation transformer. The main electrical 
characteristics of the semi-commercial HVPS are: positive voltage (40 and 12 kV), 
continuously adjustable voltage, digital indication for the output voltage and current, 
preset of the output voltage, high voltage control switch and indicator, security 
interlock and indicator (Figure 2.7 A); a basic single syringe infusion pump (KDS100, 
KD Scientific) to control the polymeric solution feeding, with flow rates ranging from 
0.1 µl/h (when a 10 µl syringe is used) to a maximum of 519 ml/h (when a 60 ml 
syringe was used) (Figure 2.7 B); and a metallic collector placed perpendicularly to
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Figure 2.7 - Photographs of the components of the electrospinning apparatus: the 
semi-commercial high voltage power supply (A); the single syringe infusion pump (B); 
and a grounded metallic collector located inside the cuboid acrylic structure, with a 
vertical position holder of the syringe pump(C). 
 
the syringe main axis to create the electric field necessary for the electrospinning 
process to take place (Figure 2.7 C). 
To prevent possible safety problems related to the use of solvents needed to 
dissolve some of the polymers used, the deposition system (needle coupled to a 
syringe and collector), operates inside  a chemical hood to protect the users from the 
contact with the solvent vapours. Since the air flow generated by the exhaustion of 
the hood disturbs the normal deposition of the fibers, a “closed” cuboid structure had 
to be designed and built (Figure 2.7 C). This chamber was enclosed by two covers 
that allow the user to access the collector, attach or fixate the syringe and program 
the syringe pump. The covers leave a opening in the top when mounted that allows 
for solvent evaporation, as well as access to the syringe pump, and exhaustion air to 
circulate without disturbing the deposition process. The upper part of the chamber is 
also used as the support of a 3D position system, allowing the user to move it in the 
x, y, z directions, being z the direction normal to the plane of the collector (parallel to 
x, y). Another advantage of this transparent acrylic box is the possibility to couple 
laterally a system to produce cylindric samples by using a rotating cylinder as 
collector. The angular velocity of the cylinder is controlled by a small motor. Due to its 
dielectric properties, acrylic was used to construct the described chamber. 
Since electrospinning involves high voltages applied to a metallic needle, an 
isolation transformer had to be added to the electrospinning setup in order to avoid 
damaging the electronic equipment. This metallic needle is normally associated to a 
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basic syringe infusion pump and, therefore, the main power network should be 
insulated from the HVPS. If the insulation is not effective, electric discharges are not 
be prevented, eventually, causing damage and/or malfunction of the equipment. 
 
In the electrospinning processing, the polymer solution is placed in a 5 ml 
plastic syringe with a metallic blunted end needle coupled to it. The tip of the needle 
has a circular internal diameter of 0.8 mm. All the electrospinning experiments were 
performed at room temperature, as well as the subsequently drying of the electrospun 
nanofiber meshes. The main parameter controlling the topography of the nanofiber 
meshes produced by electrospinning is the architecture of the collector [57]. 
Considering this statement, different metallic collectors were tested, namely a flat 
aluminium sheet, a corrugated aluminium sheet, a metallic wire net and a rotating 
plate. 
 
2.3.1.1. Processing of polycaprolactone nanofiber meshes 
 
To process polycaprolactone nanofiber meshes (PCL NFM), a polymeric 
solution of 17 % (w/v) PCL is prepared using an organic solvent mixture composed of 
Chloroform (Aldrich; Germany) and N,N-Dimethylformamide (Aldrich; Germany) (7:3 
ratio). This solution was electrospun at 9-10 kV, establishing a needle tip to ground 
collector distance of 20 cm, a flow rate of 1.0 ml/h and collecting the random 
nanofiber mesh on a flat aluminium foil or the patterned nanofiber mesh on a metallic 
wire net. These are the optimized processing conditions of PCL nanofiber meshes, 
resulting from an optimization procedure where three variables/parameters were 
systematically studied: voltage, needle tip to ground collector distance and flow rate. 
To produce dexamethasone-loaded PCL nanofiber meshes, different quantities 
(5, 10, 15 and 20 wt.% polymer) of dexamethasone (DEX; Sigma-Aldrich, Germany) 
were added to the polymeric solution previously prepared, and let to stir until 
complete dissolution (~ 20 min). The previously optimized processing conditions were 
also established in this experiment. After being produced, the nanofiber meshes were 
dried at room temperature during 1 day inside a chemical hood, to allow for complete 
evaporation of the solvent. 
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2.3.1.2. Processing of dual composition nanofiber meshes 
 
To produce dual composition electrospun nanofiber meshes, a second 
polymeric solution needs to be prepared: a solution of PEO (Mw = 100 kDa; Sigma-
Aldrich, Germany) at the concentration of 25 wt.%, in a mixture of water and ethanol 
(ratio 6:4). The polymer concentration and the water/ethanol ratio were both defined 
after several optimization stages to obtain the most stable processing conditions and 
leading to the more convenient mesh morphology. To achieve the aimed result, a 
multi-syringe holding system was developed which allows for simultaneous 
electrospinning of more than one polymeric solution. Two independently controlled 
semi-commercial HVPS were used to generate electrical voltages ranging from 8 to 
20 kV, with the lower values being applied to the PCL solution. In this experiment, the 
feeding rate was established at a constant value of 0.25 ml/h, by a second precision 
syringe pump (Aladdin-1000-220B, UK), for both solutions. A conducting plate, 
connected to the ground, and rotating at a speed of 15 r.p.m. was used as collector to 
obtain a homogeneous nanofiber mixture. A collector to needle tip distance of 12 cm 
was defined after an optimization procedure, and the syringes were placed at 9 cm 
distance to minimize the electrospun jet interference. The process was continued for 
at least 2 hours for the production of each dual composition nanofiber mesh. With the 
goal of increasing the porosity of the dual composition nanofibers meshes, the PEO 
nanofibers were selectively removed by dissolution in distillated water, for a period of 
24 hours, at 37 ºC. After the dissolution procedure the meshes were dried in an oven 
at 37 ºC. 
 
2.3.1.3. Processing of chitosan nanofiber meshes 
 
The electrospinning of chitosan nanofiber meshes (Cht NFM) was successfully 
achieved by the use of a 6 wt.% chitosan solution prepared as presented in [58], with 
some modifications. Briefly, the powder purified chitosan was added to a solvents 
mixture of Trifluoroacetic acid (TFA; Sigma) and Dichloromethane (DC; Aldrich), in a 
volume ratio of 70:30, respectively. Before electrospinning, the solution was left under 
stirring overnight at room temperature. The processing of that polymeric solution was 
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carried out using a corrugated aluminium foil as ground collector. The capillary tip-to-
collector distance and the flow rate were fixed in 12 cm and 0.8 ml/h, respectively. 
The applied voltage was in the range of 15-20 kV. These are the optimized 
processing conditions of Cht NFM, resulting from an optimization procedure where 
three variables/parameters were studied: tension, needle tip to ground collector 
distance and flow rate. Neutralization of the electrospun chitosan nanofibers meshes 
was carried out by immersing the meshes in either Methanol (Fluka) and Ammonia 
7N (Aldrich) aqueous solution (50:50 wt.%) for 7 minutes at room conditions. After the 
immersion, the meshes were repeatedly washed with distilled water until neutral pH 
was obtained. The meshes were further let to dry at room temperature. 
  
Before the in vitro studies, the random and patterned PCL nanofiber meshes, 
as well as the DEX-loaded nanofiber meshes, were cut in samples with areas of 
approximately 1 cm2 and sterilized by UV irradiation during 1 hour on each side of the 
mesh. The morphogy of the various electrospun nanofiber meshes could be observed 
at Figure 2.8. 
 
2.3.2. Rapid Prototyping 
 
Rapid prototyping has emerged as a set of powerful polymer processing 
techniques for the production of scaffolds in the tissue engineering area [59, 60]. The 
appealing characteristic of these techniques, when used for the production of 
scaffolds, is that a defined structure can be built with customized shapes linked with 
computer aided design (CAD) which provides more flexibility, versatility, and
 
 
Figure 2.8 - SEM micrographs showing the morphology of electrospun PCL random 
(A) and patterned (B) nanofiber meshes, and chitosan (C) nanofiber meshes. 
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reproducibility in creating scaffolds with precise control of its morphology [59, 61]. 
Models can be derived from computed tomography scans, magnetic resonance 
imaging scans or model data created from 3D object digitizing systems. Between the 
several rapid prototyping systems, based on laser, printing and extrusion 
technologies (i.e. selective laser sintering, stereolithography, 3D printing, fused 
deposition modeling (FDM), and 3D plotting), 3D printers and plotters are generally 
faster, more affordable and easier to use than the others [62]. Herein, a 3D plotting 
technique (Bio-plotter, EnvisionTec GmbH, Germany) was employed, consisting in 
the use of a temperature-controlled extruder to force out a thermoplastic filament 
material and deposit the semi-molten polymer onto a platform in a layer by layer 
process.  
The three-dimensional (3D) rapid prototyping scaffolds (6RP) (Figure 2.9 A) 
were fabricated using the blend of starch and polycaprolactone (SPCL; Novamont, 
Italy) previously described. SPCL polymer powder was placed into a metal barrel and 
heated at 140 ºC through a heated cartridge unit and further plotted through a nozzle 
by air pressure control. The nozzle comprises a stainless steel needle with internal 
diameter of 0.5 mm and length 6 mm. A metal piston plunger with a Teflon seal was 
used to apply pressure to the molten polymer. The machine was linked to a CAD 
software (PrimCam, Germany) which required inputs of dispensing and processing 
parameters (e.g. speed of the head, dispensing pressure and temperature) and the 
design parameters of the scaffold (e.g. scaffold dimensions, spacing between the 
polymer strands, and number of layers). The strand spacing was set to 1 mm, without 
offsets between the consecutive orthogonal layers. The orientation was changed by 
plotting the polymer with 90º angle steps between two successive layers. The 
production of hierarchical fibrous scaffolds (6RP+5NFM) (Figure 2.9 B) was achieved 
by intercalating PCL nanofiber meshes between every two consecutive layers of 
plotted microfibers. 
The scaffolds (6RP and 6RP+5NFM scaffolds) were all cut into 5x5 mm cubic 
samples from the originally deposited bulk 20 x 20 mm plates (12 layers) and 
sterilized using ethylene oxide (EO) before being used for the cell culture assays. 
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Figure 2.9 – SEM micrographs of the starch-based rapid prototyped (6RP) (A) and 
hierarchical fibrous scaffolds (6RP+5NFM) (B). 
 
2.3.3. Melt Fiber Extrusion – Fiber Bonding 
 
The extrusion of a thermoplastic material in powder or in granules involves 
heating until molten and forced in a continuous flow through a die. The extruder 
allows melting, mixing and homogeneize the melt and pump the material directly to 
the die, at a steady rate and constant temperature. This is achieved by using a 
rotating screw inside a barrel, electrically heated by heater bands or elements located 
around the barrel. The thermoplastic material is also mechanically heated by friction 
as the screw conveys the material along the barrel. Several commercial and 
laboratorial extrusion lines are available that enable manufacturing different cross-
section extrudates, such as tubing, blown tubular films, monofilament and coating of 
electrical cables [2]. Even if those devices aim at mixing small amounts of material, 
they require the availability of tens grams to few kilograms of raw material to allow the 
production of a sufficient sample. During the development stage of innovative polymer 
systems with improved performance (e.g. nanocomposites, nanoclays, polymer 
blends, modified polymers and new compounds), it is desirable to process smaller 
quantities of some components, either as a result of the synthetic method or due to 
the high cost of some of the components. In the present work, it was used a vertical, 
in house-developed miniature extrusion line (Figure 2.10) with three main purposes: 
(i) possibility of mixing/processing a few grams of material: (ii) capability of producing 
continuously an extrudate, such as a fiber; (iii) creation of a thermo-mechanical
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Figure 2.10 - Design of the micro-extruder (adapted from reference [2]) 
 
environment inside the extruder which is as similar as possible to that developed in 
commercial extruders [2]. 
The nanofiber reinforced microfibers were produced by melt extrusion of 
poly(butylene succinate) (PBS) or a particulate composite of PBS/Cht (50:50 wt), 
compounded with electrospun chitosan nanofiber meshes (0.05 wt.%). Previously, the 
PBS/Cht composite were compounded in a counter rotating twin-screw extruder 
(Carvex, Lisbon, Portugal) and milled into a powder using a Retsch mill. The Cht 
NFMs were added during a further composition step using the micro-extruder 
previously presented. The processing conditions of the nanofiber reinforced 
microfibers were: melt temperatures of 115 ºC for the PBS-based fibers and 145 ºC 
for the PBS/Cht, a  screw rotation speed of 40 r.p.m. and a die diameter of 0.5 mm, as 
previously optimized and described elsewhere [63, 64]. PBS and PBS/Cht microfibers 
without nanofiber reinforcements were also processed according to the conditions 
previously described. 
The production of microfibrous scaffolds reinforced or not with electrospun 
chitosan nanofiber meshes was achieved by a fiber bonding technique. Basically, a 
predefined quantity of microfibers (PBS or PBS/Cht), reinforced or not with 
electrospun chitosan nanofiber meshes, were randomly arrayed in the custom-
designed Teflon mold and heated at 120 ºC (for PBS-based) or 150 °C (for PBS/Cht- 
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Figure 2.11 – SEM micrographs of the PBS-based (A) and PBS/Cht-based 
microfibrous scaffolds (B). 
 
based) during 10 minutes under compression. The morphology of those scaffolds is 
shown in Figure 2.11. This method helps retain the spatial random arrangement of 
the fibers so that, when the PBS begins to melt, the fiber structure does not collapse 
[65]. Besides, fibers at intersections are welded by the combined action of pressure 
and temperature. The highly porous mesh scaffold with interconnected pores 
produced by this method enable an efficient diffusion of nutrients and oxygen to the 
adhered cells. The scaffolds were cut into cylindrical samples (6 mm in diameter and 
2 mm in thickness) and sterilized by ethylene oxide before in vitro biological assays.  
 
2.4. Modification of PCL Nanofiber Meshes Surface by Plasma Treatment  
 
Modification of biomaterials surface is possible using a plasma treatment [66]. 
A plasma may be described as a partially ionized gas composed of free radicals, ions, 
photons and electrons, excited gas atoms and molecules. In general there are two 
classes of plasma: cold or low temperature plasma and hot or elevated temperature 
plasma. We will focus on low temperature plasma which is produced by electrical 
discharge in low-pressure defined gases. The chemical composition and physical 
characteristics of the plasmas are determined, in addition to the gas used (e.g. 
Oxygen, Argon, Nitrogen and Water), by the device parameters, such as chamber 
geometry, gas flow rate, frequency and the electric power applied [67]. This method is 
used to modify the morphology and chemistry of polymer surfaces to a depth of 
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several tens of microns, thus leaving the bulk properties practically intact. The mainly 
physical modification interpreted as etching are the consequence of ion 
bombardment, while chemical modifications were mainly due to the action of neutral 
species on the plasma-activated polymer surface. The main effects of the active 
species created from the gas on the polymer chain is mainly chain scission with new 
functional group creation and crosslinking. Thus, different surface chemistry or 
roughness may be obtained with impact in the hydrophilicity.  
The PCL nanofiber meshes obtained by electrospinning were modified by 
plasma treatment. The treatment was performed in a PlasmaPrep 5 reactor (GaLa 
Instrumente, Germany) with a chamber size of 15 cm of diameter and 31 cm long 
(volume 5L) and with a fully automated process control. The samples were clamped 
between both electrodes and the chamber was evacuated. Two different gases 
(Oxygen or Argon) were used in this study and the chamber, in each case, was filled 
with the working gas five times prior to the treatment. A radio frequency (RF) source 
operating at 13.56 mHz was used and the power intensity (either 20 or 30 W) was 
applied during either 5 or 10 minutes. The pressure of the plasma chamber was kept 
at 0.2 mbar in all the conditions of the study by controlling the working gas flow. When 
the higher power level (30 W) and longer treatment time (10 min) were used as 
working conditions, it was observed an increase of the temperature inside the 
chamber (reaching a maximum temperature of 35 ºC). Prior to the biological assays, 
the untreated and plasma-modified PCL NFMs were cut in samples with areas of 
approximately 1 cm2 and further sterilized by ethylene oxide. 
 
2.5. Dexamethasone Kinetic Release Studies 
 
DEX-loaded PCL nanofiber meshes (with 4 cm2) were weighted and 
suspended in 30 ml of phosphate buffer solution agitated at 60 rpm at 37 ºC. Aliquots 
of 3 ml (10 %) were withdrawn in predetermined time intervals ( and the same volume 
of fresh medium was added to the suspension. The samples were analysed by UV-
Vis spectrophotometry at 242 nm (Shimadzu UV 1601). The DEX concentration of 
each sample was calculated using a standard curve (concentrations ranging from 
0.288 µg/ml to 72 µg/ml), relating the quantity of DEX with the absorbance intensity. 
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The results presented are an average of three measurements. Calculations of the 
amount of drug released took into account the replacement of aliquots with fresh 
medium. Control PCL nanofiber meshes (PCL NFMs) were considered as blanks in 
the performed quantification. 
Ultraviolet-visible spectroscopy or ultraviolet-visible spectrophotometry (UV-Vis 
or UV/Vis) involves the spectroscopy of photons in the UV-visible region. This means 
it uses light in the visible and adjacent regions near ultraviolet (UV) and near infrared 
(NIR) ranges. The absorption in the visible ranges directly affects the colour of the 
chemicals involved. The method is routinely used in a quantitative way to determine 
concentrations of an absorbing species in solution, using the Beer-Lambert law. This 
law states that the absorbance of a solution is directly proportional to the 
concentration of the absorbing species in the solution and the path length. This can 
be taken from references (tables of molar extinction coefficients) or, more accurately, 
determined from a calibration curve. 
 
2.6. Scaffolds Characterization 
 
When a new polymeric structure is developed or a known polymeric structure 
is physically and/or chemically modified, the surface morphology/topography, 
architecture and surface chemistry of those structures must be studied. Various 
techniques are available for those studies, being described the ones that we consider 
the most effective and extensively used for surface characterization. 
 
2.6.1. Physical Characterization 
 
2.6.1.1. Scanning Electron Microscopy 
 
Scanning electron microscopy (SEM) is a microscopic method extremely 
valuable in studying the morphology of polymeric materials and structures, along with 
many other research areas [67]. Its main attributes at that it reveals the 3D 
topography of the specimen examined at large magnifications and also the details of 
the structure up to the sub-micron level. For polymeric structures, the highest 
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magnifications are generally not possible because of the intensity of the electron 
beams damaging the thin polymeric samples which generally leads to deformation 
and even melting of the specimen. To overcome this problem, polymeric samples are 
usually coated with conductive materials such as gold or carbon by sputtering. 
The different scaffolds developed during this PhD program were sputter-coated 
with gold (Fisons Instruments, model SC502; England) for 2 minutes at 15 mA. The 
samples were further analyzed by Scanning Electron Microscopy (Leica Cambridge, 
model S360; England). Micrographs were recorded at 15 kV with magnifications 
ranging from 100 to 5000 times. 
The fiber diameter was measured from SEM micrographs with the software 
ImageJ (version 1.38X, Wayne Rasband Nacional Institutes of Health, USA). For 
each sample, at least 10 micrographs were used (at a 5000X magnification) and, in 
each micrograph, 15 different fibers were randomly selected. Pore size was also 
evaluated from SEM micrographs using the ImageJ software. The pore size values 
were obtained from SEM micrographs (magnification of 5000X), in a total of 60 
measurements for each of the conditions. The pore size values were obtained by 
converting the contour of the pore area into a circumference of equivalent perimeter 
and determined from the circumference an equivalent diameter [68]. 
 
2.6.1.2. Interferometric Optical Profilometry  
 
Surface texture is of paramount importance in engineering especially for 
applications where surfaces come into contact with each other [69]. Most surface 
texture measurements are made using stylus-based devices in direct contact with the 
surface where the movement of a probe is monitored as it travels through the surface, 
scanning it. These instruments are not adequated for measuring the texture of soft 
materials, as they tend to damage the surface. Non-contacting instruments that rely 
on optical measurements or current flow are more appropriated methods for obtaining 
data from these materials, sinse they do not directly interfere with the surface. 
Between the different non-contacting methods available, optical profilers are 
especially useful for assessing the surface roughness of soft materials [69]. Basically, 
the vertical scanning white light interferometer (WLI) uses a broadband light source 
Materials & Methods  
89 
and measures the degree of modulation contrast as a function of path difference, i.e. 
the height variations across a surface can be determined.  Vertical scanning WLI is 
very versatile and can be used to characterize the surfaces of materials ranging from 
low reflectivity plastics to high reflectivity mirrors. 
The surface topography of the plasma-treated electrospun PCL nanofiber 
meshes, random and patterned PCL nanofiber meshes was assessed by noncontact 
profilometry using an interferometer profiler (Wyko-Veeco, model NT1100; USA), in 
Vertical Scanning Interferometry (VSI) mode, with a vertical resolution of 3 nm. 
Topographic roughness parameters Ra (Roughness Average) and Rq (Root Mean 
Square (RMS) Roughness) were automatically determined by the WycoVision® 32 
analytical software, for each sample. These parameters give information regarding 
the smoothness of a surface and the deviations of the peak heights and the valley 
depths from the midline, respectively. Each sample was evaluated, at least, at three 
randomly selected and representative specimen locations. 
 
2.6.1.3. Micro-computed tomography 
 
Microtomography (or micro-computed tomography, micro-computer 
tomography, X-ray tomographic microscopy, high resolution X-ray tomography), like 
computed tomography (CT), makes use of a X-ray source to create shadow cross-
section images/projections of a 3D object that later can be used to recreate a virtual 
model without destroying the original object [70]. The term micro is used to indicate 
that the pixel sizes of the cross-sections are in the micrometer range. In general, 
there are two types of scanner setups. In one setup, the X-ray source and detector 
are typically stationary during the scan while the sample/animal rotates, which is the 
case of the micro-CT used in the present work. The second setup, much more like a 
clinical CT scanner, is mainly based stationary in space animal/specimen while the X-
ray tube and detector rotate around collecting the data. These micro-CT scanners are 
typically used for imaging small animals (e.g. bone, lung, cardiovascular, tumors or 
soft tissue), human samples (e.g. skin and bone biopsies), electronic pieces and 
microdevices, plastic foams and composite materials, wood and paper, microfossils 
and diamonds, and other studies for which detailed morphology data is desired [71]. 
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Scaffold architecture was analyzed using a desktop micro-CT scanner 
(SkyScan 1072; Aartselaar, Belgium). Each scaffold type was scanned in high-
resolution mode using a pixel size of 12 µm and an integration time of 2 ms. The X-
ray source was set at 80 keV of energy and a current of 248 µA. Representative data 
sets of 150 slices, covering the height of 1.5 x 4 mm, were transformed into binary 
using a dynamic threshold of 60-255 (gray values) to distinguish between polymer 
material and the void space. Those operating parameters were maintained for all the 
samples. For morphometric analysis, including porosity and mean pore size 
quantification, the sliced 2D tomographic raw images were reconstructed using CT 
Analyzer software from the micro-CT scanner supplier. 3D virtual models of 
representative regions in the bulk of the scaffolds was also created, visualized and 
registered using the image processing software supplied by the manufacture. 
 
2.6.1.4. Differential Scanning Calorimetry 
 
Thermal analysis techniques such as differential scanning calorimetry (DSC) or 
differential thermal analysis (DTA) allow characterizing the thermal properties of a 
material and allow calculation of the enthalpy (∆H) or entropy (∆S) changes when 
phase transitions take place [11]. In normal DSC analysis it is assumed that the heat 
capacity is thermodynamically reversible. However, for a number of transitions such 
as the glass transition temperature (Tg) measurements, the heat capacity may be 
irreversible. This results in different DSC traces of the same sample obtained by 
subsequent cooling and reheating. The glass transition temperature (Tg) or the 
temperature of transition of a polymer from the glassy state into the rubbery phase is 
one important property of amorphous polymers that is measured using the DSC 
technique. Measurements of melting temperature (Tm) and other phase transitions are 
also conveniently made by this thermal analysis technique. A melting temperature 
range is observed in all semicrystalline polymers, because of variations in the sizes 
and perfection of crystallites [72]. The value of Tm is usually taken as the temperature 
at which the larger melting crystallites disappear. This parameter depends on the 
thermal history of the sample since more perfect and larger crystallites are produced 
by slower crystallization processes in which more time is provided for the 
Materials & Methods  
91 
conformational changes needed to fit macromolecular segments into the appropriate 
crystal pattern and to reach the lower energy states.  
Differential Scanning Calorimetry (DSC) experiments were carried out using a 
DSC Q100 equipment (TA Instruments – ELNOR). The experiments were conducted, 
under a nitrogen atmosphere, on samples (5-10 mg) packed in aluminum pans. The 
samples were heated at a constant heating rate of 10 ºC/min from room temperature 
up to 300 ºC. 
 
2.6.2. Chemical Characterization 
 
The surface chemistry of a polymeric structure intended for biomedical 
applications can be searched by a number of methods, mostly based on 
spectroscopy and surface energetics. In the following section, information about some 
used techniques is provided. 
 
2.6.2.1. Fourier Transform Infra-red Spectroscopy 
 
Before the advent of other powerful techniques, the simplest and reliable 
method for polymer surface chemistry studies was infra-red spectroscopy (with or 
without attenuated total reflectance (ATR)). This method requires samples with flat or 
easily deformable surfaces and typically gives the characteristic absorption bands of 
functional groups with a depth of analysis of 0.1-10 µm into the material [67]. In recent 
years, the analysis sensitivity of Fourier transform infra-red (FTIR) spectroscopy has 
been improved, but even then FTIR can neither match the sensitivity of electron 
spectroscopy for chemical analysis (ESCA) nor can it be so focused on the surface. 
In the systems with variable composition, the two methods could be applied to 
complement each other effectively. 
FTIR analysis was performed to the DEX-loaded electrospun PCL nanofiber 
meshes. The samples were powered, mixed with KBr, and processed into pellets. 
Spectra were recorded at 48 scans with a resolution of 2 cm -1 (Shimadzu – IR 
Prestige 21). 
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2.6.2.2. X-ray Photoelectron Spectroscopy  
 
X-ray Photoelectron Spectroscopy (XPS), also called ESCA, is a technique for 
studying the energy distribution of electrons ejected from a material that has been 
irradiated with a source of ionized radiation such as X-rays [67]. Although the X-ray 
beam may penetrate deeply into the sample to produce photoelectrons, most of these 
electrons lose its energy in numerous inelastic collisions; only the atoms residing in 
the top few monolayers give rise to undistorted spectra. Therefore, the typical 
analysis depth in XPS is about 10-200 Å, constituting a surface-sensitive analytical 
technique. This powerful technique not only provides quantitative information about 
basic properties such as binding energy, charge, and valence state of the present 
elements, but also about their oxidation state and chemical identities. The impact of 
XPS in polymeric surface chemistry characterization has been twofold: it can analyze 
relatively intractable materials without the need for special sample preparation and it 
is a surface sensitive technique. Of all the presently available instrumental techniques 
for surface analysis, XPS is generally regarded as being the most quantitative, the 
most readily interpretable, and the most informative with regard to chemical 
information [73]. 
Analysis of the untreated and plasma modified electrospun nanofiber meshes 
was performed using an VG Escalab 250 iXL ESCA instrument (VG Scientific; UK), 
equipped with aluminum Ka1,2 monochromatized radiation at 1486.92 eV in the X-ray 
source. Due to the non conductive nature of the samples, it was necessary to use an 
electron flood gun to minimize the surface charging accumulation. The neutralization 
of the surface charge wasperformed by using both a low energy flood gun (electrons 
in the range of 0 to 14 eV) and an electrically grounded stainless steel screen was 
placed directly over the sample surface.  
The XPS measurements were carried out using monochromatic Al-Kα radiation 
(hν=1486.92 eV). Photoelectrons were collected from a takeoff angle of 90º relative to 
the sample surface. The measurement was performed in a Constant Analyzer Energy 
mode (CAE) with pass energy of 100 eV for the screening stage and 20 eV pass 
energy to obtain high resolution spectra.  
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Charge referencing was carried out by setting the lower binding energy C1s 
hydrocarbon (CHx) peak at 285 eV. The spectra fitting is based on a “Chi-squared” 
algorithm used to determine the effectiveness of the peak fit. Surface elemental 
composition was determined using the standard Scofield photoemission cross 
section. 
 
2.6.2.3. Contact Angle measurements 
 
The investigation of surface wettability by means of contact angle 
determination is of special interest in the characterization of the polymeric surfaces 
[67]. Contact angle may be geometrically defined as the angle formed by the 
intersection of two planes at a tangent to the liquid and solid surface at the perimeter 
of contact between the two phases and the third surrounding phase, typically air or 
vapor. Contact angle measurements are carried out in various ways of widely differing 
sensitivity. Typically they are made with a goniometry and a syringe with a flat-tipped 
needle that is used to apply the solvent droplet on the surface.   
The static contact angles were measured at room temperature with a Contact 
Angle Equipment (DataPhysics Instruments, model OCA 15plus; Germany). The 
values were obtained by the sessile drop method. The used liquids (water and 
glycerol, HPLC grade, 3µL) were applied by a motor driven syringe at different zones 
of each sample and the measurement time was extended until 5 minutes. At least five 
measurements were carried out for each sample and the presented data are 
averaged values for those measurements. 
 
2.7. Biological assays 
 
2.7.1. Cell Lines 
 
A continuously growing cell line generally is easier to maintain in commercially 
available media, with low serum dependence, increased growth rate in monolayer or 
suspension (population doubling time of 12-24 h). The cell lines present a reduced or 
absente density limitation of proliferation, and produce a higher cell yield per flask 
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[74]. Those cells are typically immortalized, then presenting the altered on growth 
control, but with the absence of virus susceptibility and differentiation capacity. Their 
disadvantages include greater chromosomal instability, divergence from the donor 
phenotype, and loss of tissue-specific markers. Continuous cell lines have escaped 
from senescence control, so the generation number becomes less important, as well 
as the number of passages. In addition, because of the increased cell proliferation 
rate and saturation density, split ratios become much greater (1:20-1:100). For the 
maintenance of a stable phenotype it is essential the standardization of culture 
conditions. Consequently, the maintenance regime (i.e. medium formulation, periodic 
medium change and subculture) should remain consistent throughout all the period of 
the cell line culture. 
Due to the advantages previously described, three types of cell lines were 
chosen to verify the efficacy of the plasma modifications performed to the PCL 
nanofiber meshes: L929, a mouse lung fibroblastic cell line; Saos-2, a human primary 
osteosarcoma cell line; and ATDC5, a mouse condrocyte teratocarcinoma-derived 
cell line, all supplied by the European Collection of Cell Cultures (ECACC; UK). L929 
and Saos-2 cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM; 
Sigma-Aldrich, Germany) supplemented with 10 % heat-inactivated fetal bovine 
serum (Biochrom AG, Germany) and 1 % antibiotic-antimycotic solution (penicillin 100 
units/ml and streptomycin 100 µg/ml) (Gibco, GB). ATDC5 cells were cultured in 
DMEM-F12 Medium (Gibco, GB) supplemented with 10 % heat-inactivated fetal 
bovine serum (Biochrom AG; Germany) and 2 mM L-Glutamine (Sigma-Aldrich, 
Germany). All cell types were cultured in a humidified incubator at 37 ºC, in 5 % CO2 
atmosphere. The various media were routinely renewed every 2-3 days. 
 
2.7.2. Seeding and Culture of the Cell Lines on the Electrospun Nanofiber Meshes 
 
The sterile samples of plasma-treated NFMs and controls, PCL solvent-cast 
membranes, and TCPS coverslips, were placed in 24-well cell culture plates (Costar®, 
Corning; NY). A 50 µl cell suspension containing 1x105 cells was added per cm2 of 
surface area of each sample and controls. The biological parameters, described 
below, were assessed at different culture periods: 1, 3, 7, and 14 days. 
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Scheme 2.2 - Schematic representation (lateral and top view) of the fixing system 
used in the biologic assay. 
 
In order to demonstrate the enhanced cellular infiltration into the nanofiber 
meshes, it was developed a system to clamp the mesh. This system consists of two 
silicone rings (with 8 mm outside and 5 mm inside diameters), held together with the 
sample in two points by a nylon stitch (Scheme 2.2). When clamped between the 
rings, the samples have no direct contact with the surface of the well. This clamping 
system was sterilized by ethylene oxide, with the meshes already mounted between 
the rings. The clamping systems containing the dual composition electrospun 
nanofiber meshes were placed in a 48 well-plate with 1 mL of ultra pure water to 
dissolve the PEO nanofibers. The well-plate was placed in an incubator at 37 ºC for a 
period of 24 hours. The seeding of Saos-2 cells was performed with 50 µL cell 
suspension (1×105 cells/mL) over the top surface of each scaffold. The developed 
nanofiber mesh fixing system confined the seeding area, avoiding cell adhesion to 
other surfaces of the culture well. 
 
2.7.3. Primary Cultures of Human Bone Marrow Mesenchymal Stem Cells 
 
Mesenchymal stem cells (MSC) are an interesting candidate for cell-based 
therapeutics and regenerative medicine [75, 76]. While several tissues remain an 
important source of therapeutic relevant differentiated cells, stem cells have emerged 
as a strong alternative due to their potential of expansion - self-renewal potential - 
and the fact that they can be obtained from autologous sources. In fact, the 
generation of autologous grafts in vitro, avoiding the harvest of autologous tissue in a 
second anatomic location, is one of the goals in tissue engineering. Additionally, 
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MSCs can be differentiated into a variety of connective tissues, including bone, 
cartilage, fat, muscle and tendon, when cultured with appropriated supplemented 
culture media and specific environments [77-79].  
Human bone marrow aspirates were obtained during routine surgical 
procedures involving knee arthroplasties, as approved by the Ethical Committee of 
the São Marcos Hospital, Braga, under the Cooperation Aggreement established 
between the 3B s´ Research Group-UM and that Hospital. A detailed Informed 
Consent (IC) was signed by each patient/donor. Bone marrow contains at least two 
distinct populations of stem cells, one hematopoietic and the other non-hematopoietic 
mesenchymal [80]. Hematopoietic stem cells in the adult give rise to all components 
of the immune and blood system, whereas MSCs can differentiate into bone, cartilage 
or adipose tissue, among others. Due to feasibility purposes, human bone marrow 
mesenchymal stem cells (hBMSCs) kindly supplied by Biopredic International 
(France) were also used in the work. Both populations of hBMSCs were isolated and 
characterized according to the method established by Delorme and Charbord [81]. 
Briefly, plastic adherent fractions of marrow cells characterized by a spindle-shape 
morphology and colony-forming unit (CFU) capacity; expression of surface antigens 
like CD 29, 73, 90 and 105, while negatives for hematopoietic markers such as CD 34 
and 45 (assessed by flow cytometry); and by their differentiation potential into the 
osteogenic, chondrogenic and adipogenic lineages. 
 
2.7.4. hBMSCs Culture, Seeding and Differentiation into the Osteogenic Lineage 
 
To reach the needed amount of undifferentiated hBMSCs, they were expanded 
in ‘basal medium’ consisting of Dulbecco’s modified Eagle’s medium (DMEM; Sigma-
Aldrich, Germany) supplemented with 10 % heat-inactivated fetal bovine serum (FBS; 
Biochrom AG, Germany) and 1 % antibiotic/antimyotic solution (Gibco; GB). Cells 
were cultured at 37 °C in a atmosphere of 5 % CO2. 
Confluent hBMSCs at passages 4-5 were harvested for static seeding onto the 
random PCL nanofiber meshes, patterned nanofiber meshes and DEX-loaded 
nanofiber meshes at a density of 1.5x105 cells/scaffold, and on nanofiber reinforced 
or not microfibrous composite scaffolds at a density of 5.0x105 cells/scaffold. The 
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constructs were culture under static conditions, in standard ‘osteogenic differentiation 
medium’ (basal medium supplemented with 50 µg/mL ascorbic acid, 10 mM β-
glycerophosphate and 10-7 M dexamethasone). The constructs were retrieved at 
different culture times: 7, 14 and 21 days. In the case of DEX-loaded PCL NFMs-
hBMSCs constructs, they were cultured under static conditions, in dexamethasone-
absent ‘osteogenic differentiation medium’ (basal medium supplemented with 50 
µg/mL ascorbic acid and 10 mM β-glycerophosphate). 
The differentiation of MSCs towards the osteogenic lineage is a highly 
programmed process that is best described in vitro. Typically it requires the 
supplementation of culture media with dexamethasone, β-glycerophosphate and 
ascorbic acid [75, 82]. Dexamethasone (DEX) is routinely added in assays of 
osteoprogenitor cells, having both inhibitory and stimulatory effects over skeletal cells. 
An emerging view is that this reflects opposite effects on precursors versus mature 
cells in the lineages. It has also been suggested that even a transient exposure of 
stem cells to DEX may be effective in inducing and maintaining the osteoblastic 
phenotype [82]. Glycerophosphate is the organic phosphate source, playing an 
important role in the mineralization process and modulation of osteoblast activities, 
namely on the alkaline phosphatase (ALP) activity and osteocalcin production. 
Ascorbic acid (AA, vitamin C) increases cell viability and is a cofactor in the 
hydroxylation of proline and lysine residues and is therefore necessary for the 
production of collagen [80]. AA has also been demonstrated to increase ALP activity. 
Together with β-glycerophosphate, AA was found to be a prerequisite for the 
formation and mineralization of the extracellular matrix. 
 
2.7.5. Evaluation of Cell Morphology and Distribution 
 
To analyse the level of cell attachment and its morphology, and distribution on 
the surface of the scaffolds it was used SEM. To achieve those goals it is required the 
use of methods of fixation or stabilization of the cells on the scaffolds to obtain 
biological samples in their natural state. Additionally, due to the non-electric 
conductivity of those samples it is also needed to coat the samples with a conductive 
material such as gold or carbon. To overcome the limitation in the level of vacuum 
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required for biological samples and/or the charging of non-conducting samples, a so-
called environmental SEM (E-SEM) was developed [83]. This technique requires a 
higher partial pressure of, e.g. water, keeps the biological structure almost in the 
native state, making this method a valuable tool for imaging. Accordingly to these 
statements and the available SEM, the constructs (scaffolds-cells) were fixed with 2.5 
% Glutaraldehyde (Sigma, USA) in Phosphate Buffer Saline (Sigma, USA) solution, 
during 1h at 4 ºC. Then, they were dehydrated through graded series of ethanol and 
let to dry overnight at room temperature. Finally, they were gold or carbon sputter 
coated (Fisons Instruments, model SC502; England) during 2 minutes at 15 mA, and 
analyzed by SEM (Leica Cambridge, model S360; England) equipped with an energy 
dispersive spectrometer (EDS; link-eXL-II). 
In parallel to this indirect observation, the constructs were also analyzed by 
fluorescence microscopy. In this technique, the biological molecules are labeled with 
a fluorescent marker and detected visually, usually by selecting an appropriated 
wavelength [83]. One advantage of the fluorescence microscopy is the fact that some 
dyes quench the fluorescence of another dye by the so-called Förster energy transfer. 
Another advantage is that the fluorescence wavelength is influenced by the 
environment; this can also be used to get more insight into the structural properties of 
a biomolecule. In other fluorescence-based microscopy, specifically in confocal 
microscopy, a laser beam is split and refocused just on the plane of interest [83]. This 
reduces one problem of normal fluorescence microscopy where the entire sample is 
illuminated and both in-focus and out-of-focus points contribute equally to the signal. 
The resolution reaches 200 nm in the xy-plane and 500 nm in the z-plane. The 
greatest advantage is the possibility of making three-dimensional maps of the 
samples to within a depth of around 100-200 µm. This is particularly relevant to 
demonstrate the penetration of cells into the tickness of PCL-PEO NFM. For that, 
PCL-PEO NFM-osteoblastic cells hybrid constructs, as well as the patterned 
nanofiber meshes-hBMSCs, were firstly fixed in 10 % formalin solution neutral buffer 
(Sigma-Aldrich, Germany) for 30 min and maintained in phosphate buffer saline 
(PBS) until further use. The nucleus and the cytoskeleton actin filaments of the cells 
were fluorescently labelled with 4,6-diamidino-2-phenyindole, dilactate (DAPI; Sigma, 
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USA; dilution 1:1000) and phalloidintetramethylrhodamine B isothiocyanate (Sigma, 
USA; dilution 1:100), respectively.  Patterned nanofiber meshes-hBMSCs constructs 
were analyzed using a fluorescence microscope (Zeiss, Germany), whereas the PCL-
PEO NFM-osteoblastic cells constructs were observed by laser scanning confocal 
microscopy (Fluoview 1000, Olympus, Germany). The former samples were excited 
simultaneously at 345 nm for DAPI and 540/545 nm for Phalloidin. Emission at 458 
nm was mapped to the blue channel and 570/573 nm to the red channel. PCL 
nanofibers were observed in DIC black ground levelling mode. 
Alternatively to the previous histological procedure, formalin-fixed nanofiber 
reinforced or not microfibrous composite scaffolds-hBMSCs constructs were 
embedded in Teknovit resin to allow their sectioning (10 µm each section). 
Hematoxylin-Eosin stainning was performed to observe the cell morphology and its 
distribution into the nanofiber reinforced microfibrous composite scaffolds. Basically, 
the constructs were stained with Harris Hematoxylin (Merck, Germany) during a 
suitable time (1-3 minutes), until reaching a desired staining intensity. They were 
washed in running tap water and afterwards a blue stain enhancement was 
performed by an immersion in 0.5 % ammonia (Aldrich, Germany), for 5–10 seconds. 
The constructs were washed again in running tap water, followed by an immersion in 
alcohol 96 %, and stained in Shandon Eosin-Y (Thermo Scientific, UK) for 30 
seconds. They were again washed in alcohol 96 % and dehydrated through two 
immersions in alcohol 100 %. Before permanent mounting in Histomount (National 
Diagnostics, UK), the stained constructs were immersed in a clearing agent, Histo-
Clear (National Diagnostics, UK) for 1-2 min. Stained sections were observed under 
an optical microscope (BX61, Olympus Corporation, Germany) and images captured 
with a digital camera (DP70, Olympus Corporation, Germany). 
 
2.7.6. Cell Viab ility Assay 
 
Viability assays were used to measure the proportion of viable cells after a 
potentially traumatic procedure, such as primary disaggregation, cell separation, or 
cryostorage [84]. The net increase in the number of cells (i.e., the growth yield) is 
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labor intensive and time consuming to set up and analyze, particularly when a large 
number of samples is involved, and the duration of each experiment may be 
anywhere from 2 to 4 weeks. Instead, a number of alternatives have been devised for 
assaying cells at higher densities, e.g. in microtitration plates. Indirect measurements 
of viability are mainly based on its metabolic activity. Indeed, the increase in the 
number of cells is proportional to the increase in the total amount of protein or DNA, 
or continued metabolic activity. In these cases, the survival is defined as the retention 
of metabolic or proliferative ability by the cell population as a whole, some time after 
removal of the toxic influence. 
At each defined culture period, metabolic activity and, consequently, cell 
viability was determined by a colorimetric assay named CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (Promega; USA). Briefly, this assay is based on the 
bioreduction of a tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfofenyl)-2H-tetrazolium, inner salt (MTS)] into a 
brown formazan product that is soluble in culture medium [85]. This conversion is 
accomplished by the production of nicotinamide adenine dinucleotide phosphate 
(NADPH) or nicotinamide adenine dinucleotide (NADH) by the dehydrogenase 
enzymes existing in the metabolically active cells. The quantity of formazan product 
bioreduced is directly proportional to the number of living cells in culture, as 
measured by the amount of 490nm absorbance in a microplate reader (Bio-Tek, 
model Synergie HT; USA), after 3h of incubation at 37 ºC. Three specimens per 
condition and per time point were characterized. 
 
2.7.7. Cell Proliferation Assay 
 
Measurements of DNA synthesis are frequently taken to be representative of 
the amount of cell proliferation [84]. Cell proliferation rate determination is often used 
to determine the response of cells to a particular stimulus, i.e. physical (e.g. 
topography of a substrate) or chemical (i.e. toxin or growth/differentiation factor). The 
most commonly used technique for measuring nucleic acid concentration is the 
determination of absorbance at 260 nm (A260). The major disadvantages of the 
absorbance method are the large relative contribution of RNA and single-stranded 
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DNA to the signal, the interference caused by contaminants commonly found in 
nucleic acid preparations, the inability to distinguish between DNA and RNA, and the 
relative insensitivity of the assay (an A260 of 0.1 corresponds to a 5 µg/mL double-
stranded DNA solution). Alternatively, DNA content may be assayed by several 
fluorescence methods, including reaction with DAPI, PicoGreen or Hoechst 33258. 
The fluorescence emission of Hoechst 33258 at 458 nm is increased by interaction of 
the dye with DNA at pH 7.4 and in high salt to dissociate the chromatin protein [86]. 
This method gives a sensitivity of 10 ng/mL, but requires intact double-stranded DNA. 
In the present work, cell proliferation was quantified by the total amount of 
double-stranded DNA (dsDNA) using an ultrasensitive fluorescent nucleic acid stain 
[87], during the culturing periods. To reach that aim, Quant-iT™ PicoGreen® dsDNA 
reagent was selected since it enables to quantify as little as 25 pg/mL of dsDNA (50 
pg dsDNA in a 2 mL assay volume) with a standard spectrofluorometer and 
fluorescein excitation and emission wavelengths. Additionally, dsDNA can be 
quantified in the presence of equimolar concentrations of ssDNA and RNA with 
minimal effect on the quantitative results obtained. The Quant-iT™ PicoGreen dsDNA 
Assay Kit (Invitrogen™, Molecular Probes™; Oregon, USA) was used according to 
the manufacturer’s instructions. Briefly, cells in the construct were lysed by osmotic 
and thermal shock and the supernatant used for the DNA quantification assay. A 
fluorescent dye, PicoGreen, was used because of its high sensitivity and specificity to 
double-stranded DNA. The fluorescence of the dye was measured at an excitation 
wavelength of 485/20 nm and at an emission wavelength of 528/20 nm, in a 
microplate reader (Synergie HT, Bio-Tek; USA). Triplicates were made for each 
sample and per culturing time. The DNA concentration for each sample was 
calculated using a standard curve (DNA concentration ranging from 0.0 to 1.5 µg/ml) 
relating quantity of DNA and fluorescence intensity. 
 
2.7.8. Alkaline Phosphatase Quantification 
 
A detailed analysis of the mineralization and of the progression of 
differentiation can be obtained by biochemical assays. Routine assessments involve 
the quantification of total calcium content and the activity of alkaline phosphatase 
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(ALP), a cell surface protein bound to the plasma membrane though 
phosphatidylinositol phospholipid complexes [80]. High ALP activity is associated with 
the active formation of mineralized matrix, and highest levels are found in the 
mineralization front of the bone healing process. 
The concentration of ALP was determined for all time culture periods, using the 
same samples used for DNA quantification. Briefly, the activity of ALP was assessed 
using the p-nitrophenol assay. Nitrophenyl phosphate disodium salt (pnPP; Fluka 
BioChemika, Austria), which is colourless, is hydrolysed by the alkaline phosphatase 
produced by the cells at pH 10.5 and temperature of 37 ºC, to form free p-nitrophenol, 
which is yellow. The reaction was stopped by the addition of 2M NaOH (Panreac 
Quimica, Spain) and the absorbance read at 405 nm in a microplate reader (Bio-Tek, 
Synergie HT; USA). Standards were prepared with 10 µmol/ml p-nytrophenol (pNP; 
Sigma, USA) solution, to obtain a standard curve ranging from 0 to 0.25 µmol/ml). 
Triplicates of each sample and standard were made, and the ALP concentrations 
read off directly from the standard curve. 
 
2.7.9. Alizarin Red Staining 
 
Von Kossa and Alizarin Red are the most used stainings to detect the 
mineralization process in osteoblasts culture. Both stainings are used to detect the 
mineralization, but the reactions that generate a positive staining are different. In fact 
the Von Kossa staining is based on a reaction of the silver nitrate that allows to 
visualize phosphate and carbonate anions that stain with a black colour, while alizarin 
red S reacts with calcium and other cations staining red [88]. Von Kossa staining can 
also react with other type of phosphate or carbonate salts, such as sodium phosphate 
staining black and generating false positives. Therefore, the Von Kossa stain is not 
specific for calcium, while alizarin red S reacts specifically with calcium and therefore 
can be considered a more reliable stain to detect the level of mineralization. 
The DEX-loaded nanofiber meshes-hBMSCs constructs were fixed in 10 % 
formalin solution neutral buffer (Sigma-Aldrich, Germany) for 30 min and maintained 
in phosphate buffer saline (PBS) until further use. The constructs were then stained 
with a 2 % Alizarin Red solution (Merk, Germany) in distilled water for 5 min, and 
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finally washed with distilled water. Stained constructs were observed under an optical 
microscope (BX61, Olympus Corporation, Germany) and images captured by a digital 
camera (DP70, Olympus Corporation, Germany). 
 
2.7.10. Immunodetection of Bone-specific Proteins 
 
Particularly important in defining the phenotype of the differentiating stem cells 
is an understanding of bone tissue development in relation to the gene expression of 
the cells [80]. Consequently, the osteogenic phenotype of hBMSCs seeded onto the 
random and patterned, and also in dexamethasone-loaded PCL nanofiber meshes 
was also assessed by the immunodetection of bone-specific proteins. Osteopontin is 
one of the most abundant noncollagenous proteins in bone; it binds to various 
extracellular molecules, including type I collagen, fibronectin and osteocalcin, and 
may add physical strength to the extracellular matrix. Osteocalcin comprises 10-20 % 
of the noncollagenous proteins in bone, depending on the age and species. Levels of 
osteocalcin are low at early stages and increase with increasing age. The function of 
osteocalcin may be to inhibit calcification until the appropriate temporal and spatial 
conditions are met. Bone sialoprotein (BSP) has been proposed as the main 
nucleator of hydroxyapatite crystal formation and correlates with the initial phase of 
matrix deposition [80]. Accordingly, immunocytochemistry was performed following 
the streptavidin-biotin-peroxidase complex approach (R.T.U. Vectastain® Universal 
Elite® ABC kit; Vector Laboratories Inc., Burlingame, CA), using a rabbit polyclonal 
antibody against osteopontin (Abcam Ltd., Cambridge, UK; dilution 1:1500), a mouse 
monoclonal antibody against osteocalcin (clone OC4-30, Abcam Ltd., Cambridge, 
UK; dilution 1:100) and a rabbit polyclonal antibody against bone sialoprotein II 
(Chemicon® International Inc., Germany; dilution 1:2500). 
Prior to the immunocytochemistry procedure, constructs were fixed in 10 % 
formalin solution neutral buffer (Sigma-Aldrich, Germany) for 30 min and maintained 
in phosphate buffer saline (PBS) until further use. The constructs were firstly treated 
with 0.3 % hydrogen peroxide in methanol during 30 min to inactivate the 
endogenous peroxidases. After washing with PBS, the constructs were blocked with 
2.5 % normal horse serum for 20 min at room temperature to avoid unspecific 
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reactions. Primary antibodies were incubated overnight at 4 ºC. Negative controls 
were set in the absence of primary antibodies incubation. After washing in PBS, the 
samples were incubated for 30 min with biotinylated secondary antibody anti-
rabbit/mouse IgG, followed by incubation with streptavidin-peroxidase complex (Elite 
ABC Reagent). The immune reaction was visualized using DAB as a chromogen 
(DAB Substrate Reagent from Peroxidase Substract Kit; Vector Laboratories Inc, 
Burlingame, CA). The constructs were observed under an optical microscope (BX61, 
Olympus Corporation, Germany) and images captured by a digital camera (DP70, 
Olympus Corporation, Germany). 
 
2.7.11. RNA isolation and Real-Time Quantitative Polymerase Chain Reaction 
 
Total RNA from the constructs was extracted using the Trizol® (Invitrogen, Life 
Technologies Inc., UK) method according to the manufacturer’s protocol. Briefly, at 
each culturing time the constructs were washed with PBS, immersed in Trizol and 
stored at -80 ºC until further use. Proteins were removed with chloroform extraction, 
and the RNA pellets were washed once with isopropyl alcohol and once with 70 % 
ethanol. The total RNA pellets were reconstituted in Rnase free water (Gibco, 
Invitrogen, UK). Determination of the RNA concentration for each scaffold replica 
(triplicates of each scaffold per time point) was performed by microspectrophotometry 
(NanoDrop ND-1000, USA). 
The mRNA expression of the genes encoding important proteins during 
osteogenic differentiation of hMSCs in vitro were not systematically investigated, and 
results from different studies are frequently contradictory [80]. Besides those genes, 
two major transcription factors involved in the osteogenic differentiation, namely the 
core binding factor α 1/runt-related gene (Cbfa1/Runx2) and the zinc finger-containing 
transcription factor Osterix (Osx), were also investigated in this work. Cbfa1/Runx2 
has been shown to preferentially initiate two steps of the differentiation process, stem 
cells into preosteoblasts and preosteoblasts into osteoblasts, whereas Osterix acts 
only during the last preosteoblast/osteoblast stage [76, 89]. Recently established real-
time quantitative RT-PCR technology has made mRNA analysis more reproducible, 
precise, and sensitive than conventional RT-PCR, because it allows: (i) measurement 
Materials & Methods  
105 
Table 2.2 - List of primer sets for bone-specific genes 
Gene  Primer sequences (5’-3’) Tm [ºC] 
ALP sense 
antisense 
CTCCTCGGAAGACACTCTG 
AGACTGCGCCTGGTAGTTG 60,0 
OP sense 
antisense 
GGGGACAACTGGAGTGAAAA 
CCCACAGACCCTTCCAAGTA 58,4 
BSP sense 
antisense 
CAACAGCACAGAGGCAGAAAAC 
CCTCGTATTCAACGGTGGTG 59,9 
OC sense antisense 
CTGAGAGGAGCAGAACTGG 
GGCAGCGAGGTAGTGAAGAG 61,4 
Runx2 sense 
antisense 
TTCCAGACCAGCAGCACTC 
CAGCGTCAACACCATCATTC 58,1 
Osterix sense 
antisense 
CCCTTTACAAGCACTAATGG 
ACACTGGGCAGACAGTCAG 57,1 
GAPDH sense 
antisense 
ACAGTCAGCCGCATCTTCTT 
GACAAGCTTCCCGTTCTCAG 58,4 
 
of the amount of amplified product with a quantitative laser-based method and (ii) 
data collection in the early exponential phase of the PCR reaction, when none of the 
reagents is rate-limiting. 
Reverse transcriptase (RT)-PCR was performed according to the protocol from 
iScript™ cDNA synthesis kit (BioRad, Hercules, CA, USA). Briefly, a reaction mixture 
consisting of 1X iScript Reaction Mix, 1 µl iScript Reverse Transcriptase, RNA 
template (1 µg total RNA from random and patterned nanofiber meshes; 300 ng total 
RNA from DEX-loaded nanofiber meshes; 150 ng total RNA from PBS-R and PBS 
scaffolds, and 1 µg total RNA from PBS/Cht-R and PBS/Cht scaffolds) and nuclease-
free water was prepared, in 20 µl of total volume. The single-strand cDNA synthesis 
occurred by incubating the complete reaction mixture 5 min at 25 ºC, followed by 30 
min at 42 ºC and terminated by an incubation at 85 ºC for 5 min. 
Amplification of the target cDNA for real-time PCR quantification were 
performed according to manufacturer, using 2 µl RT cDNA products, 1 µM each 
primer (bone-specific primer sets listed in Table 2.2), 1X iQ SYBR Green Supermix 
(BioRad, Hercules, CA, USA) and nuclease-free water, in a final volume of 25 µL. 
Forty-four cycles of denaturation (95 ºC, 10 s), annealing (temperature dependent on 
the gene, 30 s) and extension (72 ºC, 30 s) were carried out in the gradient 
thermocycler MiniOpticon real-time PCR detection system (BioRad, Hercules, CA, 
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USA) for all genes. The transcripts expression data were normalized to the 
housekeeping gene glyceraldehydes-3-phosphate-dehygrogenase (GAPDH) and the 
relative quantification calculated by the ∆CT method. 
 
2.8. Statistical Analysis  
 
Statistical Analysis was performed using the SPSS statistic software (Release 
15.0.0 for Windows). Firstly, a Shapiro-Wilk test was used to ascertain about the data 
normality [90]. The normality is strongly rejected, as observed by the very small p-
value (p < 0.001). Therefore, nonparametric tests should be used in further 
comparisons. A Mann-Whitney U test was applied to compare two independent 
samples on one variable [91]. This test was performed to analyze the effect of random 
and patterned electrospun nanofibrous structures on the hBMSCs’-derived phenotype 
(i.e. cellular proliferation and ALP quantification) and osteogenic genotype (i.e. 
relative gene expression) (Chapter 4). Mann-Whitney U test was also performed to 
compare the effect of hierarchical fibrous scaffold architecture over cell performance 
(i.e. cell viability and proliferation, and ALP quantification) (Chapter 5).  In another 
study, to find differences in terms of cell viability and proliferation among PCL NFM 
and PCL-PEO NFM after PEO dissolution, the Mann–Whitney U test was also 
performed (Chapter 7). P values lower than 0.01 were considered statistically 
significant in the analysis of the results. 
When more than two independent groups of samples are being compared for 
one variable, a Kruskal-Wallis test [92] was performed. When the Kruskal-Wallis test 
indicated significant differences between the independent groups, different multiple 
comparison tests sould be performed to find which one or how many are different. 
The Dunnett's test is a specialized multiple comparison test that allows to compare a 
single control group (e.g. TCPS or untreated PCL NFM) to all other sample groups 
[93]. Therefore, those tests were applied to analyze the effect of the various plasma 
treatments performed on the material hydrophilicity and cellular performance (Chapter 
3). Other multiple comparison test, the Tukey test, was applied to find which pairs of 
nanofibrous-based structures exhibited significant differences [94]. The Tukey 
multiple comparison procedure is also known as the "honestly significant difference 
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test" or HSD test. Those tests (i.e. Kruskal-Wallis test followed by the Tukey’s HSD 
test) were performed to compare the morphological properties (i.e. fiber diameter, 
pore size, roughness parameters and water contact angle) of the PCL NFM, the PCL-
PEO NFM and the PCL-PEO NFM after PEO dissolution (Chapter 7); and in studies 
on the effect of the electrospun nanofibers-reinforced microfibrous scaffolds (Chapter 
6) or the dexamethasone-loaded nanofiber meshes (Chapter 8) over the cell viability, 
proliferation and differentiation of hBMSCs. P values lower than 0.01 were considered 
statistically significant in all the analysis. 
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Surface Modification of Electrospun Polycaprolactone Nanofiber 
Meshes by Plasma Treatment to Enhance Biological 
Performance 
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3.1. Abstract 
 
A critical aspect in the development of biomaterials is the optimization of their 
surface properties to achieve an adequate cell response. In the present work, 
electrospun polycaprolactone nanofiber meshes (NFMs) are treated by radio-
frequency (RF) plasma using different gases (Ar or O2), power (20 or 30 W) and 
exposure time (5 or 10 min). Morphological and roughness analyses showed 
topographical changes on the plasma-treated NFMs. X-ray Photoelectron 
Spectroscopy (XPS) results indicate an increment of the oxygen-containing groups, 
mainly -OH and -C=O, at the plasma-treated surfaces. Accordingly, the glycerol 
contact angle results demonstrate a decrease in the hydrophobicity of plasma-treated 
meshes, particularly in the O2-treated ones. 
Three model cell lines (fibroblasts, chondrocytes and osteoblasts) are used to 
study the effect of plasma treatments over the morphology, cell adhesion and 
proliferation. A plasma treatment with O2 and one with Ar are found to be the most 
successful for all the studied cell types. The influence of hydrophilicity and roughness 
of those NFMs on their biological performance is discussed. Despite the often 
claimed morphological similarity of NFMs to natural extracellular matrixes, their 
surface properties contribute substantially to the cellular performance and therefore 
those should be optimized. 
 
 
3.2. Introduction 
 
Biomaterials can be used to tailor the biophysical and biochemical milieus that 
direct cellular behavior and function into the desired regeneration of tissues [1]. Thus, 
they may play a significant role in the modern strategies of regenerative medicine and 
tissue engineering. A number of naturally derived polymers, such as collagen, 
gelatine, albumin, chitosan and starch have already shown to have properties 
relevant to many biomedical applications [2]. However, biodegradable polymers 
belonging to the aliphatic polyester family currently represent the most attractive 
group of polymers that meet various medical and physical demands for safe clinical 
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applications [3]. This is mainly due to their biocompatibility, acceptable degradation 
rates and versatility regarding physical and chemical properties [4]. Undoubtedly, 
three of the most significant members of the aliphatic polyester family are the 
polyglycolide (PGA), polylactide (PLA) and the poly-ε-caprolactone (PCL). Among 
them, PCL is the most hydrophobic and degrades by hydrolysis of its ester bonds 
under physiological conditions at a much slower rate than PGA and PLA [5]. It has 
been shown that PCL is biocompatible for some applications [4, 6-8] and it has 
exceptional ability to form compatible blends and copolymers with a wide range of 
other polymers, resulting in materials with unique ranges of properties [5, 9]. 
Much attention has been also devoted to the electrospinning technique as an 
innovative processing method for biodegradable polymers [10-13]. It is a versatile 
technique allowing for the production of polymeric ultrafine fibers with diameters 
ranging from few microns down to tens of nanometers [13, 14]. Besides the 
dimensional reduction to the nano-level, the ability of this technique to shape 
materials with morphology mimicking the extracellular matrix (ECM) of many tissues 
in the body, is relevant to control cell affinity and adhesion [12, 15, 16]. The cell 
behavior on nano-structured surface materials has been extensively studied [15-22]. 
Indeed, an enhanced cell attachment and proliferation was observed on nano-
structured surfaces in comparison to the micro-structured surfaces [23]. 
An ideal biomaterial should have adequate bulk properties, while the surface 
should have enhanced affinity with cells. As it is very difficult to design biomaterials 
combining bulk properties and surface properties, a common approach is to produce 
biomaterials with adequate bulk properties followed by a surface modification to 
enhance the surface properties. The surface modification of a biomaterial can be 
achieved by various techniques, including treatments by flame, corona discharge, 
plasma, photons, electron beam, ion beam, X-ray, and γ-ray [24, 25]. In the present 
study, plasma treatment was the selected process to modify the surfaces of 
electrospun PCL nanofiber meshes (NFMs). Plasma treatment is a versatile and 
effective method for modifying the surface properties or introducing desired chemical 
groups at the surface of a material without affecting its bulk properties [24, 26-28]. 
The most apparent effects of plasma treatment are surface cleaning, microetching 
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and surface activation (attachment of chemical groups, modification of surface 
charge, increased the surface free energy) [27, 28]. A common application of this 
technique is to improve the surface hydrophilicity by forming oxygen-containing 
groups at the surface of the materials [29-31]. In recent years, plasma surface 
modifications have been used very intensively in the field of biomedical materials 
research [24, 26-28]. Typical examples of plasma-modified polymers used for cell 
culture experiments are Primaria and tissue culture polystyrene (TCPS). Both types 
of polymer surfaces induce good cell adhesion in vitro, but are not able to fulfill the 
requirements for a prosthetic implant material [32]. 
The aim of the present study was to produce electrospun PCL NFMs and 
modify their surface in order to improve the adhesion and proliferation of cells. 
Untreated and plasma modified NFMs were characterized using various surface-
sensitive techniques, namely scanning electron microscopy (SEM), interferometric 
optical profilometry, contact angle measurement and X-ray photoelectron 
spectroscopy (XPS). These techniques enable the evaluation of changes in surface 
topography, hydrophilicity, and surface chemistry, as a result of the treatment. 
Different assays were used to characterize the effects of the plasma treatments over 
fibroblast, chondrocyte, and osteoblastic cell lines when seeded on the plasma-
treated and untreated PCL NFMs. The biological relevance of each plasma treatment 
was assessed, analyzing the cell attachment, morphology, viability, and proliferation. 
To the best of our knowledge, this is the first systematic study where different plasma 
treatment conditions for electrospun biodegradable NFM modification was reported 
with respect to the performance of different cell types, and aiming at the regeneration 
of different tissues. 
 
3.3. Materials & Methods 
 
3.3.1. Electrospinning process 
 
A polymeric solution of 17 % w/v PCL (TONE , Union Carbide Chemicals and 
Plastics Division; New Jersey) was prepared using an organic solvent mixture 
composed of Chloroform (Aldrich; Germany) and N,N-Dimethylformamide (Aldrich) 
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(7:3 ratio). The solution was electrospun at 9-10 kV, a needle-to-ground collector 
distance of 20 cm, and a flow rate of 1.0 ml/h. The nonwoven fibrous meshes were 
collected on a flat aluminium foil and the solvent evaporation was performed at room 
temperature during at least 2 days. 
 
3.3.2. Surface Modification by Plasma Treatment 
 
The PCL NFMs obtained by electrospinning were modified by plasma 
treatment. The treatment was performed in a PlasmaPrep 5 reactor (GaLa 
Instrumente, Germany) with a chamber size of 15 cm diameter and 31 cm length 
(volume 5 L) and with fully automated process control. The samples were clamped 
between both electrodes and the chamber was evacuated. Two different gases (O2 or 
Ar) were used and the chamber was filled with the working gas five times prior to the 
treatment. A radio frequency (RF) source operating at 13.56 mHz was used and the 
power intensity (20 or 30 W) was applied for either 5 or 10 min. The pressure of the 
plasma chamber was kept at 0.2 mbar in all conditions by controlling the working gas 
flow. When the higher power level (30 W) and longer treatment time (10 min) were 
used as working conditions, an increase of the temperature inside the chamber (≈ 35 
ºC). 
 
3.3.3. Surface Characterization of Untreated and Plasma-Treated PCL Nanofiber 
Meshes 
 
3.3.3.1. Scanning Electron Microscopy 
 
Untreated and plasma-treated electrospun PCL NFMs were sputter-coated 
with gold (Fisons Instruments, model SC502; England) for 2 min at 15 mA. The 
samples were further analyzed by SEM (Leica Cambridge, model S360; England). 
 
3.3.3.2. Interferometric Optical Profilometry 
 
The surface topography of the untreated and plasma-treated electrospun PCL 
NFMs was assessed by noncontact profilometry using an interferometer profiler 
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(Wyko-Veeco, model NT1100; USA) equipped with the WycoVision® 32 analytical 
software. Topographic roughness parameters average roughness (Ra) and root mean 
square (RMS) roughness (Rq) were both determined for each sample. Each sample 
was evaluated, at least, at two randomly selected and representative specimen 
locations. 
 
3.3.3.3. Contact Angle Measurements 
 
The static contact angles were measured at room temperature with a Contact 
Angle Equipment (DataPhysics Instruments, model OCA 15plus; Germany). The 
values were obtained by the sessile drop method. The used liquids (water and 
glycerol, HPLC grade, 3µL) were applied by a motor driven syringe at different zones 
of each sample and the measurement time was extended until 5 min. At least five 
measurements were carried out for each sample and the presented data are 
averaged values for those measurements. 
 
3.3.3.4. X-ray Photoelectron Spectroscopy 
 
Analysis of the untreated and plasma-modified electrospun NFMs was 
performed using an VG Escalab 250 iXL ESCA instrument (VG Scientific; UK), 
equipped with Al-Kα 1,2 monochromatized radiation at 1486.92 eV in the X-ray 
source. Due to the non conductive nature of the samples, it was necessary to use an 
electron flood gun to minimize the surface charging accumulation. The neutralization 
of the surface charge was  performed by using both a low energy flood gun (electrons 
in the range of 0.00-14.00 eV) and an electrically grounded stainless steel screen was 
placed directly at the sample surface. 
The XPS measurements were carried out using monochromatic Al-Kα radiation 
(hν=1486.92 eV). Photoelectrons were collected from a takeoff angle of 90º relative to 
the sample surface. The measurement was performed in a constant analyzer energy 
mode (CAE) with 100.00 eV pass energy for the screening stage and 20.00 eV pass 
energy to obtain high resolution spectra. 
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Charge referencing was carried out by setting the lower binding energy C1s 
hydrocarbon (CHx) peak at 285.00 eV. The spectra fitting is based on a χ-squared 
algorithm used to determine the effectiveness of the peak fit. Surface elemental 
composition was determined using the standard Scofield photoemission cross 
section. 
 
3.3.4. Biological Assays 
 
3.3.4.1. Cell Lines 
 
Three types of cell lines were used: L929, a mouse lung fibroblastic cell line; 
the Saos-2, a Human primary osteosarcoma cell line; and the ATDC5, a mouse 
condrocyte teratocarcinoma-derived cell line, all supplied by European Collection of 
Cell Cultures (ECACC; UK). L929 and Saos-2 cells were maintained in Dulbecco’s 
Modified Eagle’s Medium (DMEM) (Sigma-Aldrich; Germany) supplemented with 10 
% heat-inactivated fetal bovine serum (Biochrom AG; Germany) and 1 % antibiotic-
antimycotic solution (Gibco; GB). ATDC5 cells were cultured in DMEM-F12 (Gibco; 
GB) supplemented with 10 % heat-inactivated fetal bovine serum (Biochrom AG; 
Germany) and 2 mM L-Glutamine (Sigma-Aldrich). All cell types were cultured in a 
humidified incubator at 37 ºC, in 5 % CO2 atmosphere. The media were routinely 
replaced every 2-3 days. 
 
3.3.4.2. Cell Seeding 
 
Prior to the biological assays, the untreated and plasma-modified PCL NFMs 
were sterilized by ethylene oxide. The sterile samples of NFMs and controls, PCL 
solvent-cast membranes, and TCPS coverslips, were placed in 24-well cell culture 
plates (Costar, Corning; NY). A 50 µL cell suspension containing 1x105 cells was 
added to each cm2 of each sample and controls. The biological parameters were 
assessed at different culture periods: 1, 3, 7 and 14 days. 
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3.3.4.3. Evaluation of Cell Morphology 
 
To evaluate the cell adhesion and morphology, the constructs (cells-NFMs) 
were fixed with 2.5 % glutaraldehyde (Sigma; USA) in phosphate buffer saline 
(Sigma; USA) solution, for 1 h at 4 ºC. The samples were further dehydrated through 
a graded series of ethanol and coated in a gold sputter coating equipment (Fisons 
Instruments, model SC502; England) for 2 min at 15 mA, and analyzed by SEM 
(Leica Cambridge, model S360; England). 
 
3.3.4.4. Metabolic Activity Analysis (MTS Assay) 
 
At each defined culture period, cell viability and proliferation was determined 
using the CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega; 
USA). Briefly, this assay is based on the bioreduction of a tetrazolium compound, 3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfofenyl)-2H-tetrazolium 
(MTS), into a brown formazan product that is soluble in water. This conversion is 
accomplished by the production of nicotinamide adenine dinucleotide phosphate 
(NADPH) or nicotinamide adenine dinucleotide (NADH) by the dehydrogenase 
enzymes existing in metabolically active cells. The absorbance relative to the quantity 
of formazan product is directly proportional to the number of living cells in culture, and 
was measured at 490 nm in a microplate reader (Bio-Tek, model Synergie HT; USA). 
Three specimens per condition and per time point were characterized. 
 
3.3.5. Statistical Analysis 
 
Statistical analysis was performed using the SPSS statistic software (Release 
8.0.0 for Windows). Firstly, a Shapiro-Wilk test was used to ascertain about the 
normality of the data and the results showed that the data was not following a normal 
distribution. For this reason, a Kruskal-Wallis test followed by Dunnett’s test for 
multiple comparisons was performed to analyze the effect of the various plasma 
treatments performed on material the hydrophilicity and cellular performance. The p-. 
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Figure 3.1 - SEM micrographs of untreated and plasma-treated PCL nanofiber 
meshes. A – untreated PCL nanofiber mesh; B – O2 30W 10min; C – Ar 30W 10min. 
 
values lower than 0.01 were considered statistically significant in the analysis of the 
results. 
 
3.4. Results 
 
3.4.1. Morphological Characterization of Plasma-Treated Electrospun Nanofibers 
 
The SEM photomicrographs of the untreated and plasma-treated electrospun 
PCL NFMs are shown in Figure 3.1. The O2-plasma treatments analyzed by SEM 
revealed that the 10 min treatment with 30 W power induced melting of the thinner 
nanofibers (Figure 3.1 A). This effect creates more open space between the fibers still 
present in the mesh (Figure 3.1 B). When the exposure time or the power were 
reduced, fibers with irregular morphology and non-uniform diameter and spherical 
terminated ends were observed. The melting of thinner fibers was also observed 
when the working atmosphere was changed to Ar. The exception was the treatment 
at 30 W power and 10 min exposure in which the nanofibers appear with blunted 
ends (Figure 3.1 C). 
The surface roughness parameters of the untreated and plasma-treated 
electrospun NFMs are shown in Table 3.1. The average surface roughness, Ra, of 
untreated NFM was 2.01 µm and its surface profile obtained in interferometric optical 
profilometry is presented in Figure 3.2 A. Generally, for the conditions involving higher 
power and longer exposure time, the surface of PCL NFM becomes smoother with an 
average roughness of 1.40 µm for O2-plasma (Figure 3.2 B) and 1.86 µm for Ar-
plasma. Conversely, the lower power and shorter exposure time resulted in a rougher  
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Table 3.1 - Surface roughness parameters (µm) of some plasma-treated and 
untreated electrospun PCL nanofiber meshes. Ra - Roughness Average; Rq - Root 
Mean Square (RMS) Roughness. 
Roughness  
Para meters  Untr eated 
O 2 
30W, 10 min. 
O2 
30W, 5 min. 
O 2 
20W, 10 min. 
O2 
20W, 5 min. 
Ar 
3 0W, 10 min. 
Ar  
30W, 5  min. 
Ar  
20 W, 10  m in. 
A r 
20W, 5 mi n 
Ra 2. 01  1. 40  2.26 2. 65 2.51 1.86 1.9 7 2.05 4.72 
Rq 2. 49  1. 95  2.81 3. 30 3.31 2.41 2.5 1 2.63 6.55 
 
 
 
surface, with a Ra value of 2.51 µm in the O2-plasma treatment and 4.72 µm in the Ar-
plasma treatment (Figure 3.2 C).  
 
3.4.2. Hydrophilicity of Plasma-Treated Electrospun Nanofibers 
 
Contact angle measurements for the untreated and plasma-treated 
electrospun PCL NFMs were performed to determine the effect of treatments on the 
surface hydrophilicity. The measurements were carried out at different time periods: 
the initial time points are the most important because they reflect the moment when 
the materials come into contact with body fluids. Measurements for longer times were 
intended to evaluate the equilibrium surface wettability. A direct comparison between 
each couple – modified vs. untreated-PCL NFMs was performed. A Kruskal-Wallis 
statistical analysis test was performed for each couple and time period, and 
statistically significant differences were obtained (p < 0.00001). Dunnett’s test for 
multiple comparisons was used to determine the plasma treatments that led to 
statistically significant differences when compared with untreated NFMs. 
 
 
Figure 3.2 - Optical profilometry images of the untreated PCL nanofiber meshes (A), 
Oxygen-treated at 30W during 10 minutes (B) and Argon-treated at 20W during 5 
minutes (C). 
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Initially, the contact angle measurements were performed using water. 
Untreated PCL NFMs demonstrated a water contact angle of 130º (data not shown), 
and this value was shown to be stable during the studied time periods. Considering 
the water contact angle of Ar-treated samples, a decrease of 20º was observed (data 
not shown), that is, the surfaces became less hydrophobic. Oxygen-treated NFMs 
presented water contact angles below 20º, which could not be detected by the high 
speed camera. To overcome this difficulty, a highly viscous polar liquid, glycerol, was 
used instead of water to characterize the differences in contact angle of the surface-
modified NFMs.  
As can be observed in Figure 3.3, O2-plasma treated NFMs presented 
significantly smaller contact angles than untreated NFMs (p < 0.01). The only 
exception was the treatment with O2 at 20 W for 5 min. Conversely, the Ar-treated 
NFM at 30 W for 10 min also presented significantly lower values of contact angle 
(p<0.01) when compared to untreated PCL NFMs. The combined effect of power and 
exposure time on the surface hydrophilicity should be highlighted: 30 W and 10 min 
exposure resulted in the most hydrophilic surface, while 20 W and 5 min did not show 
any significant difference in hydrophilicity. Additionally, the drop spreading profile
 
 
Figure 3.3 - Glycerol Contact Angle values of untreated and plasma modified PCL 
nanofiber meshes as function of the time. 
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Table 3.2 - Elemental composition of some plasma-treated and untreated electrospun 
PCL nanofiber meshes. C – Carbon; O – Oxygen. 
Elements Untreat ed O2 30W, 10 min. 
O2 
30W, 5 min. 
O2 
20W, 10 min. 
O2 
20W, 5  min. 
Ar  
30W, 10 min. 
Ar  
30W, 5  min. 
Ar  
20W, 10 min 
Ar  
20W, 5 min 
C 80.5  75.3  70.7 77.0 79. 0 82.2 82.6 73.1 72. 2 
O 19.0  23.9  27.7 22.9 19. 9 16.7 16.5 23.3 22. 7 
C/O ratio 4.24 3 .15 2.55 3. 36 3.96 4.92 5 .00 3.13 3.18 
 
 
 
before. Thus, it becomes clear that the different surface treatments have significant 
effects on the hydrophilicity of the NFMs. 
 
3.4.3. Chemical Composition of Plasma-Treated Electrospun Nanofibers 
 
XPS was used to analyze the surface chemistry of electrospun PCL NFMs 
before and after plasma treatment. As expected and according to the chemical 
structure of PCL, the XPS analysis of the untreated NFM indicated that the surface 
was dominated by carbon (80.5 %) and oxygen (19.0 %) species (Table 3.2). 
Generally, the elemental composition analysis of the plasma-treated samples showed 
a decrease of carbon content, probably due to the melting process. The oxygen 
content increases because of the surface oxidation. The exceptions were the PCL 
NFMs treated with Ar atmosphere at 30 W for 10 and 5 min, where the carbon 
content was enhanced. The melting process was more pronounced in the NFMs 
treated with Ar at lower power, as well as with O2 at 30 W for 10 and 5 min. The 
increment of oxygen, depending on the plasma treatment, oscillates between 19.9 %, 
for the O2- plasma treatment at 20 W for 5 min, and 27.7 % for the O2 treatment at 
30W for 5 min. The C/O ratio decreases in all conditions of plasma treatment with the 
exceptions already mentioned. 
High-resolution peak analysis of carbon 1s (C1s) at the surface was performed 
for both untreated and plasma-treated PCL NFMs to determine the chemical 
functional groups present at the surface. All studied materials exhibited three 
components of C1s core level peak, which correspond to the aliphatic carbon bonds 
(−C−C− or −C−H), carbon single bonded to oxygen (−C−OH or −C−O−) and carbonyl 
functional groups (−C=O)  located at approximately 285, 287, and 289 eV, 
respectively (Figure 3.4). As was expected, considerable differences were detected in  
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Figure 3.4 - High resolution C1s core level signals of untreated (A) and Oxygen-
treated electrospun PCL nanofiber meshes at 30W during 5 minutes (B). 
 
the intensity of these peaks for the untreated and plasma-treated electrospun PCL 
NFMs (e.g., O2 treatment at 30 W for 5 min). Thus, the XPS analyses confirmed that 
the plasma treatments lead to different surface chemistry, which in turn affects the 
wettability and, consequently, the cell attachment. 
 
3.4.4. Cellular Performance over Plasma-Treated Electrospun Nanofibers 
 
The morphology of the cells cultured on untreated and plasma-treated 
electrospun PCL NFMs was examined by SEM. For comparative purposes, biological 
studies were also performed in TCPS coverslips as an optimized substrate for 2D cell 
culture. These observations were conducted in the first day after cell culture, because 
the alterations of the surface induced by the plasma treatments have a major 
influence at the beginning of the cell adhesion process. SEM micrographs of the 
direct contact assay with fibroblast-like cells showed a typical spindle-shape 
morphology of cells cultured on Ar-treated PCL NFMs at 30 W for 5 min and at 20 W 
for 10 min (Figure 3.5 I and J). Cells were observed to be dispersed and stretched at 
the surface of the both plasma-treated and untreated mesh-like fibrous structure. The  
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Figure 3.5 - SEM micrographs of L929 cells growing onto plasma-treated and 
untreated PCL nanofiber meshes, after 1 day of culture. A – TCPS; B - PCL sovent-
casted membrane; C – untreated PCL nanofiber mesh; D – O2 30W 10min; E – O2 
30W 5min; F – O2 20W 10min; G – O2 20W 5min; H – Ar 30W 10min; I – Ar 30W 
5min; J – Ar 20W 10min; K – Ar 20W 5min. 
 
round shape of the chondrocyte-like cells was only kept on untreated PCL NFMs 
(Figure 3.6 C). 
Poor chondrocyte attachment was observed on PCL NFMs subjected to 
plasma-treatment with O2 at 30 W for 10 min and Ar at 30 W for 10 min (Figure 3.6 D 
and H), which is understandable since those cells tend to prefer hypoxic 
environments. On the O2-treated NFMs at 20 W for 10 min, Ar-treated at 30 W for 5 
min and at 20 W for 10 min, the cells presented a flatten morphology, covering almost 
all the available surface of the meshes. SEM micrographs from the assays with 
osteoblast-like cells demonstrated that the 2D PCL solvent-cast membrane induces 
the maintenance of the cell morphology (i.e. cuboid shape) (Figure 3.7 B), as well as 
on the TCPS surface (Figure 3.7 A). The largest amount of cells was observed on the 
NFMs treated with O2 at 20 W for 10 min, Ar at 30 W for 5 min and Ar at 20 W for 10 
min, forming a continuous layer of spread cells. For all the other plasma-treated 
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Figure 3.6 - SEM micrographs of ATDC5 cells growing onto plasma-treated and 
untreated PCL nanofiber meshes, after 1 day of culture. A – Tissue Culture 
Polystyrene; B - PCL sovent-casted membrane; C – untreated PCL nanofiber mesh; 
D – O2 30W 10min; E – O2 30W 5min; F – O2 20W 10min; G – O2 20W 5min; H – Ar 
30W 10min; I – Ar 30W 5min; J – Ar 20W 10min; K – Ar 20W 5min. 
 
samples, the cells adhered and interacted with the nanofibrous structure, spreading 
over the surface. 
A metabolic activity-based (MTS) assay was used to determine cell viability of 
the three cell types along the testing periods on the different studied surfaces. For 
these assays, standard TCPS surface was used as a control. For each cell type and 
culture period, the Kruskal-Wallis test was carried out in order to evaluate significant 
differences (p < 0.00001) between the studied surfaces in terms of cell activity. 
Additionally, a Dunnett’s test for multiple comparisons was performed to determine 
which plasma treatment has significant influence on the cell behavior when compared 
to standard TCPS. The results are shown in Figures 3.8-3.10. 
In the case of the fibroblastic cell type, the statistical analysis demonstrated 
that PCL NFMs modified by O2-plasma at 30 W for 10 min and at 20 W for 10 min are 
not appropriate substrates for cell adhesion (p < 0.01) considering their values of cell 
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Figure 3.7 - SEM micrographs of Saos-2 cells growing onto plasma-treated and 
untreated PCL nanofiber meshes, after 1 day of culture. A – TCPS; B - PCL sovent-
casted membrane; C – untreated PCL nanofiber mesh; D – O2 30W 10min; E – O2 
30W 5min; F – O2 20W 10min; G – O2 20W 5min; H – Ar 30W 10min; I – Ar 30W 
5min; J – Ar 20W 10min; K – Ar 20W 5min. 
 
viability after 1 day of culture (Figure 3.8). The other plasma treatments did not 
present statistically significant difference when compared with the untreated PCL
NFMs or the TCPS. 
 After 3 days of culture, the NFMs treated with O2 at 30 W for 5 min, or Ar 
atmosphere at 20 W for 10 and 5 min presented statistically significant higher values 
of cell viability (p < 0.01) when compared to those observed for the untreated 
samples. However, those values were very similar to that observed for the TCPS. At 
7 days of fibroblast culture, all Ar-treated samples presented significantly higher 
values of cell viability than untreated PCL NFMs (p < 0.01). When those values were 
compared with ones obtained for TCPS, only the Ar-plasma treatments at 20 W 
revealed significant difference (p < 0.01). At this period of culture, the O2-treated 
NFMs at 30 W for 10 and 5 min also presented significantly higher values than 
untreated PCL NFMs (p < 0.01), but they did not differ from the TCPS. For longer 
  D 
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Figure 3.8 - Box plot of MTS assay results for fibroblasts (L929 cell line) cultured on 
untreated and plasma treated PCL nanofiber meshes during 1, 3, 7 and 14 days. A – 
TCPS; B - PCL sovent-casted membrane; C – untreated PCL nanofiber mesh; D – O2 
30W 10min; E – O2 30W 5min; F – O2 20W 10min; G – O2 20W 5min; H – Ar 30W 
10min; I – Ar 30W 5min; J – Ar 20W 10min; K – Ar 20W 5min. Data were analyzed by 
nonparametric way of a Kruskal-Wallis test followed by Dunnett’s test for multiple 
comparisons. a, p < 0.01 vs untreated PCL nanofiber mesh. b, p < 0.01 vs TCPS. 
 
culture periods (14 days), the O2- plasma treatment at 30 W for 5 min and the Ar 
treatment at 20 W for 10 min, presented similar fibroblast viability to standard TCPS. 
All the other plasma treatments resulted in lower viability than TCPS (p < 0.01). 
However, a significantly higher cell viability was measured when compared to 
untreated PCL NFMs. Overall, the plasma-modified NFM with O2 at 30 W for 5min
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with Ar at 20 W for 10 and 5 min are the best substrates for fibroblastic proliferation 
for shorter (3 days) culture times, with cellular activity similar to standard TCPS. After 
7 days of culture, the samples treated with O2 at 30 W for 10 min and with Ar at 30 W 
for 10 and 5 min are the ones that performed better in terms of cellular proliferation.   
Regarding the influence of the different plasma treatments over chondrocytic 
cells (ATDC5 cell line) behavior, the surfaces modified by O2 plasma at 30 W for 5 
min and at 20 W for 10 min, as well as the Argon-treated nanofiber meshes at 20W 
during 10 and 5 minutes, presented significantly higher values of cell viability in the 
first day of culture (p < 0.01), when compared to the viability of ATDC5 observed for 
untreated PCL nanofiber meshes (Figure 3.9). However, only the treatments by O2 
presented significantly higher cellular activity than TCPS (p < 0.01). This tendency 
was kept for longer culture time (3 days) with only the exception Ar-treated NFMs at  
20 W for 5 min. Moreover, the NFMs treated in Ar atmosphere at 30 W for 10 min 
also presented higher cellular viability than untreated NFMs (p < 0.01). In comparison 
with TCPS, only the O2-treated at 20 W for 10 min NFMs presented higher cellular 
activity (p < 0.01). O2-treated NFMs for a shorter time period (5 min) showed 
significantly lower values of cellular activity (p < 0.01). The Dunnett’s test performed 
in data obtained after 7 days of culture revealed that the untreated PCL NFMs as well 
as the ones treated with O2 at 30 W and 20 W for 10 min, with Ar at 30 W for 5 min 
and at 20 W for 5 min show higher values of cell viability than standard polystyrene (p 
< 0.01), which is a remarkable result. After 14 days of culture, only the plasma 
treatment with O2 at 30 W for 5 min and with Ar at 20 W for 5 min presented higher 
values of cell viability than untreated PCL NFMs (p < 0.01). The treatments with O2 
also presented higher cellular activity than TCPS (p < 0.01). Taken as a whole, the 
O2-treated NFMs at 30 W for 5 min always show a better performance in cell 
adhesion and proliferation than untreated PCL NFMs, for shorter culture periods (up 
to 3 days). For longer culture periods (> 7 days), the Ar-treated NFMs at 20 W for 5  
min demonstrated the support of higher cellular activity. 
Concerning the influence of plasma-treatment over the activity of osteoblast-
like cells after 1 day of culture, the plasma treatments with O2 at 30 W for 5 min and 
Ar at 30 W for 10 min induced significantly higher cellular viability than untreated PCL  
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Figure 3.9 - Box plot of MTS assay results for chondrocytes (ATDC5 cell line) 
cultured on untreated and plasma treated PCL nanofiber meshes during 1, 3, 7 and 
14 days. A – TCPS; B - PCL sovent-casted membrane; C – untreated PCL nanofiber 
mesh; D – O2 30W 10min; E – O2 30W 5min; F – O2 20W 10min; G – O2 20W 5min; H 
– Ar 30W 10min; I – Ar 30W 5min; J – Ar 20W 10min; K – Ar 20W 5min. Data were 
analyzed by nonparametric way of a Kruskal-Wallis test followed by Dunnett’s test for 
multiple comparisons. a, p < 0.01 vs untreated PCL nanofiber mesh. b, p < 0.01 vs 
TCPS.  
 
NFMs (p < 0.01), but similar to the performance observed for TCPS (Figure 3.10). 
After 3 days of culture, the NFMs treated with O2 at 30 W for 5 min and 20 W  for 10 
min, and Ar at 30 W for 10 min and 20 W for 5 min presented significantly higher 
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Figure 3.10 - Box plot of MTS assay results for osteoblasts (Saos-2 cell line) cultured 
on plasma treated and untreated PCL nanofiber meshes during 1, 3, 7 and 14 days. 
A – TCPS; B - PCL sovent-casted membrane; C – untreated PCL nanofiber mesh; D 
– O2 30W 10min; E – O2 30W 5min; F – O2 20W 10min; G – O2 20W 5min; H – Ar 
30W 10min; I – Ar 30W 5min; J – Ar 20W 10min; K – Ar 20W 5min. Data were 
analyzed by nonparametric way of a Kruskal-Wallis test followed by Dunnett’s test for 
multiple comparisons. a, p < 0.01 vs untreated PCL nanofiber mesh. b, p < 0.01 vs 
TCPS. 
 
values of cell viability (p < 0.01) when compared to untreated NFMs. Those values 
are well in the range of those observed for standard polystyrene. After 7 days of 
culture, only the O2-treated NFMs at 30 W for 5 min and Ar-treated at 20 W for 5 min 
presente comparable cell activity to TCPS, as revealed by the Dunnett’s test. Those 
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conditions together with the Ar-plasma treatment at 30 W for 10 min also presented 
significantly higher cellular performance than untreated NFMs (p < 0.01) for longer 
time culture periods (14 days). In fact, these plasma treatment conditions presented 
similar cellular viability than TCPS, demonstrating its suitability for longer cell culturing 
periods. It could also be observed that the O2-treated NFMs at 30 W for 5 min were 
consistently the most effective in all the culturing periods and the NFMs treated with 
Ar at 20 W for 5 min was also very effective after 3 days of cell culture. 
 
3.5. Discussion 
 
The engineering of nanoscale surfaces allows tailoring the material surface 
characteristics, which can lead to significant effects upon the cellular behavior. The 
main advantage of this engineering approach is the ability to design the materials 
surfaces to provide microenvironments closer to the native ECM and thus facilitate 
cell activity [33]. Theoretically, an optimal substrate for cells should emulate as near 
as possible the topographical and biochemical nature of the native tissue. In the 
present study, nanostructured materials with morphologies similar to the native ECM 
were produced by electrospinning. Electrospun-processed materials have the 
potential to generate scaffolds capable of providing ECM-like surfaces, facilitating 
cell-matrix and cell-cell interactions, and therefore being very useful for tissue 
engineering strategies. However, cells recognize not only topographical clues on the 
surfaces, but also the surface chemistry, which can significantly influence their 
behavior. Surface functionalization of biodegradable synthetic polymers has been 
successfully achieved by plasma treatments, thus decreasing their intrinsic 
hydrophobicity [25]. However, only recently has the plasma surface modification of 3D 
polymer-based structures been considered as an alternative route to enhance their 
biological performance. The difficulties in the surface modification of scaffolds by 
plasma are raised by the requirement for highly porous and interconnected samples 
(the pores must be wider than the mean free path of the electrons and the Debye 
length [34]). Thus, this technique is suitable to modify electrospun structures because 
of its inherent interconnectivity. Moreover, unlike other physical and chemical surface 
modification techniques, the plasma action is limited to 10 nm below the surface and 
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does not affect the bulk properties of the material [24, 26-28, 35]. The selection of 
appropriate treatment conditions is very important since the nanosized structure of 
NFMs should not be compromised, and nor should its cellular performance. 
Depending on the treatment conditions used, such as the type of gas, pressure, 
temperature, time of exposure, and intensity (or power), both chemical and some 
physical characteristics of the surface may be tailored to develop optimal interactions 
with cells and tissues [36]. 
The electrospun NFMs subjected to different plasma treatments were 
morphologically characterized by SEM. This analysis showed that thinner nanofibers 
were not present in some plasma conditions probably because of polymer melting 
that could be due to an undesired increment of the reaction chamber temperature or 
by the electric power used. Other works reported significant morphological alterations 
by plasma surface modification [37]. The analysis of the morphological alterations 
was also performed by the characterization of the surface roughness. This analysis 
may be performed by various techniques such as atomic force microscopy (AFM) or 
interferometric optical profilometry. The latest was selected in this study because of 
its ability to scan a larger area than by AFM. Some works in literature [38, 39] 
confirmed an increase in surface roughness after the plasma treatment, due to 
polymer melting at the surface. This effect increases directly with the duration of the 
treatment. Recently, Wei et al. [40] modified the surface of electrospun polyamide 6 
nanofibers by cold gas plasma treatment and observed that the surface roughness of 
the fiber was greatly increased when compared to the surface of the untreated fiber. 
The results obtained in the present study with plasma treatments at low power and 
exposure time confirm those previous observations. However, for longer treatment 
times and higher power, a smoothing of the surface nanofibers was observed, which 
may have been due to the partial polymer melting during the plasma treatment.  
The contact angle analysis is a highly-sensitive technique for the determination 
of the surface wettability. Moreover, the surface energy can be quantified using 
standard polar and non-polar liquids and some well-established models. However, 
this test is also dependent on the surface roughness. In fact, the NFMs present a 
quite rough surface and the data herein reported is particularly valid for comparative 
Surface Modification by Plasma Treatment 
141 
purposes. The untreated electrospun PCL NFMs is highly hydrophobic (with a 
measured water contact angle of ≈ 130º). A decrease of the contact angle due to the 
plasma treatments was observed mainly after the O2 treatments. These results 
demonstrated that plasma treatment is an effective method to increase the surface 
hydrophilicity of polyester NFMs. Recently, Lai et al. [30] showed that the 
polyethylene terephthalate (PET) smoother surfaces at the microscale led to smaller 
contact angles. Generally [29, 31], plasma-induced polar chemical groups such as 
oxygen-containing groups tend to increase the surface energy of the polymers and 
thus enhance their hydrophilic behavior. O2-plasma treatment is commonly used to 
introduce those functional groups at the nanofiber surface [29]. It has been shown 
already that much of the oxidation is caused by radical reactions between the polymer 
chain backbone and the atomic oxygen in the plasma, leading to various 
functionalities such as hydroperoxides, carbonyls, carboxylic acids, and peracids [41]. 
Higher content of oxygen-containing groups (namely, -O-H and -C=O) were detected 
by XPS in our plasma-treated electrospun PCL NFMs. As previously stated, these 
changes result in a significant increase in the hydrophilicity of the surfaces. Indeed, 
Lai et al. [30] stated that the C=O bond is the main factor controlling the hydrophilicity 
of polymer surfaces. Although Ar is an inert gas, plasma-treatment with this gas can 
also introduce oxygen-containing functionality at the surface [30]. This effect is 
caused by reaction between the free radicals at the surface created during the 
treatment and the oxygen existing in the air. 
As previously mentioned, the main purpose of this work was to define 
conditions of the treatment that result in surfaces favorable for cell growth. We have 
used different cell types (i.e. fibroblasts, chondrocytes and osteoblasts) to validate the 
efficacy of a  defined plasma-treatment. Among the plasma-treated electrospun NFMs, 
the ones modified in an O2 atmosphere at 30 W for 5 min and with Ar at 20 W for 5  
min can be classified as optimal substrates for the cell adhesion and proliferation. The 
NFMs treated at those conditions shown similar cell viability as the one observed for 
TCPS. In the case of O2-modified NFM at 30 W for 5 min, we believe that the 
observed cellular activity is mainly due to the increased hydrophilic character of the 
NFM (glycerol contact angle ≈ 30º). Similar results were observed for human skin 
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fibroblasts whose spreading increased along chemically characterized gradient 
surfaces going from the most hydrophobic towards the hydrophilic end [42]. Among 
the hydrophilic surfaces, differences in charge and wettability significantly influence 
cell attachment but not spreading or cytoskeleton organization. Surface hydrophilicity 
(20–40º water contact angle) is the major parameter promoting high levels of cell 
attachment [43]. However, another study demonstrated that the maximum adhesion 
and growth of various cell types (ovary, fibroblast, and endothelial cells) on polymer 
surfaces with a wettability gradient appeared around water contact angles of 55º [44]. 
Therefore, the optimum value of contact angle for optimal cell adhesion is somewhat 
inconclusive in the literature, varying between 20º and 70º. 
The samples treated at these conditions also presented the highest oxygen 
content (XPS analysis), indicating the importance of the surface chemistry for cell 
adhesion. The oxygen atoms at the surface may be part of carbonyl, carboxyl, ester, 
or hydroxyl groups [45]. However, it is not clear which of these groups is the most 
effective in influencing the cell-biomaterial interaction. It has been suggested [46] that 
the oxygen from the carboxyl group is more effective in promoting this interaction, 
while the oxygen derived from the ester and hydroxyl groups are less effective. 
However, authors suggested that the presence of hydroxyl groups was beneficial for 
cell adhesion [47]. Furthermore, a selective blocking of the hydroxyl groups  was 
shown to result in the inhibition of the adhesion of baby hamster kidney cells or 
leukocytes, while blocking the carboxyl groups did not affect cell adhesion [48]. 
The NFMs treated in an Ar atmosphere at 20 W for 5 min presented a more 
hydrophobic character (glycerol contact angle ≈ 110º), most probably because of the 
surface roughness observed for this treated NFM. It was stated previously that 
surface topography is a key factor affecting cellular morphology, proliferation and 
differentiation [33]. Our experimental results also confirm many reports describing an 
increased proliferation of osteoblastic cells on rough substrata [49-53]. However, it is 
also possible to find reports where it is demonstrated that the surface roughness 
negatively affects the adhesion, proliferation and differentiation of different cell types, 
namely osteoblasts and chondrocytes [54-58]. Furthermore, SEM micrographs of 
bone cells on biomaterials with different surface roughnesses generally demonstrate 
Surface Modification by Plasma Treatment 
143 
that the cell spreading and monolayer formation was more effective on smoother 
surfaces [59]. In the case of fibroblastic cells, there are many studies demonstrating 
the slower cell proliferation on rough substrates compared to smooth surfaces [39, 
51, 60, 61]. Thus, we may say that the effect or influence of the surface roughness on 
the cell adhesion and proliferation is not a consensual in the literature. 
Many authors write that the NFMs are morphologically similar with the ECM of 
many tissues and this similarity must enhance the cell behavior at the surface of 
those structures. Herein, we showed that the surface chemistry has, at least, as 
strong of an effect over cell activity as the structural morphology of the NFMs. Thus, 
we propose that the performance of NFMs also requires chemical surface 
optimization. 
 
3.6. Conclusions 
 
Electrospun PCL NFMs were submitted to different plasma-treatments 
including the gas used (O2 and Ar), the electrical power, and the exposure time. The 
goal was to obtain enhanced cellular response at the surface of NFMs by adjusting 
the treatment conditions. SEM micrographs and surface roughness analysis 
demonstrated the induction of topographical alterations by the plasma-treatments. 
The contact angle analysis revealed that the electrospun NFMs became generally 
more hydrophilic after the applied modifications. The most significant changes in the 
wettability were observed for O2-treated NFMs. XPS results indicated higher oxygen-
contents at the surface of plasma-treated NFMs, including hydroxyl (C-O-) and 
carbonyl (C=O) functionalities. However, the relative content of these functional 
groups was dependent on the specific conditions used. 
Different cell types, namely fibroblasts (L929 cell line), chondrocytes (ATDC5 
cell line) and osteoblast-like (Saos-2 cells), adhered and proliferated at the surface of 
plasma-treated nanofibrous structures. It was possible to define treatment conditions 
leading to enhanced cell adhesion and faster proliferation, namely O2 at 30 W for 5 
min and Ar at 20 W for 5 min.  Using those conditions, both the hydrophilic behavior 
and the roughness of the NFM surfaces were affected. Therefore, both those plasma 
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treatment conditions could be further applied in the development of biomaterials with 
enhanced biological performance independently of the tissue to be regenerated. 
It was shown that one treatment with O2 and one with Ar outperform 
significantly the other treatment conditions and also the untreated NFMs. Our results 
show that the biological performance of NFMs can be improved by the careful control 
of its surface properties without compromising significantly the overall morphology of 
the nanofibers. 
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4.1 Abstract 
 
Electrospinning has emerged as a promising polymer processing technique, 
enabling the production of synthetic nanofibrous structures with topographical 
properties similar to those found in the natural extracellular matrix of many tissues. 
Typically, those structures are based on randomly distributed fibers, although fiber 
meshes with preferential directions of alignment can be produced using specific 
collectors. A special-designed electroconductive collector enabled the production of a 
polycaprolactone (PCL) nanofiber mesh, comprising areas of fibers parallel/uniaxially 
aligned and areas of random/orthogonal nanofibers distribution, herein referred as 
patterned nanofiber meshes (P-NFM). Human bone marrow mesenchymal stem cells 
(hBMSCs) were seeded on those nanofibrous structures and induced to differentiate 
into the osteogenic lineage. Scanning electron microscopy and fluorescence 
microscopy analysis of cultured hBMSCs showed that the cell phenotype was 
sensitive to the topography of the meshes, at the earliest time points. A progressive 
increment on the cellular proliferation and alkaline phosphatase concentration was 
observed, demonstrating the onset of the hBMSCs’ osteoblastic differentiation at the 
surface of P-NFM. Immunocytochemistry against osteopontin, bone sialoprotein and 
osteocalcin confirmed the osteoblastic phenotype of hBMSCs cultured on the P-NFM. 
Additionally, the expression of early and late genotypic markers of osteoblastic cells 
was higher in the P-NFM than in the typical random nanofiber meshes. It is concluded 
that the patterned nanofiber meshes sustain the differentiation of hBMSCs towards 
osteogenic lineage, associated with cell-deposition of mineralized extracellular matrix. 
 
 
4.2 Introduction 
 
In the Tissue Engineering field, electrospinning has received considerable 
interest and research effort as a polymeric nanofibrous scaffolds production technique 
[1-5]. The obtained mesh-like structures are typically characterized by a random 
distribution of fibers with diameters in the nanometer/sub-micrometer range and, thus, 
by a high specific surface area. The topography and surface morphology of this 
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nanofibrous scaffold resembling the fibrous structure of the natural extracellular 
matrix (ECM) of many living tissues has been considered as a major benefit of these 
structures [4]. High microporosity and improved mechanical properties are also 
important properties of the electrospun nanofiber meshes, allowing mass transport 
across the structure without compromising its structural integrity. In particular these 
properties seem to be beneficial in the adhesion, viability, proliferation, and 
maturation or differentiation of different cell types, namely keratinocytes and 
fibroblasts [6], smooth muscle and endothelial cells [7], chondrocytes [8, 9], 
osteoblasts [10, 11], cardiomyocytes [12], mesenchymal stem cells [13], and neural 
stem cells [14]. Indeed, such fiber meshes offer specific properties, as previously 
referred, for inducing tissue regeneration, once cells can bridge the scaffold pores 
and fibers, allowing a faster and more homogeneous tissue growth. 
Functional and structural engineering of musculoskeletal tissue may involve 
the use of appropriated cells cultured with specific growth factors in biomaterial 
scaffolds [15-17]. While several tissues remain an important source of therapeutic 
relevant differentiated cells, stem cells have emerged as a strong alternative due to 
their expansion potential and the fact that they can be obtained from autologous 
sources [18]. Additionally, advances in stem cell biology have shown that 
mesenchymal stem cells (MSCs) can differentiate into a variety of connective tissues, 
including bone, cartilage, fat, muscle and tendon, when cultured with appropriated 
supplemented culture media and specific environments [19]. Moreover, the 
successful differentiation of MSCs along these distinct lineages on electrospun 
nanofibrous scaffolds has been also demonstrated [13, 20-22]. 
In the electrospinning technique, a high voltage potential is applied to a 
polymeric solution held in a syringe and coupled to a pump for flow control. A jet is 
driven from the needle in the direction of the grounded collector. The larger diameter 
reduction from a millimeter fluid jet to a nanoscale solid fiber is due to an instability, 
where the jet is stretched by fast whipping and bending, in the way towards the 
collector, also involving solvent evaporation [23]. Thus, the polymeric solution 
properties (i.e. concentration, viscosity, surface tension, conductivity and type of 
solvent), the processing parameters (i.e. electric field, needle tip-to-collector distance 
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and polymeric flow rate) and the environmental conditions are all determinant factors 
for a successful electrospinning process [24, 25]. Among them, the type of collector 
may plays an important role in the production of nanofiber meshes with different 
topographies. Typically, electrospun nanofibers are collected randomly in a mesh-like 
structure due to the bending instability associated with the electrified polymeric jets. 
The main topographical achievement reported in literature was the production of 
parallel alignment of nanofibers in meshes [24, 26]. These meshes could be produced 
using rotating cylinder or plate collectors, conductive metallic strips with geometrical 
distribution and sharp metallic pieces positioned oppositely. However, the production 
of electrospun nanofiber meshes with complex ordered topographies and patterns 
remains a challenge [27]. Recently, our group and others [28-31] described the 
possibility to electrospun nanofiber meshes comprising both types of topographies 
(random and parallel alignment of nanofibers in the same mesh), designated as 
patterning of polymer nanofiber meshes. 
We report wherein the production of patterned nanofiber meshes by 
electrospinning using a specially-designed electroconductive collector, aimed of 
obtaining a chess-like geometry. These nanofibrous structures are characterized by 
areas of random/orthogonal alignment and areas of parallel/uniaxial alignment of 
fibers in the same mesh. Therefore, we aim at going a step forward in the 
nanofabrication of structures mimicking the complex ordered structure of the natural 
extracellular matrix. Although the processing parameters controlling the deposition 
and arrangement of fibers on the patterned architectures are well documented [23], 
the potential of patterned nanofiber meshes on the biomedical field was not explored. 
To test the potential of those structures for bone tissue engineering, human bone 
marrow mesenchymal stem cells (hBMSCs) were seeded on and induced to 
differentiate towards the osteogenic lineage. This cellular performance (i.e. adhesion, 
morphology, viability, proliferation and differentiation) was assessed at different time 
points to understand the influence of patterned nanofiber meshes, compared to the 
typical random nanofibrous structures produced by electrospinning. 
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4.3 Materials & Methods 
 
4.3.1 Production of Patterned Nanofiber Meshes 
 
A polymeric solution of poly(ε-caprolactone) (PCL) (TONE , Union Carbide 
Chemicals and Plastics Division; New Jersey) 17 % (w/v) was prepared using a 
mixture of chloroform and dimethylformamide (7:3), as described elsewhere [28, 29]. 
A voltage of 10 kV, a current of 0,05 µA and a needle tip-to-ground collector distance 
of 20 cm were selected as processing conditions after optimization. An 
electroconductive chess-like wire net with 1.0 mm spacing between two consecutive 
wires was used as collector. 
 
4.3.2 Characterization of Patterned Nanofiber Meshes 
 
Patterned electrospun PCL nanofiber meshes were gold sputter-coated (model 
SC502, Fisons Instruments; England) for 2 min at 15 mA. Samples were analyzed 
using a Scanning Electron Microscope (model S360, Leica Cambridge; England). 
Micrographs were recorded at 15 kV with magnifications ranging from 100 to 5000 
times. 
The surface topography of the patterned electrospun PCL nanofiber meshes 
was assessed from the noncontact profilometry using an interferometer profiler 
(model NT1100, Wyko-Veeco; Tucson, AZ) equipped with WycoVision® 32 analytical 
software. Topographic roughness parameters Ra (Roughness Average) and Rq (Root 
Mean Square (RMS) Roughness) were determined for each sample. Each sample 
was evaluated at three randomly selected and representative specimen locations. 
 
4.3.3 Expansion, Seeding and Osteogenic Differentiation of Human Bone Marrow 
Mesenchymal Stem Cells 
 
Human bone marrow mesenchymal stem cells (hBMSCs) (Biopredic 
International, France) were isolated and characterized according to the method 
established by Delorme and Charbord [32]. hBMSCs were expanded in basal medium 
consisting of Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich, Germany) 
 158 
supplemented with 10 % heat-inactivated fetal bovine serum (FBS; Biochrom AG, 
Germany) and 1 % antibiotic/antimyotic solution (final concentration of penicillin 100 
units/ml and streptomycin 100 µg/ml; Gibco, GB). Cells were cultured in a 5 % CO2 
incubator at 37 °C. 
Before the in vitro studies, the random and patterned PCL nanofiber meshes 
were cut in samples with areas of approximately 1 cm2 and sterilized by UV irradiation 
during 1 h on each side of the mesh. Confluent hBMSCs at passage 2 were 
harvested for seeding onto the patterned PCL nanofiber meshes at a density of 
1.5x105 cells/cm2 of the nanofiber mesh. Random PCL nanofiber meshes were used 
as controls in the study. The nanofiber mesh/hBMSCs constructs were left for 48h 
under agitation (orbital shaker), allowing cells to arbitrarily colonize the entire surface 
of the mesh. After the seeding was completed, the constructs were cultured during 7, 
14 and 21 days under static conditions, in standard osteogenic differentiation medium 
(basal medium supplemented with 50 µg/ml ascorbic acid, 10 mM β-glicerophosphate 
and 10-7 M dexamethasone). 
 
4.3.4 Cell Morphology and Distribution 
 
After each culture period the constructs for fluorescence microscopy analysis 
were fixed in 10 % formalin solution neutral buffer (Sigma-Aldrich, Germany) for 30 
min and maintained in phosphate buffer saline (PBS) until further use. The nucleus 
and the cytoskeleton actin filaments of the cells were fluorescently labelled with 4,6-
diamidino-2-phenyindole, dilactate (DAPI; Sigma, USA; dilution 1:1000) and 
phalloidin-tetramethylrhodamine B isothiocyanate (Sigma, USA; dilution 1:100), 
respectively and the constructs analyzed using a fluorescence microscope (Zeiss, 
Germany). 
For scanning electron microscopy (SEM) evaluation, the samples were 
previously fixed with 2.5 % Glutaraldehyde (Sigma; USA) in a Phosphate Buffer 
Saline solution (Sigma; USA) during 1h at 4 ºC, and then dehydrated through an 
increasing series of ethanol concentrations and let to dry overnight. Finally, they were 
gold sputter coated (sputter coater model SC502, Fisons Instruments; England) and 
analysed by SEM (model S360, Leica Cambridge; England). 
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4.3.5 Cell Viab ility and Proliferation (MTS assay and DNA content) 
 
Cell viability for each culturing time was determined using the CellTiter 96 
AQueous One Solution Cell Proliferation Assay (Promega; USA). This assay is based 
on the bioreduction of a tetrazolium compound, 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfofenyl)-2H-tetrazolium [MTS], into a water soluble 
brown formazan product. This conversion is accomplished by NADPH or NADH 
production by the dehydrogenase enzymes in metabolically active cells. The 
absorbance was measured at 490 nm in a microplate reader (Synergie HT, Bio-Tek; 
USA), being related with the quantity of formazan product and directly proportional to 
the number of living cells in the constructs. Three samples of each nanofiber mesh, 
per time point, were characterized. 
Cell proliferation was quantified by the total amount of double-stranded DNA, 
along the culturing time. Quantification was performed using the Quant-iT 
PicoGreen dsDNA Assay Kit (Invitrogen, Molecular Probes; Oregon, USA), 
according to the instructions of the manufacturer. Briefly, cells in the construct were 
lysed by osmotic and thermal shock and the supernatant used for the DNA 
quantification assay. A fluorescent dye, PicoGreen, was used because of its high 
sensitivity and specificity to double-stranded DNA. The fluorescence of the dye was 
measured at an excitation wavelength of 485/20 nm and at an emission wavelength 
of 528/20 nm, in a microplate reader (Synergie HT, Bio-Tek; USA). Triplicates were 
made for each sample and per culturing time. The DNA concentration for each 
sample was calculated using a standard curve (DNA concentration ranging from 0.0 
to 1.5 µg/ml) relating quantity of DNA and fluorescence intensity.  
 
4.3.6 Alkaline Phosphatase quantification and Immunodetection of Bone-specific 
Proteins 
 
The concentration of alkaline phosphatase (ALP) was determined for all time 
culture periods, using the same samples used for DNA quantification. Briefly, the 
activity of ALP was assessed using the p-nitrophenol assay. Nitrophenyl phosphate 
disodium salt (pnPP; Fluka BioChemika, Austria), which is colourless, is hydrolysed 
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by alkaline phosphatase at pH 10.5 and temperature of 37 ºC to form free p-
nitrophenol, which is yellow. The reaction was stopped by addition of 2M NaOH 
(Panreac Quimica, Spain) and the absorbance read at 405 nm in a microplate reader 
(Bio-Tek, Synergie HT; USA). Standards were prepared with 10 µmol/ml p-
nytrophenol (pNP; Sigma, USA) solution, to obtain a standard curve ranging from 0.0 
to 0.3 µmol/ml. Triplicates of each sample and standard were made, and the ALP 
concentrations read off from the standard curve. 
The osteogenic phenotype of hBMSCs seeded onto the patterned PCL 
nanofiber meshes was also assessed by the immunodetection of bone-specific 
proteins. Immunocytochemistry was performed following the streptavidin-biotin-
peroxidase complex approach (R.T.U. Vectastain® Universal Elite® ABC kit; Vector 
Laboratories Inc., Burlingame, CA), using a rabbit polyclonal antibody against 
osteopontin (Abcam Ltd., Cambridge, UK; dilution 1:1500), a mouse monoclonal 
antibody against osteocalcin (clone OC4-30, Abcam Ltd., Cambridge, UK; dilution 
1:100) and a rabbit polyclonal antibody against bone sialoprotein II (Chemicon® 
International Inc., Germany; dilution 1:2500). Prior to the immunocytochemistry 
procedure, constructs were fixed in 10 % formalin solution neutral buffer (Sigma-
Aldrich, Germany) for 30 min and maintained in phosphate buffer saline (PBS) until 
further use. The constructs were treated with 0.3 % hydrogen peroxide in methanol 
during 30 min to inactivate the endogenous peroxidases. After washing with PBS, the 
constructs were blocked with 2.5 % normal horse serum for 20 min at room 
temperature to avoid unspecific reactions. Primary antibodies were incubated 
overnight at 4 ºC. Negative controls were set in the absence of primary antibodies 
incubation. After washing in PBS, the samples were incubated for 30 min with 
biotinylated secondary antibody anti-rabbit/mouse IgG, followed by incubation with 
streptavidin-peroxidase complex (Elite ABC Reagent). The immune reaction was 
visualized using DAB as a chromogen (DAB Substrate Reagent from Peroxidase 
Substract Kit; Vector Laboratories Inc, Burlingame, CA). 
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Table 4.1 - Primers list of osteogenic markers. 
Gene  Primer sequences (5’-3’) Tm [ºC] 
ALP sense 
antisense 
CTCCTCGGAAGACACTCTG 
AGACTGCGCCTGGTAGTTG 60,0 
OP sense 
antisense 
GGGGACAACTGGAGTGAAAA 
CCCACAGACCCTTCCAAGTA 58,4 
BSP sense 
antisense 
CAACAGCACAGAGGCAGAAAAC 
CCTCGTATTCAACGGTGGTG 59,9 
OC sense antisense 
CTGAGAGGAGCAGAACTGG 
GGCAGCGAGGTAGTGAAGAG 61,4 
Runx2 sense 
antisense 
TTCCAGACCAGCAGCACTC 
CAGCGTCAACACCATCATTC 58,1 
Osterix sense 
antisense 
CCCTTTACAAGCACTAATGG 
ACACTGGGCAGACAGTCAG 57,1 
GAPDH sense 
antisense 
ACAGTCAGCCGCATCTTCTT 
GACAAGCTTCCCGTTCTCAG 58,4 
 
4.3.7 RNA isolation and Real-Time Quantitative Polymerase Chain Reaction 
 
Total RNA from the constructs was extracted using the Trizol® (Invitrogen, Life 
Technologies Inc., UK) method according to the manufacturer’s directions. Briefly, at 
each culturing time the constructs were washed with PBS, immersed in Trizol and 
storage at -80 ºC until further use. Proteins were removed with chloroform extraction, 
and the RNA pellets were washed once with isopropyl alcohol and once with 70 % 
ethanol. The total RNA pellets were reconstituted in Rnase free water (Gibco, 
Invitrogen, UK). 
 Reverse transcriptase (RT)-PCR was performed according to the protocol from 
iScript™ cDNA synthesis kit (BioRad, Hercules, CA, USA). Briefly, a reaction mixture 
consisting of 1X iScript Reaction Mix, 1 µl iScript Reverse Transcriptase, RNA 
template (up to 1 µg total RNA) and nuclease-free water was prepared, in 20 µl of 
total volume. The single-strand cDNA synthesis occurred by incubating the complete 
reaction mixture 5 min at 25 ºC, followed by 30 min at 42 ºC and terminated by an 
incubation at 85 ºC for 5 min. 
Amplification of the target cDNA for real-time PCR quantification were performed 
according to manufacturer, using 2 µl RT cDNA products, 1 µM each primer (bone-
specific primer sets listed in Table 4.1), 1X iQ SYBR Green Supermix (BioRad, 
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Hercules, CA, USA) and nuclease-free water, in a final volume of 25 µL. Forty-four 
cycles of denaturation (95 ºC, 10 s), annealing (temperature dependent on the gene, 
30 s) and extension (72 ºC, 30 s) were carried out in the gradient thermocycler 
MiniOpticon real-time PCR detection system (BioRad, Hercules, CA, USA) for all 
genes. The transcripts expression data were normalized to the housekeeping gene 
glyceraldehydes-3-phosphate-dehygrogenase (GAPDH) and the relative 
quantification calculated by the ∆CT method. 
 
4.3.8 Statistical Analysis 
 
Statistical Analysis was performed using the SPSS statistic software (Release 
15.0.0 for Windows). Firstly, a Shapiro-Wilk test was used to ascertain about the data 
normality. The results indicated that nonparametric tests should be used for all 
comparisons. A Mann-Whitney U test was performed to analyze the effect of the 
random and patterned electrospun nanofibrous structures on the hBMSCs’-derived 
phenotype (cellular proliferation and ALP quantification) and osteogenic genotype. P 
values lower than 0.01 were considered statistically significant. 
 
4.4 Results and Discussion 
 
4.4.1 Morphological Characterization of Patterned Nanofiber Meshes 
 
Typically, a random distribution of nanofibers is obtained in a static flat 
collector, caused by the chaotic motion of polymeric solution during the 
electrospinning process (Figure 4.1 A). However, when a metallic conducting wire net 
was used as collector, two distinct areas of nanofiber deposition (Figure 4.1 B), 
reproducing the architecture of the collector used, were obtained [29, 30]. The fibers 
appear aligned and collapsed on the electroconductive wires of the collector and, 
consequently, where the electric field is more intense (Figure 4.1 C). This area is 
characterized by significantly larger fiber densities, due to the preferential deposition 
and fiber agglomeration, which is believed to be caused by the excess of residual 
solvent during the deposition process. Consequently, in this area of parallel/uniaxial  
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Figure 4.1 - SEM micrographs (A-D) and optical profilometric images (E-H) of the 
typical random (A and E) and patterned (B and F) nanofiber meshes (P-NFM). P-
NFM comprise areas of parallel/uniaxial (C and G) and orthogonal (D and H) 
alignment of the fibers. 
 
alignment, the average roughness, determined by interferometric optical porfilometry 
is significantly smaller (Ra = 789,68 nm) (Figure 4.1 G), when compared to the 
random nanofiber meshes (PCL NFM) (Ra = 1,93 µm) (Figure 4.1 E). In the spacing 
between the wires, the nanofibers deposition followed an orthogonally aligned pattern 
and a lower density (Figure 4.1 D). The roughness parameter analysis revealed a 
smooth surface in the orthogonal alignment area (Ra = 1,79 µm) (Figure 4.1 H), when 
compared with the typical random nanofiber meshes (Figure 4.1 E). 
It is well known that materials with ordered microstructures and patterns may 
possess specific interest functions useful in numerous applications, such as 
microelectronic, photonic, and biomedical applications [33]. As previously mentioned 
and herein described [28, 29], our group has the possibility to electrospinning 
nanofiber meshes with controlled microstructure and pattern structures, 
demonstrating their potential for biomedical applications. In fact, those patterned 
structures were initially developed in an attempt to control the morphological and, 
consequently, the mechanical properties of the nanofiber meshes. It was 
demonstrated that P-NFM present a tensile modulus of 2.0±0.2 MPa, what was lower 
than expected due to the high degree of fiber alignment [29]. However, the orthogonal 
fiber alignment in the mesh associated with uniaxial fiber alignment, transversal to the 
testing of the main tensile test direction, explain the observed value of the modulus. 
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Those transversely aligned fibers could control the strain in the tensile test, causing a 
more compliant behaviour of the P-NFM. Even so, the semi-crystalline property of 
PCL is likely to have a beneficial effect on the structural integrity of the scaffold, 
maintaining the size and the shape of the original P-NFM, without observable 
macroscopic shrinkage. 
 
4.4.2 Phenotypic Characterization of Differentiated hBMSCs on Patterned Nanofiber 
Meshes 
 
Various studies demonstrated that electrospun PCL scaffolds exhibited optimal 
structural integrity and supported desirable cellular proliferation and differentiation 
(MSCs differentiated into osteoblastic- and chondrocytic-like cells) in vitro [9, 20, 21, 
34, 35]. In addition, 3-D porous networks, composed of PCL and collagen (COL) 
(1:1), produced by multilayered organization of electrospun nanofiber membranes 
appeared to support hBMSCs attachment [36]. Subcutaneous implantation of the 
cultured construct into nude mice demonstrated good integration with the surrounding 
tissues and neovascularisation. Electrospun PCL scaffolds seeded with autologous 
mesenchymal stem cells (MSCs) were studied as bone grafts for the regeneration of 
the omenta of rats [37]. The cell/scaffold constructs were cultured under osteogenic 
supplementation, in a rotating bioreactor, before implantation. Those studies show the 
interest of electrospun nanofibrous scaffolds as bone grafts. 
The search for surfaces and structures having strong, well-defined, beneficial 
influence on cell growth is an active subject of contemporary research [3, 38]. In fact, 
it was demonstrated that cells are sensitive to the topography of the supporting 
surface, although the exact reasons for this observation are unclear. In our previous 
studies with patterned nanofiber meshes, direct contact tests with human osteoblast-
like cells demonstrated a preferential cell adhesion to regions of random/orthogonal 
fiber alignment, although some cells were aligned with the regions of parallel 
orientation [28, 29]. Initially, in the present study, hBMSCs were seeded on random 
and patterned PCL nanofiber meshes (P-NFM) to  verify the influence of nanofiber 
mesh topography on cell morphology and distribution. SEM micrographs 
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Figure 4.2 - SEM micrographs of undifferentiated hBMSCs cultured on patterned 
nanofiber meshes, at the random/orthogonal area of alignment (A) and at the 
parallel/uniaxial fibers (B). SEM micrographs (C, F and H) and fluorescence images 
(D, E, G and I) of hBMSCS induced to differentiate into the osteogenic lineage at 
days 7 (C-E), 14 (F-G) and 21 (H-I) of culture. 
 
demonstrated that undifferentiated cells respond differently to the areas of P-NFM 
(Figure 4.2). In orthogonally distributed nanofibers, cells presented the typical
fibroblastic morphology of undifferentiated hBMSCs (Figure 4.2 A). In the area of 
parallel/uniaxial alignment, hBMSCs attached and spread along the aligned 
nanofibers of the patterned fiber meshes (Figure 4.2 B). Thus, the patterned 
nanofibrous scaffolds created in this study were found to dictate cellular morphology, 
with cell polarity following the established fiber direction. These observations are 
supported by a recent study showing that hMSCs maintained their phenotypic shape 
when seeded on randomly oriented scaffolds, and a guided growth with actin 
organization dictated by the prevailing nanofiber orientation of aligned nanofiber 
meshes [39]. Overall, the results in literature demonstrate that the highly oriented 
electrospun PCL nanofibers are capable of supporting cell attachment and 
proliferation of hMSCs. 
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Considering the previous findings, hBMSCs were induced to differentiate into 
the osteogenic lineage, aiming to understand the influence of the P-NFM on the 
osteogenic differentiation of hBMSCs, when compared with the typical PCL NFM. 
SEM and fluorescence microscopy characterization of cell adhesion and morphology 
showed cell response to the topography of the P-NFM, being spread in the area of 
nanofibers parallel/uniaxial alignment (Figure 4.2 C-E). This tendency is very clear in 
the earliest time culture period (7 days) due to the amount of dispersed cells onto the 
nanofiber mesh and the morphology of undifferentiated hBMSCs. For longer time 
culture periods, the cell numbers increase progressively and only in the outer regions 
of the mesh, where lower density of cells is present, was possible to observed cell 
alignment by the nanofibers (Figure 4.2 F-I). Furthermore, at those later culturing 
times, hBMSCs start to differentiate into the osteoblastic lineage and the cells tend to
 
 
Figure 4.3 – Box plot of DNA content of hBMSCS induced to differentiate into the 
osteogenic lineage during 21 days, cultured on random and patterned nanofiber 
meshes. Data were analysed by the non-parametric method of Mann-Whitney U test. 
a, p < 0.01 
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show a more polygonal shape. This increment on the cell numbers was confirmed by 
the cellular proliferation assay, by quantification of the double strand DNA content
(Figure 4.3). DNA content of hBMSCs, induced to differentiate into the osteogenic 
lineage, increases progressively with culture time on P-NFM. In fact, it was only found 
a highly significant difference (p < 0.00001) between the PCL NFM and P-NFM for 7 
days of culture in terms of DNA concentration. 
Osteoblastic differentiation of hBMSCs was pursued on P-NFM by the 
quantification of the alkaline phosphatase (ALP). Indeed, ALP production is a 
distinctive biochemical indicator of the presence of osteoblasts, since MSCs produce 
negligible amounts of this enzyme. It can be observed in Figure 4.4 that, the ALP 
concentration values increases progressively along time in culture of hBMSCs, when 
seeded on the patterned nanofiber meshes, reaching a median maximum value at 14 
 
 
Figure 4.4 – Box plot of ALP quantification from hBMSCS induced to differentiate into 
the osteogenic lineage during 21 days, cultured on random and patterned nanofiber 
meshes. Data were analysed by the non-parametric method of Mann-Whitney U test. 
a, p < 0.01 
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days of culture under osteogenic differentiation conditions. The corresponding values 
of the ALP concentration, for PCL NFM, maintain a constant value along time. 
Additionally, it was only found a highly significant difference (p < 0.00001) between 
the PCL NFM and P-NFM for 7 days of culture, in terms of ALP concentration. 
Immuncytochemistry against some bone-specific proteins, namely osteopontin, 
osteocalcin and bone sialoprotein, was performed to confirm the osteogenic 
phenotype of hBMSCs seeded onto the P-NFM. Photomicrographs showed a
 
 
Figure 4.5 - Optical images of immunodetected osteogenic markers, namely 
osteopontin (A-C), bone sialoprotein (D-F) and osteocalcin (G-I), expressed by 
hBMSCS, induced to differentiate into the osteogenic lineage and cultured on 
patterned nanofiber meshes during 7 (A, D and G), 14 (B, E and H) and 21 (C, F and 
I) days. 
Guide Stem C ells Differentiation 
169 
progressive expression of specific osteoblastic glycoproteins (i.e. osteopontin and
bone sialoprotein) on hBMSCs/patterned nanofiber meshes constructs along the 
culturing period (Figure 4.5), indicating their capability to deposit mineralized  
extracellular matrix (ECM) mainly in the areas of parallel/uniaxial alignment of the 
nanofibers. In fact, these phosphorylated glycoproteins are also present in the ECM  
of bone. The deposition of mineralized ECM was also confirmed by the 
immunodetection of osteocalcin protein, which binds strongly to apatite and calcium. 
In addition, the increased concentration of the enzyme alkaline phosphatase (ALP) 
until 14 days of hBMSCs culture also confirm the osteoblastic differentiation and 
mineralization of hBMSCs on patterned nanofiber meshes; because this enzyme 
catalyses the splicing of phosphate from non-phosphoric esters, constituting an early 
biochemical marker of osteogenesis and deposition of mineralized ECM. These 
observations are corroborated by a study where hybrid random nanofibrous scaffolds, 
consisting of PCL, poly(vinyl alcohol) (PVA) and chitosan, were used to culture MSCs 
and successfully sustained the induced differentiation into osteoblasts [40]. 
 
4.4.3 Genotypic Characterization of Differentiated hBMSCs on Patterned Nanofiber 
Meshes 
 
Complementary to previous biological data, the differentiation level of seeded 
hBMSCs on P-NFM was assessed by quantitative PCR of mRNA transcripts of some 
bone-specific genes. The relative expression of those genes was normalized against 
the housekeeping gene GAPDH and compared to hBMSCs cultured and 
differentiated on PCL NFM. From the analysis of Figure 4.6, it was observed that 
some transcript levels, namely Alkaline Phosphatase, Runx2 and Osterix, shown the 
tendency to be increasingly expressed on P-NFM, during the 21 days of culture. The 
remaining transcripts, specifically the Bone Sialoprotein and the Osteocalcin, were 
expressed at stable levels during the period in culture, with the exception of 
Osteopontin which presented the highest expression at 14 days. Recently, it was 
reported the expression pattern of osteoblastic markers during the differentiation of 
embryonic stem (ES) cells [41]. Three periods were defined: a proliferative phase,
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Figure 4.6 – Relative expression of bone-specific transcripts, namely Alkaline 
Phosphatase, Osteopontin, Bone Sialoprotein, Osteocalcin, Runx2 and Osterix, by 
hBMSCs induced to differentiate into the osteogenic lineage during 21 days, cultured 
on random and patterned nanofiber meshes. The expression of these genes was 
normalized against the housekeeping gene GAPDH and calculated by the ∆CT 
method.  
 
followed by the period of matrix deposition and the mineralization phase. At the end of 
the matrix deposition phase and the beginning of the mineralization phase,
Osteopontin mRNA is expressed. Bone Sialoprotein is expressed during the 
mineralization phase, corresponding to the presence of mature osteoblasts. Finally, 
Osteocalcin mRNA is expressed at very high level and so is designed as the essential 
marker of the mineralization phase. Thus, considering our results and the differences 
in the cell type used, the most important genes involved in the mineralization process 
(i.e. Osteopontin, Bone Sialoprotein and Osteocalcin genes) were constitutively 
expressed, confirming the matrix deposition and mineralization by hBMSCs cultured 
and differentiated on P-NFM. The main specific transcription factors involved in the 
osteogenesis were also quantified by qPCR, namely the core binding factor α 1/runt-
related gene (Cbfa1/Runx2) and Osterix (Osx). Cbfa1/Runx2 has been shown to 
preferentially initiate two steps of the differentiation process, stem cells into 
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preosteoblasts and preosteoblasts into osteoblasts, whereas Osterix acts only during 
the last preosteoblast/osteoblast stage [42, 43]. Our results showed that Osterix was 
the bone-specific transcript with the highest expression relative to the housekeeping 
gene (GAPDH), accompanied by the progressive expression of Runx2, corroborating 
the successful osteogenic differentiation of hBMSCs on P-NFM. 
 
Altogether, the results from phenotypic and genotypic characterization 
demonstrated the effectiveness of P-NFM on the differentiation of hBMSCs into 
osteoblastic cells and, consequently, in the deposition of mineralized ECM. 
Furthermore, this specific substrate topography could promote a favorable biological 
response, such as cell guidance and proliferation. Recently, a study demonstrated 
that ligament fibroblasts cultured on aligned nanofibrous meshes produce more 
collagen than random meshes [44]. Indeed, material structures with parallel 
orientation or patterns of different ordering may have specific biological performance 
on tissue engineering [38, 44, 45]. Therefore, it is hypothesized that by creating an 
initial synthetic ECM architecture - scaffold - , cell-formed ECM will be deposited 
along the predefined fiber direction in greater amounts in these patterned nanofibrous 
scaffolds, facilitating the formation of a neo-tissue with enhanced functional 
characteristics. 
 
4.5 Conclusions 
 
The phenotype of hBMSCs was sensitive to the unique microtopography of P-
NFM, inducing cell orientation along the uniaxially aligned fibers, mainly at earlier 
culturing periods under basal and osteogenic differentiation conditions. The unique 
topography of the patterned scaffold sustains the deposition of mineralized 
extracellular matrix, as observed by the imunodetection of osteoblast-specific 
glycoproteins (i.e. osteopontin and bone sialoprotein), as well as of osteocalcin 
protein, associated with an increased ALP concentration. Additionally, the progressive 
expression of bone-specific transcripts confirmed the osteogenic genotype of cultured 
hBMSCs on P-NFM. Our observations indicate that the presence of ordered 
microstructures and patterns support the development of bony-like engineered 
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substitutes. The application of those P-NFM for complex ordered tissues involving 
more than one cell communities may provide helpful cues enabling its self-
assembling. 
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Chapter 5 
 
 
 
Hierarchical Starch-based Fibrous Scaffold for Bone Tissue 
Engineering Applications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on the following publication: Martins A, Chung S, Pedro AJ, Sousa RA, Marques 
AP, Reis RL, Neves NM. Hierarchical starch-based fibrous scaffolds for bone tissue engineering 
applications. Journal of Tissue Engineering and Regenerative Medicine 2009; 3(1):37-42. 
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5.1. Abstract 
 
Fibrous structures mimicking the morphology of the natural extracellular matrix 
are considered promising scaffolds for tissue engineering. This work aims to develop 
a novel hierarchical starch-based scaffold. Such scaffolds were obtained by a 
combination of starch-polycaprolactone micro- and polycaprolactone nano-motifs, 
respectively produced by rapid prototyping (RP) and electrospinning techniques. 
Scanning electron microscopy (SEM) and micro-computed tomography analysis 
showed the successful fabrication of a multilayer scaffold composed of parallel 
aligned microfibers in a grid-like arrangement, intercalated by a mesh-like structure 
with randomly distributed nanofibers (NFM). Human osteoblast-like cells were 
dynamically seeded on the scaffolds, using spinner flasks, and cultured during 7 days 
under static conditions. SEM analysis showed predominant cell attachment and 
spreading on the nanofiber meshes, which enhanced cell retention at the bulk of the 
composed/hierarchical scaffolds. A significant increment in cell proliferation and 
osteoblastic activity, assessed by alkaline phosphatase quantification, was observed 
on the hierarchical fibrous scaffolds. These results support our hypothesis that the 
integration of nanoscale fibers into 3D rapid prototype scaffolds substantially 
improves their biological performance in bone tissue engineering strategies. 
 
 
5.2. Introduction 
 
Biodegradable scaffolds are generally recognized as indispensable element in 
tissue engineering and regenerative medicine strategies. They are used as temporary 
templates for cell seeding, migration, proliferation and differentiation prior to the 
regeneration of biologically functional tissue or natural extracellular matrix (ECM) [1, 
2]. Ideally, to create a tissue-engineered construct capable of regenerating a fully 
functional tissue, it should mimic both the fibrous form and the complex function of the 
native ECM [3]. Like natural ECM, a range of topographic features at the macro-, 
micro- and even nano-scale levels must lead cell response [4]. A multi-scale network 
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structure can be developed by integrating microfibrous structures, produced by wet-
spinning or rapid prototyping, with electrospun nanofibers [5-7]. 
Electrospun fibers typically have dimensions varying from the nano- to the 
micro-scale, although fiber diameters in the sub-micrometer range are mainly 
observed [8]. These mesh-like scaffold are characterized by high porosity, high 
surface:volume ratio and, most importantly, they can closely mimic the morphology of 
native ECM of many tissues. Such physical cues enhance cell adhesion, proliferation 
and differentiation, and consequently neo-tissue formation on nanofibrous meshes of 
both natural and synthetic polymers [9, 10]. 
Rapid prototyping has emerged as a powerful polymer processing technique 
for the production of scaffolds in the area of tissue engineering [11-17]. The main 
advantage of this technique is the possibility of creating structures with customized 
shapes linked with computer aided design (CAD), thus providing more flexibility, 
versatility and reproducibility in creating scaffolds [11, 18-20]. However, the typical 
pore size of RP scaffold constitutes a limitation in cell seeding efficiency [15], once it 
is relatively large as compared to cell dimensions.  
Therefore, the aim of this study was to characterize a novel hierarchical starch-
based fibrous scaffold obtained by the combination of starch-polycaprolactone 
(SPCL) micro- and polycaprolactone (PCL) nano-motifs, respectively produced by 
rapid prototyping (RP) and electrospinning. The defined strategy aimed at overcoming 
the high number of cells needed to attain sufficient adherent cells to the RP scaffolds 
[7], which can be accomplished by alternately integrating electrospun nanofiber 
meshes every two consecutive layers of plotted microfibers. In this way these 
nanofiber meshes will act as cell entrapment systems, increasing cell attachment, cell 
proliferation and tissue regeneration. Ultimately, this integration will enhance the 
potential application of such three dimensional (3D) fibrous structures in bone tissue 
engineering strategies. This work reports the results of a set of experiments where 
human osteoblast-like cells were dynamically seeded and statically cultured for 7 
days on the micro-nano fiber polymeric scaffolds designed to validate this hypothesis. 
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5.3. Materials & Methods 
 
5.3.1. Scaffold Fabrication 
 
Three-dimensional (3D) rapid prototyping scaffolds (6RP) were fabricated 
using a 3D plotting technique (Bio-plotter, EnvisionTec GmbH, Germany), using a 
30:70 (wt.%) blend of starch and polycaprolactone (SPCL; Novamont, Italy). SPCL 
polymer powder was placed into a metal barrel and heated at 140 °C through a 
heated cartridge unit, then plotted through a nozzle by air pressure control. The 
nozzle comprises a stainless steel needle with internal diameter of 0.5 mm and length 
of 6 mm. A metal piston plunger with a Teflon seal was used to apply pressure to the 
molten polymer. The machine was linked to a CAD software (PrimCam, Germany) 
which required inputs of dispensing and processing parameters (e.g. speed of the 
head, dispensing pressure and temperature) and the design parameters of the 
scaffold (e.g. scaffold dimensions, spacing between the polymer strands, and number 
of layers). The strand spacing was set to 1mm, without offsets between the 
consecutive equivalent layers. The orientation was changed by plotting the polymer 
with 90° angle steps between two successive layers. The production of hierarchical 
fibrous scaffolds (6RP+5NFM) was achieved by integrating nanofiber meshes (NFM) 
every two consecutive layers of plotted microfibers. The nanofiber meshes were 
previously produced by electrospinning, as described elsewhere [21]. Briefly, a 
polymeric solution of 17 % (w/v) PCL, dissolved in an organic solvent mixture of 
chloroform/dimethylformamide (7:3 ratio), was electrospun by establishing a electric 
tension of 9.5 kV, a needle tip-to-ground collector distance of 200 mm and a flow rate 
of 1 ml/h. The scaffolds (6RP and 6RP+5NFM scaffolds) were all cut into 5x5 mm 
cubical samples from the originally deposited bulk 20x20 mm cube (12 layers), and 
sterilized by ethylene oxide (EO) before the cell culture assays. 
 
5.3.2. Scaffold Characterization 
 
Scaffold architecture was analyzed using micro-computed tomography (µ-CT) 
with a desktop micro CT scanner (SkyScan 1072, Aartselaar, Belgium). The scanner 
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was set to a voltage of 40 kV and a current of 248 µA, and the samples were scanned 
at 8.71 µm pixel resolutions by approximately 350 slices covering the sample height 
of 2.5 mm. For imaging, the sliced 2D tomographic raw images were reconstructed 
using CT Analyzer software, and the threshold levels of the grey scale images were 
equally adjusted for all the samples to allow the measurement of the volume of pores 
providing the data for scaffold porosity. 3D modelling was also used to analyze the 
scaffold structure in a non-destructive manner using imaging software. The 
morphology of the scaffold was also analysed using scanning electron microscopy 
(SEM; Leica Cambridge, Model S360; UK). All samples were previously sputter-
coated with gold (Sputter Coater, Model SC502, Fisons Instruments, UK). 
 
5.3.3. Cell Seeding and Culture 
 
Human osteosarcoma-derived cells [Saos-2 cell line, European Collection of 
Cell Cultures (ECACC), UK], were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM, Sigma-Aldrich, Germany) supplemented with 10 % heat-inactivated fetal 
bovine serum (Biochrom AG, Germany) and 1 % antibiotic-antimycotic solution 
(Gibco, UK). Cells were cultured in a humidified incubator at 37 ºC in 5 % CO2 
atmosphere, and the medium was routinely replaced every 3-4 days. 
Confluent osteoblastic-like cells were harvested and dynamically seeded onto 
the polymeric scaffolds, as follows. The combined and the RP (controls) scaffolding 
structures were placed between stainless steel holding wires in spinner flasks (12 
scaffolds/spinner flask) containing a suspension of osteoblast-like cells with a 
concentration of 0.5x106 cells/ml in a total volume of 35 ml. The stirrer was set at 80 
r.p.m. and the spinner flasks left for 72h to allow the cells to colonize the entire 
scaffold. After the seeding was completed, the osteoblasts/scaffold constructs were 
transferred to 24-well cell culture plates (Costar; Corning, NY, USA) and statically 
cultured during 1 and 7 days, under the cultured conditions previously described for 
maintenance of the cell line. 
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5.3.4. Evaluation of Cell Adhesion, Morphology and Distribution 
 
To evaluate the cell morphology, the cells-scaffold constructs were fixed with 
2.5 % Glutaraldehyde (Sigma, USA) in Phosphate Buffer Saline (PBS; Sigma, USA) 
solution, FOR 1h at 4 ºC. Then, the samples were dehydrated through a graded 
series of ethanol and let to dry overnight. Finally, they were sputter-coated with gold 
(Model SC502, Fisons Instruments, UK) and observed in a scanning electron 
microscope (Model S360, Leica Cambridge, UK). 
 
5.3.5. Cell Viab ility Assay 
 
At each defined time culture period, the cell viability was determined using 
CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega, USA). This 
assay is based on the bioreduction of a tetrazolium compound, 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfofenyl)-2H-tetrazolium (MTS), into a water-
soluble brown formazan product. This conversion is accomplished by NADPH or 
NADH production by the dehydrogenase enzymes in metabolically active cells. The 
absorbance, measured at 490nm in a microplate reader (Bio-Tek, Synergie HT, 
USA), being related to the quantity of formazan product and directly proportional to 
the number of living cells in the constructs. Three samples per type of scaffold and 
per time point were characterized. 
 
5.3.6. DNA Quantification  
 
Cell proliferation was evaluated by quantifying the total amount of double-
stranded DNA throughout the culturing time. Quantification was performed using the 
Quant-iT PicoGreen dsDNA Assay Kit (Invitroge, Molecular Probe; OR, USA), 
according to the manufacturer’s instructions, and after the cells in the construct were 
lysed by osmotic and thermal shock. The intensity of fluorescence proportional of the 
amount of double-strand DNA, was measured at an excitation wavelength of 485/20 
nm and at an emission wavelength of 528/20 nm, in a microplate reader (Bio-Tek, 
Synergie HT, USA). Triplicates of each sample, allowed for a statistical analysis. The 
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DNA concentration for each sample was calculated using a standard curve relating 
quantity of DNA and fluorescence intensity. 
 
5.3.7. Alkaline Phosphatase (ALP) Quantification 
 
To assess the osteogenic activity of cells seeded into the 3D scaffolds (6RP 
and 6RP + 5NFM), the expression of ALP was determined for both culture time 
periods, in the same samples for DNA quantification. In each well of a 96-well plate 
(Costar; Corning, NY, USA), 20 µl of each sample were mixed with 60 µl substrate 
solution and 0.2 % wt/v p-nytrophenyl phosphate (Sigma, USA), in a substrate buffer 
of 1 M diethanolamine HCl (Merck, Germany) at pH 9.8. The plate was then 
incubated in the dark for 45 minutes at 37 ºC. After the incubation period, 80 µl stop 
solution, 2 M NaOH (Panreac, Barcelona, Spain) plus 0.2 mM EDTA (Sigma, USA), 
was added to each well. Standards were prepared with 10 µmol/ml p-nytrophenol 
(pNP, Sigma, USA) solution, to obtain a standard curve ranging from 0.0 to 0.3 
µmol/ml. Triplicates of each sample and standard were made. Absorbance was read 
at 405 nm in a microplate reader (Bio-Tek, Synergie HT, USA) and sample 
concentrations were read off from the standard curve. These ALP concentrations 
were normalized against the DNA concentrations of the same samples to determine 
the ALP activity. 
 
5.3.8. Statistical analysis 
 
Statistical analysis was performed using the SPSS statistic software (Release 
8.0.0 for Windows). First, a Shapiro-Wilk test was used to ascertain about data 
normality. Once biological results did not follow a normal distribution, Mann-Whitney 
U test was performed to compare the effect of scaffold architecture over cell 
performance. In the analysis of the results, p < 0.01 were considered statistically 
significant. 
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5.4. Results & Discussion 
 
A novel hierarchical fibrous scaffold was developed, combining starch-
polycaprolactone micro- and polycaprolactone nano-motifs, respectively produced by 
rapid prototyping (RP) and electrospinning (ES). These scaffolds were characterized 
by a 3D structure of parallel aligned rapid prototyped microfibers (average fiber 
diameter, 300 µm), periodically intercalated by randomly distributed electrospun 
nanofibers (fiber diameters in the range 400 nm -1.4 µm) (Figure 5.1B). When 
nanofiber meshes were integrated within the 3D scaffold, no delamination between 
consecutive layers of RP fibers was observed, resulting in a stable scaffold. 
Additionally, this micro-nano scaffold architecture comprises a high-throughput 
scaffold process methodology, with regular control over RP-produced structure and 
nanofibers distribution within the scaffold. The integration of these nano-motifs results 
in a decrease of scaffold porosity of around 11 % (from 79.4 % on 6RP scaffolds to 
 
 
Figure 5.1 - SEM and µ-CT micrographs of the starch-based rapid prototyped, 6RP 
(A and C), and hierarchical fibrous scaffolds, 6RP+5NFM (B and D). 
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68.3 % on 6RP + 5NFM scaffolds), as determined by µ-CT analysis (Figure 5.1 C and 
D). Despite a decrease in porosity, a fully interconnected porous structure was 
observed, allowing gas, nutrient and waste transport through the 3D structure. 
Starch-based scaffolds have been proposed as candidates for bone tissue 
engineering strategies in multiple studies [5, 22-28], supporting the choice of SPCL to 
develop the structures proposed in this study. Indeed, successful results in terms of 
cell viability, proliferation and maturation of osteoblastic cells or differentiation of bone 
marrow stromal cells. Moreover, other starch-based blends (corn starch, dextran and 
gelatine, 50:30:20 wt.%) have already been used to produce different scaffold 
designs by 3D printing (3DP) [29]. Although showing suitable physicochemical 
properties for tissue-engineering applications, the biocompatibility of those 3DP 
geometric scaffolds, with a highly interconnected porous network, remains to be 
tested. The hierarchical starch-based fibrous scaffolds developed in the present study 
were seeded with human osteoblast-like cells to observe how the scaffold 
architecture affects their behaviour. Cells were initially allowed to attach to the 
scaffold using a dynamic system; this spinner flask bioreactor allows the cells to 
efficiently penetrate into the inner regions of the scaffolds, avoiding in a certain extent 
the preferential colonization of the outer outer most parts of the scaffolds [30]. 
Consequently, a homogeneous distribution of cells throughout the entire scaffold was 
observed. However, SEM micrographs demonstrated that osteoblastic cells 
preferentially adhered to the nanofibrous meshes (Figure 5.2 B, D, G and H). This 
phenomena of cellular preference was previously described by our group and others 
[5, 31, 32], when different cell types (osteoblastic, endothelial and neural stem cells) 
were seeded in micro- and nano-fiber-based scaffolds. Additionally, the integration of 
nanofiber meshes into the 3D rapid prototyped scaffolds seemed to act as a cell 
entrapment system within the RP scaffold. It was reported by others [15] that cells go 
through the pores of rapid prototyped scaffolds and accumulate at the bottom of the 
well plate during the seeding process, without attaching the scaffold, and thus 
reducing the seeding efficiency typically down to values of 25-35 %. Thus, the 
integration of nanofiber meshes constitutes an innovative strategy to enhance cell 
seeding efficiency into 3D RP scaffolds. 
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Figure 5.2 – SEM micrographs of rapid prototyped (A, C, E and G) and hierarchical 
fibrous (B, D, F and H) scaffolds cultured with human osteoblast-like cells (Saos-2 
cell line) during 1 (A -D) and 7 days (E-H). Cross-sections (A, B, E and F) and top 
view (C, D, G and H) of the constructs. Higher magnifications enclosed. 
 
The quantification of cell viability and metabolic activity of human osteoblast-like cells 
seeded into the combined electrospun fiber meshes and RP scaffolds was evaluated 
by MTS assay (Figure 5.3). The results revealed a steadily increasing trend, with 
culture time, although there was no significant difference on the effect of the type of  
 
 
Figure 5.3 - Box plot of cell viability results of human osteoblastic cells cultured on 
rapid prototyped (6RP) and hierarchical fibrous (6RP+5NFM) scaffolds, during 1 and 
7 days. Data were analyzed by nonparametric way of a Mann–Whitney U test. 
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Figure 5.4 - Box plot of DNA content of osteoblast-like cells cultured on rapid 
prototyped (6RP) and hierarchical fibrous (6RP+5NFM) scaffolds, during 1 and 7 
days. Data were analyzed by nonparametric way of a Mann-Whitney U test; * p < 
0.01. 
 
scaffold architectures (p > 0.01). From the morphological evaluation of the constructs, 
it seems that the integrated nanofiber meshes into the 3D rapid prototyped structure 
also acted as a cell entrapment system within the scaffold. Consequently, a 
significant increment of cell proliferation and maturation, respectively assessed by 
DNA and ALP activity quantification, along the culture time, was observed on the 
hierarchical fibrous scaffolds (Figures 5.4 and 5.5) in comparison to the rapid 
prototyped scaffolds (p < 0.01), especially for longer culture periods. However, for the 
RP scaffolds, the osteoblastic activity was not maintained throughout the experiment, 
as observed by a decrease in ALP concentration from day 1 to day 7 of culture. It was 
already reported by Schantz et al. [33] that rabbit calvarial osteoblasts, seeded onto 
PCL scaffolds fabricated via fused deposition modelling (FDM) and embedded into a 
fibrin matrix (Tisseel, Baxter Hyland Immuno), showed no significant differences in 
their ALP concentration along time. These results are in accordance with those of our 
study. 
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Figure 5.5 - Box plot of ALP from osteoblastic cells (Saos-2 cell line) cultured on 
rapid prototyped (6RP) and hierarchical fibrous (6RP+5NFM) scaffolds, during 1 and 
7 days. Data were analyzed by nonparametric way of a Mann-Whitney U test; * p < 
0.01. 
 
5.5. Conclusions 
 
A novel hierarchical fibrous scaffold was developed, combining starch-
polycaprolactone micro- and polycaprolactone nano-motifs, respectively produced by 
rapid prototyping and electrospinning. It is evident that the nanofiber meshesWe 
demonstrate that the integration of nanofiber meshes supply topological cues at the 
ECM level, whereas the micro 3D fibrous structure provide the required mechanical 
stability. We here demonstrated that the integration of these two hierarchical 
structures lead to improved biological performance. Indeed, human osteoblast-like 
cells presented significantly higher proliferation and maturation when seeded on 
these hierarquical starch-based fibrous scaffolds. Overall, the results corroborate our 
hypothesis that the hierarchical structure of the scaffolds, mimicking the hierarchical 
structure of the native ECM, is favourable for bone tissue-engineering strategies. 
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Chapter 6 
 
 
 
Biodegradable Nanofiber-Reinforced Microfibrous Composite 
Scaffolds for Bone Tissue Engineering Applications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on the following publication: Martins A, Pinho ED, Correlo VM, Faria S, Marques 
AP, Reis RL, Neves NM. Biodegradable Nanofiber-Reinforced Microfibrous Composite Scaffolds for 
Bone Tissue Engineering Applications. Submitted. 
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6.1. Abstract 
 
Native bone extracellular matrix (ECM) is a complex hierarchical fibrous 
composite structure, resulting from the assembling of collagen fibrils at several length 
scales, ranging from the macro to the nanoscale. The combination of nanofibers 
within microfibers following conventional reinforcement methodologies seems to be a 
feasible solution to the rational design of highly functional synthetic ECM substitutes. 
The present work aims at the development of bone ECM inspired structures, 
conjugating electrospun chitosan (Cht) nanofibers within biodegradable polymeric 
microfibers (poly(butylene succinate) - PBS and PBS/Cht), assembled in a fiber mesh 
structure. The nanofiber-reinforced composite fiber mesh scaffolds were seeded with 
human bone marrow mesenchymal stem cells (hBMSCs) and cultured under 
osteogenic differentiation conditions. These nanofiber-reinforced composite scaffolds 
sustained ECM deposition and mineralization, mainly in the PBS/Cht-based fiber 
meshes, as depicted by the increased amount of calcium phosphates produced by 
the osteogenic differentiated hBMSCs. The osteogenic genotype of the cultured 
hBMSCs was confirmed by the expression of osteoblastic genes, namely Alkaline 
Phosphatase, Osteopontin, Bone Sialoprotein and Osteocalcin, and the transcription 
factors Runx2 and Osterix, all involved in different stages of the osteogenesis. These 
data represent the first report on the biological functionality of nanofiber-reinforced 
composite scaffolds, envisaging the applicability of the developed structures for bone 
tissue engineering. 
 
 
6.2. Introduction 
 
The native extracellular matrix (ECM) is a dynamic and hierarchically 
organized fibrous nanocomposite. It provides mechanical support for the embedded 
cells and also interacts with cells regulating various cellular functions such as 
adhesion, migration, proliferation, differentiation and tissue morphogenesis [1]. The 
ECM of connective tissues is a complex interconnected nano- or micro-ranged fibrous 
network of polysaccharides (such as glycosaminoglycans or cellulose) and proteins 
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(such as collagen and proteoglycans) secreted by the adjacent cells. The nano-
scaled fibrils are further assembled into larger collagen bundles. Thus hierarchically 
organized structure stands from the molecular level up to the macroscopic scale. In 
the case of bone, collagen assemblies and its organization ensure its multiple 
functions [2]. Besides the outstanding hierarchically organized structure, native bone 
nanofibers are also covered by hydroxyapatite nano-crystals with their c-axis aligned 
with the longitudinal axis of the fibers. Although the basic organization and 
composition of the bone is known, replicating its structure and properties has been 
very challenging [3]. 
In the context of tissue engineering, three-dimensional synthetic ECM are 
developed not only to provide the initial structural integrity for cells to adhere, but also 
to direct cell proliferation and differentiation, ultimately leading to the assembly of 
functional tissue-like substitutes [4, 5]. The understanding that the natural ECM is a 
multifunctional nanocomposite motivated researchers to rationally design synthetic 
ECM substitutes-scaffolds. Nanocomposites that emulate the structural, 
compositional and biological characteristics of natural bone, are certainly major 
candidates to be used in bone tissue engineering applications [6]. Current attempts to 
replicate the complexity and hierarchically organization of natural ECM are mostly 
restricted to dispensing nanofibers in existing implants and biomedical devices or 
used as random nanofibrous meshes [3]. In fact, nature modulates the mechanical 
properties of biological tissues by subtle adjustments of its local composition with a 
perceivable alteration of its nano-scale organization. 
To follow nature assembly, a processing method that is able to fabricate 
nanofibers from a variety of materials and mixtures is a prerequisite. The control of 
the nanofiber arrangement is also necessary to optimize the hierarchically organized 
multifunctional nanocomposites [3, 7-9]. Electrospinning allows the production of 
ECM-mimetics that exhibit a physical structure similar to that of the fibrous proteins in 
the native ECM, albeit their completely different chemical composition [10, 11]. 
Submicron electrospun polymer fibers are good candidates as reinforcing agents in 
the development of advanced nanocomposites due to their continuity, orientation, 
inherent flexibility, and potential high compatibility with polymer matrices. However, 
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only a limited number of composites reinforced with electrospun nanofibers have 
been developed, and mainly for providing some outstanding physical characteristics, 
namely optical transparency and mechanical properties [12-20]. The pioneer work on 
electrospun nanofiber-reinforced composite materials was developed by Kim and 
Reneker [21], reporting improvement on the mechanical properties (i.e. fracture 
toughness and the modulus) of a poly-benzimidazole (PBI)-reinforced epoxy resin 
composite and of a nanofiber-reinforced styrene-butadiene rubber (i.e. Young’s 
modulus and tear strength). In the same year, Bergshoef and Vancso [12] described 
the incorporation of electrospun nylon-4,6 nanofibers with 30 to 200 nm diameter in 
phenolic epoxy films prepared by curing, with a thickness of 100 µm. The composite 
films obtained by fiber reinforcement exhibited a characteristic transparency, due to 
the fiber sizes smaller than the wavelength of visible light. Fong et al. [13, 22] used 
electrospun nanofibers to improve the flexural strength, elastic modulus and work of 
fracture of Bis-GMA/TEGDMA dental restorative resin, using relatively small mass 
fractions (from 1-5 %) of electrospun nylon 6 nanofibers impregnation. Sihn et al. [23] 
used non-woven meshes, either of poly(2,6-dimethyl-1,4-phenylene oxide)/carbon 
nanotubes or polystyrene/carbon nanotubes composite nanofiber, as a nano-
interfacial layer in laminated composites. With this nano-interfacial layer, the stress 
required for the onset of delamination and micro-crack formation was increased 
resulting in an increment of the ultimate strength of the composite. Although a 
prospective physical characterization of the nanofiber-reinforced composites was 
pursued, their biological functionality remains to be explored. 
Like natural ECM, a range of topographic features at the macro-, micro- and 
even nano-scale levels may lead cell response [24]. A combination of nanofibers with 
conventional reinforcement at the micron scale may captive interesting features of the 
native ECM [25]. Recently, our group and others [26-31] developed multi-scale 
network structures by integrating electrospun nanofibers within the microfibrous 
structures, produced by wet spinning or rapid prototyping tecniques. Biological data 
demonstrated that the hierarchical fibrous structure of those scaffolds is favourable 
for bone tissue-engineering strategies. Considering the above referred background, 
the present work aims at producing bone ECM inspired structures, conjugating 
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electrospun chitosan (Cht) nanofibers with biodegradable polymeric microfibers 
(poly(butylene succinate) - PBS and PBS/Cht). Despite the recent increment of works 
on electrospun nanofiber-reinforced dental restorative composites resins [13, 16, 17, 
19, 20, 22], this is the first work, from the best of our knowledge, reporting the 
biological functionality of nanofiber-reinforced composite scaffolds. 
Functional and structural engineering of musculoskeletal tissue may involve 
the use of appropriated cells cultured with specific growth factors in biomaterial 
scaffolds. While several tissues remain an important source of therapeutic relevant 
differentiated cells, stem cells have emerged as a strong alternative due to their 
expansion potential - self-renewal potential - and the fact that they can be obtained 
from autologous sources [32]. Additionally, advances in stem cell biology have shown 
that mesenchymal stem cells (MSCs) can differentiate into a variety of connective 
tissues, including bone, cartilage, fat, muscle and tendon, when cultured with 
appropriated supplemented culture media and specific environments [33]. Herein, 
human bone marrow mesenchymal stem cells (hBMSCs) were cultured on those 
hierarchical nanocomposite structures, under osteogenic differentiation inductive 
conditions, to validate the applicability of the developed structures for bone tissue 
engineering. A phenotypic and genotypic characterization of osteoblastic markers 
was performed to quantitatively evaluate the formation of bone-like tissue. 
 
6.3. Materials & Methods 
 
6.3.1. Production of the Nanofiber-Reinforced Microfibrous Composite Scaffolds 
 
The processing of chitosan (Cht) nanofiber meshes by electrospinning and 
their subsequent neutralization process were detailed described elsewhere [14]. The 
nanofiber-reinforced microfibers were produced by melt extruding poly(butylene 
succinate) (PBS) or a blend of PBS/Cht (50:50 wt.%), compounded with electrospun 
chitosan nanofiber meshes (0.05 wt.%). The processing conditions of the nanofiber-
reinforced microfibers, as well as the PBS and PBS/Cht microfibers without nanofiber 
reinforcement, used as controls, were described elsewhere [14, 15]. Briefly, the 
processing conditions of those microfibers were: melt temperatures of 115 ºC for the 
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PBS-based fibers and 145 ºC for the PBS/Cht, a screw rotation speed of 40 r.p.m. 
and a die diameter of 0.5 mm. 
The assembling of the microfibrous scaffolds, reinforced or not with 
electrospun chitosan nanofiber meshes, was achieved by fiber bonding. Basically, a 
predefined quantity of microfibers (PBS or PBS/Cht), reinforced or not with 
electrospun chitosan nanofiber meshes, was randomly arrayed in the custom-
designed Teflon mold and heated at 120 ºC (for PBS-based) or 150 °C (for PBS/Cht-
based) during 10 minutes under compression. Cylindrical samples of 6 mm in 
diameter and 2 mm in thickness were cut and sterilized by ethylene oxide before the 
in vitro biological assays. 
 
6.3.2. Characterization of the Nanofiber-reinforced Microfibrous Composite Scaffolds 
 
Nanofiber-reinforced microfibrous composite scaffolds were gold sputter-
coated (model SC502, Fisons Instruments; England) for 2 min at 15 mA and analyzed 
with a Scanning Electron Microscope (model S360, Leica Cambridge; England). 
Micrographs were recorded at 15 kV with magnifications ranging from 100 to 5000 
times. 
To better visualize and quantify the 3D internal structure of prepared scaffold, 
micro-computed tomography (µ-CT) analyses were conducted using a desktop micro 
CT scanner (SkyScan 1072, Aartselaar, Belgium). Each scaffold type was scanned in 
high-resolution mode using a pixel size of 8.79 µm and an exposure time of 2.2 ms. 
The X-ray source was set at 40 keV of energy and a current of 248 µA. From the 
resulting voxel data, a cylindrical volume of interest with a diameter of 4 mm and 1.3 
mm thick (corresponding to 150 slices) was selected in order to eliminate side effects 
that could be induced by the irregularity of the sample. The grey-scale images were 
transformed into binary data using a dynamic threshold of 60-255 (gray values) to 
distinguish between polymer material and the void space. Those operating 
parameters were maintained for all the samples. For morphometric analysis, including 
porosity and mean pore size quantification, the sliced 2D tomographic raw images 
were reconstructed using a CT Analyzer software from the micro CT scanner 
supplier. 3D virtual models of representative regions in the bulk of the scaffolds were 
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also created, visualized and processed using the image analysis software supplied by 
the manufacturer. 
 
6.3.3. Expansion, Seeding and Osteogenic Differentiation of Human Bone Marrow 
Mesenchymal Stem Cells 
 
Human bone marrow aspirates were obtained, after Informed Consent (IC), 
during routine surgical procedures involving knee arthroplasties, as approved by the 
Ethical Committee of the São Marcos Hospital, Braga and under the Cooperation 
Agreement established between the 3B s´ Research Group-UM and that Hospital. 
Human bone marrow mesenchymal stem cells (hBMSCs) were isolated and 
characterized according to the method established by Delorme and Charbord [34]. 
hBMSCs were expanded in basal medium consisting of MEM alpha medium (α-MEM; 
Gibco, GB) supplemented with 10 % heat-inactivated fetal bovine serum (FBS; 
Biochrom AG, Germany) and 1 % antibiotic/antimyotic solution (final concentration of 
penicillin 100 units/ml and streptomycin 100 µg/ml; Gibco, GB). Cells were cultured in 
a 5 % CO2 incubator at 37 °C. 
Confluent hBMSCs at passages 4-5 were harvested for seeding onto the 
nanofiber-reinforced microfibrous composite scaffolds at a density of 5.0x105 
cells/scaffold. Unreinforced microfibrous scaffolds (PBS and PBS/Cht) were used as 
controls. The constructs were cultured in standard osteogenic differentiation medium 
(basal medium supplemented with 50 µg/mL ascorbic acid, 10 mM β-
glicerophosphate and 10-7 M dexamethasone) for 7, 14 and 21 days. 
 
6.3.4. Analysis of Cell Morphology and Distribution, and ECM Mineralization 
 
 For scanning electron microscopy (SEM) analysis, the constructs were fixed 
with 2.5 % Glutaraldehyde (Sigma; USA) in a Phosphate Buffer Saline solution 
(Sigma; USA) during 1h at 4 ºC. The constructs were further dehydrated through an 
increasing series of ethanol concentrations and let to dry overnight. Before being 
analyzed by SEM (model S360, Leica Cambridge; England) equipped with an energy 
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dispersive spectrometer (EDS; link-eXL-II), the samples were gold or carbon sputter 
coated (sputter coater model SC502, Fisons Instruments; England). 
 Formalin-fixed constructs were embedded in Teknovit resin and sectioned (10 
µm each section) for histological purposes. Hematoxylin-Eosin stain was performed to 
analyse cell distribution within the microfibrous composite scaffolds. Stained sections 
were observed under an optical microscope (BX61, Olympus Corporation, Germany) 
and images captured by a digital camera (DP70, Olympus Corporation, Germany). 
 
6.3.5. Cell Viab ility and Proliferation Assessment 
 
Cell viability for each culturing time was determined using the CellTiter 96 
AQueous One Solution Cell Proliferation Assay (Promega; USA), following 
manufacturer instructions. The absorbance of three different samples per type of 
scaffold and time point was measured at 490 nm in a microplate reader (Synergie HT, 
Bio-Tek; USA) and related with the number of living cells in the constructs.  
Cell proliferation was quantified by the total amount of double-stranded DNA, 
along the culturing time. Quantification was performed using the Quant-iT 
PicoGreen dsDNA Assay Kit (Invitrogen, Molecular Probes; Oregon, USA), 
according to the instructions of the manufacturer. Briefly, cells in the construct were 
lysed by osmotic and thermal shock and the supernatant used for the DNA 
quantification assay. The fluorescence was measured at an excitation wavelength of 
485/20 nm and at an emission wavelength of 528/20 nm, in a microplate reader 
(Synergie HT, Bio-Tek; USA). Triplicates were made for each sample and per 
culturing time. The DNA concentration for each sample was calculated using a 
standard curve relating DNA concentration (ranging from 0.0 to 1.5 µg/mL) and 
fluorescence intensity.  
 
6.3.6. Alkaline Phosphatase Quantification 
 
The concentration of alkaline phosphatase (ALP) was determined for all time 
culture periods, using the lysates used for DNA quantification. Briefly, the activity of 
ALP was assessed using the p-nitrophenol assay [35]. The reaction was stopped by 
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adding 2M NaOH (Panreac Quimica, Spain) and the absorbance read at 405 nm in a 
microplate reader (Bio-Tek, Synergie HT; USA). Standards were prepared with a 10 
µmol/ml p-nytrophenol (pNP; Sigma, USA) solution, to obtain a standard curve 
ranging from 0 to 250 µM. Triplicates of each sample and standard were made, and 
the ALP concentrations read off from the standard curve. 
 
6.3.7. RNA isolation and Real-Time Quantitative Polymerase Chain Reaction 
 
Total RNA from the constructs was extracted using the Trizol® (Invitrogen, Life 
Technologies Inc., UK) method according to the manufacturer protocol. Briefly, at 
each culturing time the constructs were washed with PBS, immersed in Trizol and 
stored at -80 ºC until further use. Proteins were removed with chloroform extraction, 
and the RNA pellets were washed once with isopropyl alcohol and once with 70 % 
ethanol. The total RNA pellets were reconstituted in Rnase free water (Gibco, 
Invitrogen, UK). Determination of the RNA concentration for each scaffold replica 
(triplicates of each scaffold per time point) was performed by microspectrophotometry 
(NanoDrop ND-1000, USA). 
 Reverse transcriptase (RT)-PCR was performed according to the protocol from 
iScript™ cDNA synthesis kit (BioRad, Hercules, CA, USA). Briefly, a reaction mixture 
consisting of 1X iScript Reaction Mix, 1 µl iScript Reverse Transcriptase, RNA 
template (150 ng total RNA for PBS-R and PBS scaffolds, and 1 µg total RNA for 
PBS/Cht-R and PBS/Cht scaffolds) and nuclease-free water was prepared, in 20 µl of 
total volume. The single-strand cDNA synthesis occurred by incubating the complete 
reaction mixture 5 min at 25 ºC, followed by 30 min at 42 ºC and terminated by an 
incubation at 85 ºC for 5 min. 
Amplification of the target cDNA for real-time PCR quantification were 
performed according to the manufacturer protocol, using 2 µl RT cDNA products, 1 
µM each primer (osteoblastic genes primer sets listed in Table 6.1), 1X iQ SYBR 
Green Supermix (BioRad, Hercules, CA, USA) and nuclease-free water, in a final 
volume of 25 µL. Forty-four cycles of denaturation (95 ºC, 10 s), annealing 
(temperature dependent on the gene, 30 s) and extension (72 ºC, 30 s) were carried 
out in the gradient thermocycler MiniOpticon real-time PCR detection system 
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Table 6.1 - Primers list of osteogenic markers. 
Gene  Primer sequences (5’-3’) Tm [ºC] 
ALP sense 
antisense 
CTCCTCGGAAGACACTCTG 
AGACTGCGCCTGGTAGTTG 60,0 
OP sense 
antisense 
GGGGACAACTGGAGTGAAAA 
CCCACAGACCCTTCCAAGTA 58,4 
BSP sense 
antisense 
CAACAGCACAGAGGCAGAAAAC 
CCTCGTATTCAACGGTGGTG 59,9 
OC sense antisense 
CTGAGAGGAGCAGAACTGG 
GGCAGCGAGGTAGTGAAGAG 61,4 
Runx2 sense 
antisense 
TTCCAGACCAGCAGCACTC 
CAGCGTCAACACCATCATTC 58,1 
Osterix sense 
antisense 
CCCTTTACAAGCACTAATGG 
ACACTGGGCAGACAGTCAG 57,1 
GAPDH sense 
antisense 
ACAGTCAGCCGCATCTTCTT 
GACAAGCTTCCCGTTCTCAG 58,4 
 
(BioRad, Hercules, CA, USA) for all genes. The transcripts expression data were 
normalized to the housekeeping gene glyceraldehyde-3-phosphate-dehydrogenase 
(GAPDH) and the relative quantification calculated by the ∆CT method. 
 
6.3.8. Statistical Analysis 
 
Statistical Analysis was performed using the SPSS statistic software package 
(Release 15.0.0 for Windows). Firstly, a Shapiro-Wilk test was used to ascertain 
about the data normality. The results indicated that nonparametric tests should be 
used for all comparisons. P values lower than 0.01 were considered statistically 
significant. 
Firstly, a Kruskal-Wallis test was performed to analyze the effect of the 
electrospun nanofibers-reinforced microfibrous composite scaffolds over hBMSCs 
viability and proliferation, ALP quantification, and osteogenic genotype. When this test 
indicated significant differences among scaffolds, a multiple comparison procedure, 
Tukey’s HSD test, was performed to find where the differences occur.  
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6.4. Results 
 
6.4.1. Morphology of the Nanofibers Reinforced Microfibrous Composite Scaffolds 
 
PBS and PBS/Cht microfibers reinforced (i.e. PBS-R and PBS/Ch-R) or not 
(i.e. PBS and PBS/Cht) by electrospun chitosan nanofiber were processed by melt 
extrusion. The production of the fibrous scaffolds was achieved by fiber bonding, 
obtaining a random mesh-like structure. Their morphology and architecture are shown 
in the Figure 6.1. From the analysis of SEM micrographs it is possible to notice that 
PBS and PBS-R fibers have a very regular and smooth surface (Figure 6.1 A and B). 
Conversely, PBS/Cht and PBS/Cht-R fibers presented very irregular and rough 
surfaces (Figure 6.1 C and D) due to the presence of the chitosan microparticules (50 
wt.%) within the PBS matrix (50 wt.%). 
The µ-CT analysis allows obtaining a representative volumetric region of the 
different porous fibrous scaffolds (Figure 6.1 E-H). These 3D images corroborate the 
observations previously stated by the SEM morphological analysis paragraph. The 
reconstructed 3D models also provide a quantitative morphometric analysis of the 
microfibrous scaffolds reinforced or not by electrospun chitosan nanofibers. 
 
 
Figure 6.1 - Morphology and architecture of the electrospun chitosan nanofibers 
reinforced (A, C, E and G) and non-reinforced (B, D, F and H) microfibrous scaffolds 
on photomicrographs from scanning electron microscopy (A-D) and 3D models from 
micro-computed tomography (E-H). A and E –PBS-R; B and F – PBS; C and G - 
PBS/Cht-R; D and H – PBS/Cht. 
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Accordingly, the porosity and mean pore size parameters for each type of fibrous 
scaffold were, respectively: 53.6 % and 333.9 µm for PBS-R scaffolds; 60.4 % and 
414.2 µm for PBS scaffolds; 62.9 % and 303.6 µm for PBS/Cht-R scaffolds; 53.4 % 
and 303.6 µm for PBS/Cht scaffolds. 
 
6.4.2. Morphology, Viability and Proliferation of Human Bone Marrow Mesenchymal 
Stem Cells on Nanofiber-reinforced Microfibrous Composite Scaffolds 
 
hBMSCs were cultured under osteogenic differentiation conditions on the
  
 
Figure 6.2 - SEM photomicrographs of nanofibers reinforced (A, C, E, G, I and K) 
and non-reinforced (B, D, F, H, J and L) microfibrous scaffolds cultured with hBMSCs 
during 7 (A-D), 14 (E-H) and 21 days (I-L), under osteogenic conditions. A, E and I – 
PBS-R; B, F and J – PBS; C, G and K – PBS/Cht-R; D, H and L – PBS/Cht. Optical 
photographs from cross-sections of PBS-R (M), PBS (N), PBS/Cht-R (O) and 
PBS/Cht (P) constructs after 21 days of culture. 
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different microfibrous scaffolds, reinforced or not by electrospun nanofiber meshes, to 
validate the bone tissue engineering applicability of the developed structures. From 
the SEM micrographs was possible to observe dense sheets of hBMSCs crossing 
adjacent fibers of PBS or PBS-R, mainly for the longer culture periods (Figure 6.2 I 
and J). Cells covering the fibers surface, eventually embedded in a matrix, were also 
observed in the HE stained cross-section of these scaffolds (Figure 6.2 M and N). In 
the case of the composite fibrous scaffolds PBS/Cht or PBS/Cht-R, the hBMSCs not 
only adhere to the rough fibrous surface but also colonize the inner pores/regions of 
the scaffold (Figure 6.2 K and L). Furthermore, occlusion of those pores was not 
observed, allowing the exchanging of oxygen and nutrients for and metabolites from 
the proliferating cells. Those remarks were also possible to observe in the HE stained 
cross-section of these scaffolds (Figure 6.2 O and P). 
By energy dispersive spectrometry (EDS) it was possible to obtain the spectra 
for the PBS/Cht-R (Figure 6.3 A) and for the PBS/Cht (Figure 6.3 B) scaffolds 
cultured with hBMSCs under osteogenic conditions. The analysis of the EDS spectra 
allows to detect an increment of the Calcium (Ca) and Phosphorus (P) elements from 
the day 14 to the day 21 of culture, corresponding to the deposition of a mineralized 
 
 
Figure 6.3 - EDS spectra for electrospun nanofibers reinforced (i.e. PBS/Cht-R) (A) 
and non-reinforced PBS/Cht (B) scaffolds seeded with hBMSCs and cultured under 
osteogenic conditions, after 14 and 21 days. 
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matrix by the cells. These two chemical elements, characteristic of the inorganic 
phase of the native bone, were not found in the PBS-based constructs (PBS-R and 
PBS fibrous scaffolds) seeded and cultured with hBMSCs under the same conditions. 
The viability of the hBMSCs cultured on the nanofiber-reinforced microfibrous 
composite scaffolds was followed along the 21 days of the experiment using the MTS 
assay. As depicted in Figure 6.4, all the studied fiber mesh scaffolds (nanofiber-
reinforced and non-reinforced microfibrous scaffolds) presented progressively 
increasing values of cell viability over the period of culture. At 7 days of culture, no 
significant differences were observed between all the fiber mesh scaffolds (Kruskal-
Wallis test, p = 0.259). At day 14, the hBMSCs cultured on non-reinforced PBS 
scaffolds presented a significantly higher viability than PBS-R (p = 0.002), PBS/Cht-R 
(p < 0.001) and PBS/Cht (p = 0.003). At this culture time, PBS/Cht scaffolds also 
exhibited significantly higher cell viability than PBS/Cht-R (p < 0.001). On the 21 day  
 
 
Figure 6.4 - Box plot of the hBMSCs viability cultured in PBS-R, PBS,PBS/Cht-R and 
PBS/Cht, under osteogenic conditions. Data were analyzed by nonparametric way of 
a Kruskal-Wallis test followed by Tukey’s HSD test: a denotes significant differences 
compared to PBS; b denotes significant differences compared to PBS/Cht. 
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of culture, PBS scaffolds showed significantly higher values of cell viability than PBS-
R and PBS/Cht-R (p = 0.001). 
Considering the proliferation of hBMSCs seeded onto the studied structures 
(Figure 6.5), PBS-R scaffolds presented significantly higher DNA concentration than 
the other three types of scaffolds (p < 0.001), for the 7 days of culture. Moreover, PBS 
scaffolds also presented a significantly higher proliferation than PBS/Cht-R and 
PBS/Cht (p < 0.001). At the day 14, hBMSCs cultured on PBS/Cht exhibited 
significant lower DNA concentration than the other three scaffolds (p < 0.001), while 
PBS-R scaffolds showed a significantly higher cell number than PBS/Cht-R (p < 
0.001). After 21 days of culture, PBS-R and PBS scaffolds presented significant 
higher DNA quantity than the PBS/Cht-R and PBS/Cht (p < 0.001). 
 
 
Figure 6.5 - Box plot of the hBMSCs proliferation, cultured on PBS-R, PBS,PBS/Cht-
R and PBS/Cht scaffolds under osteogenic conditions. Data were analyzed by 
nonparametric way of a Kruskal-Wallis test followed by Tukey’s HSD test: a denotes 
significant differences compared to PBS; b denotes significant differences compared 
to PBS/Cht; c denotes significant differences compared to PBS-R. 
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6.4.3. Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells 
on Nanofiber-Reinforced Microfibrous Composite Scaffolds 
 
To ascertain about the osteogenic phenotype of the hBMSCs cultured on the 
nanofiber-reinforced microfibrous composite scaffolds and the control fiber mesh 
scaffolds, quantification of an enzyme involved in the onset of the mineralization 
process - alkaline phosphatase (ALP) - was performed (Figure 6.6). No significant 
differences were found between the fibrous scaffolds at the 7th day of cultured under 
osteogenic differentiation conditions. A significantly higher quantity of this enzyme 
was produced by hBMSCs cultured on non-reinforced PBS fiber meshes for the 14 
and 21 days (p < 0.001). Additionally, hBMSCs cultured on the other fibrous scaffolds 
(reinforced or not), under osteogenic differentiation conditions, present lower but 
constant values of ALP during the course of the experiment. 
 
 
Figure 6.6 - Box plot of the alkaline phosphatase (ALP) from hBMSCs cultured on 
PBS-R, PBS,PBS/Cht-R and PBS/Cht scaffolds under osteogenic conditions. Data 
were analyzed by nonparametric way of a Kruskal-Wallis test followed by Tukey’s 
HSD test: a denotes significant differences compared to PBS. 
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The osteogenic genotype of the hBMSCs cultured on nanofiber-reinforced 
microfibrous composite scaffolds was assessed by quantitative PCR. The expression 
of the osteoblastic transcripts was normalized against the expression of a 
housekeeping gene, which expression is constitutive along the experimental course, 
without being influenced by the osteogenic differentiation culture conditions. From the 
analysis of the Figure 6.7 we could notice similar expression patterns of the 
osteoblastic genes between the nanofiber-reinforced microfibrous composite 
scaffolds (PBS-R and PBS/Cht-R) and the non-reinforced microfibrous scaffolds (PBS 
and PBS/Cht). No significant differences were found between the expression patterns 
of hBMSCs cultured on the PBS/Cht-R and PBS/Cht, excepting their significantly
 
 
Figure 6.7 - Relative expression of osteoblastic transcripts, namely Alkaline 
Phosphatase, Osteopontin, Bone Sialoprotein, Osteocalcin, Runx2 and Osterix, by 
hBMSCs cultured on PBS-R, PBS,PBS/Cht-R and PBS/Cht scaffolds under 
osteogenic conditions. The expression of these genes was normalized against the 
housekeeping gene GAPDH and calculated by the ∆CT method. Data were analyzed 
by nonparametric way of a Kruskal-Wallis test followed by Tukey’s HSD test: b 
denotes significant differences compared to PBS/Cht; c denotes significant 
differences compared to PBS-R. 
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higher expression of Alkaline Phosphatase than hBMSCs cultured on PBS-R, after 21 
days of culture (p = 0.004 and p = 0.002, respectively). Inversely, the expression of 
Bone Sialoprotein was significant lower on the PBS/Cht-R than in the non-reinforced 
PBS/Cht fiber mesh scaffolds (p = 0.007).  
 
6.5. Discussion 
 
By definition, polymer nanocomposites are two-phase systems consisting of 
polymers loaded with high-surface-area reinforcing fillers [36]. In addition, 
nanocomposites are compatible with conventional polymer processing, thus avoiding 
the costly layup required for the fabrication of conventional fiber-reinforced 
composites. The polymer-based nanocomposites are much less investigated than 
nanocomposites based on ceramics and metals matrices, and their studies are mostly 
limited to layered and particulate systems [25]. The emergence of functionalized 
nanoscale reinforcements having large surface area has enabled the design of novel 
nanocomposites with new and complex structures [3]. 
It is well-known that advanced composites possessing outstanding mechanical 
properties for structural applications are usually compounded with reinforcing of 
strong fibers dispersed in a continuous matrix material [21, 25]. The most important 
requirements of a nanofiber-reinforced composite are: adequate interface properties 
between the reinforcing phase and polymeric matrix [13]; the reinforcing phase should 
be homogenously distributed/dispersed as isolated nanofibers and individually coated 
with the polymer matrix [37]. Nevertheless, even without taking into account the 
interfacial phenomena, the hierarchical nano-/micro-composite reinforced with a 
mixture of nano- and microfibers exhibit extreme properties [25]. We recently 
developed novel biodegradable reinforced fiber-based composites that combines 
electrospun chitosan nanofibers with polymeric microfibers, showing improved 
mechanical (i.e. tensile modulus) and degradation properties (i.e. water uptake) [14, 
15]. It was also speculated that the mechanical properties of electrospun nanofibers 
reinforced composites could be substantially improved by forming a scaffold-like, 
highly interpenetrated and porous framework [20]. This hypothesis was the leading 
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force of the present work: the development of chitosan nanofiber-reinforced 
composite fiber mesh scaffolds.  
Biodegradable synthetic polymers, such as polycaprolactone (PCL), poly 
(lactic acid) (PLA), poly (glycolic acid) (PGA), polyethylene glycol (PEG), polyvinyl  
alcohol (PVA) and polyurethane (PU) have been thoroughly explored as biomaterials 
in the field of tissue engineering [4, 38, 39]. Poly(butylene succinate) (PBS), an 
aliphatic thermoplastic polyester initially developed by Showa HighPolymer and 
proposed for environmentally driven applications under the trade name Bionolle® [40, 
41], have been recently proposed as a novel biodegradable synthetic polymer for 
biomedical applications due to its interesting physical and biological properties [42-
47]. Herein, the influence of electrospun chitosan nanofiber reinforcement on the 
biological performance of PBS microfibrous scaffolds was assessed; being the first 
report on the biological functionality of nanofiber-reinforced composite scaffolds. The 
main discriminatory results were observed at the phenotypic level: the higher 
proliferation potential of hBMSCs culture on nanofiber-reinforced PBS scaffolds (PBS-
R) and the significant higher concentration of the enzyme ALP produced by hBMSCs 
cultured under osteogenic conditions on non-reinforced PBS scaffolds, also 
accompanied by significantly higher cell viability. At the genotypic level, no significant 
differences were observed between the nanofiber-reinforced (PBS-R) and non-
reinforced (PBS) fiber mesh scaffolds. Anyway, the constitutive expression of the 
most important genes involved in the osteogenic differentiation process could confirm 
the matrix deposition and mineralization by hBMSCs cultured and differentiated on 
nanofibers reinforced composite scaffolds. Those observations could be justified by 
the location of the small amount of electrospun nanofibers (0.05 wt.%) within the bulk 
PBS microfibers matrix. Therefore, although electrospun nanofibers present high 
specific surface area, which could increase the cell-synthetic ECM interaction, this 
characteristic of the composite microfibers was not sensed by the adjacent cultured 
cells. 
Considering the requirements of synthetic ECMs or scaffolds for tissue 
engineering applications, blends/compositions made of synthetic and natural 
biodegradable polymers can be designed and tailored to obtain a wide range of 
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desirable properties in exquisite combinations (i.e. mechanical properties, 
degradation, hydrophilicity and biocompatibility). It is possible to combine the 
processing freedom offered by synthetic polymers, with the biocompatibility and 
excellent biological interface of natural polymers with cells [42, 48]. Indeed, some 
natural-origin polymers may offer the advantage of being similar to native ECM 
macromolecules. In the present case, chitosan is a polysaccharide structurally similar 
to the glycosaminoglycans of the native ECM found in different human tissues. 
Moreover, natural polymers present the attractive characteristic of being degraded by 
naturally occurring enzymes and, eventually, metabolized by physiological 
mechanisms. The aliphatic polyester PBS previously described presents a 
hydrophobic character. Inversely, the chitosan molecule is rich in polar groups (i.e. –
OH and –NH2) and thus very hydrophilic. Therefore, the presence of chitosan in the 
composite enhances the hydrophilic properties, thus resulting in enhanced 
degradation properties associated with a loss of tensile modulus [47]. The 
incorporation of electrospun nanofibers into the composite not only provides 
additional elastic modulus, but also enhances the surface area of the chitosan phase, 
facilitating the water uptake capability [14]. 
The composite microfibers of PBS/Cht reinforced by electrospun nanofibers, 
assemble in a fiber mesh structure, were also seeded with human bone marrow 
mesenchymal stem cells and cultured during 21 days under osteogenic differentiation 
conditions. No substantial differences were observed in the biological data 
(phenotypic and genotypic results) between nanofiber-reinforced (PBS/Cht-R) and 
non-reinforced (PBS/Cht) fiber mesh scaffolds. The constitutive expression of the 
transcripts involved in the osteogenesis, corroborate the successful differentiation of 
hBMSCs into osteoblasts on nanofiber-reinforced composite scaffolds. On those 
composite scaffolds, the electrospun nanofibers and also the chitosan microparticules 
are covered by a thin PBS rich layer [42, 43], preventing a close interaction of cells 
with the chitosan domains. However, the presence of the chitosan microparticles 
seems to have an important role in the deposition of mineralized ECM, as suggested 
by the increased amount of calcium phosphates produced by the osteogenic 
differentiated hBMSCs. This remarkable result was not observed in the PBS-based 
Nanofi ber-Reinforced Microfibrous Scaffolds  
213 
microfibers, indicating that the natural origin material used in the composites (i.e. 
chitosan) plays an important role in the cell mediated mineralization process. 
Therefore, while a detailed mechanism is beyond the scope of this work (i.e. 
nanofiber reinforcement), the biological performance of the biodegradable 
nanofibrous reinforced microfibrous scaffolds is mainly a function of the 
physicochemical (e.g. roughness and chemical composition) surface properties. 
 
6.6. Conclusions 
 
Novel complex hierarchical fibrous composite scaffolds were developed based 
on biodegradable polymeric microfibers (PBS or PBS/Cht) reinforced by electrospun 
chitosan nanofibers. The osteogenic potential of these nanofiber-reinforced 
composite fiber mesh scaffolds was assess by seeding and culturing human bone 
marrow mesenchymal stem cells (hBMSCs). Data demonstrated that the electrospun 
chitosan nanofibers used to reinforce the microfibers, although improving the 
mechanical and degradation properties of the composite fibers, still preserve the 
excellent in vitro biological performance already described for PBS/Cht fiber mesh 
scaffolds. Among the developed fiber meshes, the PBS/Cht-based scaffolds 
sustained an ECM deposition and mineralization by the osteogenic differentiated 
hBMSCs. This is the first biological work reporting the potentiality of nanofiber-
reinforced microfibrous scaffolds for bone tissue engineering approaches. 
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7.1. Abstract 
 
Electrospinning is a simple and versatile polymer processing technique, which 
applies electrostatic forces to a polymeric solution, generating ultrafine fibers. This 
technique has been gaining popularity, since it allows the production of non-woven 
meshes with high surface area-to-volume ratio and high micro-porosity. Additionally, 
these nanofiber meshes can mimic the morphology of the extracellular matrix of many 
human tissues and, therefore, have a specific interest as scaffolds for Tissue 
Engineering applications. However, electrospun nanofiber meshes present an 
important limitation to this type of application: the obtained pore size is typically too 
small to allow cell penetration into the inner regions of the nanofibrous scaffold. To 
overcome this problem, PCL and PEO solutions are electrospun simultaneously to 
obtain a dual composition nanofiber mesh. By the selective dissolution of the PEO 
nanofiber fraction, a mesh with higher pore size will be obtained. The electrospun 
nanofiber meshes, after the PEO dissolution show a statistically significant increased 
pore size, when compared with PCL nanofiber meshes with comparable quantity of 
material, and confirmed by interferometric optical profilometry. The biologic 
performance of these enhanced pore size nanofibrous structures is assessed with 
human osteoblast-like cells, using a specially designed fixing system that enables 
only cell infiltration across the thickness of the mesh. By scanning electron 
microscopy and laser scanning confocal microscopy it is observed that cells could 
penetrate into the nanofibrous structure and even migrate to the opposite side of the 
mesh. An electrospun mesh with sufficient pore size to allow cell infiltration into its 
structure was produced, enabling obtaining a fully populated construct appropriate for 
3D Tissue Engineering applications. 
 
 
7.2. Introduction 
 
 Tissue Engineering is an emergent research area that offers the promise of 
tissue regeneration, relevant for many clinical conditions. The success of tissue 
engineering is highly dependent of a scaffold that will act as a temporary matrix for 
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cell proliferation and extracellular matrix deposition, with consequent tissue in-growth 
until the new tissue is totally regenerated [1]. So, an appropriate 3D scaffold (i.e. its 
biocompatibility, pore size, porosity and interconnectivity, biodegradability, and 
adequate surface chemistry and mechanical properties) is an essential component for 
a tissue engineering strategy [2, 3]. Polymers are believed to be the ideal material for 
tissue engineering applications. Both natural and synthetic origin polymers can be 
applied in this kind of strategy. Much of the current research is focused on natural 
materials by their improved biocompatibility (among others we can find, collagen [4-
6], fibrinogen [7], chitosan [8-10], starch [11-13], hyaluronic acid [14, 15] and 
poly(hydroxybutyrate) [16]. Synthetic biodegradable polymers are the ones that are 
more commonly used within the biomedical engineering field. Their chemical 
versatility and processability varies according to their structure and nature. 
Besides the choice of adequate materials, the macro and micro-structural 
properties of the materials are of utmost importance. It is very important that the 
scaffold can mimic, as much as possible, the physicochemical cues provided by 
extracellularmatrix (ECM), to guide communities of cells to rebuild the native tissue 
structure [17-21]. In many tissues, cells are surrounded by an intricate network of 
protein fibrils and interwoven fibers within a hydrated network of glycosaminoglycan 
chains that determine the physical properties of the tissue [22]. Those components 
produce an interconnected nano- or micro-ranged fibrous network in the ECM. The 
ECM provides an appropriate microenvironment for cells, controls the tissue structure 
and regulate many cellular functions including the adhesion, migration and 
proliferation to maintain the tissue structure. ECM is also responsible for transmitting 
signals to cell membrane receptors, and to orchestrate the controlled release of 
growth factors and signaling molecules that control the structure and function of the 
tissue [22-24] .  
 A series of processing techniques such as solvent casting [25], fiber bonding 
[26, 27], wet-spinning [28], melt based technologies [12, 29], high pressure-based 
methods [30, 31], freeze drying [32], and rapid prototyping technologies [33-35] were 
developed with the aim of producing scaffolds with adequate properties for tissue 
engineering. Electrospinning has attracted great attention in the field of Tissue 
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Engineering, since the produced structures are composed by nanoscale, or more 
correctly submicron, fibers with interconnected micro-pores and an high surface to 
volume ratio, which show features that are similar to the topographic characteristics of 
the ECM [17, 23, 36]. Additionally, electrospinning is a relatively versatile polymer 
processing technique, in the sense that several polymeric blends and compositions 
with other materials or additives (such as growth factors and other cell regulatory 
biomolecules) and even proteins [37] and living cells [38, 39] can be used to 
developfunctionally active nanofibrous structures. The electrospinning process is 
based on the application of an electric field, generated by a high voltage power supply 
applied, between a polymeric solution and a metal ground collector. When the electric 
field reaches a critical value, the electrostatic force overcomes the surface tension of 
the polymeric solution and a charged polymer jet is ejected from the capillary tip of 
the needle. As the jet travels towards the grounded collector, undergoes a stretching 
process together with a fast solvent evaporation. This process results in the formation 
of a random non-woven mesh composed by solid and long nanofibers [40, 41]. The 
remaining solvent in the fibers allows for the establishment of links between 
successive layers of the fibers in the mesh. 
Despite all the advantages of using electrospun scaffolds for Tissue 
Engineering applications, these meshes have a major limitation. The pores formed in 
the electrospun fibrous meshes typically do not allow cell infiltration into the inner 
regions of the structure. This is a major shortcoming of those structures that can 
compromise the otherwise interesting potential of electrospun nanofiber meshes in 
the tissue engineering and regenerative medicine [17]. Much research has been 
devoted focus in the on development of fibers with smaller diameters to maximize 
surface area. However, it was demonstrated that the mean pore radius varies directly 
with the fiber diameter, leading to smaller pore size [42]. Thus, the nanofiber mesh 
will essentially behave as a two dimensional sheet where the cells can only proliferate 
at the surface, instead of allowing a three-dimensional structure where cells are able 
to infiltrate. Sometissues may still benefit from such 2D structures but most tissues 
need 3D structuring. The use of porogen agents, such as salt particles [43, 44], 
chemical blowing agents [45] or post processing by laser machinery [46] are other 
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possible strategies that have been already described in literature, aiming at 
increasing pore size of electrospun meshes. In the referred salt leaching technique, 
salt particles are deposited layer by layer, which causes the final delamination of the 
nanofiber scaffold. The structures obtained have still limitations for cell infiltration that 
only takes place trough the lateral side of the scaffold and not across the thickness of 
the nanofiber mesh [43]. By using a blowing agent pores are created in discrete 
points of the mesh, but cellular infiltration is not fully demonstrated [45]. Laser post-
processing is also capable of producing localized cavities or channels in the nanofiber 
meshes. Biological assays were not yet reported to verify the extent of cell infiltration 
through those laser processed holes in the mesh structure [46]. 
 
In this work is presented a different strategy to increase the pore size of 
electrospun nanofibers meshes that consists in creating a dual composition (two 
types of polymer nanofibers produced simultaneously) non-woven nanofiber mesh. 
After the production of the mesh, one of these polymers was selectively removed, to 
increase the void volume and, consequently, the pore size. To test this concept, we 
combined an in-house developed dual-spinneret electrospinning setup with a rotating 
plate as collector, to obtain a homogenous mixture of the two polymeric nanofiber 
types. Other authors [47] described the use of a similar strategy applied to aligned 
nanofiber meshes, trying to overcome the dense fiber packing and reduced pore size. 
It is known however that the random distribution is the most typical morphology of 
electrospun meshes, thus being the morphology where the effective control of the 
pore size is much more challenging, imperative and also of wider application. We 
propose herein the production of composite meshes of polycaprolactone (PCL) and 
poly(ethylene oxide) (PEO) with the posterior selective removal of the PEO fraction to 
control the pore size. 
To determine the success of our approach, the characterization of the 
produced electrospun nanofiber meshes was performed by scanning electron 
microscopy (SEM), interferometric optical profilometry and contact angle tests, 
characterizing some physical properties that may influence the cellular behavior. We 
also characterized the fiber diameter and pore size of the meshes by image analysis 
of SEM micrographs. Biologic assays were preformed to show the efficacy of the 
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processing method, facilitating cell penetration into the nanofiber meshes with 
increased pore size. A novel clamping system was developed to undoubtedly prove 
the cellular penetration through all the thickness of the produced meshes. The 
cultured cells were analysed by SEM and laser scanning confocal microscopy. MTS 
and DNA assays were performed to conclude about the cell viability and proliferation, 
respectively. We conclude that the proposed method can be used to control the pore 
size without compromising the cell viability and proliferation. 
 
7.3. Materials & Methods 
 
7.3.1. Electrospinning processing 
 
Polycaprolactone (PCL), with a molecular weight of 80000 Da (TONE™, Union 
Carbide Chemicals and Plastics Division, New Jersey), was dissolved in an organic 
solvent mixture of chloroform (Sigma-Aldrich) and dimethylformamide (DMF) (Sigma-
Aldrich) in a 7:3 ratio and at 17 % (w/v) concentration, as described elsewhere [48]. 
PEO (Sigma-Aldrich) with molecular weight of 100000 Da was dissolved at 25 % 
(w/v) in a mixture of water/ethanol (6:4 ratio). Both polymer concentrations and 
chloroform/DMF ratio were defined after several optimization stages to obtain the 
most stable processing and leading to the more convenient mesh morphology. 
To produce the dual composition electrospun nanofiber meshes it was developed a 
system that allows the simultaneous electrospinning of more than one polymeric 
solutions. Two independently controllable high voltage power supplies (semi-
commercial from UltraVolt and Bosh) were used to generate electrical voltages 
ranging from 8 kV to 20 kV, with the lower values being applied to the PCL solution. 
Each polymer solution was placed in a 10 ml syringe coupled to a needle of 21G with 
a blunt tip. The feeding rate was established at a constant value of 0.25 ml/h, by 
precision syringe pumps (Aladdin-1000-220B, UK), for both polymeric solutions.  
A conducting and rotating plate, connected to the ground and with a rotating 
speed of 15 r.p.m., was used as collector to obtain a homogeneous nanofiber 
mixture. A collector to needle tip distance of 12 cm was defined after an optimization 
procedure, and the syringes were placed at 9 cm distance to minimize the 
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electrospun jet interference. The process was continued for at least 2 hours for the 
production of each dual composition nanofiber mesh with a final thickness of 50-60 
µm. The nanofiber meshes were further dried at room temperature for at least 1 day 
to remove all the remaining solvent. 
With the goal of increasing the pore size of the dual composition nanofibers 
meshes, the PEO nanofibers were selectively removed by dissolution in distillated 
water, for a period of 24 hours, at 37 ºC. After the dissolution procedure the meshes 
were dried in an oven at 37 ºC. 
 
7.3.2. Physical characterization 
 
 The morphology of the electrospun nanofiber meshes was assessed by 
scanning electron microscopy (SEM) (Leica Cambridge S360, England). The meshes 
were sputter coated with gold (sputter coater model SC502, Fisons Instruments, 
England) and then observed with an accelerating voltage of up to15 kV. Samples 
were analyzed with the dual composition (PCL-PEO NFM) and after the selective 
PEO dissolution (PCL-PEO NFM, after PEO dissolution).  
The fiber diameter was measured from SEM micrographs with the software ImageJ 
(version 1.38X, Wayne Rasband Nacional Institutes of Health, USA). For each 
sample, at least 10 micrographs were used (at a 5000X magnification) and, in each 
micrograph, 15 different fibers were randomly selected. Pore size was also evaluated 
from SEM micrographs using the ImageJ software. The pore size values were 
obtained from SEM micrographs (magnification of 5000X), in a total of 60 
measurements for each the condition. The pore size values were obtained by 
converting the contour of the pore area into a circumference of equivalent perimeter 
and determined from the circumference an equivalent diameter [49]. 
 Interferometric Optical Profilometry was used to assess the topography of the 
samples. A surface profiler (DEKTAK3ST, Veeco) in Vertical Scanning Interferometry 
(VSI) mode, with a vertical resolution of 3 nm, was used to measure the surface 
roughness. Five different regions (119 µm × 91 µm) for each sample were measured. 
The Average Roughness (Ra) and root mean square (RMS) roughness (Rq) values 
were automatically calculated by the equipment analytical software WycoVision® 32.  
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The wettability of the surfaces was assessed by contact angle measurements. 
Measurements of the static contact angle were carried out by the Sessile Drop 
method using contact angle equipment (model OCA 15plus, DataPhysics 
Instruments, Germany) with a high performance image processing system. The used 
standard polar liquid, water (2 µl, HPLC grade) was added by a motor driven syringe, 
at different zones of each sample, and the measurement time was extended until 20 
minutes at room temperature. At least three measurements were carried out for each 
sample (PCL NFM, PCL-PEO NFM and PCL-PEO NFM, after PEO dissolution). 
 
7.3.3. Biological assays 
 
The dual composition electrospun nanofiber meshes were cut into small disks 
with 8 mm diameter. In order to demonstrate the enhanced cellular infiltration into the 
nanofibers meshes, it was developed a system to clamp the mesh. This system 
consists in two silicone rings (with 8 mm and 5 mm of outside and inside diameter, 
respectively), held together with the sample in two points by a nylon stitch (Scheme 
7.1). When clamped between the rings, the samples have no direct contact with the 
surface of the well. This fixing system was sterilized by ethylene oxide, with the 
meshes already clamped between the rings. 
In this study, it was used a well established cell line of human primary 
osteosarcoma (SaOs-2 cell line; European Collection of Cell Cultures (ECACC), UK), 
cultered in Dulbecco’s Modified Eagle Medium (DMEM) (Sigma-Aldrich, Germany)
  
 
Scheme 7.1 - Schematic representation of the fixing system used in the biologic 
assay. Lateral and top views. 
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with 10 % fetal bovine serum (Biochrom AG, Berlin, Germany) and 1 % of antibiotic-
antimycotic antimycotic mixture (Gibco, GB), and harvested by trypsinization before 
the scaffolds’ seeding. 
Before the seeding, the fixing systems containing the dual composition 
electrospun nanofiber meshes were placed in a 48 well-plate with 1 ml of ultra pure 
water to dissolve the PEO nanofibers. The well-plate was placed in a incubator at 37 
ºC for a period of 24 hours. The seeding was performed with 50 µL cell suspension 
(1×105 cells/ml) over each scaffold. The developed nanofiber mesh fixing system 
confined the seeding area, avoiding cell adhesion to other surfaces of the culture well. 
The cell-seeded scaffolds were incubated in a humidified atmosphere at 37 ºC, 
containing 5 % CO2, during 4 hour and, then, it was added 1 ml of culture medium to 
each well. The culture medium was changed every 3 to 4 days. Triplicates were used 
for every time culture period (1, 3, 7 and 14 days). 
To evaluate the cell morphology and their distribution in the nanofibrous 
scaffolds, the constructs were previously washed with phosphate buffer saline 
(Sigma, USA) and fixed with 2.5 % glutaraldehyde solution (Sigma, USA). Then, they 
were dehydrated by immersion in a series of ethanol solutions with increasing 
concentration, and air-dried overnight in a hood. The samples were sputter coated 
with gold (sputter coater model SC502, Fisons Instruments, England) and observed in 
the SEM (Leica Cambridge S360, England). 
 The penetration of the cells into the nanofiber mesh was evaluated by laser 
scanning confocal microscopy (Olympus, Fluoview 1000). The samples were fixed 
with formaline for 30 minutes at room temperature and then washed with PBS. The 
staining was made with 4,6-diamidino-2-phenyindole dilactate (DAPI) (Sigma, 
Germany) and phalloidin-tetramethylrhodamine B isothiocyanate (Sigma, Germany) 
for the nucleolus and actin filaments, respectively. The constructs was then mounted 
on glass microscope slides and observed. Samples were excited simultaneously at 
345 nm for DAPI and 540/545 nm for phalloidin. Emission at 458 nm was mapped to 
the blue channel and 570/573 nm to the red channel. Nanofibers were observed in 
DIC black ground levelling mode. Representative images were taken as individual 
slices and the images are built from series of stacked images. 
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Cell viability was determined by the colorimetric MTS assay (CellTiter 96® 
AqQueous One Solution Cell Proliferation Assay, Promega, USA) on days 1, 3, 7 and 
14 of culture. The constructs were immersed in phenol red- and FBS-free DMEM and 
MTS reagent was added in a proportion of 5 to 1, in a total of 600 µL per well. The 
well-plate was incubated at 37 ºC during 3 hours, according to the MTS reagent 
manufacturer instructions. Five replicas of 100 µL were pipetted from each well and 
placed in a 96 Costar flat bottom well-plate and its absorbance read in a microplate 
reader (Synergie HT, Bio-Tek, USA) at a 490 nm. 
Cell proliferation was assessed by the DNA quantification assay. This test 
determines the total amount of double-stranded DNA, corresponding to different 
culturing time. Quantification was performed using the Quant-iT PicoGreen dsDNA 
Assay Kit (Invitrogen, Molecular Probes; Oregon, USA), according to the 
instructions of the manufacturer. Briefly, cells in the construct were lysed by osmotic 
and thermal shock and the supernatant used for the DNA quantification assay. A 
fluorescent dye, PicoGreen, was used because of its high sensitivity and specificity to 
double-stranded DNA. The fluorescence of the dye was measured at an excitation 
wavelength of 485/20 nm and at an emission wavelength of 528/20 nm, in a 
microplate reader (Synergie HT, Bio-Tek; USA), being the intensity of the signal 
proportional to the amount of DNA. Triplicates were made for each sample, allowing 
performing a statistical analysis. The DNA concentration of each sample was 
calculated using a standard curve relating quantity of DNA and fluorescence intensity. 
 
7.3.4. Statistical analysis 
 
Statistical analysis was performed using the SPSS statistic software (Release 
8.0.0 for Windows). Firstly, a Shapiro-Wilk test was performed to ascertain about the 
data normality. This test showed that some results do not follow a normal distribution. 
In the analysis of the results, p-values lower than 0.01 were considered statistically 
significant. 
To compare the morphological properties (i.e. fiber diameter, pore size, 
roughness parameters and water contact angle) of the produced NFMs, a Kruskal-
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Wallis test was performed. When the analysis indicated significant differences among 
the produced NFMs, a Tukey’s HSD test for multiple comparisons was performed to 
find where the differences occur. In the case of biological results, which also did not 
follow a normal distribution, a Mann-Whitney U-test was performed to determine the 
cell performance when cultured in those NFMs. 
 
7.4. Results 
 
Initially, PCL and PEO solutions were individually electrospun under several 
solution parameters (polymer and solvent concentration) and processing parameters 
(voltage, needle tip to collector distance and flow rate) to produce homogeneous 
fibers with uniform diameters in the absence of visible defects, namely bead-like 
morphology. Both polymers were electrospun with a needle tip to collector distance of 
12 cm and voltages in the range of 9-15 kV for PCL solution and 13-19 kV for PEO 
solution. Due to the process instability, caused by the relative proximity of the two 
electrically driven polymer jets, forced us to vary the applied voltages for both 
polymers, being always required higher voltage for the PEO solution. Lower applied 
voltages were observed to result in fibers with visible defects and also regions of 
polymer aggregation (Figure 7.1 A1). Higher applied voltages produced less uniform 
fibers with larger diameter variations on the same fiber mesh (Figure 7.1 C1). 
Smooth, uniform fibers without bead-like structures were observed using intermediate 
voltages (Figure 7.1 B1). This sample was processed at 15 kV for PCL solution and 
17 kV for PEO solution. The dual composition PCL-PEO nanofiber meshes (NFM) 
used afterwards were all processed using those optimal processing conditions. 
To determine the ideal dissolution conditions for PEO nanofibers, several 
electrospun dual composition PCL-PEO NFM were immersed in distilled water 
without mechanical agitation. It was described in the literature that the PEO 
dissolution kinetics in water increases in the temperature range 20–40 ºC [50]. Thus, 
a distilled water bath was heated at 37 ºC to attain conditions promoting a faster and 
complete dissolution of the PEO fraction. After a dissolution period of 2 hours and 24 
hours, the meshes processed at lower voltages showed a beaded morphology with 
significant variation in fiber diameter and polymer accumulation (Figures 7.1 A2 and  
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Figure 7.1 - SEM micrographs of electrospun dual composition PCL-PEO NFM, 
produced with different applied tensions, from lower (A) to higher (C), without 
dissolution (1), after 2 hours (2) and 24 hours of dissolution (3) at 37 ºC. Details 
evidenced by arrows. Original magnification of 500X. 
 
A3). After PEO dissolution during 24 hours it is shown that the nanofibers maintain 
their continuity and general morphology in meshes processed at intermediate voltage. 
The PCL nanofibers, after the dissolution of the PEO fraction, assumed a twisted 
morphology (Figure 7.1 B3). The final morphology of the mesh obtained with higher 
voltage shows discontinuous fibers with abrupt variations of the fiber diameter and 
polymer accumulation points (Figure 7.1 C3). All samples presented visible surface 
marks caused by the dissolution of PEO fibers (Figures 7.1 A3, B3, C3). A detail of 
those marks is shown magnified in an insight micrograph of Figure 7.1 B3. The SEM 
micrographs showed that PCL-PEO meshes, when submitted to the dissolution 
process during 24 hours, have enhanced pore size caused by the dissolution of the 
PEO fraction. All subsequent dissolutions were preformed during a period of 24 hours 
at 37 ºC. Meshes were randomly selected for posterior characterization assays. 
Sol ving Cell Infiltrati on Limitations of Nanofiber Meshes  
233 
7.4.1. Physical characterization 
  
 PCL and PEO solutions were simultaneously processed by electrospinning, 
resulting in a three-dimensional dual composition nanofibrous structure with 
interconnected micro-pores, and composed of uniform and randomly oriented 
nanofibers (Figure 7.2 A2). Applying the Kruskal-Wallis test to the fiber diameter 
results, we found a highly significant difference between the produced NFMs (p < 
0.0001). The Tukey’s HSD test indicated that the fiber diameter distribution in PCL-
PEO NFM, after PEO dissolution is comparable with the ones observed for the control 
PCL NFM (p = 0.183) (Figure 7.3). It was just noticed that the PCL-PEO NFM 
submitted to the dissolution process showed a marginal increase in the average fiber 
diameter (~157 nm), which did not significantly affects the fiber diameter distribution 
when compared with the control PCL NFM.  
 Comparing the SEM micrographs of control PCL NFM (Figure 7.2 A1) and the 
dual composition PCL-PEO NFM (Figure 7.2 A2) with the PCL-PEO NFM, after PEO 
dissolution (Figure 7.2 A3) it was observed an apparent increment on the size of the 
pores, accomplished by a decrease in the number of pores. Indeed, the PCL-PEO
 
 
Figure 7.2 - SEM micrographs (A) and Interferometric Optical Profilometry images 
(B) of electrospun control PCL NFM (1), dual composition PCL-PEO NFM (2) and 
PCL-PEO NFM, after PEO dissolution (3). Original magnification of 1000X and 51.8X, 
respectively. 
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Figure 7.3 - Box plot of fiber diameter for control PCL NFM, dual composition PCL-
PEO NFM and PCL-PEO NFM, after dissolution. * p < 0.01 versus control PCL NFM; 
** p < 0.01 versus PCL-PEO NFM. 
 
Figure 7.4 - Box plot of pores size on control PCL NFM, dual composition PCL-PEO 
NFM and PCL-PEO NFM, after dissolution. * p < 0.01 versus control PCL NFM; **  
p < 0.01 versus PCL-PEO NFM. 
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NFM, after PEO dissolution has statistically significant larger pores (p < 0.001), as 
revealed by the Tukey’s HSD test (Figure 7.4). Interferometric Optical Profilometry 
images confirmed the pore size increment in the samples and consequent 
topographical alterations. The higher in depth scale of the PCL-PEO NFM, after PEO 
dissolution could be an indicative of a more open structure and presence of loosely 
connected fibers in this sample (Figure 7.2 B3). An increment of the pore size was 
also confirmed by the significant higher average roughness of the PCL-PEO NFM, 
after PEO dissolution (p = 0.001) (Figure 7.5), also determined by Interferometric 
Optical Profilometry. Briefly, both SEM and Interferometric Optical Profilometry show 
consistent results with the increased level of pore size, when performing PEO fibers 
dissolution. 
 
 
Figure 7.5 - Box plot of roughness parameters, namely Ra (average roughness) and 
Rq (root mean square roughness), on control PCL NFM, dual composition PCL-PEO 
NFM and PCL-PEO NFM, after dissolution. * p < 0.01 versus control PCL NFM. 
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Figure 7.6 - Box plot of water contact angle values for control PCL NFM, dual 
composition PCL-PEO NFM and PCL-PEO NFM, after PEO dissolution NFM, as a 
function of time. * p < 0.01 versus control PCL NFM; ** p < 0.01 versus PCL-PEO 
NFM. 
 
To ascertain about the influence of these topographical alterations over the 
hydrophobic/hydrophilic character of the samples, the water contact angle evolution 
during a period of 20 minutes was measured for control PCL NFM, dual composition 
PCL-PEO NFM and PCL-PEO NFM, after PEO dissolution (Figure 7.6). Generally, all 
samples show a hydrophobic character. However, the dissolution of PEO induced a 
statistically significant reduction of the water contact angle (p < 0.001), as revealed by 
the Tukey’s HSD test, until 16 minutes of wettability. At this time, there were not 
statistically significant differences in the water contact angle between the control PCL 
NFM and the dual composition PCL-PEO NFM (p = 0.007). For the time point of 18 
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min was only observed statistically significant differences in the wettability between 
the dual composition PCL-PEO NFM and the PCL-PEO NFM, after PEO dissolution 
(p < 0.01). Moreover, for the time point 20 min was observed the inexistence of 
statistically significant differences in the wettability between the three types of NFMs 
(p > 0.01). 
 
7.4.2. Biological assays 
 
The adhesion, spreading, viability and proliferation of human osteoblastic cells 
on the dual composition electropun nanofiber meshes, after PEO dissolution, were all 
evaluated for 1, 3, 7 and 14 days of culture (control PCL NFM were include as 
controls). Figure 7.7 shows SEM micrographs of cultured cells on the electrospun 
meshes. In the case of the control PCL NFM, the adhesion only happens at the 
surface of the nanofiber mesh (Figure 7.7 A). Cell infiltration into the mesh is 
observed on PCL-PEO NFM, after PEO dissolution for longer culture periods (Figure 
7.7 B3). Cells are visible in different layers of the NFM, clearly bellow the upper level 
of the nanofibers and inside the mesh structure (Figures 7.7 B3 and B4). After 14 
days of culture, both samples have their top surface (seeding surface) almost fully 
covered with cells. Additionally, in control PCL NFM there was observed a confluent 
cell layer, which is not observed in the dual composition meshes. 
 To further confirm cell penetration into the nanofiber meshes, the opposite side 
of the seeding surface of the meshes was also observed by SEM (Figure 7.7 C). As 
the seeding was performed in the area confined by the clamping silicone ring, the 
cells present in the opposite surface of the mesh can only migrate through the 
thickness of the nanofiber mesh. This results show that the increased pore size and 
the overall morphology of the PCL-PEO, after PEO dissolution allow the cell 
penetration into the mesh. For longer culture periods, it was observed an increment in 
the cell number at the surface of the nanofiber mesh. In this side of the mesh, it is 
visible a progressive infiltration of the cells, from the interior of the mesh to its surface, 
along the culturing periods (Figure 7.7 D). In control PCL NFM this infiltration was not 
observed and the cells were absent at the opposite side of the mesh (Figure 7.7 C), 
which also demonstrates the efficiency of the ring system in confining the cell 
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Figure 7.7 - SEM micrographs of electrospun control PCL NFM (A) and PCL-PEO 
NFM, after PEO dissolution (B), and opposite face of control PCL NFM (C) and PCL-
PEO NFM, after PEO dissolution (D) cultured with human osteoblastic cells during 1 
(1), 3 (2), 7 (3) and 14 days (4). Original magnification of 500X. Details of cellular 
infiltration on PCL-PEO NFM, after PEO dissolution (E). Original magnification of 
2200X. 
 
adhesion. Detailed and further magnified micrographs illustrate cellular infiltration into 
the PCL-PEO NFM, after PEO dissolution (Figure 7.7 E). SEM micrographs show a 
progressive cell penetration during the culture periods. Cells are visible underneath 
several fibers and in different layers across the mesh thickness (Figures 7.7 E3 and 
E4). 
 To further confirm the cellular penetration observed in SEM, laser scanning
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Figure 7.8 - Laser scanning confocal microscopy images of electrospun control PCL 
NFM (A) and PCL-PEO NFM, after PEO dissolution (B), after 1 (1) and 7 days (2) of 
human osteoblastic-like cells culture. Cells nucleus were stained with DAPI and actin 
filaments stainded with Phalloidine. Original magnification of 10X. 
 
confocal microscopy was conducted on control PCL NFMs and PCL-PEO NFM, after 
PEO dissolution cultured with human osteoblastic cells (Figure 7.8). Cells appeared 
rounded, but uniformly distributed over the scaffolds surfaces for 1 day (Figures 7.8 
A1 and B1). For longer culture periods (7 days), control PCL NFM still present cells 
mainly at the surface of the mesh (Figures 7.8 A2). In contrast, in PCL-PEO NFM, 
after PEO dissolution cells appear spread and were detected in the inner/deeper 
layers of the NFM (Figures 7.8 B), colonizing the full thickness of the scaffold and 
infiltrating into the unseeded side of the mesh. Thus, these observations corroborate 
the ones from SEM analysis. 
 
 
Figure 7.9 - Box plot of human osteoblast-like cells viability cultured on control PCL 
NFM control and PCL-PEO NFM, after PEO dissolution. * p < 0.01 versus control 
PCL NFM. 
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 The viability of the osteoblastic cells cultured on the control PCL NFMs and on 
the PCL-PEO NFM, after PEO dissolution was assessed by MTS assay (Figure 7.9). 
Cell viability was significantly higher on the PCL-PEO NFM, after PEO dissolution (p 
<0.001), as revealed by the Mann-Whitney U-test, for almost all the time points. The 
only exception was the culturing time 7 days, where any significant differences were 
found between the both NFMs (p = 0.063). The higher viability of cells seeded PCL-
PEO NFM, after PEO dissolution can be justified by the attachment and growth of 
cells into the open structure of the mesh. Additionally, a progressive increment of cell 
viability along culturing time was also observed for both nanofiber meshes. 
Cellular proliferation was estimated based on the DNA quantification assay 
(Figure 7.10). In control PCL NFM, DNA content increases slightly until 3 days of 
culture, reaching the maximum value, and reducing the DNA quantity from that time 
point onwards. In PCL-PEO NFM, after PEO dissolution was observed a statistically 
significant decrease in DNA content at the 3rd day (p = 0.002), followed by a
 
 
Figure 7.10 - Box plot of cell proliferation on control PCL NFM and PCL-PEO NFM, 
after PEO dissolution, estimated according to the DNA quantification assay. * p < 0.01 
versus control PCL NFM. 
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progressive increment for longer culture periods. Despite this progressive increment 
of DNA quantity, any statistically significant difference was found between PCL-PEO 
NFM, after PEO dissolution and the control PCL NFM (p > 0.01), as revealed by the 
Mann-Whitney U-test. 
 
7.5. Discussion 
 
 In natural tissues the cells are surrounded by the extracellular matrix (ECM), 
which provides structural support for the cells, controls the tissue structure and 
regulates cell adhesion, migration, proliferation and, consequently, tissue 
morphogenesis. The ECM is a dynamic and hierarchal organized structure composed 
of polysaccharides (glycosaminoglycans) and proteins (collagen and proteoglycans). 
These components are organized as an interconnected nano- or micro-ranged fibrous 
network [17]. In the past two decades, nanofiber meshes produced by electrospinning 
have been described as having a large potential in the tissue regeneration field [17, 
40, 51]. Due to the their nanoscale structure, electrospun meshes highly resembles 
the ECM and can act as a functional replacement of the ECM [17, 51]. The most 
serious limitation on the use of the nanofiber meshes as Tissue Engineering scaffolds 
in 3D tissues is probably the fact that the pores created by the random deposition of 
nanofibers are too small to allow cell infiltration into the inner regions of the nanofiber 
mesh [17, 23, 51]. Most of the reports in literature using electrospinning to produce 
tissue templates do not provide any strategy to overcome this problem, compromising 
the scaffolds effectiveness for the proposed applications.  
 Herein, we propose the electrospinning of a dual composition nanofibrous 
structure that is intentionally designed for cells penetration, obtained by the selective 
extraction of one material of the nanofiber mesh. This strategy would create larger 
pores that could promote cell infiltration to the inner region of the mesh and, at same 
time, maintain the structural and biological properties that resemble the ECM 
structure. Unlike some previously described strategies to increase pore size, such as 
techniques that use blowing agents [45] or post processing by laser [46], our strategy 
modifies the nanofiber mesh as a whole, providing an homogeneous pore size 
distribution. The developed system allows an independent voltage control, since the 
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PCL and PEO solutions have different properties and, consequently, need to be 
processed at different conditions. Additionally, the proposed post processing 
technique is very simple and does not involves any extra component that could 
eventually compromise the cellular behavior.  
 It is hypothesized that the PEO dissolution products are non-toxic and will not be 
detrimental for the cell viability. In fact, the dissolution of PEO nanofibers in water has 
revealed itself as an efficient method to obtain the selective removal. This was 
verified by the “fingerprinting” marks of PEO nanofibers visible on the remaining PCL 
fibers, constituting an important characteristic of the obtained meshes. Those marks 
result from the deposition of the fibers in the collector not completely dry and are 
caused by the overlap of PEO and PCL fibers. According to previous experimental 
results from the literature, the solubility of PEO in water increases in the temperature 
range of 20-40 ºC and tends to saturate at higher temperatures [50]. Thus, the PEO 
dissolution was performed at the temperature of 37 ºC, being also the temperature at 
which the biologic assays are conducted and ensuring that the PEO was successfully 
and completely removed at that temperature. This temperature is lower than the melt 
temperature of both polymers, which does not involve nanofiber morphology 
alterations during the process of dissolution. Due to the presence of impurities in the 
PEO solution, some aggregates of PEO were also observed and produced during the 
dissolution in water [50] which may cause morphologic alterations in the nanofiber 
mesh. Considering the hydrophobic character of PCL, the PCL nanofibers no 
significant morphological alterations are expected. To confirm this statement, different 
topographical properties of the electrospun meshes, namely fiber diameter, pore size 
and roughness, were characterized. Fiber diametermeasurements show that most of 
the produced fibers have diameters in the range of 175-875 nm, thus in the sub-
micrometric range. Considering the main aim of the present study, it is not 
advantageous to have very small fiber diameters since, as was already discussed 
[42], increasing fiber diameter results in an increase in the mean pore size. 
Hypothetically, the slightly higher, but not statistically significant, diameter of the fibers 
measured in the PCL-PEO NFM after PEO dissolution can also contribute to a larger 
pore size in these meshes. Even so, the electrospun nanofiber meshes have 
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maximum probability of being effective in mimicking the natural ECM and allowing cell 
infiltration.  
 Different methods have been proposed in the literature to measure the pore size 
and amount of porosity. Sieving methods [52], mercury intrusion porosimetry [53, 54] 
and flow porosimetry [54] are among the most used methods to determine pore size. 
In the present study the evaluation of the pore size was performed by quantitative 
image analysis of SEM micrographs to obtain the size of the pores [56]. As expected, 
PCL-PEO NFM, after PEO dissolution has the largest pore sizes. The dissolution of 
PEO fibers allows obtaining pore sizes significantly higher than similar PCL meshes, 
which is in agreement with the removal of half of the fibers that constitute the mesh. 
The enhanced pore size meshes present a median pore diameter of 5.017 µm. This 
pore sizes are in the same range of values previously reported by Tzezana et al [56]. 
The PCL-PEO NFM, after PEO removal showed clearly larger pores, as depicted by 
the Interferometric Optical Profilometry images. These meshes also present larger 
topography gradients between the top and bottom fibers, which can be an indication 
of a more open mesh structure and of the presence of loosely connected nanofibers. 
Considering this higher distances and the fact that the fibers are slightly larger, it is 
consistent with a considerably higher average roughness of those samples, being the 
rougher of all three samples analyzed by this technique.  
 These roughness differences could have also influence in the 
hydrophobic/hydrophilic character of the samples and, consequently, on the cell 
behavior [57]. The contact angle assay showed a decrease of the hydrophobicity of 
the PCL-PEO NFM, after PEO dissolution, when comparing with control PCL NFM. 
Despite the maintenance of a hydrophobic character, the PEO dissolution turned the 
PCL-PEO NFM into a more hydrophilic structure. This effect can be related to the 
increased fiber diameter of the dual composition PCL-PEO NFM. As reported in the 
literature, the increase in the fiber diameter causes a decrease in the water contact 
angle [57]. Also, it has been shown that smaller pore sizes leads to higher air 
entrapment in the pore structure, which may cause an increase in water contact angle 
[57]. This is particularly evident on control PCL NFM. Conversely, higher pore size 
induced a decrement on water contact angle, as shown in our results. 
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 The biologic performance of the PCL-PEO NFM, followed by PEO dissolution 
was assessed by the cellular infiltration level, cell viability and proliferation into the 
inner regions of the produced nanofibrous meshes. To demonstrate that human 
osteoblastic cells could migrate through the all thickness of the NFM, a special setup 
system was developed. This system was designed to have the double function of 
limiting the seeding area and to clamp the meshes at a certain distance from the 
bottom of the culture well-plate. Thus, while in control PCL NFM the cell infiltration is 
limited to the top surface of the nanofiber mesh (because the pore size is insufficient 
to allow infiltration), in the PCL-PEO NFM, after PEO dissolution the infiltration of the 
cells into the inner regions of the mesh was observed, mainly for longer culture 
periods. In these meshes, the cells are clearly visible at various depths within the 
nanofiber mesh and covering different levels of the mesh, as confirmed by laser 
scanning confocal microscopy. The extent of cell infiltration was also evaluated by 
SEM observation of the opposite face of the mesh that was not seeded with cells. It 
was observed the presence of cells in this surface only in the PCL-PEO NFM, after 
PEO dissolution. In fact, in the initial days of culturing, the cells are seen inside the 
mesh, progressing along the culturing period and reaching the opposite surface of the 
mesh. Conversely, control PCL NFM shows no cells in the opposite side of the mesh 
even for long culturing periods. This result demonstrates that the presence of cells in 
the opposite surface of the PCL-PEO NFM, after PEO dissolution is in fact due to cell 
infiltration through the mesh thickness, and not due to any other cell colonization 
alternative. The previously published work on dual-polymer composite fiber-aligned 
scaffolds [47] did not reported results showing a even distribution of cells through the 
scaffold thickness. Our results demonstrate unequivocally that the obtained pore size 
and porosity are sufficient to allow extensive cell infiltration from one face of the mesh 
to the other. 
 The enlargement of the pore size may facilitate already the cell penetration in 
the dual composition meshes. However, this result may also be related with the 
loosely connected structure of electrospun meshes that are formed by differently 
oriented fibers lying without physical connection with the neighboring fibers (caused 
by the dissolution of the PEO fibers). The removal of the PEO fibers may also lead to 
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discontinuities in the remaining PCL fibers. By this way, the surrounding fibers will 
offer only minor resistance to the migration of cells [58]. It is remarkable that the 
biological results herein reported are obtained using a shorter culturing period (14 
days) and cells with lower migratory capabilities when comparing with mesenchymal 
stem cells used in other work [47]. Additionally, our results show infiltration of cells 
through the full thickness of the nanofiber mesh. Others, following a similar strategy, 
reported a gradient of cells from the edge (~ 45 % of cells remain in the outer quarter) 
to the center of the construct (~ 12 % of total cell population reaches the center 
region).  
The viability of cultured cells was also assessed by the MTS test, showing 
significant improved cell viability in the PCL-PEO, after PEO dissolution when 
compared with control PCL NFM. The extra access to the inner mesh structure 
facilitates the attachment of cells and allowing further cell penetration. The 
progressive increase in cell viability also demonstrates that PEO dissolution and also 
PEO dissolution products do not affect negatively the cell viability. Additionally, the 
cellular proliferation assay shows a progressive increment in DNA content along the 
culture periods, with the exception of the 3rd day. Despite the differences not being 
statistical significant between control PCL NFM and PCL-PEO NFM, after PEO 
dissolution, those meshes present higher cell proliferation, which indicate easier 
access of inner surfaces for cells to proliferate into, than in the case PCL NFM. 
Additionally, these results confirm that the PEO dissolution did not affected negatively 
neither cell proliferation nor its viability. 
 
7.6. Conclusions 
 
We demonstrated the efficacy of a dual composition strategy to increase the 
pore size and solve the low cell infiltration capacity of random electrospun nanofiber 
meshes. This strategy consists in producing a dual composition nanofiber mesh and 
selectively removing one of the polymeric fibers leaving the other fraction intact. It 
was observed that this method indeed increases the pore size without major 
alterations of the mesh structure. Pore size measurements showed a significant 
increase of pore size (doubling) in those meshes when comparing with control PCL 
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NFM. The biologic assays showed that the cells not only were able to proliferate into 
the nanofibrous scaffold, but also were capable to migrate into the opposite side of 
the mesh. The approach herein proposed can be followed to successfully overcome 
the critical limitation of the control of the pore size in electrospun meshes for 3D 
Tissue Engineering applications. 
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Chapter 8 
 
 
 
hBMSCs Osteogenic Induction by Electrospun Scaffolds with 
Dexamethasone Release Functionality 
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on the following publication: Martins A, Duarte ARC, Faria S, Marques AP, Reis 
RL, Neves NM. hBMSCs Osteogenic Induction by Electrospun Scaffolds with Dexamethasone Release 
Functionality. Submitted. 
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8.1. Abstract 
 
Electrospun structures were proposed as scaffolds owing to their 
morphological and structural similarities with the extracellular matrix found in many 
native tissues. These fibrous structures were also proposed as drug delivery systems 
based on the principle that the dissolution rate of a drug increases with the increase 
of the surface area of both the drug and the corresponding carrier. Dexamethasone 
(DEX), a synthetic glucocorticoide, is routinely added in culture medium aimed to 
induce the differentiation of stem cells towards the osteogenic lineage. Different 
concentrations of the drug (5, 10, 15 and 20 wt.% polymer) were incorporated into 
polycaprolactone (PCL) nanofibers produced by electrospinning, in a single-step 
process. The incorporated DEX into the polymeric carrier in an amorphous state, as 
determined by DSC experiments, did not influence the typical morphology of the 
nanofibers. In vitro drug release studies demonstrated that dexamethasone release 
was sustained over a period of 15 days. 
Bioactivity of the released dexamethasone was assessed by cultivating human 
bone marrow mesenchymal stem cells (hBMSCs) on 15 wt.% DEX-loaded PCL 
NFMs, under dexamethasone-absent osteogenic differentiation medium formulation. 
An increased concentration of alkaline phosphatase and deposition of a mineralized 
matrix was observed. Phenotypic and genotypic expression of osteoblastic-specific 
markers corroborates the osteogenic activity of the loaded growth/differentiation 
factor. 
Our data suggests that the electrospun biodegradable nanofibers can be used 
as carriers for the sustained release of growth/differentiation factors relevant for bone 
tissue engineering strategies. 
 
 
8.2. Introduction 
 
Drug release systems are used to improve the therapeutic efficacy and safety 
of drugs, and enhancing the quality of life of patients, by delivering them to the site of 
action at a rate dictated by the need of the physiological environment [1]. The 
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limitations of the current drug delivery systems include suboptimal availability, limited 
effective targeting and potential cytotoxicity resulting from deficient control of the 
release kinetics. Nano-scale drug delivery systems can be designed to tune the 
release kinetics, to regulate distribution and to minimize toxic side effects, thereby 
enhancing the therapeutic efficacy of a given drug. Drug delivery with polymer 
nanofibers is based on the principle that the dissolution rate of a drug increases with 
increased surface area of both the drug and the corresponding carrier [2]. Unlike 
common encapsulation systems involving some complex preparation process [3], 
electrospinning allows the convenient incorporation of therapeutic/bioactive 
compounds into the carrier polymer nanofibers in a single step process [4]. Indeed, it 
was observed that enzymes and antibiotics encapsulated in electrospun nanofibers 
preserved higher catalytic activity than the ones incorporated in solvent casting 
membranes [5, 6]. 
Electrospinning is considered a promising and versatile processing technique, 
since several polymeric systems [7, 8], proteins [9, 10] and even living cells [11] can 
be applied to develop functionally active nanofibrous structures. Recently, 
electrospun nanofibers were used as a carrier for both hydrophobic and hydrophilic 
drugs [6, 12-14], where the drug release profile can be controlled by the modulation of 
scaffold morphology, porosity, and composition. Usually, the incorporation of 
bioactive materials (i.e. proteins and growth factors) within electrospun fibers is 
achieved by “two-phase” electrospinning, where an aqueous solution of the biological 
molecule is mixed with an organic polymeric solution to form a biphasic suspension 
[10, 15-17], resulting in the encapsulation of aqueous reservoirs within the polymer 
fibers. In another possible alternative, two or more components can be co-
electrospun through coaxial capillary channels and integrated into one core-shell 
composite fiber structure [8]. Consequently, obvious problems in the kinetic release, 
such as the burst release effect, of those bioactive molecules could be predicted [18-
20]. So far, research has been conducted to obtain the controlled delivery of anti-
inflammatory agents, antibiotics and anticancer agents [21]. The controlled release of 
growth and differentiation factors from electrospun meshes was not previously 
explored.  
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Functional and structural engineering of musculoskeletal tissue, using a tissue 
engineering approach, may involve the use of appropriated cells cultured with specific 
growth factors after seeding in biomaterial scaffolds. In fact, growth factors play a 
crucial role in the communication and cross-talk between cells and their 
microenvironment in a tissue engineering construct [22]. They modulate (i.e. regulate 
the stimulation or inhibition) the cellular activities including proliferation, differentiation, 
migration, adhesion and gene expression and by this way strongly influencing cell 
fate [23]. Typically, growth factors are administrated in a soluble form, usually 
obtained by recombinant technology, being rapidly degraded and inactivated by 
enzymes and other chemical and physical degradation reactions occurring at body 
temperature and hence have short bioavailability and biological half-lives. Matrix-
bound growth factors, on the other hand, are dispensed locally where they are 
needed and protected from degradation and are often latent or physiologically 
unavailable for receptor binding. The shorter half-lives of the growth factors, their 
relatively large size, slow tissue penetration and their potential toxicity at high 
systemic levels, suggest that conventional routes of administration are unlikely to be 
effective for many, if not all, growth factors [22]. In fact, for regenerative and 
therapeutic effects, tissue must often be exposed to exogenous delivered growth 
factors during relatively long periods with repetitive administrations. 
Tissue engineering can be viewed as a special case of drug delivery in the 
sense that it should immobilize cells at the injury site. Controlled release of 
therapeutic/bioactive molecules from biodegradable scaffolds will enhance the 
efficacy of tissue engineering approaches [1]. In fact, polymeric biomaterials are 
frequently used as delivery systems, since they can readily deliver growth factors at 
the desired site either by direct protein delivery approaches or indirectly by gene 
therapy or by cell transplantation [22]. Consequently, herein we propose the 
development of electrospun biodegradable nanofibers as a delivery system of an 
established osteogenic differentiation factor - dexamethasone - of mesenchymal stem 
cells (MSCs). Dexamethasone (DEX) is a synthetic glucocorticoid, which has been 
shown to stimulate MSCs proliferation and to support osteogenic lineage 
differentiation in vitro, together with β-glycerophosphate and ascorbic acid in defined 
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concentrations [24, 25]. β-glycerophosphate, the organic phosphate source, play an 
important role in the mineralization process and in modulating osteoblast activities, 
such as the alkaline phosphatase (ALP) activity and in expression of osteocalcin. 
Moreover, ascorbic acid is also essential for increasing cell viability and to stimulate 
the production of Collagen type I by osteogenic cells. Therefore, the in vitro 
osteogenesis of MSCs might be more successfully established if the culturing 
substrate/scaffold combines at its surface the adequate physical (i.e. ECM-like 
nanofibers) and chemical (i.e. growth/differentiation factors) stimulus. Ultimately, we 
aim at improving the efficacy and reduce the total time required to regenerate a 
functional bone tissue. 
Other authors in the literature reported on electrospun silk fibroin composite 
fiber scaffolds, containing bone morphogenetic protein 2 (BMP-2) and/or 
nanoparticles of hydroxyapatite (nHAP), and cultured them with human bone marrow-
derived mesenchymal stem cells (hMSCs) [44]. The results demonstrated that those 
scaffolds, not only support growth and osteogenic differentiation of hBMSCs, but 
significantly enhance calcium deposition and mRNA transcript levels of bone-related 
genes. Recently, in a similar work [45], recombinant human bone morphogenetic 
protein-2 (rhBMP-2) was loaded into poly(D,L-lactide-co-glycolide)/hydroxylapatite 
(PLGA/HAp) composite electrospun fibrous scaffolds. Cell culture experiments with 
BMSCs showed that the encapsulation of HAp could enhance cell attachment to 
scaffolds and lower cytotoxicity effect. Both works described electrospun fibrous as 
delivery system incorporating a growth/differentiation factor with known clinical 
potential (FDA approved) for bone and cartilage repair [46]. However, the required 
cocktail of BMPs able to induce a controlled osteogenic differentiation of 
mesenchymal stem cells is still to be defined. 
 
8.3. Materials & Methods 
 
8.3.1. Production of Nanofiber Meshes Loaded with Dexamethasone 
 
A polymeric solution of poly(ε-caprolactone) (PCL) (TONE , Union Carbide 
Chemicals and Plastics Division; New Jersey) 17 % (w/v) was prepared using a 
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mixture of chloroform and dimethylformamide (7:3), as described elsewhere [26]. 
Different quantities (5, 10, 15 and 20 wt.% polymer) of dexamethasone (Sigma-
Aldrich, Germany) were added to the polymeric solution previously prepared, and let 
to stir until complete dissolution was achieved (approximately during 20 min). A 
tension of 9.5 kV, a current of 3.32 µA, a needle tip-to-ground collector distance of 20 
cm and a flow rate of 1 ml/h were defined as optimized processing conditions for the 
specific material being processed. 
 
8.3.2. Characterization of Dexamethasone-loaded PCL Nanofiber Meshes 
 
DEX-loaded electrospun PCL nanofiber meshes were gold sputter-coated 
(model SC502, Fisons Instruments; England) for 2 min at 15 mA. Samples were 
analyzed using a Scanning Electron Microscope (model S360, Leica Cambridge; 
England). Micrographs were recorded at 15 kV with magnifications ranging from 100 
to 5000 times. 
Fourier Transform Infra-Red Spectroscopy (FTIR) analysis was performed with 
the DEX-loaded electrospun PCL nanofiber meshes. The samples were powdered, 
mixed with KBr, and processed into pellets. FTIR spectra were recorded at 48 scans 
with a resolution of 2 cm -1 (Shimadzu – IR Prestige 21) 
Differential Scanning Calorimetry (DSC) experiments were carried out using a 
DSC Q100 equipment (TA Instruments – ELNOR). The experiments were conducted 
under a nitrogen atmosphere on samples (5-10 mg) packed in aluminium capsules. 
The samples were heated in two stages at a constant heating rate of 10 ºC/min from 
room temperature up to 300 ºC. The samples were kept at this temperature for a 
period of 2 minutes and cooled at the same rate to the initial temperature. 
 
8.3.3. Dexamethasone Kinetic Release Studies 
 
DEX-loaded PCL nanofiber meshes (with 4 cm2) were weighted and incubated 
at 37 ºC in 30 ml of phosphate buffer solution stirred at 60 rpm. Aliquots of 3 ml were 
retrieved in predetermined time intervals and the same volume of fresh medium was 
added to the suspension. The samples were analysed by UV-Vis spectroscopy at 242 
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nm (Shimazu UV 1601). The DEX concentration of each sample was calculated using 
a standard curve (concentrations ranging from 0.0 to 72 µg/ml), relating the quantity 
of DEX with the intensity of light absorbance. The results presented are an average of 
three measurements. Calculations of the amount of drug released took into account 
the replacement of aliquots with fresh medium. 
 
8.3.4. Expansion, Seeding and Osteogenic Differentiation of Human Bone Marrow 
Mesenchymal Stem Cells 
 
Human bone marrow mesenchymal stem cells (hBMSCs) (Biopredic 
International, France) were isolated and characterized according to the method 
established by Delorme and Charbord [27]. hBMSCs were expanded in basal medium 
consisting of MEM alpha medium (α-MEM; Gibco, GB) supplemented with 10 % heat-
inactivated fetal bovine serum (FBS; Biochrom AG, Germany) and 1 % 
antibiotic/antimyotic solution (final concentration of penicillin 100 units/ml and 
streptomycin 100 µg/ml; Gibco, GB). Cells were cultured at 37 °C in an atmosphere of 
5 % CO2. 
Before the in vitro studies, PCL nanofiber meshes loaded with 15 wt.% 
dexamethasone were cut in samples with areas of approximately 1 cm2 and sterilized 
by UV irradiation during 1 h on each side of the mesh. Confluent hBMSCs at passage 
4 were harvested for seeding onto the DEX-loaded PCL NFMs at a density of 1.0x105 
cells/cm2 of the nanofiber mesh. Unloaded PCL nanofiber meshes were used as 
controls. The DEX-loaded PCL NFMs-hBMSCs constructs were cultured under static 
conditions, in basal and dexamethasone-absent osteogenic differentiation media 
(basal medium supplemented with 50 µg/ml ascorbic acid and 10 mM β-
glicerophosphate). The control PCL NFMs-hBMSCs constructs were also cultured 
under static condition, in basal and standard osteogenic differentiation media (basal 
medium supplemented with 50 µg/ml ascorbic acid, 10 mM β-glicerophosphate and 
10-7 M dexamethasone). The constructs were retrieved at different culture times: 7, 14 
and 21 days. 
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8.3.5. Cell Morphology and Distribution, and Chemistry of Deposited Matrix 
 
For scanning electron microscopy (SEM) observation, the samples were fixed 
with 2.5 % Glutaraldehyde (Sigma; USA) in a Phosphate Buffer Saline solution 
(Sigma; USA) during 1h at 4 ºC. The samples were further dehydrated through 
increasing series of ethanol concentrations and let to dry overnight. Previous to the 
analysis by SEM (model S360, Leica Cambridge; England) equipped with an energy 
dispersive spectrometer (EDS; link-eXL-II), the samples were gold or carbon sputter 
coated (sputter coater model SC502, Fisons Instruments; England). 
 
8.3.6. Cell Viab ility and Proliferation Assessment 
 
Cell viability for each culturing time was determined using the CellTiter 96 
AQueous One Solution Cell Proliferation Assay (Promega; USA). This assay is based 
on the bioreduction of a tetrazolium compound, 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfofenyl)-2H-tetrazolium [MTS], into a water soluble 
brown formazan product. The absorbance was measured at 490 nm in a microplate 
reader (Synergie HT, Bio-Tek; USA), being related with the quantity of formazan 
product and directly proportional to the number of living cells in the constructs. Three 
samples of each nanofiber mesh per time point were characterized. 
Cell proliferation was quantified by the total amount of double-stranded DNA, 
along the culturing time. Quantification was performed using the Quant-iT 
PicoGreen dsDNA Assay Kit (Invitrogen, Molecular Probes; Oregon, USA), 
according to the instructions of the manufacturer. Briefly, cells in the construct were 
lysed by osmotic and thermal shock and the supernatant used for the DNA 
quantification assay. The fluorescence of the dye was measured at an excitation 
wavelength of 485/20 nm and at an emission wavelength of 528/20 nm, in a 
microplate reader (Synergie HT, Bio-Tek; USA). Triplicates were made for each 
sample and per culturing time. The DNA concentration for each sample was 
calculated using a standard curve (DNA concentration ranging from 0.0 to 1.5 µg/ml) 
relating quantity of DNA and fluorescence intensity.  
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8.3.7. Alkaline Phosphatase Quantification 
 
The concentration of alkaline phosphatase (ALP) was determined for all time 
culture periods, using the lysates used for DNA quantification. Briefly, the ALP 
quantity was assessed using the p-nitrophenol assay, in which the colourless 
nitrophenyl phosphate disodium salt (pnPP; Sigma, USA) is hydrolysed by the ALP 
(Sigma, USA) at pH 10.5 and temperature of 37 ºC to form yellow free p-nitrophenol. 
The reaction was stopped by addition of 2M NaOH (Panreac Quimica, Spain) and the 
absorbance read at 405 nm in a microplate reader (Bio-Tek, Synergie HT; USA). 
Standards were prepared with 10 µmol/ml p-nytrophenol (pNP; Sigma, USA) solution, 
to obtain a standard curve ranging from 0 to 0.250 µmol/ml. Triplicates of each 
sample and standard were made, and the ALP concentrations read off from the 
standard curve. 
 
8.3.8. Alizarin Red Staining 
 
After culture, the DEX-loaded nanofiber meshes-hBMSCs constructs were 
fixed in 10 % formalin solution neutral buffer (Sigma-Aldrich, Germany) for 30 min and 
maintained in phosphate buffer saline (PBS) until further use. The constructs were 
further stained with a 2 % Alizarin Red solution (Merk, Germany) in distilled water for 
5 min, and finally washed with distilled water. Stained constructs were observed 
under an optical microscope (BX61, Olympus Corporation, Germany) and images 
captured by a digital camera (DP70, Olympus Corporation, Germany). 
 
8.3.9. Immunodetection of Bone-specific Proteins 
 
Immunocytochemistry was performed following the streptavidin-biotin-
peroxidase complex approach (R.T.U. Vectastain® Universal Elite® ABC kit; Vector 
Laboratories Inc., Burlingame, CA), using a rabbit polyclonal antibody against 
osteopontin (Abcam Ltd., Cambridge, UK; dilution 1:1500), a mouse monoclonal 
antibody against osteocalcin (clone OC4-30, Abcam Ltd., Cambridge, UK; dilution 
1:100) and a rabbit polyclonal antibody against bone sialoprotein II (Chemicon® 
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International Inc., Germany; dilution 1:2500). Prior to the immunocytochemistry 
procedure, constructs were fixed in 10 % formalin solution neutral buffer (Sigma-
Aldrich, Germany) for 30 min and maintained in phosphate buffer saline (PBS) until 
further use. The constructs were treated with 0.3 % hydrogen peroxide in methanol 
during 30 min to inactivate the endogenous peroxidases. After washing with PBS, the 
constructs were blocked with 2.5 % normal horse serum for 20 min at room 
temperature to avoid unspecific reactions. Primary antibodies were incubated 
overnight at 4 ºC. Negative controls were set in the absence of primary antibodies 
incubation. After washing in PBS, the samples were incubated for 30 min with 
biotinylated secondary antibody anti-rabbit/mouse IgG, followed by incubation with 
streptavidin-peroxidase complex (Elite ABC Reagent). The immune reaction was 
visualized using DAB as a chromogen (DAB Substrate Reagent from Peroxidase 
Substract Kit; Vector Laboratories Inc, Burlingame, CA). The constructs were 
observed under an optical microscope (BX61, Olympus Corporation, Germany) and 
images captured by a digital camera (DP70, Olympus Corporation, Germany). 
 
8.3.10. RNA isolation and Real-Time Quantitative Polymerase Chain Reaction 
 
Total RNA from the constructs was extracted using the Trizol® (Invitrogen, Life 
Technologies Inc., UK) method according to the manufacturer’s directions. Briefly, at 
each culturing time the constructs were washed with PBS, immersed in Trizol and 
storage at -80 ºC until further use. Proteins were removed with chloroform extraction, 
and the RNA pellets were washed once with isopropyl alcohol and once with 70 % 
ethanol. The total RNA pellets were reconstituted in Rnase free water (Gibco, 
Invitrogen, UK). 
 Reverse transcriptase (RT)-PCR was performed according to the protocol from 
iScript™ cDNA synthesis kit (BioRad, Hercules, CA, USA). Briefly, a reaction mixture 
consisting of 1X iScript Reaction Mix, 1 µl iScript Reverse Transcriptase, RNA 
template (300 ng total RNA) and nuclease-free water was prepared, in 20 µl of total 
volume. The single-strand cDNA synthesis occurred by incubating the complete 
reaction mixture 5 min at 25 ºC, followed by 30 min at 42 ºC and terminated by an
incubation at 85 ºC for 5 min. 
Dexamethasone-loaded Nanofibrous  Release Sys tem 
265 
 
Table 8.1 - Primers list of osteogenic markers. 
Gene  Primer sequences (5’-3’) Tm [ºC] 
ALP sense 
antisense 
CTCCTCGGAAGACACTCTG 
AGACTGCGCCTGGTAGTTG 60,0 
OP sense 
antisense 
GGGGACAACTGGAGTGAAAA 
CCCACAGACCCTTCCAAGTA 58,4 
BSP sense 
antisense 
CAACAGCACAGAGGCAGAAAAC 
CCTCGTATTCAACGGTGGTG 59,9 
OC sense antisense 
CTGAGAGGAGCAGAACTGG 
GGCAGCGAGGTAGTGAAGAG 61,4 
Runx2 sense 
antisense 
TTCCAGACCAGCAGCACTC 
CAGCGTCAACACCATCATTC 58,1 
Osterix sense 
antisense 
CCCTTTACAAGCACTAATGG 
ACACTGGGCAGACAGTCAG 57,1 
GAPDH sense 
antisense 
ACAGTCAGCCGCATCTTCTT 
GACAAGCTTCCCGTTCTCAG 58,4 
 
Amplification of the target cDNA for real-time PCR quantification were 
performed according to manufacturer, using 2 µl RT cDNA products, 1 µM each 
primer (bone-specific primer sets listed in Table 8.1), 1X iQ SYBR Green Supermix 
(BioRad, Hercules, CA, USA) and nuclease-free water, in a final volume of 25 µL. 
Forty-four cycles of denaturation (95 ºC, 10 s), annealing (temperature dependent on 
the gene, 30 s) and extension (72 ºC, 30 s) were carried out in the gradient 
thermocycler MiniOpticon real-time PCR detection system (BioRad, Hercules, CA, 
USA) for all genes. The transcripts expression data were normalized to the 
housekeeping gene glyceraldehydes-3-phosphate-dehygrogenase (GAPDH) and the 
relative quantification calculated by the ∆CT method. 
 
8.3.11. Statistical Analysis 
 
Statistical Analysis was performed using the SPSS statistic software (Release 
15.0.0 for Windows). Firstly, a Shapiro-Wilk test was used to ascertain about the data 
normality. The results indicated that nonparametric tests should be used for all 
comparisons. A Kruskal-Wallis test followed by Turkey’s HSD test were performed to 
analyze the effect of the DEX-loaded electrospun nanofibrous meshes on the 
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hBMSCs’ viability and proliferation, ALP quantification, and osteogenic genotype. P 
values lower than 0.01 were considered statistically significant. 
 
8.4. Results  
 
8.4.1. Physicochemical Properties of the Dexamethasone-loaded Electrospun PCL 
Nanofiber Meshes 
 
 
 
 
Figure 8.1 – Morphological characterization of a typical electrospun PCL nanofiber 
mesh (A) and the electrospun nanofiber meshes incorporating different 
concentrations of dexamethasone: 5 wt.% (B), 10 wt.% (C), 15 wt.% (D) and 20 wt.% 
(E). 
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In the present work, a glucocorticoid drug - dexamethasone - was dissolved at 
different concentrations (5, 10, 15 and 20 wt.% polymer) in the polymeric solution to 
be electrospun. A mesh-like structure composed by randomly distributed fibers with 
diameters ranging from 150 nm – 1.6 µm (Figures 8.1 B-E) was produced. The 
incorporation of dexamethasone at concentrations ranging from 5 to 15 wt.% (Figures 
8.1 B-D) shows the appearance of thinner fibers in large number than in the control 
nanofiber meshes (Figure 8.1 A). However, those differences in morphology are 
probably not sufficient to induce any specific cell response. This observation was 
expected since the solvent is able to dissolve simultaneous the polymer and the 
incorporated drug. In this way, the drug is very well dispersed in the bulk polymeric 
matrix of the electrospun nanofibers without inducing significant morphological 
variation of the electrospun fibers. Relevant morphological alterations, namely an 
increment of nanofibers diameter, was observed only in the electrospun meshes 
incorporation 20 wt.% DEX (Figure 8.1 E). 
To confirm the presence of dexamethasone incorporated in the electrospun 
PCL nanofibers a FTIR analysis was performed. Figure 8.2 shows the spectra of PCL 
 
 
Figure 8.2 - FTIR spectra of raw dexamethasone, control PCL NFMs, DEX-loaded 
PCL NFMs at 10 wt.%, 15 wt.% and 20 wt.%.  
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nanofibers, raw dexamethasone and also of the different DEX-loaded electrospun 
PCL nanofiber meshes. The characteristic peaks of dexamethasone at 900 and 1650 
cm -1 are observed in the nanofiber meshes prepared with the different DEX 
concentrations, which confirms the presence of the glucocorticoid in the polymeric 
matrix. 
Thermal analysis of the DEX-loaded nanofiber meshes was carried out to 
ascertain about the crystalline state of the incorporated dexamethasone. Figure 8.3 A 
shows the DSC thermograms of PCL nanofiber meshes and raw dexamethasone. In 
this graph is possible to observe the melting peaks of the polymer at 56.9 ºC and of 
dexamethasone at 262.2 ºC. However, the characteristic endothermic peak of 
dexamethasone is not present in the DEX-loaded nanofiber meshes (Figure 3 B). 
These thermal properties of DEX-loaded PCL nanofiber meshes suggest that 
dexamethasone, precipitated from the polymeric/organic solution during the 
electrospining processing, is not in its crystalline state when incorporated in the 
nanofiber meshes. This is a typical observation, since the mobility of the DEX inside 
the fibers is highly hindered. 
 
8.4.2. Release Kinetics of Dexamethasone from the Electrospun PCL Nanofiber 
Meshes 
 
The release profile of dexamethasone from the different DEX-loaded PCL NFM  
 
 
Figure 8.3 – DSC thermogram of control PCL NFMs (black line) and raw 
dexamethasone (grey line) (A), and DEX-loaded PCL nanofibers at 5 wt.%, 10 wt.%, 
15.wt % and 20.wt % (B). 
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Figure 8.4 – Release profile of the different dexamethasone concentrations 
incorporated into the electrospun PCL nanofiber meshes during 360h (A); zoom up of 
the initial 24h of dexamethasone release (B). 
 
was followed during 21 days, in accordance with the culture time usually needed to 
observe a complete osteogenic differentiation of MSCs in vitro.  As depicted in Figure 
8.4 B, a significant initial release of dexamethasone - burst release - was observed in 
the case of PCL NFMs incorporating above 5 wt.% of the growth/differentiation factor. 
It was noticed that a higher amount of drug lead to a faster release rate (Figure 8.4 
A). After 100h, a slow sustained release of dexamethasone was observed for all 
release systems. Considering the release profiles of the different DEX-loaded PCL 
NFMs, the dexamethasone concentrations achieved and the morphology of the 
nanofiber meshes, the 15 wt.% DEX-loaded PCL NFMs was chosen for further in vitro 
biological assays.  
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8.4.3. Biological Activity of the Dexamethasone Released from the Electrospun 
Nanofiber Meshes 
 
To ascertain about the biological activity, and inherent structural integrity, of 
the released dexamethasone from the electrospun PCL NFMs, human bone marrow 
mesenchymal stem cells (hBMSCs) were cultured on 15 wt.% DEX-loaded PCL 
NFMs. From the MTS assay data (Figure 8.5) it was possible to observe that, until the 
14th day of culture, the different culture conditions did not induce significant changes 
over hBMSCs viability (p > 0.01). However, at day 21, hBMSCs cultured on DEX-
loaded NFMs on dexamethasone-absente osteogenic differentiation medium 
(NFM+DEX_Osteo), on DEX-loaded NFMs (NFM+DEX_Basal) and on control PCL 
NFMs (NFM_Basal) on basal medium showed significant lower viability than those 
cultured on standard osteogenic differentiation medium (NFM_Osteo) (p < 0.01). 
 
 
Figure 8.5 – Box plot of the hBMSCs viability (MTS assay) cultured on NFM_Osteo, 
NFM_Basal, NFM+DEX_Osteo and NFM+DEX_Basal, after 7, 14 and 21 days. Data 
were analyzed by nonparametric way of a Kruskal-Wallis test followed by Tukey’s 
HSD test: a denotes significant differences compared to NFM_Osteo; b denotes 
significant differences compared to NFM_Basal. 
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Moreover, for this culturing time, DEX-loaded NFMs cultured on basal 
(NFM+DEX_Basal) and dexamethasone-absent osteogenic differentiation media 
(NFM+DEX_Osteo) presented significantly higher hBMSCs’ viability than those 
cultured on control PCL NFMs under basal conditions (NFM_Basal)  (p < 0.01). 
Complementary to the analysis of hBMSCs’ viability along the course of the 
experiment, the proliferation or replication rate of those cells was also quantified 
based on the DNA content (Figure 8.6). DEX-loaded NFMs constructs cultured on 
dexamethasone-absent osteogenic differentiation medium (NFM+DEX_Osteo) 
present significant lower proliferation capability than hBMSCs cultured under all the 
other conditions (p < 0.01). Conversely, control PCL NFMs cultured under basal 
medium (NFM_Basal) demonstrated significantly higher DNA concentration than all 
 
 
Figure 8.6 – Box plot of the hBMSCs proliferation (DNA concentration) cultured on 
NFM_Osteo, NFM_Basal, NFM+DEX_Osteo and NFM+DEX_Basal, after 7, 14 and 
21 days. Data were analyzed by nonparametric way of a Kruskal-Wallis test followed 
by Tukey’s HSD test: a denotes significant differences compared to NFM_Osteo; b 
denotes significant differences compared to NFM_Basal; c denotes significant 
differences compared to NFM+DEX_Osteo. 
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the other substrates and corresponding culture medium (p < 0.01), just for the 14th 
day. 
Despite the above described proliferative cell population cultured on the DEX-
loaded PCL NFMs under basal (NFM+DEX_Basal) or dexamethasone-absent 
osteogenic differentiation media (NFM+DEX_Osteo), the expression of alkaline 
phosphatase (ALP) is similar to the one observed in control PCL NFMs cultured on 
standard osteogenic differentiation medium (NFM_Osteo) (p > 0.01) (Figure 8.7). An 
exception was observed for the 14 days of culture: hBMSCs cultured on DEX-loaded 
NFMs under dexamethasone-absent conditions (NFM+DEX_Osteo) produced 
significant higher quantities of ALP than the control PCL NFMs under osteogenic 
conditions (NFM_Osteo) (p < 0.01). Undifferentiated hBMSCs cultured on the control 
  
  
Figure 8.7 – Box plot of the alkaline phosphatase (ALP) produced by hBMSCs 
cultured on NFM_Osteo, NFM_Basal, NFM+DEX_Osteo and NFM+DEX_Basal, after 
7, 14 and 21 days. Data were analyzed by nonparametric way of a Kruskal-Wallis test 
followed by Tukey’s HSD test: a denotes significant differences compared to 
NFM_Osteo; b denotes significant differences compared to NFM_Basal; c denotes 
significant differences compared to NFM+DEX_Osteo. 
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PCL NFMs (NFM_Basal) produce negligenceable quantities of ALP, as depicted by 
the significant lower ALP concentration compared to all the other substrates and 
corresponding culture medium (p < 0.01). Consequently, from this test on further 
characterization of the osteogenic phenotype and genotype do not includes this 
condition. 
The morphology and distribution of the hBMSCs cultured on DEX-loaded NFM 
was analyzed by SEM. The cells interacted with the fibrous structure, bridging 
contiguous fibers and formed a dense cellular construct that was clearly visible at day  
 
 
Figure 8.8 – SEM micrographs of hBMSCs cultured on DEX-loaded NFMs during 7 
(A), 14 (B) and 21 days (C). Higher magnifications are shown to evidence the 
mineralization nodules produced by the hBMSCs. Alizarin red staining of the DEX-
loaded NFMs-hBMSCs constructs after 14 (D) and 21 days (E). Energy dispersive 
spectrometer (EDS) spectra of the calcium phosphates nodules produced by 
hBMSCs cultured on DEX-loaded NFMs after 14 and 21 days (F). 
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7 (Figure 8.8 A). It was also possible to observe deposition of minerals over the 
dense cellular layer from day 14 onward (Figures 8.8 B and C), resulting from the 
matrix mineralization that occurs along the differentiation of hBMSCs into osteoblasts. 
To confirm the matrix mineralization, an alizarin red staining was performed to 
specifically detect the calcium presented in those mineralized nodules. The intense 
red/purple dotes dispersed in the construct correspond to the mineralized nodules, 
after 14 and 21 days of hBMSCs culture on DEX-loaded NFM under dexamethasone-
absent osteogenic differentiation medium formulation (Figures 8.8 D and E).  Using 
an Energy Dispersive Spectrometer (EDS) it was possible to identify the elemental 
composition of the minerals deposited on the DEX-loaded PCL NFM-hBMSCs 
constructs (Figure 8.8 F). EDS data confirms the presence of Calcium and 
Phosphorous deposition by the adjacent cells, and the increasing amount from day 14 
to 21 of hBMSCs culture under dexamethasone-absent osteogenic differentiation 
medium formulation. Those observations were not found in control PCL NFM cultured 
with hBMSCs under standard osteogenic differentiation conditions, nor in the DEX-
loaded PCL NFM culture with hBMSCs on basal medium (data not included here).  
The osteogenic phenotype of hBMSCs seeded onto DEX-loaded nanofiber 
meshes was also assessed by the immunodetection of some specific osteoblastic 
proteins, namely osteopontin, bone sialoprotein and osteocalcin. Photomicrographs 
seem to show a progressive expression of the specific osteoblastic glycoprotein 
osteopontin on the DEX-loaded NFMs-hBMSCs constructs during the 21 days of 
culture (Figure 8.9). In the case of the bone siaoloprotein and osteocalcin protein, its 
maximum expression seems to be achieved at the 14th day of hBMSCs culture under 
dexamethasone-absent osteogenic differentiation medium. Similar osteoblastic 
protein expression pattern was observed in the control PCL NFM cultured with 
hBMSCs under standard osteogenic differentiation conditions and, also, in the DEX-
loaded PCL NFM culture with hBMSCs in basal medium (data not showed). 
Complementary to the phenotypic analysis, a genotypic quantification of the 
expression of some bone-specific genes was performed to ascertain about the 
differentiation level of seeded hBMSCs on DEX-loaded PCL NFMs. The relative 
expression of those genes was normalized against the housekeeping gene GAPDH  
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Figure 8.9 – Immunodetection of some bone-specific proteins, namely Osteopontin, 
Bone Sialoprotein and Osteocalcin, expressed by hBMSCs cultured on DEX-loaded 
NFMs during 7, 14 and 21 days. 
 
and compared to hBMSCs cultured on control PCL NFM under standard osteogenic 
differentiation conditions. A constitutive expression of all mRNA transcripts (i.e. 
Alkaline Phosphatase, Osteopontin, Bone Sialoprotein, Osteocalcin, Runx-2 and 
Osterix) was observed during the 21 days of culture. Although Alkaline Phosphatase 
was present in a stable fashion, its expression is significant lower by hBMSCs 
cultured on DEX-loaded PCL NFMs, in both culture conditions (p < 0.01) (Figure 
8.10). Between those bone-specific genes, Bone Sialoprotein and Osterix were the 
highest expressed, followed by the Osteopontin gene. 
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Figure 8.10 - Relative expression of bone-specific transcripts, namely Alkaline 
Phosphatase, Osteopontin, Bone Sialoprotein, Osteocalcin, Runx2 and Osterix, by 
hBMSCs cultured on NFM_Osteo, NFM+DEX_Osteo and NFM+DEX_Basal, after 7, 
14 and 21 days. The expression of these genes was normalized against the 
housekeeping gene GAPDH and calculated by the ∆CT method. Data were analyzed 
by nonparametric way of a Kruskal-Wallis test followed by Tukey’s HSD test: a 
denotes significant differences compared to NFM_Osteo. 
 
8.5. Discussion 
 
8.5.1. Electrospun PCL Nanofiber Meshes Incorporating and Releasing 
Dexamethasone 
 
The rate of drug release depends on a multitude of factors, such as the nature 
of the polymer matrix (i.e. chemical composition, backbone stability and water 
solubility), matrix architecture, loading capacity and drug-matrix interaction. 
Therefore, for the development of an ideal drug delivery system, the polymer should 
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be biodegradable, have appropriate degradation rate, nontoxic degradation products, 
appropriate solubility and simplicity of fabrication [28]. The herein developed drug 
carrier was based on the convenient processing of nanofibrous structures by 
electrospinning, using an adequate organic solvent to simultaneously dissolve the 
biodegradable polymer - polycaprolactone - and the incorporated drug - 
dexamethasone. This drug delivery system allows a suitable interaction between the 
PCL and the dexamethasone, being the drug well distributed in a polymer matrix. 
Consequently, the drug presents a good physicochemical interaction with the 
polymer. Thus, the structural integrity of the differentiation factor, as well as its 
biological activity could be maintained during the processing step. The large surface 
area associated with the nanofiber mesh allows fast and efficient solvent evaporation, 
which provides to the incorporated drug a limited period of time to recrystallize, 
favouring the formation of amorphous dispersed phase [2, 6, 13]. The presence of 
amorphous dexamethasone in our polymeric carrier was also observed in our DCS 
data. 
The most widely investigated delivery system for the encapsulation of bioactive 
compounds is micro- and nano-particles.  Nanoparticules have facility to diffuse 
through cell membranes, allowing controlling or modifying the cell activity. The 
osteogenic differentiation factor herein incorporated in electrospun biodegradable 
nanofibers was already studied, by our group and others [29-37], in other drug 
delivery systems, including micro- and nano-particles and scaffolds. Those polymeric 
drug delivery systems are based in starch-polycaprolactone (SPCL) microparticles or 
carboxymethylchitosan/poly(amidoamine) dendrimer (CMCht/PAMAM) nanoparticles. 
Both devices were intended to be used as part of an injectable system or in a 
polymeric 3D scaffold. In the present work was presented a novel dexamethasone 
delivery system, based on electrospun biodegradable nanofibers as carrier. It is 
aimed at developing a system that simultaneously acts as a scaffold for mesenchymal 
stem cells differentiation toward the osteogenic lineage. The next generation of 
engineered tissues relies on the development of biodegradable scaffolds as physical 
supports to deliver bioactive molecules that control cell attachment, proliferation and 
differentiation [38]. 
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Due to the relatively slow wetting, as a consequence of the highly hydrophobic 
character of the PCL NFM, and its slow degradation rate it was possible to deduce 
that dexamethasone release occurred primarily by diffusion, demonstrating that a 
biodegradable nanofibrous system can be used to obtain a release profile that was 
effective in differentiating stem cells. The burst release effect common in polymer-
based release systems, is connected to the high gradients of concentration observed 
on the initial stages of release. In the system of 20 wt.% DEX-loaded PCL NFMs, the 
burst release effect may be primarily caused by an imperfect distribution/entrapment 
of the dexamethasone into the polymer matrix or by their tendency to migrate to the 
nanofiber surface during the electrospinning process [39]. As the nanofibers are 
placed in an aqueous environment, at the initial stage water penetrates into the 
nanofibers surface and a large amount of dexamethasone is faster released due to 
the initial surface erosion. Subsequently, water pemeates into the bulk of the 
nanofibers causing polymer swelling, bond cleavage and bulk erosion, generating 
interconnecting pores and channels within nanofibers that allow the slow sustained 
release of the remaining dexamethasone [39]. 
 
8.5.2. Bioactivity of the Dexamethasone Released from the Electrospun Nanofiber 
Meshes 
 
Drug delivery systems are developed to maximize the therapeutic activity while 
minimizing the toxic side effects of drugs. However, the scope of those devices is 
limited for targeting tissues rather than individual cells [1]. In tissue engineering, the 
required bioactive molecules are typically supplied to the cells growing on the scaffold 
in the culture medium, in the soluble form. The present drug carrier was designed to 
operate as a synthetic extracellular matrix - scaffold - for mesenchymal stem cell 
growth and, simultaneously, to allow directly supplying the differentiation factor to the 
adherent cells. This may it is intended to supply locally the required amount to 
promote the proliferation and differentiation towards the osteogenic lineage. To 
validate this hypothesis, an osteogenic differentiation study was conducted. The 
osteogenic differentiation is sensitive to the dose and duration of glucocorticoides 
exposure [40]. Jaiswal et al. [25] suggested that the effective concentration of DEX for 
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the osteogenic differentiation of MSCs should be in the range of 10 nM to 100 nM, 
showing toxic effects at 1000 nM. 
The electrospun PCL NFMs loaded with 15 wt.% dexamethasone were 
cultured with hBMSCs under dexamethasone-absent osteogenic differentiation 
medium formulation. Our biological results confirm the biological activity of the 
incorporated dexamethasone, as shown by the increased amount of deposited 
calcium phosphates produced by the differentiated cells (also stained by alizarin red 
and identified by EDS). Additionally, the increasing concentration of the enzyme 
alkaline phosphatase (ALP) also confirms the osteoblastic differentiation and 
mineralization of hBMSCs cultured on DEX-loaded PCL NFMs. In fact, this enzyme 
catalyses the splicing of phosphate from non-phosphoric esters, constituting a 
biochemical indicator of the osteoblasts’ presence and the deposition of mineralized 
ECM, since MSCs produce negligible amounts of this enzyme, as depicted by our 
results. This hypothesis of osteoblastic differentiation was confirmed by the 
expression of specific osteoblastic glycoproteins, namely osteopontin and bone 
sialoprotein, which are also present in the ECM of bone. The deposition and 
mineralization of ECM, previously observed in the SEM micrographs, stained with 
alizarin red and chemically identified by EDS, were also confirmed by the 
immunodetection of the osteocalcin protein, which binds strongly to apatite and 
calcium. 
In the literature three periods were identified on the osteogenic differentiation 
of embryonic stem (ES) cells [41], corresponding to the expression pattern of the 
osteoblastic markers: a proliferative phase, followed by the period of matrix deposition 
and the mineralization phase. The highest expression peak of Osteopontin mRNA at 
14 days of hBMSCs culture determines the end of the matrix deposition phase and 
the beginning of the mineralization phase. The very high expression level of Bone 
Sialoprotein confirms the presence of mature osteoblasts, corresponding to the 
mineralization phase. Finally, this phase was confirmed by the expression of 
Osteocalcin mRNA, which is designed as the essential marker of the mineralization 
phase, reaching a maximum expression just before or during tissue mineralization 
[31]. Therefore, considering our results and the differences in the cell type used, the 
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most important genes involved in the osteogenic differentiation process were 
constitutively expressed, confirming the matrix deposition and mineralization by 
hBMSCs cultured and differentiated on DEX-loaded NFMs. The main specific 
transcription factors involved in the osteogenesis were also quantified by qPCR, 
namely the core binding factor α 1/runt-related gene (Cbfa1/Runx2) and Osterix 
(Osx). Cbfa1/Runx2 was already shown to be involved in the two steps of the 
differentiation process: driving stem cells into preosteoblasts and also preosteoblasts 
into osteoblasts. Osterix acts only during the last stage involving the transition 
preosteoblast/osteoblast [42, 43]. Our results showed that Osterix was one of the 
bone-specific transcripts with the highest expression level, similar to Bone 
Sialoprotein gene. This result further corroborates the successful differentiation of 
hBMSCs into osteoblasts on DEX-loaded NFMs. Similar osteoblastic gene expression 
patterns were observed for hBMSCs culture on DEX-loaded NFMs under basal 
conditions. This surprising result corroborates the hypothesis that even a transient 
exposure of stem cells to DEX (specifically during the 1st week) may be effective in 
inducing and maintaining the osteoblastic phenotype [25]. 
 
8.6. Conclusions 
 
We report herein the development of electrospun biodegradable nanofibers 
has a delivery system of an established osteogenic differentiation agent of hBMSCs - 
dexamethasone. Dexamethasone was incorporated at different concentrations (5, 10, 
15 and 20 wt.% polymer) in the polymeric nanofibers, and released accordingly in an 
amorphous state. The 15 wt.% delivery system was selected for cell studies to assess 
the bioactivity of the released dexamethasone. An increased alkaline phosphatase 
concentration and deposition of mineralized matrix was observed on dexamethasone 
releasing nanofibrous system cultured with hBMSCs in dexamethasone-absent 
osteogenic differentiation medium. The phenotypic and genotypic expression of 
osteoblastic-specific markers confirmed the osteogenic inducing potential of the 
loaded growth/differentiation factor. Thus, a novel osteogenic inductive scaffold was 
developed aimed for bone tissue engineering strategies. 
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9.1. Conclusions 
 
The three common strategies employed in cell-based tharapies for tissue 
regeneration are infusion of isolated cells, treatment with molecules inducing tissue-
morphogenesis, and implantation of a cell–scaffold hybrid construct. Of the three 
strategies, the use of cell–scaffold hybrids generally leads to a more controlled 
outcome. In contrast to the infusion of cells, the scaffold acts as a synthetic 
extracellular matrix (ECM) substitute in which the cells can proliferate, migrate and/or 
differentiate, produce a mature matrix and a functional tissue, recapitulating the 
normal tissue development process and allowing cells to mature their own preferred 
microenvironments. 
Much attention has been given recently to the production of scaffolds that 
mimic the extracellular microenvironment. Indeed, the design and production of 
polymeric structures that resemble the hierarchical composite structure of the natural 
extracellular matrix remains a challenging task. At the macroscopic level, a scaffold 
should impart a 3D geometry, having adequate mechanical properties to support the 
physiologic loads developing at the tissue site. At the microscopic level, a highly 
porous structure is needed for diffusion of cells, nutrients and metabolic products 
throughout the scaffold. The optimal pore size should be tailored to the specific cell 
type and be large enough to allow for cell infiltration and ECM formation yet not being 
so small that lead to pore occlusion. The scaffold surface morphology and chemistry 
should facilitate cell adhesion and migration through the scaffold, provide 
developmental signals to the cells, and promote cell recruitment from the surrounding 
tissue. Additionally, in most cases the scaffold should be constructed from a 
degradable nontoxic, non-immunogenic and biocompatible material. To this end, 
numerous natural and synthetic materials have been proposed for use in tissue 
scaffolds. 
 
Among the various nanostructured scaffolds recently developed, enabled by 
the advent of the nanotechnology and nanoscience, membranes made of nanofibers 
from synthetic and natural-origin polymers have received increased attention due to 
their easy fabrication and the ability to control their compositional, structural and 
Concludi ng Remarks  
291 
functional properties. Herein, the resurged polymer processing technique – 
electrospinning – was exploited in the development of nanofibrous structures and, 
subsequently, testing its applicability in the tissue engineering field. The key 
advantage of producing fibers with extremely small diameters is their very high 
specific surface area, high porosity and micro-range pore size. Besides the 
topographical properties of the electrospun nanofiber meshes, the fibers surface 
chemistry also plays an important role on cell adhesion. In fact, the presence of 
functional chemical groups facilitates the adhesion of protein and cell adhesion. To 
enhance the biofunctionality of electrospun synthetic NFMs, they were submitted to 
different plasma treatments including the gas used (O2 and Ar), the electrical power, 
and the exposure time. SEM micrographs and surface roughness analysis 
demonstrated the induction of some unintended topographical alterationsby the 
plasma treatments. The contact angle analysis revealed that the electrospun NFMs 
became generally more hydrophilic after the applied modifications, being the most 
significant changes in the wettability observed for O2-treated NFMs. XPS results 
indicated higher oxygen-contents at the surface of plasma-treated NFMs, including 
hydroxyl (-OH) and carbonyl (-C-O) functionalities. Three model cell types, namely 
fibroblasts (L929 cell line), chondrocytes (ATDC5 cell line), and osteoblast-like (Saos-
2) cells, were used to study the effect of plasma treatments over the morphology, cell 
adhesion, and proliferation. From the biological results it was possible to define 
treatment conditions leading to significantly enhanced cell adhesion and faster 
proliferation, namely O2 at 30W for 5 min and Ar at 20W for 5 min. Despite the often 
claimed morphological similarity of NFMs to natural ECMs, both those plasma 
treatment conditions could enhance the biological performance showing that the 
surface chemistry is at least as important as the surface morphology.  
 
It is frequently mentioned in the literature that the typical random distribution of 
the electrospun nanofibers in a mesh-like structure resembles the topography of the 
native collagen ECM of various connective tissues. However, the complex ordered 
organization of the ECM is not usually replicated in this typical randomly aligned 
nanofibrous structure. Herein we presented an ordered microporous fibrous structure 
composed of both random/orthogonal and parallel/uniaxial aligned fibers, designated 
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as patterned nanofiber meshes. In fact, those patterned structures were initially 
developed in an attempt to control the topography and, consequently, the mechanical 
properties of the nanofiber meshes. It is shown that this elaborated structure induces 
guidance of human bone marrow mesenchymal stem cells (hBMSCs) along the 
uniaxially aligned fibers, mainly at earlier culturing periods under basal and 
osteogenic differentiation conditions. Although it was demonstrated that the cells are 
somewhat sensitive to the topography of the supporting surface, the exact reasons for 
this observation are still unclear. Additionally, the results from phenotypic and 
genotypic characterization demonstrated the effectiveness of P-NFM on the 
differentiation of hBMSCs into osteoblastic cells and, consequently, in the deposition 
of mineralized ECM. Our results undoubtedly represent a new and enhanced 
functional outcome of the patterned electrospun nanofiber meshes.  
Ideally, to create a tissue-engineered scaffold capable of regenerate a fully 
functional tissue, it should mimic both the fibrous morphology and the complex 
structure/functionality of the native ECM. This ECM analogue should have 
topographical features and geometry on the macro-, micro and even nanoscale 
levels, as each may influence cell response to the scaffold. Electrospun nanofibrous 
structures, due to their inherent planar structure, could compromise a successful 
reconstruction or regeneration of bone tissue. Herein, multi-scale polymeric fibrous 
structures were developed by integrating microfibrous structures, produced rapid 
prototyping or fiber bonding techniques, with electrospun nanofiber meshes. In this 
study, novel hierarchical starch-based scaffold were obtained by a combination of 
starch-polycaprolactone (SPCL) micro- and polycaprolactone (PCL) nano-motifs, 
respectively produced by rapid prototyping (RP) and electrospinning techniques. 
These scaffolds were characterized by a 3D structure of parallel aligned rapid 
prototyped microfibers, periodically intercalated by randomly distributed electrospun 
nanofibers. The integration of these nano-motifs resulted in an 11 % decrease of the 
scaffold porosity, although maintaining the necessary interconnectivity. The integrated 
nanofiber meshes provide topological cues at the ECM level, whereas the micro 3D 
fibrous structure provides the required mechanical stability. Human osteoblast-like 
cells presented significantly higher proliferation and maturation when dynamically 
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seeded on these hierarchical starch-based fibrous scaffolds. Particularly, SEM 
micrographs demonstrated that the osteoblastic cells preferentially adhered and 
spread on the nanofiber meshes, constituting an innovative strategy to enhance cell 
seeding efficiency/cell adhesion into the microfibrous scaffolds. Ultimately, this 
nanofiber mesh integration will significantly improves the potential application of such 
3D fibrous structures in bone tissue-engineering strategies. 
Current attempts to replicate the complexity and hierarchically organization of 
natural ECM are mostly restricted to dispensing nanofibers in existing implants and 
biomedical devices or used as random nanofibrous meshes. In another study, we 
developed novel highly functional fibrous composite scaffolds by the integration of 
electrospun chitosan (Cht) nanofibers within biodegradable polymeric microfibers 
(poly(butylene succinate) - PBS and PBS/Cht), assembled in a fiber mesh structure. 
The influence of electrospun chitosan nanofiber reinforcement on the biological 
performance of PBS and PBS/Cht microfibrous scaffolds was assessed, using 
hBMSCs under osteogenic differentiation inductive conditions. Biological data 
demonstrated that the electrospun chitosan nanofibers used to reinforce the 
microfibers, although improving the mechanical and degradation properties of the 
composite fibers, still preserve the excellent in vitro biological performance already 
described for PBS/Cht fiber mesh scaffolds. Among the developed fiber meshes, only 
the PBS/Cht-based scaffolds sustained an ECM deposition and mineralization, as 
suggested by the increased amount of calcium phosphates produced by the 
osteogenic differentiated hBMSCs. Therefore, while a detailed mechanism to explain 
this behaviour is beyond the scope of this work (i.e. nanofiber reinforcement), the 
biological performance of the biodegradable nanofibrous reinforced microfibrous 
scaffolds is mainly a function of the physicochemical (e.g. roughness and chemical 
composition) surface properties. These data represent the first report on the biological 
functionality of biodegradable nanofiber-reinforced composite scaffolds, envisaging 
the applicability of the developed structures for bone tissue engineering. 
 
As previously mentioned, the main properties of electrospun nanofiber meshes 
were the extremely small fibers diameters and, consequently, their very high specific 
surface area, high porosity and micro-range pore size. However, electrospun 
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nanofiber meshes present a critical limitation hindering its application in 3D tissue 
engineering applications: the obtained pore size is typically too small to allow for cell 
infiltration into the inner regions of the nanofibrous scaffold. To overcome this 
problem, we proposed the simultaneous electrospinning of PCL and PEO solutions to 
obtain a dual composition random fiber mesh, followed by the selective dissolution of 
the PEO fraction to increase the porosity. It was observed that this method indeed 
increases the pore size without major alterations of the mesh structure. Pore size 
measurements shown a significant increase of pore size (doubling) in those meshes 
when comparing with control PCL NFM, and confirmed by interferometric optical 
profilometry. A novel clamping system was developed to have the double function of 
limiting the seeding area and to clamp the meshes at a certain distance from the 
bottom of the culture well-plate. By scanning electron microscopy and laser scanning 
confocal microscopy it was observed that the meshes allow for the infiltration of 
human osteoblastic cells into the 3D structure, migrating from one side of the mesh 
into the opposite side. Those cultured cells present enhanced viability and 
proliferation due to the colonization of the entire thickness of the fibrous scaffold. 
Consequently, a fully celularized electrospun nanofiber mesh was obtained, being 
also appropriated for 3D Tissue Engineering applications. 
The chemical and topographical properties of the scaffolds should provide an 
appropriated environment for tissue development, allowing also for the incorporation 
of biological signals to enhance tissue formation. This is still today one of the main 
challenges in the field. Electrospun fibrous structures were also proposed as drug 
release systems based on the concept that the dissolution rate of a drug increases 
with the increase of the surface area of both the drug and the corresponding carrier. 
We report herein the development of electrospun biodegradable nanofibers as a 
release system of an established osteogenic differentiation agent of hBMSCs - 
dexamethasone. Dexamethasone was incorporated at different concentrations (5, 10, 
15 and 20 wt.% polymer) in the polymeric nanofibers, being the 15 wt.% system 
selected for cell studies because of its sustained release. An increased alkaline 
phosphatase concentration and deposition of mineralized matrix was observed on 
dexamethasone releasing nanofibrous system cultured with hBMSCs in 
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dexamethasone-absent osteogenic differentiation medium. The phenotypic and 
genotypic expression of osteoblastic-specific markers confirmed the osteogenic 
inducing potential of the loaded growth/differentiation factor. Thus, a novel osteogenic 
inductive scaffold was developed aimed for bone tissue engineering strategies. 
 
As a final remark, we can say that many of the challenges discussed in the 
review paper were touched during the course of the work leading to the present PhD 
thesis. We believe that the contributions herein compiled helped to improve our 
knowledge on the ways not only to overcome the limitations of electrospun nanofiber 
scaffolds but, in some cases, to take advantage of those limitations to present new 
solutions to specific challenges of designing highly functional scaffolds for specific TE 
problems.  
 
9.2. Future work 
 
The scientific and technology development processes are a never-ended 
journey. Each closed research project opens a new range of questions that can be 
exploited in multiple directions. The work developed in the scope of this thesis is not 
an exception. 
 
By using patterned meshes we believe that new opportunities may be explored 
for the regeneration of more complex and ordered tissues (e.g. bone and skin) 
involving more than one cell communities. In a similar approach, the application of 
hierarchical fibrous scaffolds could be an outstanding point on the in vitro generation 
of hierarchically structured tissues, namely vascularised tissues like bone. The 
strategy of dual composition nanofiber mesh, followed by the selective removal of one 
fraction, can be systematically implemented to successfully overcome the critical 
limitation of the control of the pore size in electrospun meshes. The electrospun 
nanofiber mesh incorporating a growth/differentiation factor only release one of the 
supplements of a standard osteogenic differentiation medium. More complex release 
system, incorporating those differentiation factors, could be developed based on a co-
electrospinning strategy. 
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Several nanofibrous-based structures were developed, namely complex 
ordered scaffolds, highly porous nanofiber meshes and bioactive elecrospun 
nanofibers, and tested biologically in vitro. However, in the nanofibrous-based 
scaffolds studied with cell lines the obtained data should be further confirmed using 
primary cells, prior to the in vivo studies. The studies where mesenchymal stem cells 
were differentiated into the osteogenic lineage, it is desired to observe the in vivo 
performance of the corresponding nanofibrous-based scaffolds. 
 
Considering the diversity of developed scaffolds with independent physical or 
chemical properties, the conjugation of those properties into one structure will 
theoretically improve its biological performance. As an example, the optimum surface 
plasma modifications could be applied for any presented nanofibrous-based scaffold. 
The functional complexity of the hierarchical fibrous scaffolds could be also improved 
by the incorporation of biological factors into the nanofibers. Specifically in the case of 
hierarchical fibrous scaffold, the opportunity of incorporation biological factors into 
electrospun nanofibers makes possible to spatially and temporally control, layer by 
layer, the differentiation of progenitor cells toward desired lineages. 
 
It is also important to mention that some of those strategies are being followed 
for some of my group colleagues. For ethical reasons and intellectual property 
protection, any more details will be presented in this thesis. 
 
 
